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Abstract  
Background 
Aging is associated with progressive loss of muscle (sarcopenia), which can lead to 
reduced muscle strength and an increased risk of falls.  Sarcopenia exists in 
otherwise healthy elderly people and its aetiology is not fully understood.  Many 
epidemiological studies have shown that high protein intake is associated with 
preserving muscle mass and strength in the elderly.  To date there have been few 
randomized trials of sufficient duration and power to examine the effects of dietary 
protein supplement on muscle mass and strength in the elderly.  The objective of this 
study was to examine the effectiveness of whey protein supplementation on 
preventing sarcopenia in elderly women. 
 
Methods 
A population based, one-year randomized, double blind and placebo controlled trial 
of protein supplementation was conducted on 219 community-dwelling ambulant 
women aged 70 to 80 years.  Participants in the protein supplement group (n=109) 
consumed a drink daily which contained 30 g of protein.  The control group (n=110) 
consumed a drink with the same energy (kilojoules) but only contained 2 g of 
protein.  Assessments were taken at baseline and one year.  Body composition was 
assessed by anthropometry and whole body dual-energy x-ray absorptiometry.  
Peripheral quantitative computer tomography was used to assess calf muscle cross-
sectional area.  Hand grip, ankle dorsiflexion, knee and hip strengths were assessed 
using an isokinetic dynamometer.  Mobility was assessed by the ‘Timed Up and Go’ 
test.  Standing balance was assessed by the Romberg test.  Dietary intake was 
assessed by a 3-day weighed food record.  Compliance with the dietary intervention 
was assessed by 24-hour urinary nitrogen and by counting the returned empty 
supplement containers.  Serum insulin-like growth factor one (IGF-1) was also 
measured. 
 
Results 
One-hundred and ninety-five participants aged 74±3 years completed the one year 
trial.  There were no significant differences in baseline characteristics between the 
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protein supplemented group (n=100) and control group (n=95).  Compared to their 
baseline values, both groups significantly increased whole body lean mass (protein 
group: +1.6%, p<0.05; control group: +2.3%, p<0.05), appendicular lean mass 
(protein group: +1.3%, p<0.05; control group: +1.8%, p<0.05), body weight (protein 
group: +0.8%, p<0.05; control group: +1.5%, p<0.05) and knee strength (protein 
group: +31%, p< 0.05; control group: +36%, p<0.05) after one year.  The total fat 
mass increased from baseline only in the control group (protein group: +0.7%, 
p=0.19; control group: +1.5%, p<0.05).  There were however no significant 
differences between the two drink groups in any of the above mentioned parameters.  
Over one year serum IGF-1 increased significantly in the protein group but decreased 
in the control group (protein group: +7.6%, p = 0.006; control group: -1.0%, p = 
0.005), and the changes were significantly different between two drink groups (p = 
0.006).  The protein supplement also showed a protective effect on preserving 
balance function at one year.  The prevalence of ‘poor standing balance’ and ‘fall 
rates’ were significantly increased in the control group at one year. 
 
Conclusion 
Muscle mass and strength increased equally in both drink groups.  Although fat mass 
only increased in the control group at one year there was no statistically significant 
difference in the changes in fat mass between the two groups due to the wide 
variance in response.  Protein supplementation resulted in an increased serum IGF-1 
level at one year compared with the control group.   
 
These data are consistent with the concept that in this age group increased energy 
intake regardless of the macronutrient composition of the supplements improves 
muscle mass and function.  It is possible that achieving this through increased protein 
rather than carbohydrate may prevent the increase in fat mass noted with the 
carbohydrate supplement for the control drink perhaps by an effect of the protein to 
increase serum IGF-1.  The metabolic significance of this remains to be explored.    
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Definitions 
Appendicular lean mass (Baumgartner, Koehler et al. 1998): non-bone lean mass of 
arms and legs assessed by dual energy x-ray absorptiometry.  
 
Adjusted appendicular lean mass (Baumgartner, Koehler et al. 1998): appendicular 
lean mass adjusted for height square. 
 
Arm muscle area: is calculated from triceps skinfold thickness and mid-arm 
circumference by the following equation (Heymsfield, McManus et al. 1982):  Arm 
muscle area (mm2) = (Mid-arm circumference in millimetre – π(skinfold))2 / 4π . 
 
Corrected arm muscle area (Hammond 2004): bone-free for women by the following 
equation: corrected arm muscle area (cm2) = arm muscle area (cm2) – 6.5;  bone-free 
for men: corrected arm muscle area (cm2) = arm muscle area (cm2) – 10.   
 
Ceiling effect: In statistics and measurement theory, an artificial upper limit on the 
value that a variable can attain, causing the distribution of scores to be skewed. For 
example, the distribution of scores on an ability test will be skewed by a ceiling 
effect if the test is much too easy for many of the respondents and many of them 
obtain perfect scores (Colman 2006).  
 
Coefficient of variation: The standard deviation divided by the mean (generally 
expressed as a percentage). It is used to obtain a measure of relative variation 
(Dawson and Trapp 2004). 
 
Frankfort plane: a craniometric plane determined by the inferior borders of the bony 
orbits and the upper margin of the auditory meatus. It passes through the two 
orbitales and the two tragions (Marfell-Jones, Olds et al. 2006).  It is used in 
positioning the head for the taking of stature. 
 
Intraclass correlation coefficient (ICC): is used to assess consistency or conformity 
between two or more measurements (Shrout and Fleiss 1979; Muller and Buttner 
1994). 
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Chapter 1 Introduction 
  
 2
1.1 Background 
1.1.1 Public health significance of the problem  
Aging is associated with a progressive loss of muscle mass (sarcopenia) (Welle, 
Thornton et al. 1993; Balagopal, Rooyackers et al. 1997) and bone mineral content 
(BMC) (Chen, Lin et al. 2008).  This can lead to reduced muscle strength and 
increased risk of physical disability (van den Beld, Blum et al. 2003), falls and 
fractures (Smith, Khairi et al. 1975; Wasnich, Ross et al. 1989; Wolfson, Judge et al. 
1995; Tinetti and Williams 1997; Loeser and Delbono 1999; Fried, Tangen et al. 
2001).   
 
Falls are the leading cause of injury-related hospitalisation in elderly people 
worldwide (Baker and Harvey 1985; Close, Ellis et al. 1999; Cripps and Carman 
2001; Scuffham, Chaplin et al. 2003). It is an important public health problem both 
in Australia and overseas (Gillespie, Gillespie et al. 2003; Osteoporosis Australia 
2007).  In elderly Australians, 82% of fractures can be attributed to falls (Sambrook, 
Cameron et al. 2007) and over 90% of hip fractures involve a fall (Gillespie, 
Gillespie et al. 2003).  Hip fracture is the costliest injury (Roudsari, Ebel et al. 2005) 
and leads to the most devastating consequences including loss of independence and 
life quality in the elderly (Wallace, Ross et al. 1993; Carey and Laffoy 2005).   
 
Aging populations will raise the burden and costs to public health systems worldwide 
(Kannus, Sievanen et al. 2005).  In Western Australia, fall related hospitalisation 
among people aged 65 years and over, between 1985 and 1994, increased by 31% 
(Ashwell, Pinder et al. 1996).  In the Eastern Region of Ireland in 2002, there were a 
total of 2029 hospitalisations due to falls among people aged 65 years and over, 78% 
were female and the total inpatient costs were 10.6 million Euros (Carey and Laffoy 
2005).  The mean hospitalisation cost due to falls among people aged 65 or older was 
17,483 US dollars in 2004 in the United States of America calculated using the 
Marked Scan Medicare database.  Many developing countries such as China, are also 
experiencing an increased burden on their public health system due to their aging 
populations.  The direct cost of a hip fracture treated in the United States is estimated 
to be $US30,000 (Khan, Liu-Ambrose et al. 2001).  The estimated cost to the health 
system of fall-related injuries in people age 65 or over was $406.4 million in1993-
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1994 in Australia (Mathers and Penm 1999) and 981 million pounds in the UK in 
1999 (Scuffham, Chaplin et al. 2003).  The inevitable increasing rate of fall-related 
injuries in elderly people due to the growing aging population in Australia and in 
many other countries is imposing a huge burden on health care systems.   
 
1.1.2 Risk factors for fracture in older people 
Fracture risk in the elderly is determined by many risk factors such as osteoporosis 
related low bone density, impaired balance and loss of muscle mass and strength 
resulting in a greater risk of falls (Australian National Consensus Conference 1996 
1997) as shown in Figure 1.1.  These factors also interact with each other.  For 
example, decreased muscle strength, especially lower limb muscle strength, appears 
to be an important determinant of balance (Lord, Clark et al. 1991) and postural 
stability in the elderly (Lord, Clark et al. 1991).  Balance performance gradually 
declines with age (Isles, Choy et al. 2004).  Lower extremity strength affects balance 
ability and agility in correcting gait when falling (Woollacott, Shumway-Cook et al. 
1986).  Studies have shown that ankle dorsiflexion, knee extension and hip abduction 
strength are inversely correlated with the rate of falls (Wiles, Busse et al. 2006). 
 
In recent years, muscle weakness related falls and poor bone strength in the elderly 
has become a focus of osteoporosis research.  Studies have shown that age related 
muscle weakness is not only related to the risk of falls but also directly and indirectly 
affects bone strength and structure (Klein, Allman et al. 2002; Capozza, Cure-Cure et 
al. 2008).  Therefore decreased muscle mass and strength, along with a decline in 
physical activity in elderly people, may accelerate the progress of osteoporosis.   
 
The aetiology of aging related sarcopenia and its prevention is not well understood.  
The current study focused on a dietary intervention, a non-pharmaceutical method, to 
investigate if a protein supplement could improve muscle preservation in elderly 
women.  
 
 
 4
 
Figure 1.1 Fracture risk factors in elderly people. 
 
 
Adapted from (Australian National Consensus Conference 1996 1997)
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1.1.3 The problem of the reduction of muscle mass and strength in older people 
1.1.3.1 Aging and decrease of muscle mass and strength 
As much as one third of muscle mass can be lost during the three decades after the 
age of 50 years (Borst 2004).  This loss is accelerated after 60 years of age both in 
men and women (Kyle, Genton et al. 2001).  Muscle strength peaks around the third 
decade of life, remains almost constant to the fifth decade, and then declines with age 
(Larsson, Grimby et al. 1979; Forrest, Zmuda et al. 2007) at a rate of approximately 
8-15% per decade (Young, Stokes et al. 1984; Kallman, Plato et al. 1990; Frontera, 
Hughes et al. 1991; Lindle, Metter et al. 1997).  A recent longitudinal study followed 
up twelve healthy men (initial mean age 65 years) over a 12-year period (Frontera, 
Hughes et al. 2000).  The computed tomography scans showed that the cross-
sectional areas of different sites of muscles all decline, with a reduction rate of 1.4% 
per year (Frontera, Hughes et al. 2000).  The reduction in appendicular or leg fat-free 
mass was the main predictor of increased disability in older men and women (Fantin, 
Di Francesco et al. 2007).  The decrease in muscle strength in older adults was found 
to correlate with a decreased proportion of type II muscle fibres (Larsson, Grimby et 
al. 1979; Lexell and Downham 1992), muscle cross-sectional area (Narici, Maganaris 
et al. 2003) and other unknown mechanisms including the functional and structural 
decline in neural regulating system on skeletal muscle (Delbono 2003).  
 
1.1.3.2 Muscle mass, muscle strength and fall risk 
Falls are associated with many risk factors as shown in Figure 1.1.  Both falls and 
low body weight have been identified as factors which increase fracture risk in the 
elderly (Kannus, Sievanen et al. 2005; Sambrook, Cameron et al. 2007; Chen, 
Simpson et al. 2008).  Decreased muscle strength, especially lower limb strength, is 
one of the most important risk factors associated with increasing risk of falling in the 
elderly (Owings, Pavol et al. 2001; de Rekeneire, Visser et al. 2003; Sambrook, 
Cameron et al. 2007).  Strong leg strength has been shown to be associated with the 
ability to prevent a fall after the disruption of gait (Pijnappels, Reeves et al. 2008; 
Pijnappels, van der Burg et al. 2008).  A one year prospective study in 95 older 
adults living in an aged care hostel in Sydney (mean age 82.7 years) found that 
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quadriceps strength was poorer in the multiple fallers compared with the non-fallers 
and once-only fallers (Lord, Clark et al. 1991).  Another prospective population-
based study followed up 187 community-dwelling women aged 75 years or older for 
10 years and found that high muscle strength was associated with a low incidence of 
fall-related limb fractures (Sipila, Heikkinen et al. 2006).  These prospective studies 
indicate that muscle strength has an important role in falls prevention in the elderly.  
Muscle power has been reported to be a strong predictor of self-reported functional 
status in elderly women (Foldvari, Clark et al. 2000).  The loss of muscle power, or 
‘explosive strength’, with aging has been found to be directly related to an increased 
number of falls (Lindle, Metter et al. 1997).  The Baltimore Longitudinal Study of 
Aging found that muscle power declined more rapidly than strength after age of 40 
years in men (Metter, Conwit et al. 1997). 
 
1.1.3.3 Relationship between body weight, muscle mass and strength with bone 
health in elderly people 
A cross-sectional study investigating 942 community-dwelling (England) men and 
women aged 65-74 years showed that approximately one third of the decline in bone 
mineral density with aging could be explained by the associated age-related decline 
in weight (May, Murphy et al. 1994).  Compared to fat mass, lean mass was 
generally more strongly related to bone density in elderly women (Aloia, McGowan 
et al. 1991; Gjesdal, Halse et al. 2008).  Cross-sectional calf muscle area, leg muscle 
mass and muscle power were found to be significantly correlated with bone strength 
in elderly women (Ashe, Liu-Ambrose et al. 2008; Binkley and Specker 2008). 
 
A number of mechanisms have been proposed to explain the close relationship 
between muscle and bone health in the elderly.  Firstly, the weight of muscle mass 
has a weight-bearing effect on the bone and muscle contraction exerts force on bone 
(Cifuentes, Johnson et al. 2003; Capozza, Cointry et al. 2004).  Muscle contraction 
by exerting a force on bone may modify its structure (Bemben, Fetters et al. 2000).  
Muscle also contributes to body mass which requires increased force on the skeleton 
to counteract the effect of the increased weight (Cifuentes, Johnson et al. 2003). 
Secondly, muscle and bone also share biological mechanisms and interact with each 
other (Ferretti, Cointry et al. 2003). For example, insulin-like growth factor 1 (IGF-
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1) has been recognized as an important regulator both for muscle (Cappola, Bandeen-
Roche et al. 2001; Adamo and Farrar 2006) and bone (Yakar, Rosen et al. 2002; 
Sacco, Doyonnas et al. 2005).  IGF-1 regulates muscle and bone metabolism, 
including myoblast proliferation, differentiation and protein accretion through 
multiple mechanisms (Adamo and Farrar 2006) which are not fully understood 
(detailed in section 2.1.3.2).  Studies have also shown that muscle cross-sectional 
area and structural bone strength share genetic and environmental effects in older 
women (Mikkola, Sipila et al. 2008; Mikkola, Sipila et al. 2008).  
 
In summary, muscle mass and strength, and bone density decline with age.  Body 
weight, muscle mass and strength are significantly correlated with bone health in the 
elderly.  The decline in muscle mass and strength, especially a decline of lower limb 
muscle mass and strength, are important risk factors for falls, which are closely 
related to the incidence of fractures in the elderly.   
 
1.1.4 Possible ways to prevent sarcopenia 
Many efforts have been made to try to find effective ways to slow the decrease of 
muscle mass and strength in the elderly experienced as a part of the aging process.  
There are three potential approaches to maintaining or increasing muscle mass and 
function: hormonal therapy, exercise, and nutrition (Wolfe 2006).  From the public 
health perspective for prevention, exercise and dietary interventions are more 
desirable than using pharmaceutical interventions.  Evidence from previous studies 
suggests that although muscle loss appears inevitable with aging, it could possibly be 
modified by adequate diet (e.g. adequate protein and energy intake) and exercise 
(Timmerman and Volpi 2008).  To date, these dietary factors have not been 
adequately researched.  
 
1.1.4.1 Exercise interventions 
Most studies have demonstrated that exercise, and especially progressive resistance 
training, can increase muscle mass and/or strength in the elderly(Slade, Miszko et al. 
2002; Figueroa, Going et al. 2003; Miszko, Cress et al. 2003).  Progressive resistance 
training has been thought to be the only effective approach to treat and prevent 
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sarcopenia to date (Rolland and Vellas 2009).  Previous studies have shown that 
aging muscle can respond to resistance training using evidence from muscle biopsy 
of the hypertrophy of muscle fibres (Pyka, Lindenberger et al. 1994).  However, 
other studies have shown that sarcopenia also exists in active elderly individuals who 
are physically active (Westerterp and Meijer 2001; Wiswell, Hawkins et al. 2001; 
Hughes, Frontera et al. 2002; Marcell 2003).  Many other questions remain, such as 
what kind of exercise is more effective and feasible, and what intensity and duration 
of exercise is required to overcome the muscle mass decline with aging?  
 
1.1.4.2 Dietary intervention  
A decrease in dietary intake is common in the elderly.  This may be due to decreased 
appetite and reduced physical activity which reduces energy requirements.  Even 
when dietary intakes are normal, decreased efficiency of digestion and utilization of 
nutrients could also play a role in malnutrition in the elderly.  
 
Epidemiological studies have shown that adequate diet or higher protein intake 
appeared to be able to compensate for the loss of muscle mass with aging (Devine, 
Dick et al. 2005; Houston, Nicklas et al. 2008).  Previous studies have shown energy, 
protein and other macronutrient intakes decrease in the elderly along with decreasing 
weight, lean body mass and increasing body fat mass (Nes, Sem et al. 1992).  
Habitual high protein intake was shown to reduce fracture risk in elderly men and 
women (Munger, Cerhan et al. 1999; Wengreen, Munger et al. 2004).  
 
Timmerman and Volpi reviewed recent studies and found that age related sarcopenia 
may be halted or even reversed by changes in daily protein intake and exercise 
(Timmerman and Volpi 2008).  They noted however that further evidence from 
intervention studies was needed.  
 
There are few long-term protein supplement intervention studies (Lauque, Arnaud-
Battandier et al. 2000; Bunout, Barrera et al. 2001; Payette, Boutier et al. 2002; 
Bonnefoy, Cornu et al. 2003).  All of these studies have shown the weight gaining 
effect of the protein-energy supplements and no significant change in fat-free mass.  
Only one study found a significant beneficial effect of protein-energy supplements 
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on increasing muscle strength at three months, but failed to show an effect at nine 
months (Bonnefoy, Cornu et al. 2003).  The study recruited 57 elderly men and 
women volunteers aged over 72 years in France and grouped participants into four 
groups: dietary supplemented group, placebo group, physical exercise group and a 
memory training group (Bonnefoy, Cornu et al. 2003).  Although this study had a 
relatively long study period (9 month), the sample sizes of the subgroups were small.  
Lanque and colleagues conducted a 60-day randomized controlled nutritional 
intervention trial in 88 men and women aged 65 and over living in nursing homes in 
France (Lauque, Arnaud-Battandier et al. 2000).  The 88 subjects were divided into 
four groups: 19 well-nourished subjects received no supplements, 41 who were at 
risk of malnutrition were randomized into two groups - received no supplements or 
received supplements, and 28 malnourished subjects received supplements.  After 60 
days, only those malnourished subjects who had received supplements were found to 
have a significant increase in weight, but no changes were found in hand grip 
strength.  There were no changes in weight or muscle strength in the remainder of the 
subjects. 
 
In summary, these studies had small sample sizes (Lauque, Arnaud-Battandier et al. 
2000), relatively unwell elderly populations (Lauque, Arnaud-Battandier et al. 2000) 
and short study duration (Lauque, Arnaud-Battandier et al. 2000; Payette, Boutier et 
al. 2002). In addition many of the studies combined both dietary and exercise 
interventions in the one study (Bunout, Barrera et al. 2001; Bonnefoy, Cornu et al. 
2003).  Most of studies also included both men and women making it difficult to 
examine gender differences.  The proportion of protein to energy varied between 
studies and most did not mention the protein source used in the supplements 
(Fiatarone, O'Neill et al. 1994; Gray-Donald, Payette et al. 1995; Wouters-
Wesseling, Van Hooijdonk et al. 2003).  All of the above factors contribute to a lack 
of power to draw conclusions and contribute to population based dietary 
recommendations for the well elderly.  
 
Evidence from amino acid studies on muscle protein metabolism suggested that an 
effective nutritional intervention aiming to increase muscle mass in the elderly may 
need to be based on a protein source that has high bioavailability and amino acid 
utilisation, such as whey protein (Volpi, Ferrando et al. 1998; Walzem, Dillard et al. 
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2002; Volpi, Kobayashi et al. 2003).  This study will investigate if a dietary protein 
supplement which is based on whey protein can maintain, or improve, muscle mass 
and strength in healthy elderly women.  
 
1.1.5 Definition of ‘elderly people’ 
The definition of ‘elderly people’ varied between studies (Al Snih, Markides et al. 
2002; Barbosa, Souza et al. 2005; Aagaard, Magnusson et al. 2007).  PubMed 
defines people aged over 65 year as ‘Aged’ (PubMed).  Aged over 65 is the widely 
used criteria to define  ‘elderly’, ‘older adult’, or ‘older person’ although there is no 
physiological basis for this (Binns 1999).  During the consultation process of 
“Dietary Guidelines for older Australians”, the majority also felt that 65 years was 
the most appropriate age to be considered to be an older Australian (Binns 1999).  
The recent version of the Nutrient Reference Values of Australia and New Zealand 
uses age ≥ 70 years to define ‘elderly people’(National Health and Medical Research 
Council 2006).  The current study recruited elderly women aged between 70 to 80 
years.  
 
1.2 Aim of this study 
The aim of this study was to undertake a one year randomised, double blind, placebo 
controlled trial to examine the effectiveness of whey protein supplementation on 
muscle mass and strength and serum levels of IGF-1 in healthy elderly women.  
 
1.3 Significance of this study 
Sarcopenia contributes to loss of independence in the elderly (Doherty 2003).  It 
increases the risk of fractures and falls in the elderly, which are major health 
problems in the community in terms of disability and cost.  The results of this 
randomised, controlled study will clarify the role of protein on muscle mass and 
function in the elderly and possible mechanisms of action.  By ensuring that the 
recruitment is population based and by using conservative exclusion criteria it is 
envisaged that if positive, the results of this research will translate into immediately 
applicable intervention strategies that are relevant at both a program and an 
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individual level.  Finally the data will directly contribute to the development of a 
phase three cost effectiveness study of a non-pharmaceutical intervention to prevent 
sarcopenia in the aging population. 
 
To the best of our knowledge, following a search of the literature, this is the largest 
randomized controlled trial investigating the effect of whey protein supplementation 
on the human skeletal muscle system in relatively healthy community-dwelling 
elderly women.  
 
1.4 Hypotheses 
 The muscle mass in the protein supplemented group will increase and there 
will be significant changes in whole body composition, with a proportional 
increase in body lean mass and a decrease in body fat mass relative to the 
control group. 
 The mobility, balance and muscle strength in the protein supplemented group 
will improve relative to the control group. 
 The effects of protein supplementation will be associated with increased 
concentrations of serum IGF-1 (mechanism).  
 
1.5 Objectives 
In healthy elderly women, the primary objectives of this study are (assess the effects 
of a protein intervention): 
1) To determine the effects of protein supplementation on muscle mass and size 
and body composition measured using whole body dual energy X-ray 
absorptiometry (DXA) and peripheral quantitative computed tomography 
(pQCT) of the mid calf muscle cross-sectional area. 
2) To examine the effect of protein supplementation on body composition using 
anthropometry (height, weight, hip and waist circumference, mid upper arm 
girth, skin fold). 
3) To examine the effect of protein supplementation on mobility, balance and 
muscle strength by ‘Timed Up and Go’, ‘Romberg balance’ and ‘muscle 
strength’ tests.  
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4) To assess the effects of protein supplementation on the risk of falling using 
self-reported falls in the past three months before assessments. 
5) To determine if the effects of increased dietary protein on muscle wasting is 
related to changes in circulating insulin-like growth factor one (IGF-1). 
6) To assess the effect of the supplements on weight gain. 
Secondary objectives (baseline cross-sectional study):  
7) To assess the dietary intake from 3-day food records, and the relationship 
between habitual diet with body composition at baseline. 
8) To validate dietary protein intake assessed by 3-day weighed food record by 
using 24 hour urine nitrogen as a biomarker.   
9) To assess the prevalence of sarcopenia, and the relationship of lean body 
mass with body mobility, balance and upper and lower limb muscle strength 
at baseline. 
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Chapter 2 Literature review 
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2.1 Sarcopenia 
2.1.1 Definition (absolute and relative sarcopenia) 
In 1988, Rosenberg introduced the term ‘sarcopenia’ for the phenomena of age-
related progressive loss of skeletal muscle mass (Rosenberg 1997).  Sarcopenia was 
derived from the Greek terms sarx meaning flesh and penia meaning loss.  The term 
‘sarcopenia’ generally refers to a relative status of deficiency of muscle mass with 
aging.   
 
A number of ways to define sarcopenia in a quantifiable way have been proposed by 
the research groups as discussed below.  Common to these methods was that 
appendicular lean mass measured by DXA was the key outcome variable for all 
studies.  As appendicular lean mass consists mostly of muscle, this makes a very 
reasonable index for the quantity of body muscle.  Appendicular lean mass has also 
been reported to be predictor of disabilities in elderly men and women, and its 
decline accounted for approximately a two-fold increase in disability risk (Fantin, Di 
Francesco et al. 2007).   
 
There is however, little consistency in the definitions used in different studies.  Some 
studies used the term “skeletal muscle mass (SMS)” instead of “lean body mass”.  In 
most cases, they refer to the same concept, which is the non-bone lean body mass 
measured by DXA under the assumption that all non-fat and non-bone tissue is 
skeletal muscle (Houston, Nicklas et al. 2008).   
 
Absolute sarcopenia 
In 1998, Rosenberg et al. introduced the term ‘adjusted appendicular lean mass’ 
(ALM) as an index of relative skeletal muscle mass adjusted for body size which also 
has been called ‘absolute sarcopenia’ (Baumgartner, Koehler et al. 1998).  They took 
an approach analogous to the use of the body mass index (Weight/height squared) 
which adjusts mass with height squared to define underweight, overweight, and 
obesity.  That is, ALM is defined as appendicular lean mass in kg divided by height 
squared in meter, ALM (kg)/height2 (m2).  Appendicular lean mass is measured by 
dual-energy x-ray absorptiometry.  They defined sarcopenia in women as 
ALM/height2 less than 5.45 kg/m2.  5.45 kg/m2 is the two standard deviations below 
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the mean of ALM/height2 of a young reference group.  This was later referred to as 
absolute sarcopenia (Estrada, Kleppinger et al. 2007).  The cut-off point used varied 
slightly between studies.  In the Third National Health and Nutrition Examination 
Survey (USA), using the same definition (ALM/heigh2), cut-off points of ≤ 5.75 
kg/m2 and 5.76-6.75 were selected to denote high and moderate physical disability 
risk in women (Janssen, Baumgartner et al. 2004).   
 
Relative sarcopenia 
A number of studies have adjusted skeletal muscle mass for body weight as an index 
to define sarcopenia, such as using total skeletal muscle mass/body mass (Janssen, 
Heymsfield et al. 2002) or ALM (kg)/weight (kg) (Estrada, Kleppinger et al. 2007). 
This was termed relative sarcopenia (Estrada, Kleppinger et al. 2007).   
 
A cross-sectional study of 189 healthy older persons found that the absolute 
sarcopenia (ALM/height2) was a better indicator of mobility and that  the relative 
sarcopenia (ALM/weight) was a better predictor of isolated muscle group function 
(Estrada, Kleppinger et al. 2007).  The current study used the ALM/height2 to define 
sarcopenia since body weight and BMI are highly collinear with lean body mass 
(Garn, Leonard et al. 1986).  
 
Residuals method 
The residual method uses the residuals obtained from linear regression of 
appendicular lean mass on height (meter) and body fat mass (kg) to define sarcopenia 
as the 20th percentile of the residuals.  The appendicular lean mass and body fat mass 
are derived from DXA.  The Health ABC study in the US, a longitudinal population 
based study following up 2976 healthy men and women aged 70-79 for five years, 
showed that the residuals method was better for predicting disability than the 
ALM/height2 method since it accounts for the effect of body fat mass (Delmonico, 
Harris et al. 2007).  They found that using the original ALM/height2 method 
(absolute sarcopenia index), many obese subjects who were sarcopenic would be 
misclassified as normal.  They defined sarcopenia if the value fell into the gender 
specific lowest 20% of the distribution of the index which was 5.67 kg/ht2 for 
women.  Obese elderly persons with sarcopenia are at high risk of negative health 
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outcomes including functional limitation and mortality (Stenholm, Harris et al. 
2008).   
 
Other methods 
Kyle and colleague proposed another sarcopenia index based on whole body 
counting of potassium (TBK) and body cell mass (BCM) (Kyle, Genton et al. 2001; 
Kyle, Genton et al. 2001).  The reason for using the TBK method is because 
potassium is the primary intracellular cation and 99.5% of the potassium in the body 
is rapidly exchangeable with an administered isotope (Moore 1980).  Sarcopenia was 
defined as having values of BCM/height2<-2 SD (standard deviation) below the sex-
specific mean for BCM index (BCM/height 2) in healthy control subjects younger 
than 35 years old (<6.96 kg/m2 in women).  TBK was measured by a whole-body 
scintillation counter (Kyle, Genton et al. 2001).  BCM was calculated from TBK by 
the equation, BCM (kg) = 0.00833 x TBK (mmol).  A higher proportion of elderly 
participants were defined as sarcopenic by this method compared to the results 
obtained using the Baumgartner adjusted appendicular lean mass (ALM/height2) 
index.  The researchers concluded that this was due to the greater decrease in TBK 
and BCM than the decrease in skeletal muscle mass and fat-free mass.  This suggests 
that there is a change in the composition of fat-free mass with aging.  The authors’ 
rationale for using the BCM index was that TBK is the single best predictor of 
nutritional status because it represents BCM, the ‘working’ portion of fat-free mass 
which is mainly muscle and bone (Kehayias, Fiatarone et al. 1997; Kyle, Genton et 
al. 2001).  However, this method includes bone which could be the source of the 
difference from other methods which exclude this aspect in their definitions.  The 
equipment required for this method, a whole-body scintillation counter, is not widely 
available compared with DXA which is available in most laboratories.   
 
Miller and colleagues recently developed and validated a sarcopenia measure in the 
African American health project in which 998 participants aged 49-65 years were 
involved (Miller, Malmstrom et al. 2009).  The method was to combine whole body 
lean mass measured by DXA (muscle quantity), timed chair rises and hand grip 
strength/height (muscle function) into a single scale called the ‘short portable 
sarcopenia measure’ (SPSM).  The SPSM score is based on three weighted 
component scores: chair stands score weighted 1, lean BMI (derived from 
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bioelectrical impedance body compositional measurement) weighted 1.5, and grip 
strength weighted 2.  The SPSM scores range from 0 (greatest sarcopenia) to 18 
(least sarcopenia) with 0.5 increments.  They validated this method by studying the 
correlation of SPSM scores with knee strength (knee extension and knee flexion), 
physical performance (4 and 6 meter walk, usual gait speed and standing balance 
score), and psychological measurements.  They found this unidimensional scale was 
significantly correlated with these measurements, with the strongest correlation with 
knee strength (r = 0.61-0.68, p < 0.01).  However, this method has not been validated 
in other populations.   
 
In summary, there is no consensus for a standardized definition of sarcopenia.  
Appendicular lean mass is the most important component used to define sarcopenia 
in previous studies.  Adjustment for height or height and body fat mass are the major 
methods used in the previous studies to minimize the influence of body size.  The 
Baumgartner method (which defines sarcopenia as ALM/height2 < 2 standard 
deviation below a young reference group) has been widely used due to its practical 
measurement methods and straightforward demonstration.  For elderly populations, 
adjustment for body fat mass should be considered because this method is able to 
identify obese sarcopenic individuals.   
 
2.1.2 Prevalence of sarcopenia 
The prevalence of sarcopenia varies by gender and ethnicity (Baumgartner, Koehler 
et al. 1998).  The prevalence was higher in elderly women than in elderly men, and 
higher in elderly Hispanic women than in elderly non-Hispanic white women 
(Baumgartner, Koehler et al. 1998), and is lower in Asians than in white and 
Hispanic populations (Lau, Lynn et al. 2005).  Sarcopenia also varies widely between 
studies, ranging from 2.8% to 59% (Melton, Khosla et al. 2000; Janssen, Heymsfield 
et al. 2002; Delmonico, Harris et al. 2007; Tichet, Vol et al. 2008), depending on the 
age range of the study population and the definition used.  The prevalence of 
sarcopenia was reported to be about 33-36 % in 173 non-Hispanic white women age 
between 70-80 years (Baumgartner, Koehler et al. 1998).  Based on Baumgartner’s 
definition of sarcopenia (ALM/height2 below two standard deviations of the mean of 
ALM/height2 of a young reference group), the prevalence was 25.9% in 89 healthy 
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women aged 68 ± 5 in US (Estrada, Kleppinger et al. 2007), 22.6% in 195 women 
and 26.8% in 142 men aged 64 - 93 years (Iannuzzi-Sucich, Prestwood et al. 2002), 
and 50.4% in 216 women aged 74 ± 5 years in Italy (Coin, Perissinotto et al. 2008).   
 
In Asia, a study in 527 community-dwelling elderly Chinese men and women 
showed that the prevalence of sarcopenia was 12.3% in Chinese men and 7.2% in 
Chinese women aged 70 years and older (Lau, Lynn et al. 2005).  This study defined 
sarcopenia as ALM/height2 two standard deviations or more below the normal mean 
for young Asian men and women which were 7.4±0.84 kg/m2 and 6.4±0.79 kg/m2 
respectively.  The mean and SD of ALM/height2 were 6.7±0.8 kg/m2 for elderly 
Chinese men and 5.7±0.6 for elderly Chinese women.  These values are lower than 
the New Mexico study where the mean (SD) of ALM/height2 was 7.7 (0.7) for men 
and 5.9 (0.7) for women aged 70 years or over (Baumgartner, Koehler et al. 1998).  
The lower prevalence of sarcopenia in Asians compared to white or Hispanics may 
be due to the lower muscle mass in young Asians, which is used as the reference, and 
then results in a lower threshold for diagnosing sarcopenia (Lau, Lynn et al. 2005).  
The differences in diet and physical activity may also play a role in the difference in 
the prevalence of sarcopenia between different ethnic groups (Lau, Lynn et al. 2005).   
 
A population-based epidemiological study of 883 elderly men and women living in 
New Mexico found that women with sarcopenia had 3.6 times higher rates of 
disability, and men 4.1 times higher rates, compared with study participants with 
normal muscle mass (Baumgartner, Koehler et al. 1998).  The study also showed that 
there were significantly greater odds ratios for the use of walking aids and fall 
history in sarcopenic subjects, which persisted after adjustment for age, race, obesity, 
income, alcohol intake, physical activity, current smoking and comorbidity.  
Sarcopenia was independently associated with important health outcomes, including 
metabolic and functional impairments and disabilities in this relatively healthy 
ambulatory population.   
 
2.1.3 Aetiology of sarcopenia 
Sarcopenia is a multifactorial condition (Morley 2003) which is characterised by a 
progressive loss of muscle mass and strength with aging (Dutta and Hadley 1995; 
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Dreyer and Volpi 2005). This results in an increased risk of physical disability (van 
den Beld, Blum et al. 2003), falls and fractures (Loeser and Delbono 1999; Fried, 
Tangen et al. 2001).  All of these factors are incorporated into a model for illustrative 
purposes in Figure 2.1 and discussed in the following sections.   
 
The aetiology of skeletal muscle loss with aging is not fully understood, but factors 
have been suggested include decreased energy and protein intake (Chernoff 2004; 
Walrand and Boirie 2005; Fujita and Volpi 2006), physical inactivity (Baumgartner, 
Waters et al. 1999), altered protein synthesis and turnover (Carmeli, Coleman et al. 
2002), reductions in IGF-1 (Carmeli, Coleman et al. 2002), decreased sex hormones 
(van den Beld, de Jong et al. 2000; Iannuzzi-Sucich, Prestwood et al. 2002; Roy, 
Blackman et al. 2002), increased production of inflammatory markers (Visser, Pahor 
et al. 2002), and neuromuscular changes with aging (Loeser and Delbono 1999; 
Morley, Baumgartner et al. 2001) (Figure 2.1).   
 
 
 20
Figure 2.1 Possible etiology of sarcopenia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* GH: growth hormone; IGF-1: insulin-like growth factor one.  This diagram is generated from the following references (Dutta and Hadley 
1995; Baumgartner, Waters et al. 1999; Loeser and Delbono 1999; van den Beld, de Jong et al. 2000; Fried, Tangen et al. 2001; Morley, 
Baumgartner et al. 2001; Carmeli, Coleman et al. 2002; Iannuzzi-Sucich, Prestwood et al. 2002; Roy, Blackman et al. 2002; Visser, Pahor et al. 
2002; Morley 2003; van den Beld, Blum et al. 2003; Chernoff 2004; Dreyer and Volpi 2005; Walrand and Boirie 2005; Fujita and Volpi 2006).  
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2.1.3.1 Decrease in physical activity 
In general, physical activity declines with aging.  The decrease in muscle mass and 
strength is not only due to the aging process itself, but also  to the complex 
interaction of aging, disease and muscle disuse (Schwartz and Buchner 1999).  
Resistance training has been shown to increase muscle mass and/or strength in 
elderly people (Baumgartner, Waters et al. 1999; Roth, Ivey et al. 2001).  However, 
whether the decline in physical activity is directly associated with a decrease in 
muscle mass and strength with aging, or whether regular exercise can overcome 
sarcopenia is still being debated (Marcell 2003).   
 
2.1.3.2 Growth hormone/Insulin like growth factor 1 and skeletal muscle 
Physiology of growth hormone/Insulin-like growth factor 1 
Insulin-like growth factor 1 (IGF-1) is a polypeptide protein hormone and its 
chemical structure is similar to insulin.  Growth hormone (GH) is the major 
hormonal determinant of IGF-1 plasma concentrations (Clemmons 2006).  The 
pituitary gland releases GH, and IGF-1 is produced in the liver, endothelial and 
smooth muscle cells (Sonntag, Lynch et al. 2000; Fanciulli, Delitala et al. 2009).  
The GH/IGF-1 axis and GH regulation is a complex process in which there are many 
hormones involved , including GH-releasing hormone, glucocorticoids, gonadal sex  
and thyroid hormones (Giustina and Veldhuis 1998).  The simplified GH/IGF-1 axis 
and GH regulation is shown in Figure 2.2.  All tissues in the body contain IGF-1 
receptors (Clemmons 2007).  IGF-1 plays a critical role in development, growth, 
repair, and maintenance of muscle, bone, cartilage and other tissues (Florini, Ewton 
et al. 1996; Loeser and Delbono 1999; Booth 2006).  IGF-1 is also a recognized bone 
growth promoting factor in elderly persons who have sustained a hip fracture 
(Schurch, Rizzoli et al. 1998). It also directly regulates bone growth and density in 
adults (Yakar, Canalis et al. 2009; Yakar, Rosen et al. 2009).   
 
Aging, IGF-1 and muscular skeletal health 
Growth hormone and IGF-1 levels decrease with aging (Corpas, Harman et al. 1993).  
Cross-sectional studies have shown that IGF-1 levels are positively associated with 
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the increased muscle mass and strength in elderly men and women (Baumgartner, 
Waters et al. 1999; Payette, Boutier et al. 2002; Roubenoff, Parise et al. 2003).  Low 
IGF-1 levels were associated with poorer lower limb strength and functions in a cross 
sectional study of 619 community-dwelling elderly women aged 70-79 years 
(Cappola, Bandeen-Roche et al. 2001).   
 
Growth hormone treatment studies in animals and humans 
Both animal and human studies have demonstrated the beneficial effect of growth 
hormone treatment on muscle mass and strength (Barton-Davis, Shoturma et al. 
1998; Attanasio, Bates et al. 2002).  Research using animal models has found that 
when IGF-1 was induced to mice muscles, there were significant increases in muscle 
mass and strength both in young and old mice compared with controls (Barton-
Davis, Shoturma et al. 1998).  Recombinant human GH (rhGH) has been used in 
human trials which were based on the rationale of replacing the age-dependent 
decline in circulating GH (Franco, Andersson et al. 2007; Johannsson 2007).  GH 
dose titration is usually monitored by measuring serum IGF-1 (Fanciulli, Delitala et 
al. 2009).  A 3-year study in 242 adult patients with hypopituitarism showed that lean 
body mass was significantly increased after 3 years of treatment with human growth 
hormone (Attanasio, Bates et al. 2002).  The rhGH supplementation studies showed 
an increase in IGF-1, lean body mass, bone density and a decrease in body fat mass 
both in elderly men (Rudman, Feller et al. 1990; Papadakis, Grady et al. 1996; 
Hennessey, Chromiak et al. 2001) and in elderly women (Thompson, Butterfield et 
al. 1995).   
 
The results from previous growth hormone treatment studies on skeletal muscle are 
inconsistent. A number of  studies found that there was no effect of rhGH 
supplementation on the skeletal muscle system in elderly women (Blackman, Sorkin 
et al. 2002; Christmas, O'Connor et al. 2002).  An animal study in old rats found that 
the short-term administration of GH late in life did not overcame the functional 
decline in muscle quality and size and may even accelerate apoptosis in slow-twitch 
muscles (Marzetti, Groban et al. 2008).  To date, there is no definitive evidence to 
support the hypothesis that GH treatment is beneficial to the elderly to protect against 
the aging progress.  Further studies are needed to assess the safety of long-term use 
of GH (Fanciulli, Delitala et al. 2009).    
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Figure 2.2 Diagram of growth hormone/insulin-like growth factor 1 axis.  
 
 
 
Insulin-like growth factor 1 (IGF-1) axis involves hypophysiotropic hormones 
controlling pituitary growth hormone (GH) release, IGF-1 production in the liver and 
elsewhere, and tissue responsiveness to GH and IGF-1.  Adapted from (Fanciulli, 
Delitala et al. 2009). 
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2.1.3.3 Decrease in food intake  
Food intake declines with aging (Clarkston, Pantano et al. 1997; Morley 1997).  A 
10-year longitudinal study conducted in New Mexico recruited 304 healthy elderly 
men and women, aged 72 years at the entry to the study in 1980.  The participants 
were seen as outpatients each year and 3-day food records were used to assess their 
food intake (Vellas, Hunt et al. 1997).  For those who dropped out or died, the 
annually assessed dietary intake data of their last visit were used.  The study found 
that the decrease in energy intake was greater in those who died or dropped out of the 
study.  In 1990, participants who were healthy, frail or sick, or dropped out or died 
decreased their mean energy intake by 0.13, 0.19 and 0.22 kcal/kg body weight per 
year, respectively.  Therefore those who remained healthy were consuming more 
energy than all the other participants. The decline in food intake with aging is not 
fully understood, but several possible peripheral and central mechanisms have been 
proposed by Morley (2001) are as below: 
 Alteration in taste and smell with aging 
 Decline in adaptive relaxation of the fundus of the stomach 
 Increased cholecystokinin level with aging resulting in increased sensitivity to 
 satiety 
 Increased leptin level secondary to the age-related decline in testosterone 
 Decrease in physical activity resulting in a decline in the central feeding drive 
A study compared eight healthy older and seven healthy young male subjects and 
found that the effect of a small intestinal lipid infusion on hunger was attenuated and 
the stimulation of phasic pyloric pressure waves increased in the healthy older 
participants (Cook, Andrews et al. 1997).  The gastrointestinal hormone, 
cholecystokinin (CCK), is a peptidergic neurotransmitter and is involved in multiple 
digestive functions including delay of gastric emptying, regulation of insulin 
secretion, emptying of the gallbladder (Ubilluz 1994).  CCK increases with age 
which may contribute to the decrease in appetite in elderly (MacIntosh, Andrews et 
al. 1999).  A study of 64 healthy postmenopausal women found that serum leptin 
concentration was negatively correlated with the habitual food intake independent of 
body fat content (Larsson, Elmstahl et al. 1998).  More studies, and especially human 
trials, are needed to establish and confirm these proposed mechanisms.   
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However, it is not clear if the decrease in food intake in the elderly is due to aging 
per se or some other underlying health problem.  Lower albumin concentration is 
associated with decreased muscle mass (Baumgartner, Koehler et al. 1996) and 
strength (Schalk, Deeg et al. 2005).  A recent study of 36 young and older adults who 
completed three 18-day periods of controlled feeding with three levels of protein 
intakes (Thalacker-Mercer, Johnson et al. 2007) found that there was no difference in 
the post-absorptive serum albumin concentration and postprandial albumin synthesis 
rate between age groups.  This suggests that the elderly respond well to protein 
ingestion and that increasing protein intake could improve nutritional status in the 
elderly.   
 
2.1.3.4 Protein intake, muscle mass and muscle strength 
Animal studies 
Animal studies have shown that a high protein diet (50% protein) decreases net 
muscle catabolism and improves muscle morphology, strength and function in 
murine (Zdanowicz, Slonim et al. 1995).  A high protein diet (23% protein) was 
sufficient to increase body weight and restore basal values of liver weight and protein 
content in malnourished adult and old rats (Walrand, Chambon-Savanovitch et al. 
2000).  This study also found that in old rats, a very high protein diet (27% protein) 
was more effective than a high protein (23% protein) diet in increasing body weight, 
albuminemia, muscle weight and protein content, and plasma arginine concentration 
(Walrand, Chambon-Savanovitch et al. 2000).  In another study, whey protein down 
regulated fatty acid synthesis and increased glycogen content in the liver (Morifuji, 
Sakai et al. 2005; Morifuji, Sakai et al. 2005), and also increased skeletal muscle in 
the exercise-trained rats (Morifuji, Sakai et al. 2005).  It was proposed that whey 
protein may reduce accumulation of body fat in rats (Morifuji, Sakai et al. 2005).   
 
Studies in hospitalized patients 
Increased protein intake or use of a protein based nutrition supplements have been 
shown to have a significant benefit in improving muscle mass or strength in very 
elderly (age≥75 years) hospitalized patients (Price, Daly et al. 2005).  The 
hospitalized patients are at greater risk of malnutrition due to pre-existing diseases or 
reduced physical activity.  As malnourished patients are likely to have large 
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depletion of their body protein, they may respond better to protein and other 
nutritional supplements than relatively healthy elderly people.   
 
Cross-sectional and longitudinal studies in healthy elderly people 
A cross-sectional study in Canada examined the habitual diets and body composition 
in 38 healthy, normal weight, sedentary women aged 57-75 years (Lord, Chaput et al. 
2007).  The study found a significant correlation between muscle mass index (MMI 
= FFM (kg)/height (m)2, (FFM is fat-free mass measured by DXA) and muscle 
protein content, animal and total protein intake.  Animal protein intake was the only 
independent predictor of MMI in the stepwise regression analysis.  The authors 
suggested that protein intake, especially from animal sources, may be associated with 
a better preservation of MMI.  However, a population-based cross-sectional study of 
1404 elderly men and women did not find an association between dietary protein 
intake assessed by food frequency questionnaire and body lean mass assessed by 
DXA (Mitchell, Haan et al. 2003).  Another cross-sectional study of 44 elderly men 
showed that adequate protein intake did not offset the age-related loss of 
appendicular lean mass (Starling, Ades et al. 1999).   
 
Two longitudinal studies have shown that a higher protein diet was significantly 
correlated with reduced  loss of lean body mass (Houston, Nicklas et al. 2008) and 
fewer health problems over the study period in elderly people (Vellas, Hunt et al. 
1997).  The US study of 2066 community-dwelling men and women aged 70-79 
years over three years, found that participants in the highest quintile of protein intake 
lost approximately 40% less total body lean mass and appendicular lean mass than 
did those in the lowest quintile of protein intake (Houston, Nicklas et al. 2008).  The 
10-year longitudinal study of 304 healthy elderly men and women found that women 
with a protein intake greater than 0.8-1.2 g/kg of body weight had fewer health 
problems over the next 10 years than those with protein intakes <0.8 g/kg (Vellas, 
Hunt et al. 1997).  Therefore, dietary intake, especially protein intake, may be a 
modifiable risk factor for sarcopenia in the elderly (Houston, Nicklas et al. 2008).   
 
In summary, previous studies have shown that a diet high in protein content was 
correlated with higher muscle mass (Meng, Zhu et al. 2009) and strength in the 
elderly (Price, Daly et al. 2005).  However, the results have been inconsistent 
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between studies.  The role of protein in the long-term regulation of body composition 
in the elderly is not clear and long-term intervention studies are needed.   
 
2.1.3.5 Protein intake, serum IGF-1 and protein metabolism 
Protein intake and serum IGF-1 
Dietary protein intake has positive effects on the production and action of serum 
IGF-1 (Bonjour, Schurch et al. 1997).  It has been reported that marginal protein 
intake results in reduced IGF-1 levels and skeletal muscle fibre atrophy in elderly 
women (Castaneda, Gordon et al. 2000).  A dietary protein supplement of 20 g/day 
has been shown to increase circulating levels of IGF-1 in a study of elderly hip 
fracture patients (Schurch, Rizzoli et al. 1998).  A 9-week study of 32 elderly men 
and women with usual protein intakes <0.85 g/kg/d showed that the high protein 
intake group (0.75 g/kg/d protein intake) had significantly higher levels of serum 
IGF-1 (a bone growth factor) than the low protein intake group (0.04 g/kg/d protein 
intake) (Dawson-Hughes, Harris et al. 2004).  The high protein intake group also had 
significantly lower levels of urinary N-telopeptide (a marker of bone resorption) than 
the low protein intake group over the study period.  However, the study sample size 
was small, especially for the subgroups, such as by gender.  The study duration was 
also short.  All study participants were on a habitually low protein diet when entered 
into the study and therefore may not be representative of the general elderly 
population.  Dietary protein intake above habitual intakes does appear to have the 
ability to raise IGF-1 concentrations.  It is not clear however, whether the increase in 
IGF-1 is of clinical relevance and translates to effects on bone and muscle. 
 
Altered protein metabolism and dietary protein intake 
Muscle protein turnover is a complex process of protein degradation and synthesis 
regulated by several physiological stimuli (Marcell 2003) as shown in Figure 2.3.  
Altered protein metabolism in the elderly may result from reduced ability of aging 
skeletal muscle to respond to anabolic stimuli, such as insulin and amino acid (Fujita 
and Volpi 2006).  However, aging does not impair the muscle anabolic response to a 
protein-rich meal (Symons, Schutzler et al. 2007).  This study compared the plasma 
amino acid concentrations in ten healthy young (41±8 years) and ten elderly (75±5 
years) after ingestion of 113g of lean beef.  Both groups reached the peak plasma 
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amino acid concentrations 100 minutes after beef ingestion, but the levels were 
substantially higher in the elderly (Symons, Schutzler et al. 2007).  In a study 
investigating the response of amino acid transport and protein synthesis in six 
healthy elderly men age 71±2 years, the free amino acids concentrations and muscle 
cells (assessed by muscle biopsy) increased significantly during amino acids infusion 
(Volpi, Ferrando et al. 1998).  This study demonstrated that the increased availability 
of amino acids has positive effects on muscle anabolism in elderly subjects whose 
muscle mass was reduced (Volpi, Ferrando et al. 1998).   
 
Animal (Pansarasa, Flati et al. 2008) and human studies have showed that aging 
muscle can respond as well to the excess amino acid as in young adults (Fujita and 
Volpi 2006).  A high protein diet (greater than 0.8-1.2 g/kg of body weight) was 
associated with a lower loss of lean body mass (Houston, Nicklas et al. 2008) and 
fewer health problems (Vellas, Hunt et al. 1997) compared with a lower protein diet.  
However, long-term intervention studies with larger sample sizes are needed to 
verify the long-term effect of high protein intake on IGF-1 levels in elderly.   
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Figure 2.3 Skeletal muscle protein turnover.  
 
 
 
Adapted from (Marcell 2003) 
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2.1.3.6 Sex hormones and sarcopenia 
Sex hormone status is an important factor for muscle mass and strength level in 
elderly men but not in women (Baumgartner, Waters et al. 1999).  Most of the 
previous studies have shown that the decline in testosterone with aging in men was 
associated with a decline in muscle mass and strength (Morley, Kaiser et al. 1997; 
Baumgartner, Waters et al. 1999) and physical function (Perry, Miller et al. 2000).  
Testosterone replacement therapy also has been shown to have positive effects on 
increasing muscle mass and strength in elderly men (Snyder, Peachey et al. 1999).  
However, a recent 3-year cohort study of 1557 elderly men showed that low levels of 
testosterone were neither associated with a 3-year decline in physical performance 
nor with the decline in muscle strength (Schaap, Pluijm et al. 2008).  The authors 
explained that it is possible that their findings are sample-specific as the participants 
in their study were healthy elderly men, but further studies are needed to confirm 
these results.  Another possibility is the ceiling effect of the physical performance 
scores used in their study as the physical performance scores may have been set too 
low to detect changes in the physical activity in these healthy men.   
 
In elderly women, oestrogen was not associated with muscle mass and strength 
(Baumgartner, Waters et al. 1999).  Oestrogen replacement therapy did not show a 
protective effect against the loss of muscle mass and strength with aging in non-
obese, community-dwelling elderly women (Kenny, Dawson et al. 2003).  Therefore 
sex hormone status and sarcopenia appear to be only important in elderly men based 
on the current evidence.   
 
2.1.3.7 Neuromuscular changes with aging 
Loeser and Delbono reviewed the evidence from human and animal studies, and 
suggested the following pathogenesis of sarcopenia (Loeser and Delbono 1999).  
They acknowledged that the processes of neuromuscular changes with aging are still 
poorly understood.  
 neuronal alterations (e.g. reduction in number and/or cell size of spinal cord  
  motor neurons) 
 neuromuscular transmission alterations (e.g. decrease in nerve terminal   
  numbers) 
 31
 primary muscle alterations (e.g. primary muscle fibre atrophy) 
 other aging related general mechanisms that involve skeletal muscle (e.g. age-
  related vasculopathy) 
 
The decrease in protein turnover and repair capacities of aging muscle and impaired 
mitochondrial functions and energy reserve systems have also been proposed 
(Carmeli, Coleman et al. 2002).  Marzetti and colleague reviewed recent animal and 
human studies and suggested that the accelerated apoptosis of muscle fibres may be a 
key mechanism of sarcopenia (Marzetti and Leeuwenburgh 2006).  Other factors, 
such as the lesser stimulation of the mammalian target of the rapamycin (mTOR) 
signalization pathway and  increased proteolysis with aging were also proposed 
(Schneider, Boirie et al. 2008).  mTOR is a serine/threonine protein kinase that 
regulates cell metabolism (Hay and Sonenberg 2004).  However, more studies are 
needed to establish a clear integrated picture of the interaction of these pathways and 
their roles in sarcopenia.   
 
2.1.3.8 Inflammatory markers and sarcopenia 
An increase in inflammatory markers, such as interleukin-6, C-reactive protein 
(CRP), and tumour necrosis factor alpha have been found to be associated with aging 
(Steinle, Sharma et al. 2009) and the risk of cancer incidence and death (Il'yasova, 
Colbert et al. 2005).  High levels of inflammatory markers, such as interleukin-6, 
CRP, or tumour necrosis factor-alpha were correlated with lower muscle mass and 
strength in well-functioning older men and women in population based studies 
(Visser, Pahor et al. 2002; Schaap, Pluijm et al. 2006).  CRP is an acute-phase 
protein found in the blood in response to inflammation, and is produced by liver and 
fat cells (Pepys and Hirschfield 2003; Lau, Dhillon et al. 2005; Pepys, Hirschfield et 
al. 2006).  CRP is produced by adipocytes (Lau, Yan et al. 2006),  and has been 
shown to be strongly associated with adiposity in both men and women.  It is 
elevated in obese cardiovascular patients and decreases with weight loss (Lau, Yan et 
al. 2006; Thorand, Baumert et al. 2007).  A study in 286 elderly people showed that 
CRP and interleulin-6 were positively associated with total fat mass and negatively 
associated with appendicular lean mass (measured by DXA) (Cesari, Kritchevsky et 
al. 2005).  However, a study of 20 young and 26 elderly men showed that 
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interleukin-6 did not increase with age (Beharka, Meydani et al. 2001).  The author 
suggested that increased interleukin-6 was not a normal consequence of aging but 
might reflect an underlying, undiagnosed disease state.  More studies with larger 
sample sizes are needed to confirm the relationship between aging and these 
inflammatory markers.  The underlying diseases should be considered when studying 
the relationship between the inflammatory markers and changes in body composition 
with aging.   
 
2.1.4 Summary 
In summary, sarcopenia is common in aging populations.  Sarcopenia increases the 
risk of physical disability for elderly people.  There appear to be multiple factors 
which contribute to this condition and its aetiology is not fully understood.  The 
interaction of the genetically determined aging process (e.g. decrease in IGF-1 and 
testosterone), decrease in food intake especially protein intake, and decline in 
physical inactivity have been suggested.  Diet and physical activity are modifiable 
life style risk factors which appear to play a role in the aetiology of sarcopenia.  
Based on the above evidence, the current study is based on the hypothesis that long 
term protein supplementation may have a beneficial effect on preserving skeletal 
muscle mass and strength in elderly women. 
 
2.2 History of protein 
In the middle of the seventeenth century, scientists noticed that there were some 
gluey substances which existed both in plant and animal foods that have common 
animal properties (Carpenter 1986).  It took scientists another century to find out that 
these gluey materials were nitrogen based.  Swedish chemist Jons Jakob Berzelius 
and Gerrit Mulder named this material ‘protein’ in 1838 (Tanford and Reynolds 
2001).  Justus Liebig, the German organic chemist asserted in1845, that the various 
nitrogen compounds such as albumin, fibrin, casein and gluten can convert one to 
another in the animal body and that protein was the main compound in muscle 
metabolism (Carpenter 1986).  By the early 1900s, scientists understood that protein 
is a large complex molecule made up of amino acids joined by peptide linkages 
(Tanford and Reynolds 2001).  Max Perutz and Sir John Cowdery Kendrew 
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discovered the structures of haemoglobin (Perutz, Rossmann et al. 1960) and 
myoglobin (Kendrew, Bodo et al. 1958) respectively in 1958 (Tanford and Reynolds 
2001).  They won the Nobel Prize for chemistry in 1962 for their contribution to 
solving the mystery of the protein structure.  By the 1970s, scientists revealed that 
protein is the protoplasm of all cells and all the process within cells.  For instance, 
enzymes and antibodies are protein and proteins form a substantial part of cell 
membranes (Tanford and Reynolds 2001).  Myosin, a major portion of the muscle 
protein was isolated for the first time by Willy Kuhne in 1859 but the study of 
muscle protein was neglected for a long period of time.  However in recent decades 
much evidence has emerged of the critical role of proteins in the structure and 
function of all living cells.   
 
2.3 Physiology of protein 
The main source of body nitrogen is from protein, and about half of this protein is 
present as skeletal muscle (Lentner 1981; National Health and Medical Research 
Council 2006).  However, protein is not a reserve energy store as fat since only 1% 
of body protein is available for energy metabolism (Young, Hussein et al. 1968).  To 
avoid depleting the musculoskeletal system to provide energy, sufficient protein and 
energy intake from the diet is required to maintain human functions (Hansen, Raja et 
al. 2000).   
 
Proteins are made of twenty-two amino acids and the body can only synthesize 
fourteen of the twenty-two (Sakami and Harrington 1963).  The remaining eight are 
referred to as essential amino acids which have to be obtained from the diet (Furst 
and Stehle 2004).   
 
There are three stages for protein metabolism in general (Panel on Macronutrients, 
Panel on the Definition of Dietary Fiber et al. 2005; National Health and Medical 
Research Council 2006).  The first stage is the digestion and absorption of protein 
which ends with the breaking down of protein into amino acids.  The second stage is 
the balance of the ‘amino acid pool’, and the third stage is the deamination and 
excretion of amino acids.  For the first stage, the quality of dietary protein itself and 
age related decreased function in digestion and absorption could affect how much 
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dietary protein would be needed to generate sufficient levels of amino acids.  The 
balance of the amino acid pool is related to the balance of anabolism and catabolism.  
With aging, both anabolic and catabolic functions are decreasing.  The third stage, 
deamination and excretion of amino acid metabolism mainly through urine, skin 
(sweat) and faeces.  Urea is the principal excretory form of amino acid degradation.   
 
2.4 Clinical effects of inadequate protein intake 
Protein as the fundamental component of all body cells, has an essential role in the 
growth and function of the human body, including as enzymes, hormones and other 
important molecules (Panel on Macronutrients, Panel on the Definition of Dietary 
Fiber et al. 2005).  Insufficient protein intake and nonprotein energy intake (i.e., 
carbohydrates, fats) has adverse effects on all organs (Corish and Kennedy 2000).  
Protein deficiency also has been shown to have adverse effects on the immune 
system and increased risk of infection (McMahon and Bistrian 1990; Chandra 1997; 
Chandra 2002). A gene expression study found that short-term inadequate protein 
intake (0.5 g/kg/d) caused changes in skeletal muscle transcript levels in older people 
compared with those on an adequate diet (1.2 g/kg/d protein intake) (Thalacker-
Mercer, Fleet et al. 2007).  Energy metabolism and protein synthesis and 
proliferation were different between the inadequate protein intake group and the 
adequate protein intake group.  This study also showed the differentially expressed 
transcripts in functional classes for immune, inflammatory, stress responses, 
contraction, movement, and development, and extracellular connective tissue 
between the inadequate protein intake group and the adequate protein intake group. 
 
Protein energy deficiency is common in both children and adults in developing 
countries (Stephenson, Latham et al. 2000).  In industrialized countries, it is more 
often found in hospitalized patients and elderly people (Bistrian 1990; Allison 1995).  
The prevalence of protein-energy malnutrition was 5% in a study of 1206 randomly 
selected free-living elderly Swedish people aged 65 to 80 years (Thorslund, Toss et 
al. 1990).  Their study defined protein-energy malnutrition as having three of more 
subnormal values (> 2SD below the mean for albumin and prealbumin, or below the 
tenth percentile for anthropometric measurements, and relative energy) or two or 
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more very low values (> 3SD below the mean or below the fifth percentile 
respectively).   
 
Humans consume a wide range of dietary protein and there is limited literature on the 
adverse effects of having a very high protein diet long term (Panel on 
Macronutrients, Panel on the Definition of Dietary Fiber et al. 2005).  No adverse 
effects of high protein intake have been found in groups, such as in Eskimos, 
explorers, trappers and hunters during winters (Panel on Macronutrients, Panel on the 
Definition of Dietary Fiber et al. 2005).  Studies have shown correlations between 
high protein diets and some chronic diseases, including osteoporosis, renal calculi, 
renal insufficiency, cancer, coronary artery disease and obesity. However, there is 
insufficient evidence to permit any recommendation of the upper level of protein 
intake at the current stage (Panel on Macronutrients, Panel on the Definition of 
Dietary Fiber et al. 2005).  The recent version of Nutrient Reference Values for 
Australia and New Zealand also agreed that it is impossible to set up the upper limit 
of intake of protein based on the data available at present (National Health and 
Medical Research Council 2006).   
 
2.5 Protein requirement assessment methods 
There are mainly three methods for studying protein requirements, the factorial 
method, nitrogen balance method and the amino acid method (Panel on 
Macronutrients, Panel on the Definition of Dietary Fiber et al. 2005; National Health 
and Medical Research Council 2006).   
 
2.5.1 Factorial method (obligate nitrogen loss method)  
The factorial method is based on estimating the obligatory nitrogen loss from urine, 
faeces, sweat, and other miscellaneous losses, such as nasal secretions, menstrual 
losses or seminal fluid when a person is on a essentially protein free but the energy 
balanced diet (US panel of macronutrient 2005 P608). This allows the calculation of 
the amount of dietary protein needed to replace obligatory losses.  
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The weakness of this method is that the relationship between protein intake and 
nitrogen retention is curvilinear, and the measurement of miscellaneous losses is 
inordinately difficult, and these can make significant differences in results between 
studies (Rand and Young 1999).  Moreover, humans can adapt to a large range of 
protein intakes.  For example, a person who had a high protein habitual diet would 
have higher nitrogen losses in the urine when they switch to a low protein diet, 
compared to one who was on a habitual low protein diet (Panel on Macronutrients, 
Panel on the Definition of Dietary Fiber et al. 2005).  Therefore, the one who was on 
a habitual low protein diet would have a lower nitrogen excretion from urine.  The 
estimated obligatory nitrogen loss would be higher for the one who was on a habitual 
high protein diet, and the estimated protein requirement would be falsely higher than 
the actual requirements.  The differences in the initial nutritional status in individuals 
and the adaptability of the human body make it difficult to assess protein 
requirements at the population level.   
 
2.5.2 Nitrogen balance method 
The nitrogen balance method is still the most commonly used method to assess 
protein requirements.  Although this method also has serious limitations, there is no 
validated or acceptable alternative to date (Panel on Macronutrients, Panel on the 
Definition of Dietary Fiber et al. 2005).  This method is based on the assumption that 
nearly all of total body nitrogen is incorporated into protein (Gibson 2005).  The 
theory is that when the needs are met, the nitrogen balance is zero.  When protein 
intakes are lower than required, nitrogen balance is negative.  When the protein 
intakes are higher than required, nitrogen balance becomes positive.  In general, this 
method involves feeding increasing amounts of protein in a diet that is adequate in 
total energy to determine the minimal amount required to balance the total nitrogen 
losses in urine, faeces, skin (sweat), and miscellaneous losses (blood, nails, hair, 
semen) (Mackenzie, Clark et al. 1985; Panel on Macronutrients, Panel on the 
Definition of Dietary Fiber et al. 2005).   
 
Two different  equations have been used to calculate nitrogen balance (Gibson 
2005): 
1. Nitrogen balance = I – (U – Ue) + (F – Fe) + S  
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I = nitrogen intake (protein intake in g/6.25 as protein contains 16% nitrogen); U = 
total urinary nitrogen; Ue = endogenous urinary nitrogen; F = faecal nitrogen (as 
unabsorbed protein); Fe = endogenous faecal nitrogen losses; S = dermal nitrogen 
losses (nitrogen lost in sweat and sloughed-off skin cells). 
 
2. Nitrogen balance = protein intake (g) / 6.25 – (urinary urea nitrogen (g) + 2 + 2) 
The correction of 2g is for the estimation of dermal and faecal losses of nitrogen and 
another 2 g is for the nonurea nitrogen components of the urine. 
 
The first equation is a theoretical approach because several parameters are not 
measurable, such as endogenous urinary and faecal nitrogen (Manore and Thompson 
2000).  Total urinary nitrogen includes urea (86-94% of total urinary nitrogen), 
creatinine (4.5%), ammonia (2.8%), uric acid (1.7%), and other nitrogen-containing 
compounds (5%) (Manore and Thompson 2000).  Using just urinary urea nitrogen is 
more common than measuring total urinary nitrogen in routine clinical investigations 
as it is cheaper and less time consuming for patients and staff (Gibson 2005).  
However, total urinary nitrogen is more commonly used in research as accuracy is 
increased by measuring total nitrogen losses from urine instead of using the same 
fixed estimated losses for all subjects.   
 
Reported nitrogen balance results tend to be biased towards a positive balance 
(Gibson 2005).  This could be due to the underestimation of nitrogen excretion 
because of unmeasured nitrogen losses, including endogenous urinary and faecal 
nitrogen losses, losses of faeces and urine on toilet paper and in stool and urine 
containers, losses from exfoliated cells, sweat, hair and nail growth, menstrual fluid 
and semen (Gibson 2005).   
 
There are a few limitations of the nitrogen balance method that need to be considered 
when assessing human protein needs.  Firstly, humans can adapt to a wide range of 
protein intakes to achieve nitrogen equilibrium by increasing or reducing nitrogen 
excretion and reutilising endogenous amino acids (FAO/WHO/UNU 1985).  The 
concept of a steady state is relative.  Each level of protein intake requires several 
days to reach a new equilibrium.  It has been suggested that older people may need 
more than 10 days to achieve steady state for a given level of protein intake (Morse, 
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Haub et al. 2001).  One objective in determining protein requirements is to define the 
point at which adaptation is exceeded; beyond this point there will be progressive 
loss of body protein and deterioration of tissue function (FAO/WHO 1975).  A short 
term nitrogen study usually refers to a study period of 2-3 weeks (Morse, Haub et al. 
2001).  A long-term study is needed to assess the optimal protein intake level in 
terms of maintaining muscle mass and strength.  In addition, most of the studies 
either did not measure the miscellaneous losses of nitrogen (e.g. faeces, sweat, and 
hair etc) or estimated the miscellaneous losses as the same for each individual.  
Therefore most of the short-term nitrogen balance studies are not convincing.   
 
The 1985 FAO/WHO/UNU Panel suggested adding 5mg of nitrogen per kg body 
weight to allow for integumental and miscellaneous unmeasured losses 
(FAO/WHO/UNU 1985).  However, some studies have shown that the miscellaneous 
losses actually could differ significantly between studies and this would affect the 
estimated protein requirement significantly (Rand and Young 1999).  Campbell and 
colleagues studied 23 younger (aged 21-46 years) and 19 older (aged 63-81 years) 
men and women for three 18-day trials with protein intakes of 0.50, 0.75, and 1.00 g 
protein/kg/day (Campbell, Johnson et al. 2008).  They concluded that these short-
term nitrogen balance results suggested that there is no difference for the dietary 
protein requirement for healthy older adults and for younger adults.  Morse and 
colleagues conducted a 18-day nitrogen balance study in 11 elderly women aged 70-
81 years (Morse, Haub et al. 2001).  The study showed that the nitrogen balance was 
not achieved during week 2 and week 3, and suggested that the total protein needs of 
elderly women were at or above the current recommended protein intake of 0.8 
g/kg/d.  They also pointed out that shorter-term nitrogen balance protocols are 
insufficient to firmly establish the recommendation for protein intake of elderly 
women.   
 
2.5.3 Amino acid response method 
The amino acid method is to measure the balance of selected amino acids at different 
levels of intake of the amino acids. Techniques include the plasma amino acid 
response method, the direct amino acid oxidation method, the 24-hour amino acid 
balance method, and measurement of the indicator amino acid oxidation method 
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(Panel on Macronutrients, Panel on the Definition of Dietary Fiber et al. 2005).  In 
general, protein requirements estimated by nitrogen balance derived from amino acid 
requirements were lower than values derived by the other methods (Young, Bier et 
al. 1989; Millward 1990).  This difference may be due to the excess nonprotein 
energy used in the nitrogen balance studies and protein requirement is sensitive to the 
total energy intake (Panel on Macronutrients, Panel on the Definition of Dietary 
Fiber et al. 2005).   
 
The leucine oxidation method has been the most common method reported in the 
literature.  The advantage of this method is that adaptations in amino acid 
metabolism (at least for leucine) can be achieved in 24 hours (Motil, Opekun et al. 
1994). This is much quicker than the classical nitrogen balance studies which usually 
take seven to ten days for urinary nitrogen equilibrate in adults (Rand, Young et al. 
1976).  It was based on the assumption that values of leucine oxidation and balance 
reflect the whole body protein oxidation and balance (Kurpad and Vaz 2000).  It was 
thought to be a more sensitive index of the adequacy of protein intake than nitrogen 
balance (Castaneda, Dolnikowski et al. 1995) though it has limitations (Fuller and 
Garlick 1994).  For example, since it is a measurement only made during a short 
period where food is given at regular hourly intervals, it cannot represent the whole 
day status (Panel on Macronutrients, Panel on the Definition of Dietary Fiber et al. 
2005).   
 
2.6 Protein requirements for elderly people 
2.6.1 Historical developments of protein requirement 
The first known investigation of protein requirements dates back to the 19th century 
after the discovery of protein.  Carpenter (1994) reviewed the historical development 
of human dietary protein recommendations.  In 1853, Lyon Palyfair reported the 
diets provided to the paupers, prisons and servicemen contained 14 g of nitrogen, 
which is equivalent to approximately 88 g protein in modern terms (Carpenter 1994).  
In 1863, Edward Smith, a British physician undertook  a dietary survey in prisoners 
undertaking hard labour in London (Carpenter 1994).  He found that the estimated 
protein intake was 55 g per day with a total energy intake of 2190 kcal per day.  
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During this historical period there were no published studies targeting protein 
requirements in the elderly.  It was thought that elderly people need less protein than 
other adult groups because of the decrease in physical activity.  However, with 
increasing knowledge of sarcopenia in the aging process, evidence now suggests that 
the elderly may need more protein than was previously thought.  The following 
sections summarized the important periods of research in dietary protein 
requirements in the general population and in elderly people.   
 
2.6.1.1 The Voit standard for protein requirements 
The studies in the period of 1890-1920 were mostly on the protein requirements of 
physical working men.  The recommendation at this period was mainly based on 
observation of how much people ate.  German physiologist Dr. Carl Voit (1831-
1908) suggested in 1875 that 118 grams of protein intake per day was needed for a 
physical worker (equivalent to 105 g digestible protein).  His theory was based on the 
observation of eating habits of people with sufficient income to afford almost any 
choice of foods.  The belief that protein was the source of muscle energy and 
observation of the high protein consumption in the more successful social groups or 
nations contributed to the preference for high protein intake in this period (Carpenter 
1986).   
 
2.6.1.2 Protein recommendations by the United States Department of 
Agriculture  
In the U.S., 1891-1911 is referred to as the “Atwater Period” as Atwater’s work 
dominated the science of nutrition at this time (Dirks and Duran 1998).  Wilbur 
Atwater was trained in Germany and was greatly influenced by Voit’s techniques.  
He has been described as the founder of the science of nutrition in the United States.  
He undertook many studies on the nitrogen and energy intakes in different groups, 
including mechanics and farmers (Carpenter 1994).  Based on those studies, he 
adjusted Voit’s standard to 100 g protein per day for an elderly man with an energy 
intake of 2400 kcal, and 118 g protein with 3000 kcal energy intake for a labourer 
doing moderate work, and 145 g protein with 3300 kcal energy for one doing heavy 
work.   
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Hamilton C. Bowie, a visiting worker in Voit’s laboratory calculated nitrogen 
balance in a series of short-term nitrogen balance experiments which were originally 
designed to evaluate the digestibility of individual foods (e.g. white bread, milk, 
meat).  He claimed that his findings supported Voit’s standard.  He found that the 
subject was in negative balance when the protein intake was less than 65 gram 
digestible protein per day, and was in positive balance when the protein intake was at 
120 g or above (Carpenter 1986).   
 
2.6.1.3 Criticism for Voit’s standard 
The criticism of the Voit’s standard is that it was based largely on what men ate 
rather than what they needed to eat, and did not consider the human body’s 
adaptation to a low protein intake.  Initially, adaptability to a low protein intake was 
found in dogs in Voit’s study in 1867 (Carpenter 1986).  Then a German physician 
changed his own diet from high protein to one which contained only 42 to 45 g 
protein per day.  He found his urine nitrogen decreased gradually for the first four 
days when he changed from a high protein diet to a low protein diet.  The results 
indicated the ability of human body to adapt to low protein diet in the short term 
(Carpenter 1986).   
 
2.6.1.4 Challenges to high protein intake requirements 
Chittenden, R.H. (1856-1943) also raised the question as to whether the previous 
recommendation (Voit standard) for protein intake was too high (Carpenter 1986).  
He was concerned that consuming too much protein may impose a greater 
physiological strain on the kidneys.  He experimented on himself, four of his 
colleagues, eight university students, and thirteen volunteers from the U.S. army.  
Chittenden found that a 61-64 g/d protein intake could maintain a positive nitrogen 
balance and remain in good health over five to six months periods.  He concluded 
that 50 g/d was adequate for adults and ‘body equilibrium can be maintained on far 
less than 3000 kcal per day by the brain worker’ (Chittenden 1904; Cowgill 1944).   
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However, Chittenden’s conclusion was not fully convincing.  The self report about 
feelings, such as fatigue, was more subjective than based on scientific evidence.  
Moreover, Atwater reported that almost all subjects reverted to a more traditional 
diet rich in meat at the end of Chittenden’s study.  Therefore, Atwater believed that 
the human body may adapt to a wide range of nitrogen levels but studies were 
needed to evaluate the optimal level (Carpenter 1994).   
 
2.6.1.5 Recommendations by the World Health Organization (WHO) 
The WHO and the Food Agriculture Organization of the United Nations (FAO) have 
revised the protein intake recommendation several times since 1950s (Table 2.1).   
 
In 1950, protein requirements regained attention after a relatively quiet period from 
1920 to 1950 when individual vitamins and amino acids were discovered (Carpenter 
1986).  Between 1950s and 1970s, the expert committee of FAO and WHO had 
revised the recommendation for protein requirements several times.  Many important 
points were addressed in these revisions (Carpenter 1994; Weisell 1995).  For 
example, the expert group emphasized the important relationships between total 
energy intake and protein or other nutrient intakes.  They recognized that the quality 
of nutrients, such as the quality of protein from different resource also needs to be 
considered while studying protein requirements.  The expert committee also clarified 
that the average requirement suggested by the committee should apply for group of 
persons rather than individuals.  They suggested that other aspects such as 
differences in age, gender and physical activity level also needed to be taken into 
account in studies of nutrient requirements.  Studies in this period were more focused 
on protein and energy malnutrition in young children.  For adults, most study 
populations were younger adults.   
 
The report of FAO/WHO in 1973 recommended a safe protein intake of 0.57 g per 
kg body weight for young men based on an egg protein study (FAO/WHO. 1973).  
However, later experiments indicated that this level of protein intake was too low for 
young men (Garza, Scrimshaw et al. 1977). The different results between studies 
might be because of the following reasons (FAO/WHO/UNU 1985).  Firstly, some 
earlier studies tended to promote weight gain rather than balance. Secondly, some 
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studies set up the balance point as negative balance. Thirdly, there were differences 
in the estimation of nitrogen losses other than in feces and urine between studies.   
 
In 1985, FAO/WHO recommended that the safe protein intake for adults age > 19 
years (which includes the elderly) should not be lower than 0.75 g/kg/d 
(FAO/WHO/UNU 1985).  This recommendation was made by increasing 25% of 
0.605 g/kg/d.  0.605g/kg/d is the average value of protein requirement derived from 
long-term and short-term nitrogen balance studies, and these studies were mainly 
conducted in young men.  Increasing by 25% is to meet the needs of almost all 
persons (up to plus 2 standard deviations or 97.5%) of individuals in a population. 
FAO/WHO also suggested that there was insufficient evidence to support a higher 
requirement for the elderly (FAO/WHO/UNU 1985).   
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Table 2.1 Successive recommendations by international groups for protein 
intake in adult man. 
Report Average for N balance 
(g/kg/day) 
Recommended intake for 
population (g/kg/day) 
FAO 1957 0.35 0.66 
FAO/WHO 1965 0.59 0.89 
FAO/WHO 1973 0.34 0.75 
FAO/WHO/UNU 1985 0.60 0.75 
Adapted from (Scrimshaw 1996) 
  
 45
2.6.1.6 WHO recommendation in 1994 
In 1994, the Working Group on Protein and Amino Acid Requirements of 
FAO/WHO/UNU held a meeting in London.  The meeting proposed to increase the 
protein requirement to 0.8 g/kg/d.  The participants agreed that the nitrogen balance 
data for young adults were sufficient but not for older adults (Clugston, Dewey et al. 
1996).  After reviewing the nitrogen balance data for the elderly, it was realized that 
0.75 g/kg/d may not meet the requirements of the elderly, but more data were needed 
to make a recommendation for a higher protein intake.   
 
The results of nitrogen balance studies in elderly people have been inconsistent.  A 
meta-analysis of data from 19 nitrogen balance studies showed that there was no 
significant effect of ageing on protein requirements in older adults (Rand, Pellett et 
al. 2003).  Ten healthy men and women aged 55-77 years were able to achieve 
nitrogen balance after 2 weeks when given 0.8 g/kg/d protein (Campbell, Trappe et 
al. 2001).  They were in positive balance after 8 and 14 weeks, but the thigh muscle 
area was significantly reduced after 14 weeks.  The existence of muscle wasting at 
nitrogen balance status in the elderly indicated that nitrogen balance itself is not an 
optimal criterion when assessing the protein requirements in the elderly.  Further 
studies are needed to investigate new criteria for assessing protein requirement in the 
elderly in addition to the nitrogen balance method.   
 
2.6.1.7 Current recommendations for the elderly  
In the United States and Canada, the current Recommended Dietary Allowance 
(RDA) of protein for all adults groups is 0.80 g/kg/d of good quality protein (Panel 
on Macronutrients, Panel on the Definition of Dietary Fiber et al. 2005).  The RDA is 
the intake that meets the nutrient needs of almost all (97-98 percent) individuals in a 
group (Panel on Macronutrients, Panel on the Definition of Dietary Fiber et al. 
2005).  However, there was evidence that indicates that protein intake greater than 
the RDA can improve muscle mass, strength and functions in elderly (Wolfe, Miller 
et al. 2008).   
 
In Australia, the Recommended Dietary Intake (RDI) for protein for the elderly was 
not specifically addressed until 1999, which was 0.84 g/kg/d for men and 0.75 g/kg/d 
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for women age over 70 years old.  The National Health and Medical Research 
Council (NHMRC) published the Nutrient Reference Values for Australia and New 
Zealand in 2006The RDIs were increased to 1.07 g/kg/d for men and 0.94 g/kg/d for 
women aged over 70 years old (National Health and Medical Research Council 
2006).  The NHMRC acknowledged however that the data supporting this increase is 
limited.     
 
2.6.1.8 Summary of the changing of the protein intake recommendation for the 
elderly  
Dietary protein requirements have been studied for over one hundred years but the 
protein requirement for the elderly was not specifically addressed until recent 
decades.  The WHO recommended a protein intake of 0.75 g per kg body weight per 
day for all adults in 1994.  Evidence from nitrogen balance studies (Campbell and 
Evans 1996; Campbell, Trappe et al. 2001) conducted in recent years in the elderly 
suggested that elderly people may need more protein than younger adults.  In 2006 
the NHMRC of Australia recommended a protein intake of 1.07 g/kg/d for men and 
0.94 g/kg/d for women aged over 70 years but acknowledged that more studies are 
needed in supporting this recommendation.  Therefore there is a need for further 
research on protein requirements in the elderly. 
 
2.6.2 Studies of protein requirement in elderly people 
2.6.2.1 Short term and long term nitrogen balance studies 
Few nitrogen balance studies have been undertaken in the elderly as shown in Table 
2.2 (Cheng, Gomez et al. 1978; Uauy, Scrimshaw et al. 1978; Zanni, Calloway et al. 
1979; Gersovitz, Motil et al. 1982; Campbell, Crim et al. 1994; Castaneda, Charnley 
et al. 1995; Campbell, Trappe et al. 2001; Morse, Haub et al. 2001; Kortebein, 
Ferrando et al. 2007).  These nitrogen balance studies generally have small sample 
sizes and are of relatively short duration which may explain the lack of consistent 
findings.  Most of the recent studies have shown that a protein intake of 0.8 g/kg 
body weight per day was not adequate for elderly adults to maintain muscle mass 
(Campbell, Trappe et al. 2001; Kortebein, Ferrando et al. 2007).  A study conducted 
in 15 young and older men showed that there were no significant differences between 
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younger and older men in protein requirements (Cheng, Gomez et al. 1978).  This 
may be due to the efficiency of protein use or the ability to adapt to changes in 
protein intake levels (Cheng, Gomez et al. 1978).   
 
Two short-term studies were carried out in resistance training participants (Campbell, 
Crim et al. 1994; Welle and Thornton 1998).  The first study with twelve participants 
aged 56-80 years showed that a high protein intake (1.6 g/kg vs. 0.8 g/kg) did not 
influence changes in body composition in a 10 day period (Campbell, Crim et al. 
1994).  For studying changes in body composition, longer study durations are 
needed.  In another study of nine men and nine women aged over 60 years, the acute 
consumption of a high protein content meal (28% of energy intake) did not enhance 
myofibrillar synthesis after resistance exercise, compared to those had a low protein 
meal (7% of energy) (Welle and Thornton 1998).   
 
 
 48
 
Table 2.2 Nitrogen balance studies of protein requirement in the elderly. 
Studies Subjects 
number, 
sex 
Age 
(year) 
Study period Protein intake 
(g/kg/d) 
Results *Adequacy of 
protein intake of 
0.8 g/kg/d 
Kortebein 2007 6 M 6 F 67±5 10 days bed 
rest 
0.8  Nitrogen balance - negative throughout the study 
 Protein synthesis ↓ 
 Whole body lean mass ↓ 
 Lower extremity lean mass ↓ 
 Muscle strength ↓ 
Not adequate 
 
 
 
 
 
Morse 2001 11 F 75±4 3x18 days 0.50, 
0.75, 
1.00 
 From week 2 to week 3, more positive nitrogen 
balances occurred at all three protein intake levels 
 shorter-term nitrogen balance protocols are 
insufficient to firmly establish the recommendation 
At or above 0.76 
g/kg/d 
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Studies Subjects 
number, 
sex 
Age 
(year) 
Study period Protein intake 
(g/kg/d) 
Results *Adequacy of 
protein intake of 
0.8 g/kg/d 
Campbell 2001 10 M&F 66±3 14 weeks 0.8  Urinary nitrogen - decreased 
 Whole body protein metabolism – no change 
 Whole body composition – no change 
 Mid-thigh muscle area  – decreased  
Not adequate 
 
 
 
 
Castaneda 1995a 12 F 66-79 9 weeks 0.45 
vs. 
0.92 
 Protein intake               0.45g/kg/d            0.92g/kg/d
 Nitrogen balance         negative             balance     
 Lean tissue                        ↓                   no change
 immune response              ↓                   improved 
 muscle function                 ↓                  improved  
Not adequate 
 
 
 
 
 
Campbell 1994 12 M&F 56-80 10 days 0.8 
vs. 
1.6 
  Protein intake               0.8 g/k/g/d          1.6 g/kg/d 
nitrogen balance                negative              positive 
 1.0 g/kg/d is required to achieve nitrogen 
equilibrium 
Not adequate 
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Studies Subjects 
number, 
sex 
Age 
(year) 
Study period Protein intake 
(g/kg/d) 
Results *Adequacy of 
protein intake of 
0.8 g/kg/d 
Gersovitz 1982 7 M 
8 F 
75±4 
78±9 
30 days 0.8  Men: 4 had distinctly negative nitrogen balance in 
the 2nd  period and 3 men were negative in the final 
period 
 Women: 4 were negative in the 1st and final 
periods and 7 were negative during the 2nd period. 
Not adequate 
 
 
 
 
 
Zanni 1979 6 M 63-77 17 days Protein-free  
diet with 
adequate energy 
intake 
 Nitrogen losses from fecal and urinary were 
0.79±0.18 and 2.27±0.22 g/d respectively. 
 Nitrogen requirement for balance: 95 mg nitrogen 
or 0.59 g protein/kg ideal body weight 
Adequate 
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Studies Subjects 
number, 
sex 
Age 
(year) 
Study period Protein intake 
(g/kg/d) 
Results *Adequacy of 
protein intake of 
0.8 g/kg/d 
Uauy 1978 7 M 
7 F 
68-74 
70-84 
10 days M: 0.57, 
0.70, 
0.85 
F: 0.52, 
0.70, 
0.80 
 0.52 g/kg/d: all women were negative balance 
 0.83 g/kg/d was required for elderly women  
Not adequate 
 
 
 
 
 
 
Cheng 1978 7 M 
8 M 
61-73 
23-29 
3x11 days 0.4, 
0.8, 
1.6 
 0.4 g/kg: all subjects had negative nitrogen 
balance. 
 1.6 g/kg: all subjects had positive nitrogen 
balance. 
 0.8 g/kg: 3 young men and 4 aged men had 
positive balance 
 No significant differences in protein requirement 
between young and aged men 
Adequate 
M: male, F: female. * Original conclusion of the authors 
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2.6.2.2 Reviews and meta-analysis studies of nitrogen balance studies 
Many research groups have reviewed recent nitrogen balance studies as shown in 
Table 2.3 (FAO/WHO/UNU 1985; Prothro 1989; Garlick, McNurlan et al. 1999; 
Rand, Pellett et al. 2003; Panel on Macronutrients, Panel on the Definition of Dietary 
Fiber et al. 2005; Morais, Chevalier et al. 2006; National Health and Medical 
Research Council 2006) .  Generally, the findings are consistent and indicate that 
protein requirements in the elderly are higher than the previously suggested 
recommendation of 0.75 g per kg body weight per day.  Most reviews support the 
recommendation for a protein intake of 0.8 g/kg/d or above for the elderly (Prothro 
1989; Rand, Pellett et al. 2003; Panel on Macronutrients, Panel on the Definition of 
Dietary Fiber et al. 2005).  The most recent review suggested that a protein intake of 
1.0 – 1.3 g/kg/d is required to maintain nitrogen balance in the elderly (Morais, 
Chevalier et al. 2006).   
 
Reviews and meta-analyses of available studies show that previous nitrogen balance 
studies have not provided sufficient information to estimate protein requirements for 
the elderly.  This is due to the limited number of available nitrogen balance studies in 
the elderly and the limitations of the nitrogen balance method itself as discussed in 
the previous section (2.1.5.2).  
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Table 2.3 Review studies of protein intake and nitrogen balance studies. 
 Recommended protein intake for 
elderly people by reviewers 
Other results Study types 
Morais 2006 1.0-1.3 g/kg/d Elderly may need more protein intake due to: 
 Lower energy intake 
 Impaired insulin action 
 Reduced muscle mass  
 Lower rates of myofibrillar protein turnover 
Review 
 
 
 
 
National Health and 
Medical Research Council 
2006 
M>70y: 81g/d (1.07g/kg) 
F>70y: 57g/d (0.84g/kg) 
 Review and 
recommendation 
 
 
Panel on Macronutrients 
2005 
0.8 g/kg  No sufficient data to suggest the upper limit of protein 
intake of total energy intake 
 Usually is about 15% of total energy intake 
Review and 
recommendation 
 
 
Rand 2003 132 mg nitrogen/kg/d 
(0.83 protein g/kg/d) 
 Meta-analysis 
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 Recommended protein intake for 
elderly people by reviewers 
Other results Study types 
Garlick 1999  No strong evidence supported that high protein diets 
confer any advantage for muscle strength or health  
Review 
 
 
Prothro 1989 1g/kg/d  
(12-14% of total calories  
should be provided by protein) 
 Factorial method underestimated the protein 
requirement  
 Results were inconsistent for recommended 0.8g/kg/d  
Review 
 
 
 
FAO/WHO/UNU 1985 0.75 g/kg/d The recommended value could be too low as the value 
was based on nitrogen balance studies conduct at high 
energy intakes. 
Review and 
recommendation 
M: male, F: female 
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2.6.2.3 Cross-sectional and longitudinal studies of protein intake and body 
composition in relative healthy elderly population 
Results from protein intake and body composition cross-sectional studies in the 
elderly are inconsistent as shown in Table 2.4 (Vellas, Hunt et al. 1997; Starling, 
Ades et al. 1999; Mitchell, Haan et al. 2003; Devine, Dick et al. 2005; Houston, 
Nicklas et al. 2008), which could be due to the differences in the study population, 
assessment methods, and study duration.  For example, in some studies subjects were 
a population based sample and have large sample sizes (Mitchell, Haan et al. 2003; 
Devine, Dick et al. 2005; Houston, Nicklas et al. 2008). Others studies however, had 
relatively small sample sizes and were recruited through advertisements, which 
introduces a new set of biases (Vellas, Hunt et al. 1997; Starling, Ades et al. 1999).  
Some studies included both men and women (Mitchell, Haan et al. 2003; Houston, 
Nicklas et al. 2008) and other studies only investigated men (Starling, Ades et al. 
1999) or women (Devine, Dick et al. 2005).  As can be seen from Table 2.4, the age 
ranges of study participants also varied between studies.  Although DXA was used 
by most of the studies, dietary intakes were assessed by different methods.  Some 
studies used food-frequency questionnaire, and other studies used 3-day food records 
(Vellas, Hunt et al. 1997; Starling, Ades et al. 1999).  Study designs ranged from 
cross-sectional surveys to a 10-year longitudinal study.   
 
Two earlier cross-sectional studies found that protein intake and physical activity 
were not correlated with age-related muscle loss in elderly people (Starling, Ades et 
al. 1999; Mitchell, Haan et al. 2003).  However, a population based cross-sectional 
study (Devine, Dick et al. 2005) and two longitudinal studies found that high protein 
intake was correlated with higher lean body mass and higher bone mineral density 
(Houston, Nicklas et al. 2008) and fewer health problems over a 10-year period 
(Vellas, Hunt et al. 1997) in elderly people.  A study of 1077 elderly Australian 
women aged 75 ± 3 years showed that women in the lowest protein intake tertile had 
significantly lower hip bone mineral density compared to those in the highest protein 
intake tertile (Devine, Dick et al. 2005).  The population based Health ABC 
longitudinal study in the US found that the community-dwelling older people in the 
highest quintile of protein intake lost about 40% less lean mass and appendicular lean 
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mass than did those in the lowest quintile of protein intake over a 3-year period 
(Houston, Nicklas et al. 2008).  Vellas and colleagues followed up 304 healthy 
elderly men and women for10 years and found that women with protein intake 
greater than 0.8 – 1.2 g/kg/d tended to have fewer healthy problems over the study 
period than those with protein intake < 0.8 g/kg/d (Vellas, Hunt et al. 1997).  For 
assessing the correlation between diets and changes in body composition, 
longitudinal studies are preferable.  The evidence from these longitudinal studies 
suggests that protein intake may be a modifiable risk factor for sarcopenia.   
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Table 2.4 Cross-sectional and longitudinal studies in protein intake and body composition in elderly people. 
Studies Subjects 
number, sex 
Age 
(year) 
Study 
population 
Study  
type 
Method Results 
Houston 2008 2066 
M & F 
75±3 Population-based 
random sample 
3-year 
longitudinal
FFQ 
DXA 
Participants in the highest quintile of 
protein intake lost about 40% less lean 
mass and appendicular lean mass than did 
those in the lowest quintile of protein 
intake.  
The associations were attenuated slightly 
after adjustment for change in fat mass, 
but the results remained significant. 
 
Devine 2005 1077 F 75±3 Population-based 
random sample 
Cross-
sectional and
longitudinal
FFQ 
QUS 
The mean protein intake 80.5+/-27.8 
(1.19+/-0.44 g/kg/d). 
Subjects in the lowest tertile (<66g/d) had 
significantly lower hip BMD (2.6%) than 
did the subjects in the higher tertile 
(>87g/d). 
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Studies Subjects 
number, sex 
Age 
(year) 
Study 
population 
Study  
type 
Method Results 
Mitchell 2003  1404 
M & F 
elderly Population-based 
sub-sample 
Cross-
sectional 
FFQ 
DXA 
PAQ 
 
Lean muscle mass was not associated with 
dietary intake and physical activity. 
Starling 1999 44 M 67±11 Healthy 
volunteers 
Cross-
sectional 
3-day  
food record, 
DXA,  
accelerometer 
Maintaining regular physical activity and 
adequate protein intake did not offset the 
age-related loss of appendicular skeletal 
muscle mass. 
 
Vellas 1997 304 
M & F 
72 
(median) 
at entry  
Healthy 
volunteers 
10-year 
longitudinal
3-day  
food record 
Women with protein intake>0.8-1.2 g/kg/d 
tended to have fewer health problems over 
the next 10 years than those with protein 
intake<0.8 g/kg/d. 
M: male, F: female; FFQ: food frequency questionnaire; DXA: dual energy x-ray absorptiometry; PAQ: physical activity questionnaire; QUS: 
quantitative ultrasound. 
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2.6.2.4 Randomized controlled trials of protein and energy supplementation  
There are a few studies on the effects of dietary protein supplementation on body 
composition and muscle mass and function in elderly participants as shown in Table 
2.5 (Fiatarone, O'Neill et al. 1994; Gray-Donald, Payette et al. 1995; Bunout, Barrera 
et al. 2001; Payette, Boutier et al. 2002; Bonnefoy, Cornu et al. 2003; Wouters-
Wesseling, Van Hooijdonk et al. 2003; Bunout, Barrera et al. 2004; Maesta, Nahas et 
al. 2007; Aquilani, Opasich et al. 2008).  Most of the studies combined dietary 
supplements with resistance training in the study protocol and assessed the combined 
effect of supplements and exercise.  The sample size of these studies was generally 
small (around 40 to 80), with only two studies having more than 100 study 
participants (Bunout, Barrera et al. 2001; Bunout, Barrera et al. 2004).  Protocols 
also varied between studies, such as differences in the total energy or protein content 
of the supplements and study duration.  For example, the supplement sources varied 
from essential amino acids (Aquilani, Opasich et al. 2008) to soy protein (Maesta, 
Nahas et al. 2007), but most of studies did not detail the type of protein source.  The 
amount of protein supplements varied from around 15 g (Bunout, Barrera et al. 2004) 
to 30 g (Bonnefoy, Cornu et al. 2003) per day, and the energy intake from protein 
supplements varied from  14% (Wouters-Wesseling, Van Hooijdonk et al. 2003) to 
90% (Payette, Boutier et al. 2002).  The study population varied largely between 
studies, including different  age ranges of the participants, ranging from 45-70 
(Maesta, Nahas et al. 2007) years to 72-98 years (Fiatarone, O'Neill et al. 1994).  The 
differences in the study populations and study protocols make analysis of pooled 
results difficult and contributes to the inconsistent results between the studies.   
 
Most protein supplement studies were conducted in unwell older people, such as hip 
fracture patients (Avenell and Handoll 2006) or hospitalized patients with other 
illnesses, such as congestive heart failure (Milne, Potter et al. 2005).  There were 
very few long term protein supplement studies undertaken in relatively healthy 
community free-living older populations.  Frequently the study subjects have been 
malnourished or frail (Lauque, Arnaud-Battandier et al. 2000; Payette, Boutier et al. 
2002; Bonnefoy, Cornu et al. 2003).   
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The impact of an 18-month nutritional supplementation and a resistance training 
program was studied in 149 healthy free-living Chilean elderly age ≥ 70 years 
(Bunout, Barrera et al. 2001).  Body weight and fat-free mass did not change in 
either group, but fat mass increased in all groups.  The rate of bone loss was less in 
the supplemented group compared to the control group.  Muscle strength and 
physical function improved in the trained subjects.  A total of 98 participants 
completed the follow-up at 18 months (31 supplemented and trained, 26 
supplemented, 16 trained and 25 with no intervention).  The supplement was of soup 
or porridge consistency and given twice a day as a snack.  The total energy from the 
supplement per day was 873kJ with 13% energy (13g) from protein.  Compliance 
with taking the supplement was 48%.  The daily activities remained constant in the 
supplemented subjects and decreased in the other groups over the period of the study.  
Body weight did not change in any of the groups.  Although the study duration was 
long, the low protein content in the supplement in their study may explain the lack of 
an effect on body weight observed in this study.   
 
Fiatarone et al. conducted a 10-week randomized, placebo-controlled trial in 100 frail 
elderly men and women (63) aged 87.1±0.6 years living in nursing homes (Fiatarone, 
O'Neill et al. 1994).  The study compared four groups: progressive resistance training 
group, multi-nutrient supplementation group, a group with both interventions, and a 
control group with neither intervention.  The 250ml nutritional supplement was given 
once daily in the evening.  It contained 1512 kJ (360 kcal) in the form of 17% of soy-
based protein (15 g), 60% of carbohydrate and 23% of fat.  They found that the 
nutritional supplement had no effect on muscle strength or muscle size during the 10 
weeks study period in any of the groups.  However, the study duration of 10 weeks 
may not be long enough to detect the changes in muscle strength.  The significant 
reduction in the voluntary food intake after the trial in the supplemented only group 
may also explain the lack of effect of the supplement on muscle strength and size as 
the total energy intake did not change from baseline.   
 
A 9-month randomized controlled trial conducted in France investigated whether a 
progressive exercise program and nutritional supplements would increase muscle 
mass and strength in 57 elderly men and women aged over 72 years from six 
retirement homes (Bonnefoy, Cornu et al. 2003).  There were four groups in the 
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study.  The dietary supplements group was compared with a placebo group, and the 
physical exercise group was compared to the non-exercise group.  Muscle strength 
was assessed by a leg-extensor machine and was significantly increased by 57% at 3 
months in the supplement group, and it wasn’t significant at 9 months.  Whole body 
fat-free mass did not increase significantly (2.7%).  They found exercise did not 
improve muscle power but improved functional tests (the ‘five-time-chair rise’).   
 
In summary, few studies have shown any benefit on improvement in muscle strength 
and physical function by taking protein supplements alone.  One possibility for the 
lack of effect of the protein intervention observed in most studies is that an 
insufficient dose and/or the inefficient source of protein supplement may have been 
used.  As discussed in section 2.1.3.3, elderly people tend to eat less.  As the 
digestibility of protein is a critical determinant of protein utilisation (addressed in 
detail in section 2.8), the protein source and dose of protein supplement are important 
in nutritional intervention trials.  There has been no consensus on the effective dose 
of protein supplement or the protein source for dietary intervention studies.  Exercise 
training has been shown to improve some physical function with or without 
nutritional supplements in some studies.  The nutritional status of the subjects, 
known to influence protein requirements may also influence the response. The study 
populations in most of these studies were relatively unwell or very frail or 
undernourished elderly people.  Because of these limitation it is difficult to 
extrapolate these results to the well elderly.   
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Table 2.5 Randomized controlled trials of protein-energy supplementation with or without resistance training. 
Studies Subjects 
number 
& sex 
Age 
(years) 
Study 
period 
Study 
group 
Study 
population 
       Supplement Fat mass or 
anthropometric 
measurements 
Fat-free 
mass 
Muscle 
strength 
Physical 
functional 
tests 
Aquilani 
2008 
27M 
11F 
74±4 8 
weeks 
2 groups: 
Supp 
Non-supp 
Chronic heart 
failure with 
severe 
depletion of 
muscle mass 
Essential amino acids 
8g/day 
(however, all patients 
had adequate energy-
protein intake) 
 
N/A 
 
N/A N/A ↑ in supp 
group 
Maesta 
2007 
46F 61±5 16 
weeks 
4 groups: 
Supp 
Training 
Both 
Placebo 
 
Post-
menopausal 
Brazilian 
women 
25 g soy protein or  
25 g maltodextrine-
(placebo) 
↓ in training 
group 
↑ in  
training 
group 
NA NA 
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Studies Subjects 
number 
& sex 
Age 
(years) 
Study 
period 
Study 
group 
Study 
population 
       Supplement Fat mass or 
anthropometric 
measurements 
Fat-free 
mass 
Muscle 
strength 
Physical 
functional 
tests 
B. Bunout 
2004a 
101 
M&F 
≥70 1 year 4 groups: 
Supp 
Training 
Both 
Neither 
2 
outpatient 
clinics 
Total energy: 400 kcal 
Protein: 15 g 
 
 Fat mass ↑in 
all groups 
No change 
 in either 
group 
↑ in training 
group with  
or without 
supplemented
Improved in 
training 
group with or 
without 
supplement 
 
Bonnefoy 
2003 
57  
M&F 
>72 9 
months 
4 groups: 
Supp 
Placebo 
Exercise 
Non-exercise
16 
retirement 
home, 
frailty 
Twice daily of 200ml 
drink:1686 kJ(total) 
30% protein (30g) 
50% carbohydrate (50g) 
20% lipids (8.8g) 
BMI ↑ in supp 
group, 
decreased in 
placebo group 
↑in supp 
group,  
but not 
significant 
↑ in supp 
groups at  
3 months  
but only a 
tendency  
at 9 months. 
No change  
in exercise 
group. 
 
Improved in 
exercise 
group 
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Studies Subjects 
number 
& sex 
Age 
(years) 
Study 
period 
Study 
group 
Study 
population 
       Supplement Fat mass or 
anthropometric 
measurements 
Fat-free 
mass 
Muscle 
strength 
Physical 
functional 
tests 
Wouters-
Wesseling 
2003 
68 
M&F 
82±7 6 
months 
2 groups: 
Supp 
Placebo 
Nursing home, 
BMI≤25kg/m2 
Twice daily of 125ml 
drink:1050 kJ (total) 
14% protein (17.5g) 
46% carbohydrate (57g) 
40% fat (22.5g) 
 
Anthropometric 
measurements–
no change 
No  
difference 
between 
groups 
No 
difference 
between 
groups 
Payette 
2002 
83 
M&F 
80±7 16 
weeks 
2 groups: 
Supp 
Control 
Community-
living, under-
nourished 
2x235 ml commercial 
drink (Ensure or  
Ensure Plus) 
Total 710 kcal  
90% protein 
Weight↑ in 
supp group;  
Other 
Anthropometric 
indexes–no 
differences 
between groups
 No  
difference 
between 
groups 
 
No 
difference 
between 
groups. 
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Studies Subjects 
number 
& sex 
Age 
(years) 
Study 
period 
Study 
group 
Study 
population 
       Supplement Fat mass or 
anthropometric 
measurements 
Fat-free 
mass 
Muscle 
strength 
Physical 
functional 
tests 
D. Bunout 
2001 
149 
M&F 
≥70 18 
months 
4 groups: 
Supp 
Training 
Both 
Neither 
3 public 
outpatient 
clinics 
Twice daily of soup: 
Total energy: 873kJ 
Protein: 13g 
Carbohydrate: 62.4g 
Fat: 11g 
 
Fat mass↑  
in all groups; 
Weight–no 
change in  
either group. 
No change 
in either 
group 
Improved  
in trained 
groups 
Improved in 
trained 
groups. 
Fiatarone 
1994 
63F 
37M 
87 
(72-
98) 
10 
weeks 
4 groups: 
Training 
Supp 
Both 
Neither 
725 
nursing  
homes 
240ml liquid daily: 
360kcal (total),  
60% carbohydrate  
23% fat 
17% soy-based protein 
 Cross-
sectional 
muscle area 
–no 
differences 
between 
groups 
Improved  
in exercise 
group 
Improved in 
exercise 
group. 
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Studies Subjects 
number 
& sex 
Age 
(years) 
Study 
period 
Study 
group 
Study 
population 
       Supplement Fat mass or 
anthropometric 
measurements 
Fat-free 
mass 
Muscle 
strength 
Physical 
functional 
tests 
Gray-
Donald 
1995 
50  
M&F 
78±7 12 
weeks 
2 groups: 
Supp 
Control 
Community-
living,  
under- 
nourished  
Twice daily of 235ml 
liquid:1045-1480 kJ 
(total), 
14-14.7% protein 
31.5-32% fat 
54.5-53.3% 
carbohydrate 
Weight ↑ in 
supp group 
  No 
difference 
between 
groups. 
Significantly 
fewer falls in 
supp group. 
M: male, F: female; Supp: supplemented group. 
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2.6.2.5 Amino acid supplementation and muscle protein metabolism 
Supplementation with infusions of pure amino acids has shown positive effects on 
muscle protein synthesis both in young and elderly individuals (Volpi, Ferrando et al. 
1998; Paddon-Jones, Sheffield-Moore et al. 2004).  A study conducted in six healthy 
males aged 71±2 yr found that protein breakdown did not change during an amino 
acid infusion (Volpi, Ferrando et al. 1998).  Thus a positive net balance of amino 
acids across the muscle was achieved (Volpi, Ferrando et al. 1998).  This indicated 
that adequate protein intake may be protective against muscle wasting in the elderly.  
Volpi and colleagues further compared the muscle metabolism after supplementing 
with 18 g of essential amino acids and 40 g balanced amino acids (18 g essential 
amino acids + 22 g nonessential amino acids) (Volpi, Kobayashi et al. 2003).  They 
found no difference in muscle protein metabolism between the two groups. 
Therefore, they concluded that essential amino acids are primarily responsible for 
muscle metabolism.  Supplementation of the diet with essential amino acid plus 
arginine for 16 weeks has been shown to improve lean body mass, muscle strength 
and physical function in 12 glucose intolerant elderly individuals (Borsheim, Bui et 
al. 2008).  This implies that the protein source is important and that protein rich in 
essential amino acids is more efficient for muscle metabolism.  Increased protein 
intake especially high quality protein intake may slow the onset of sarcopenia in the 
elderly.   
 
Recently, a one year randomized controlled trial compared the effect of essential 
amino acids supplements (β-hydroxy- β-methylbutyrate, L-arginine, L-lysine) to an 
isonitrogenous control-supplement (mixture of nonessential amino acids: alanine, 
glutamic acid, glycine, serine and ascorbic acid) on protein metabolism in elderly 
people (Baier, Johannsen et al. 2009).  A totally of 38 men and 39 women aged 
76±1.6 years living in senior citizen centres and adult assisted-living and care 
facilities participated. Subjects were included in the study if their ‘Get-up-and-go’ 
test scores were greater than 10 seconds but less than 20 seconds.  They found that 
subjects supplemented with essential amino acids had increased their protein 
turnover and body lean tissue significantly compared to subjects in the control group 
at one year, but there were no significant differences in changes in fat mass or 
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percentage body fat.  In their study, the amount of supplements was not fixed but 
varied by participates’ baseline weight and no information was provided about the 
total energy content of the supplements.  In contrast, a 3-month randomized placebo 
controlled trial conducted on 30 healthy elderly women aged 71±4 years found that 
long-term leucine supplementation (7.5g/d) did not increase skeletal muscle mass 
and strength (Verhoeven, Vanschoonbeek et al. 2009).  The inconsistent results 
between these two randomised controlled studies (Baier, Johannsen et al. 2009; 
Verhoeven, Vanschoonbeek et al. 2009) may be due to the differences in their study 
population and study duration.  The study subjects in Baier’s study were living in 
nursing homes and were older (76±1.6 years) than the study subjects in Verhoeven’s 
study (71±4 years).  Baier’s study had a one year duration, which was longer than 
Verhoeven’s study of three months duration.  Therefore, the results are not directly 
comparable.   
 
In summary, it is the essential amino acids that are primarily involved in muscle 
metabolism.   In the studies reported above essential amino acid supplementation has 
a positive effect on protein turnover and lean body mass gain in elderly people and 
can improve muscle strength and physical function in glucose intolerant elderly 
individuals.  More long-term studies are needed into the effect of amino acid 
supplements on the musculoskeletal system in relatively healthy elderly.   
 
2.6.2.6 Cochrane systematic review of protein supplement studies in hip 
fracture elderly patients 
Avenell and Handoll undertook a comprehensive review for the comparison of 
nutritional supplements versus control studies in hip fracture elderly patients aged 
over 65 years (Avenell and Handoll 2006).  Twenty-one randomised trials involving 
1727 participants were included in their meta-analysis. Of these twenty-one trials 
only 4 trials (Tkatch, Rapin et al. 1992; Schurch, Rizzoli et al. 1998; Espaulella, 
Guyer et al. 2000; Neumann, Friedmann et al. 2004) compared high protein 
supplements with low protein or non-protein containing supplements.  Most of the 
studies involved nutritional supplements, which provided non-protein energy, some 
vitamins and minerals orally, or feeding nasogastrically.  They concluded that the 
overall trial quality was poor.  The meta-analysis showed that there was no 
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statistically significant effect of protein supplementation on mortality, but protein 
supplements may reduce ‘unfavourable outcomes’, such as death or complications 
compared to not using supplements in hip fracture patients (risk ratio 0.78, 95% CI 
0.65 to 0.95) as shown in Table 2.6.   
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Table 2.6 Comparison of mortality and unfavourable outcomes of studies with 
high protein containing supplements versus low protein or non-protein 
supplements in hip fracture patients. 
Outcome No.of 
studies
No.of 
participants 
Effect size* 
Mortality by end of study 4 361 1.42 [0.85, 2.37] 
 protein v non-protein supplement 3 315 1.38 [0.82, 2.34] 
 High protein v low protein supplement 1 46 2.18 [0.21, 22.42]
Unfavourable outcome (deaths or  
      complications) at end of study 
2 223 0.78 [0.65, 0.95] 
 Protein v non-protein supplement 2 223 0.78 [0.65, 0.95] 
 High protein v low protein supplement 0 0 Not estimable 
Adapted from: (Avenell and Handoll 2006). * Effect size: risk ratio [99% confident 
interval] 
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2.6.2.7 Cochrane system review of randomized and quasi-randomized trials of 
oral protein and energy supplementation studies  
Milne and colleagues reviewed 55 randomized and quasi-randomized controlled 
trials of oral protein and energy supplementation compared with placebo or control 
groups in older people (aged over 65 years) (Milne, Avenell et al. 2006).  However, 
most of the study subjects were unwell and had been hospitalized due to various 
illnesses including fracture, heart failure or stroke, or had just been discharged from 
hospitals. For dichotomous variables, such as mortality or number of patients with 
complications, the effect size was calculated as the risk ratio with 95% confidence 
intervals.  For continuous variables, such as percentage of weight change and hand 
grip strength, the effect size was calculated as weighted mean differences and 95% 
confidence intervals using a fixed effects model which assumes the same underlying 
effect in all studies and considers any heterogeneity between trials to be due to 
random errors.   
 
Their meta-analysis as shown in Table 2.7 showed that weight gain was common in 
supplemented subjects, and there was a reduced mortality in the supplemented 
compared with control groups (relative risk 0.74, 95% CI 0.59 to 0.92).  There was 
no significant functional benefit, such as hand grip strength and no difference in the 
risk of complication between supplemented and control groups (relative risk 0.95, 
95% CI 0.81 to 1.11).    
  
 72
Table 2.7 Comparison of oral protein-energy supplements versus routine care. 
Outcome or subgroup title No. of 
studies 
No. of 
participants
Effect size 
Mortality 34 3021 0.74 [0.59, 0.92] 
Mortality by nutritional status 34 3021 0.74 [0.59, 0.92] 
 Undernourished 21 1825 0.72 [0.55, 0.64] 
 Nourished 13 1196 0.78 [0.53, 1.15] 
Mortality by kcal offered per day 31 2905 0.74 [0.60, 0.93] 
 ≥400 kcal  19 2177 0.71 [0.56, 0.90] 
 <400 kcal/day 12 728 0.98 [0.52, 1.82] 
Mortality by age group 32 2940 0.72 [0.58, 0.90] 
 Mean age ≥75 years 24 2033 0.69 [0.54, 0.87] 
 4.2 Mean age<75 years 8 907 0.99 [0.51, 1.82] 
Mortality by period of supplementation 30 2600 0.73 [0.57, 0.94] 
 <35 days supplementation 10 1063 0.70 [0.44, 1.11] 
 ≥35 days supplementation 20 1537 0.75 [0.56, 1.00] 
Mortality by wellness 34 3021 0.74 [0.59, 0.92] 
 Well 6 393 0.98 [0.25, 3.78] 
 Unwell 28 2628 0.73 [0.59, 0.92] 
Mortality by hospital or community 31 2799 0.73 [0.58, 0.92] 
 In-patients 19 2022 0.67 [0.52, 0.86] 
 Community 12 777 1.07 [0.64, 1.78] 
Mortality by diagnostic group 32 2933 0.74 [0.59, 0.92] 
 Geriatric conditions 20 2314 0.72 [0.57, 0.92] 
 Hip fracture 7 337 0.89 [0.47, 1.68] 
 Congestive heart failure 1 22 1.44 [0.10, 20.21] 
 Chest conditions 2 120 3.07 [0.13, 73.30] 
 Perioperative 1 100 1.33 [0.16, 11.38] 
 Stroke 1 40 0.29 [0.07, 1.21] 
Complications 14 1169 0.95 [0.81, 1.11] 
% weight change 36 2474 2.32 [1.93, 2.0] 
% arm muscle circumference change 15 1246 1.22 [0.44, 1.99] 
Handgrip 4 246 -0.27 [-1.10, 0.56] 
(Adapted from (Milne, Avenell et al. 2006))  
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2.6.2.8 Summary of protein requirement studies 
Evidence from short and long term nitrogen balance studies suggests that elderly 
people may need more protein than the current US/Canadian recommended 0.8 
g/kg/d (Panel on Macronutrients, Panel on the Definition of Dietary Fiber et al. 
2005).  Most of researchers recommend a protein intake of 1.0-1.3 g/kg for elderly 
people.  This is the position taken by the Australian NHMRC when making its 
Nutrieint Reference Value Recommendations.  However, there has been no universal 
consensus due to lack of sufficient evidence from long term studies.   
 
Evidence from cross-sectional studies and longitudinal studies are not consistent in 
the beneficial effect of high dietary protein intake on preventing lean body mass loss 
with aging in elderly people. 
 
There have been a limited number of randomized controlled trials of protein 
supplementation in non-hospitalized elderly people.  Most of them have shown a 
weight gain benefit from protein supplements but few have shown that protein 
supplements improve muscle mass, strength and physical functions in the elderly.  
Moreover, the study population, source and amount of protein supplement and study 
duration varied considerably between studies.   
 
2.6.3 Factors affecting the estimation of protein requirement in the elderly 
Total energy intake needs should be considered when evaluating protein 
requirements because protein metabolism and the nitrogen balance method are 
sensitive to total energy intake and balance (Bier, Motil et al. 1981; Blackburn 1984; 
Fukagawa and Young 1987; Young, Yu et al. 1991).  If a nitrogen balance study 
conducted with a high energy intake, the body still can achieve nitrogen balance or 
even positive balance with a relatively low protein intake.  Elderly people tend to eat 
less food than their younger counterparts, and it is likely that there is a decrease in 
total energy intake in elderly people (Evans 2004).  Therefore, the provision of 
adequate energy intake is important in nitrogen balance studies in the elderly.  In 
order to minimize the differences in protein metabolism induced by the differences in 
total energy intake, for cross-sectional studies energy intake should be adjusted in the 
analysis.   
 74
 
Body size is the major determinant of the absolute requirements for energy and 
protein (FAO/WHO 1975).  Provided that energy intake is adequate, nitrogen losses 
are closely related to body weight and basal metabolic rate (Scrimshaw, Hussein et 
al. 1972; Castaneda, Charnley et al. 1995; Castaneda, Dolnikowski et al. 1995).  
Thus, body size needs to be adjusted when evaluating protein requirements in long 
term studies.  BMI gives a measure of weight for height that is largely independent 
of height (FAO/WHO/UNU 1985).   
 
2.7 Protein and energy intake in relatively healthy elderly people 
In general both American and Australians consume diets with a moderate to high 
protein intake, but some sub groups of the population, including the elderly, consume 
diets with less protein (Morley 1997; Australian Bureau of Statistics 1998; Morley, 
Baumgartner et al. 2001).  There are few available data on dietary protein intake in 
elderly populations in developing countries.  Details of the studies found are shown 
in Table 2.8 (Munro, McGandy et al. 1987; Woo, Cheung et al. 1988; Deschamps, 
Astier et al. 2002; Correa Leite, Nicolosi et al. 2003; Watanabe, Hanamori et al. 
2004; Aghdassi, McArthur et al. 2007; Feart, Jutand et al. 2007; Fulgoni 2008; 
Meng, Zhu et al. 2009).  The recommended dietary intakes for protein differ between 
countries.   
 
In a US survey using 3-day food diaries in 691 American men and women aged 60-
98 years, the daily protein intake was 1.02-1.05 g/kg body weight. This is much 
higher than the current US/Canada RDA (Recommended Dietary Allowance), which 
is 0.8 g/kg good quality protein (Munro, McGandy et al. 1987).  However, in the 
2003-2004 National Health and Nutrition Examination Survey, protein intake (as 
assessed by 24-hour recall) was 67 ± 19 g/d amongst women aged 51-70 years and 
59 ± 15 g/d amongst women aged 71 years and older. Approximately 8% of older 
adult women reported consuming protein levels below their estimated average 
requirement (Fulgoni 2008).   
 
In Canada, 3-day food records were obtained from 407 elderly men and women with 
an average age of 85 ± 8 years. Their average BMIs were 24 ± 6 kg/m2 and they were 
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living in 11 long-term care facilities.  The average daily energy intake was 1513±3 
63 kcal and protein provided 15% of energy.  A total of 29.5% of the respondents 
had protein intakes below the US/Canada RDA which is 0.8 g/kg (Aghdassi, 
McArthur et al. 2007).   
 
In France, 1786 subjects aged between 68-95 years completed a 24 hour dietary 
recall.  Protein provided 18% of energy intake. The total energy intake was lower in 
women and in older participants (>=85 years).  High energy intake was associated 
with higher income, but not with education level.  The study suggests that being 
female, older, being widowed and low income level were the risk factors for 
inadequate dietary intake (Feart, Jutand et al. 2007).  Another study conducted in 
France investigated 169 elderly people free-living in the community and found that 
the median protein intake was 1.33 g, but in this study no correlation was found 
between poor nutrition and mortality (Deschamps, Astier et al. 2002).   
 
In Italy, a study by 24-hour dietary recall in a random sample of 257 independent-
living elderly aged above 75 years found that the average daily energy intake was 6.3 
± 2.1 MJ (1508 ± 502 kcal) in women (Nes, Sem et al. 1992).  The energy from fat 
was 41.7% in women which is higher than the usually recommended level.  In this 
study 14% of the women had a BMI below 18.5 kg/m2, and 2% were below 16.   
 
In Japan, a survey was conducted in 2001 in 57 (women 26) healthy free-living 
people aged over 70 years (Watanabe, Hanamori et al. 2004).  The energy and 
protein intake for women were 38.1 ± 7.6 kcal/kg/d and 1.51 ± 0.26 g/kg/d 
respectively.  In this study protein provided 16% of energy.   
 
In a population based study in Australia, dietary intake was assessed using a food 
frequency questionnaire in 1077 women aged 75 ± 3 years who were randomly 
selected from the community (Devine, Dick et al. 2005).  The protein intake was 81 
± 28 g/d (or 1.2 ± 0.4 g/kg/d), which was higher than the current Australian/New 
Zealand RDI (Recommended Dietary Intake) of 0.94 g/kg/d protein for women aged 
over 70 years.  The energy intake was 7155 ± 2192 kJ/d, slightly higher than the 
Australia National Nutrition Survey of 1995-1996 for the age group of 70-79, which 
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was 6200 kJ/d (1482 kcal) (Australian Bureau of Statistics 1998).  Protein provided 
19±3% of energy intake.    
 
In summary, few studies have examined protein intakes in elderly living in 
developing countries.  Protein intake in the elderly varied between countries which 
ranged from 59 to 81 g/d in elderly females (Munro, McGandy et al. 1987; Woo, 
Cheung et al. 1988; Deschamps, Astier et al. 2002; Correa Leite, Nicolosi et al. 2003; 
Watanabe, Hanamori et al. 2004; Aghdassi, McArthur et al. 2007; Feart, Jutand et al. 
2007; Fulgoni 2008; Meng, Zhu et al. 2009).  In general, elderly men consume more 
protein than elderly women but the percentage energy intake from protein intake was 
similar in both genders and across countries and ranged from 15-19% of total energy.   
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Table 2.8 Dietary protein intakes in relatively healthy elderly population. 
 Country Dietary 
assessment 
method 
Subjects 
number, 
sex 
Age of 
subjects 
(years) 
Protein intake 
mean or 
mean ± SD 
% Protein 
intake (%)
mean or 
±SD 
Fulgoni 
2008 
America 24-hour 
recalls 
618 F 
419 F 
51-70 
71+ 
67 ± 19 g/d 
59 ± 15 g/d 
16±3 
16±2 
Munro 
1987 
 
America 3-day  
food  
diary 
619 M&F
289 F 
158 F 
60-98 
60-75 
≥76 
1.02-1.05 g/kg/d 
 1.02±0.02 g/kg/d† 
  1.06±0.03 g/kg/d† 
NA 
18±0.2 † 
18±0.4 † 
Meng 
2009 
Australia FFQ 862 F 75±3        81±28 g/d 
 1.2±0.4 g/kg/d 
19±3 
Aghdassi 
2007 
Canada 3-day  
food 
record 
108 M 
299 F 
84±8 
86±8 
0.9±0.3 g/kg/d 
1.0±0.4 g/kg/d 
16±2 
15±2 
Feart  
2007 
 
France 24-hour 
recall 
1786 M&F
666 M 
1120 F 
 68-95 75±27 g/d 
85±27 g/d 
69±25 g/d 
18±5 
17±4 
19±5 
Deschamps
2002 
France 3-day  
food 
record 
169  
M&F 
75.4 * 1.33 g * NA 
Correa 
2003 
Italy FFQ 847 M 
1465 F 
≥65 106 g/d 
89 g/d 
17.4 
17.2 
Watanabe 
2004 
 
Japan 3-day 
weighed 
food 
57 M&F 
31 M 
26 F 
74  
1.80±0.35 g/kg/d 
1.51±0.26 g/kg/d 
 
16 
16 
Woo  
1998 
China 
(Hong 
Kong) 
3-day  
food  
recall 
417  
M&F 
≥ 60 1.2 g/kg/d NA 
M: male, F: female; FFQ: food frequency questionnaire; * median.  
† mean ± standard error.  
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2.8 Protein source for dietary intervention 
2.8.1 Digestibility of protein 
Digestibility determines the utilisation of protein by the body.  Ageing does not 
impair the anabolic response to a high-quality protein meal and therefore Paddon-
Jones proposed including 25-30 g of high quality protein per meal for the elderly to 
maximize muscle protein synthesis (Paddon-Jones and Rasmussen 2009).   
 
In general, animal based protein has higher digestibility (FAO/WHO/UNU 1985).  
However, the results are inconsistent.  A study in 38 normal weight, sedentary 
women aged between 57-75 years showed that protein intake particularly from 
animal sources was associated with a better preservation of muscle mass index (MMI 
= Fat-free mass (kg)/height(m)2) (Lord, Chaput et al. 2007).  Fat-free mass was 
measured by DXA, and muscle protein content was measured by the use of 
creatinine excretion.  In contrast, a prospective study with a mean duration of 7.0±1.5 
years on 1000 community-dwelling elderly women aged greater than 65 years 
suggested that a high ratio of dietary animal to vegetable protein increases the rate of 
bone loss and the risk of fracture in postmenopausal women (Sellmeyer, Stone et al. 
2001). However, Heaney suggested that there was inconsistency in Sellmeyer’s 
study, that is the subjects with the highest ratios of animal to vegetable protein intake 
had marginally higher bone mineral densities (BMDs) on entry into their study 
(Heaney 2001).  The positive correlation between protein intake and BMD at 
baseline and negative correlations between protein intake and BMD at follow-up 
need to be further investigated.   
 
It has been suggested that rapidly digested protein, such as whey protein, may be 
more efficient for maintaining muscle mass in the elderly than slowly digested 
protein (Dangin, Guillet et al. 2003).  This may be due to the fact that whey protein is 
rich in essential branched-chain amino acids and thus it has different digestion and 
absorption properties than other proteins (Dangin, Boirie et al. 2002; Hall, Millward 
et al. 2003; Layman 2004; Bowen, Noakes et al. 2006).  The speed of protein 
digestion and amino acid absorption from the gut has a major effect on whole body 
protein anabolism after one single meal (Boirie, Dangin et al. 1997).  The stimulation 
of protein synthesis depends on the sensing of the concentration of extracellular 
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amino acid availability (Bohe, Low et al. 2003).  To date, there is no consensus on 
optimal protein sources for elderly in term of skeletal muscle metabolism, but high 
quality protein rich in essential branched-chain amino acids are suggested by the 
majority of studies.   
 
2.8.2 Whey protein 
Whey protein is a by-product of cheese making.  The major components of dairy 
whey are several proteins (α-lactalbumin, β-lactoglobulin, immunoglobulins, bovine 
serum albumin, glycomacropeptides and lactoperoxidase), peptides, and branched-
chian amino acids (Walzem, Dillard et al. 2002).  It is particularly rich in essential 
branched-chain amino acids (BCAA) (26% in whey protein compared to soy protein 
isolate 18% and wheat protein 15%).  Whey protein appears to play a significant role 
in preserving lean body mass (Walzem, Dillard et al. 2002).  The whey protein 
products also contain some non-protein components, such as lactose, minerals, and 
traces of milk fat.   
 
There are three main types of whey protein supplements: hydrolysed whey protein, 
whey protein concentrate, and whey protein isolate.  The physical composition of 
whey protein depends on the manufacturing procedure.  With the hydrolysed whey 
protein, the protein is broken down into peptides, which gives it a bitter taste and 
makes it costly to manufacture.  Whey protein concentrate products have between 
25%-89% of protein, but the 80% protein content form is the most commonly used.  
Whey protein isolate (WPI) is the purest form which contains 90% to 95% protein 
and has very little lactose (less than 1%) (Toba, Takada et al. 2001).  On the above 
basis, whey protein isolate was selected as the test product in the current study.   
 
2.9 Ageing and body composition  
2.9.1 Body composition in the general population 
Body composition varies by age, gender, racial/ethical groups.  In general, men have 
a higher total body mass and higher percentage of fat-free mass, muscle mass and 
bone mass and lower percentage of body fat mass than women (McArdle 2006).  
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White females have lower fat-free body density than other ethnic groups, including 
native American, African American and Hispanic (McArdle 2006).   
 
2.9.2 Changes in body soft tissue composition with aging 
With aging, there is a loss of lean body mass, and increased body fat mass and 
abdominal fat mass (Bunout, de la Maza et al. 2007; Fantin, Di Francesco et al. 2007; 
Chen, Lin et al. 2008).  Studies in different populations have shown similar trends 
(Guo, Zeller et al. 1999; Chen, Lin et al. 2008).  A study of 301 men and women 
aged 65-97 years in the US found that age related loss of muscle mass could occur in 
relatively healthy well-nourished elderly men and women and had a multifactorial 
basis (Baumgartner, Waters et al. 1999).  Physical activity, underlying disease, IGF-1 
level and body fat mass were found to be significantly associated with muscle mass 
(Baumgartner, Waters et al. 1999).   
 
Lean body mass peaks during the 5th decade (Chen, Lin et al. 2008) and the decline is 
accelerated after 60 years of age (Kyle, Genton et al. 2001; Chen, Lin et al. 2008).  A 
cross-sectional study of 433 healthy ambulatory Caucasian men and women from 18 
to 94 years of age showed that  whole body lean mass measured by DXA decreased 
by 11.8% and 9.7% in men and women aged over 75 year compared to the 18 to 34 
years old subjects, respectively (Kyle, Genton et al. 2001).  The appendicular skeletal 
muscle mass decreased 16.4% and 12.3% in men and women respectively.  This 
indicates that the loss of skeletal muscle mass was greater than the loss of non-
skeletal muscle mass.  Another cross-sectional study of 316 healthy Chinese women 
aged 20 to 74 years found that bone mineral content (BMC) and whole body lean 
mass measured by DXA declined 18.1% and 5.2% respectively at age 74 years 
(Chen, Lin et al. 2008).  The differences in the definition of body lean mass between 
these two studies may explain the differences in the rate of loss of body lean mass.  
In Kyle’s study, whole body lean mass includes bone mineral content, but Chen’s 
study whole body lean mass referred to bone-free lean mass.  A cross-sectional study 
in the US used the whole body magnetic resonance imaging to measure skeletal 
muscle mass in 468 men and women (Janssen, Heymsfield et al. 2000).  The majority 
of participants were Caucasian (67%), 17% were African-American, 8% were Asian 
and 7% were Hispanic.  The study observed a small reduction of skeletal muscle 
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mass in the third decade and an increased rate of loss that started at the end of the 
fifth decade.  They also found a curvilinear correlation between skeletal muscle mass 
and body weight.   Total skeletal muscle mass decreased about 17% and 18% in 
women and men respectively after age of 70 years compared to those of age of 39 
years or younger.  
 
Several longitudinal studies have also shown that muscle mass decreases by 
approximately 1% per year after age 65 (Frontera, Hughes et al. 2000; Visser, Pahor 
et al. 2003).  A study examined the changes in skeletal muscle size and functions in 
twelve sedentary men (initial mean age 65 years) over a period of 12 years (Frontera, 
Hughes et al. 2000).  The cross-sectional area of the thigh, all thigh muscles, 
quadriceps femoris muscle and flexor muscles assessed by the computed tomography 
showed reductions ranged from 12.5% to 16.1%.  A population based study assessed 
the body composition in 2040 well-functioning black and white American men and 
women aged 70-79 years at baseline and after 1 year  and 2-year follow-up (Visser, 
Pahor et al. 2003).  In women, total body mass decreased by 0.4% at 2 years, and fat-
free mass decreased 0.6% after 2 years with no change in body fat mass.  Among 
men, total body mass decreased by 0.3%, fat-free mass decreased by 1.1% and there 
was an increase in total fat mass of 2%.   
 
Mazariegos investigated the body composition in 19 weight- and height- matched 
pairs of young (age 19-35 years) and older (age>65 years) healthy white females 
using isotope dilution, dual photon, whole-body counting, hydrodensitometry and 
anthropometric method (Mazariegos, Wang et al. 1994).  They also found that the 
older females had significantly high total body fat, significantly less fat-free body 
mass and total body water when compared with the younger females (Mazariegos, 
Wang et al. 1994).  Age-related decline in fat-free mass reached significance in white 
women at age 75-79 years (Obisesan, Aliyu et al. 2005).  Skeletal muscle mass 
decreased with aging in both men and women (Gallagher, Visser et al. 1997; Fantin, 
Di Francesco et al. 2007).  The decreases in fat-free mass with aging were smaller in 
women than in men, and had wide inter-individual variation depending on the degree 
of weight change (Gallagher, Visser et al. 1997; Hughes, Frontera et al. 2002).  In the 
elderly, with weight loss, there was significantly more lean mass loss than fat mass 
loss (Newman, Lee et al. 2005).   
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Both weight gain and weight loss are common in the elderly.  The factors involved in 
the changes of body composition with age are a decline in physical activity, a decline 
in basal metabolic rate, a decrease in the synthesis rates of muscle protein (Nair 2005; 
Short, Bigelow et al. 2005), a decrease in IGF-1 levels and inadequate nutritional 
intake.    
 
2.10 Body composition assessment 
2.10.1 History and overall of assessing human body composition 
Human body composition can be assessed directly or indirectly.  There are two 
methods used to assess body composition directly: chemical analysis and cadaver 
dissection (McArdle 2006).  Both are costly, time-consuming, and also involve 
ethical issues (Driskell 2000).  The most complete cadaver dissection study was 
conducted by Clarys and colleagues in 1984 (Clarys, Martin et al. 1984).  A total of 
25 cadavers sampled from an elderly Belgian population were dissected into gross 
tissue masses of skin, adipose tissue, muscle tissue, bone, and residuals.  The results 
showed that females had higher percentage of adipose tissue and less muscle tissue 
than males.  There were 40.5% and 28.1% of adipose tissue in females and males 
respectively, and 28.6% and 37.4% of muscle tissue in females and males 
respectively.   
 
All other body composition methodologies provide indirect assessment of body 
composition.  Body composition can be assessed at five levels: atomic level, 
molecular level, cellular level, tissue-organ level and whole-body level (Wang, 
Pierson et al. 1992).  Beside anthropometry measurements, currently available 
methods for research include underwater weighing (UWW), hydrometry (total body 
water), whole-body counting (total body potassium) and neutron activation analysis, 
dual-energy x-ray absorptiometry (DXA), bioelectrical impedance analysis, and 
computed tomography and magnetic resonance imaging (Shen, St-Onge et al. 2005).  
These methods are mainly based on the most common approach, which is to consider 
body mass as two compartments: fat and fat-free mass.  It is based on the knowledge 
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that lipids are hydrophobic and thus free of water.  Therefore, fat mass, percentage 
body fat and fat-free mass can be calculated from total body water (Schoeller 2005).   
 
Underwater weighing was long considered as the ‘gold standard’ for assessing body 
composition and used as the reference criterion to validate other body composition 
assessment methods.  Recently, other techniques have been shown to be as reliable 
and precise as UWW.  These include total body water (TBW); total body potassium 
(TBK); and dual energy x-ray absorptiometry (DXA).  DXA is now the most 
commonly used method to assess body composition.  This is due to its relatively 
simple operating procedure, low cost, and wide availability in many institutions.  In 
the current study, DXA was used to assess the body composition.   
 
2.10.2 Dual-energy x-ray absorptiometry 
2.10.2.1 DXA history and types  
Dual-energy x-ray absorptiometry (DXA) was developed from dual-photon 
absorptiometry.  It was originally designed to estimate bone mineral content (BMC) 
and bone mineral density (BMD).  A dual-energy x-ray absorptiometry has an x-ray 
tube with low- and high-energy peaks which  allow it to measure fat-free mass 
(FFM) and fat mass (FM).  FFM is also called lean soft tissue mass.   
 
There are two types of DXA: pencil-beam DXA and fan-beam DXA.  The current 
study used the Hologic 4500A, an advanced version of the fan-beam DXA.  The 
analyses are reported as fat mass, bone-free lean mass, lean mass combined with 
bone mineral content (BMC), BMC and BMD.  The analysis of fat mass and lean 
mass is reported for whole body and for regional (head, arms, trunk and legs).   
 
There are two assumptions used in the DXA which are related to the assessment of 
whole body soft tissue (Lohman and Chen 2005).  Firstly, DXA assumes the constant 
attenuation of pure fat and of bone mineral-free lean tissue.  Secondly, it is assumed 
that DXA measurements are not affected by body thickness.  However, DXA is 
unable to distinguish the thickness of soft tissue but uses a Step Phantom to adjust for 
tissue thickness.   
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The advantages of using DXA to assess body composition are the very low radiation 
exposure, wide availability and low cost (Wang, Wang et al. 1999).  The radiation 
exposure ranges from 0.02 to 1.5 mrem depending on the instrument and the scan 
speed and can be used for subject of all ages (Lohman and Chen 2005).  This dosage 
is very low compared with yearly background radiation (e.g. radiation from gas from 
ground and cosmic rays), which is about 1.9 mSv (equals to 190 mrem) in Perth, 
Australia.  1 mrem equals to 0.01 mSv (Australia and New Zealand Bone and 
Mineral Society 2005).   
 
2.10.2.2 Validation of DXA measured fat mass and fat-free mass 
There is a general agreement that DXA is a precise method to estimate whole body 
and regional body composition including lean soft tissue and appendicular muscle 
mass, fat mass and bone mineral density.  Although the precision for estimation of 
regional composition is less than for total body composition (Lohman and Chen 
2005).  
 
The accuracy of DXA depends on the subjects’ body thickness and size, calibration 
procedures, instrument and software version, company and model.  The coefficients 
of variation (CV) for DXA measured fat mass, lean mass and fat mass vary between 
labs depending on the DXA machine type and brand.  The CVs of DXA (Hologic 
4500A) for total lean mass and total fat mass of our lab were 1.1% and 1.6% 
respectively.   
 
Salamone and colleagues evaluated the accuracy of total body fat mass (FM) and leg 
fat-free mass (FFM) measured by Hologic 4500A in 60 healthy elderly (aged 70-79 
years) compared with computed tomography (CT) (Visser, Fuerst et al. 1999; 
Salamone, Fuerst et al. 2000).  They suggested DXA is an accurate method for the 
measurement of fat mass and fat-free mass for the elderly though there is a 
systematic overestimation of fat-free mass and underestimated of fat mass.  
Schoeller, Tylavsky and colleagues had the similar results using the Hologic QDR-
4500A DXA scanner (Tylavsky, Lohman et al. 2003; Schoeller, Tylavsky et al. 
2005).  Schoeller and colleagues compared DXA measured body composition (fat 
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mass and fat-free mass) from seven studies, with total body water from four centres, 
densitometry from one centre, and four-compartment analysis at two centres 
(Schoeller, Tylavsky et al. 2005).  The study cohort included 1195 subjects, 602 men 
and 593 women aged 18-82 years with a body mass index of 16-44 kg/m2.  They 
found that the fan-beam DXA significantly overestimated fat-free mass (p < 0.05), 
and there was a significant difference in all seven data sets for the fat-free 
measurements (mean±SE was 5±1%).  They recommended that the FFM estimate 
with the Hologic QDR 4500A be reduced by 5% and for FM be increased by 5%.   
 
2.10.2.3 Validation of DXA measured regional body composition 
DXA measured regional body composition such as abdominal fat and limb muscle 
mass have also been validated.  Svendsen and colleagues found that DXA measures 
of abdominal fat accounted for 80% of the variance in the intra-abdominal fat 
assessed by computed tomography (CT) (Svendsen, Hassager et al. 1993).  Snijder 
and colleagues studied 3075 black and white men and women age 70-79 years 
(Snijder, Visser et al. 2002).  They found the trunk fat measured by Hologic QCR 
1500 DXA was strongly correlated with total abdominal fat derived from CT scan at 
the L4-L5 level (r = 0.84 in white women).   
 
2.10.2.4 Validation of DXA measured changes in body composition 
The ability of DXA to detect the changes in body composition has been validated by 
comparing the DXA measurements to other criterion body composition 
measurements, such as densitometry and UWW.  DXA estimated percentage change 
of body fat mass was found to have comparable accuracy to estimates obtained using 
other methods (Evans, Saunders et al. 1999).  A study in 17 subjects during a 
dehydration-rehydration protocol found that DXA is able to detect small individual 
changes in the total body mass and soft-tissue mass (Going, Massett et al. 1993).  A 
16-week intervention study of combined diet and exercise found that the 
Coefficients’ of Variation of changes in percentage of body fat measured by DXA, 
bioelectrical impedance analysis and body mass index were similar, ranging from ± 
2.0-2.4% (Evans, Saunders et al. 1999).   
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DXA was more accurate in assessing body fat mass (FM) in elderly men and women 
when compared to underwater weighing (UWW) and the total body water method 
(TBW) (Goran, Toth et al. 1998).  When using UWW, there was significant 
overestimate of fat mass among leaner subjects and an underestimate in fatter 
subjects.  For TBW, there was a significant underestimation of fat mass among 
leaner subjects and overestimation in fatter subjects.  In Goran’s study (1998), a four 
compartment model was used as a criterion method. The four compartment model is 
based on the chemical model of body composition, that is, water, mineral, protein 
and fat, presented by Heymsfiled et al (Heymsfield, Lichtman et al. 1990).  As all 
indirect methods are based on assumptions (detailed in the following sections), the 
four compartment model combines the components which can be measured directly 
without assumptions in different methods and then combined using a complex 
model.  This model assumes densities of 0.9 g/cc for fat, 0.99g/cc for water, 3.042 
g/cc for bone mineral and 1.34 g/cc for the unmeasured fraction of the body 
composed of protein and glycogen (Baumgartner, Heymsfield et al. 1991).  Body 
water can directly be measured by the isotope dilution method without any 
assumptions and bone mineral is measured by DXA.  The four compartment model 
combines these direct measures with a direct measure of total body density by 
hydrodensitometry in a model to estimate body fat mass with minimal assumption.   
 
Although several studies have shown a good agreement between DXA and other 
criterion methods, since all methods are indirect, it is difficult to determine which 
method gives the best agreement with the true tissue masses.   
 
2.10.2.5 Validation of DXA measured muscle cross-sectional area  
Computed tomography (CT) and magnetic resonance imaging are the current 
criterion methods for measuring muscle cross-sectional area.  DXA is not a validated 
method for measuring muscle cross-sectional area, and especially for evaluating any 
changes (Hansen, Williamson et al. 2007).  A study compared mid-thigh muscle 
mass estimated by DXA, a relatively cheaper and more accessible method, with the 
mid thigh muscle cross-sectional area measured by CT in 30 elderly hospitalized 
patients (aged 81±8 years) recovering from hip fracture (Hansen, Williamson et al. 
2007).  Fat-to-lean soft tissue ratios were calculated in both methods.  They found 
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that the baseline ratios of mid-thigh fat-to-lean ratios were similar in the two 
methods, but the DXA measured follow-up changes of fat-to-lean ratio was only 
weakly correlated with CT measurements.  The authors suggested that DXA 
measured muscle cross-sectional area should not apply to individuals or to evaluate 
the response to interventions (Hansen, Williamson et al. 2007).   
 
2.10.2.6 Animal validation studies of DXA 
Several animal studies evaluated the accuracy of body composition measurement by 
DXA (Hologic and Lunar instruments) compared with the direct method of chemical 
analysis.  Often these studies are difficult to compare as different DXA machines and 
different versions of software have been used. A study assessed the accuracy of 
body-composition measured by Lunar DPX (3.2) in seven pig carcasses compared to 
the chemical analysis after post-mortem homogenization (Svendsen, Haarbo et al. 
1993).  The study showed that the correlation r values between DXA measurements 
and chemical analysis for fat mass, lean body mass, and percent fat were all >0.97.  
The mean differences in body composition measurements between the DXA 
measurements and those by chemical analysis were all insignificant (all p>0.05: -
2.2±1.0%, -1.7±0.8kg, and 0.4±1.2kg for percentage of fat mass, fat mass and lean 
body mass, respectively).   
 
Another study assessed the accuracy and reproducibility of the Hologic QDR 2000 in 
13 piglets (Picaud, Rigo et al. 1996).  The authors found that the DXA measured 
body weight, bone mineral content, and fat mass were significantly correlated with 
body weight, ash weight, chemical calcium, and chemically measured fat.  Body 
weight was accurately measured by DXA, but fat content was overestimated by 
DXA.  The precision of DXA was 0.23% for body weight and 4.44% for calcium 
content.  The precision of DXA measured fat content was 8.85% compared to the 
chemical fat analysis.   
 
2.10.3 Underwater Weighing 
The Underwater weighing (UWW) method is based on Archimedes’s principle of 
buoyancy. It measures body density and calculates fat mass and fat-free mass using 
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equations. When a subject is submerged in water; body volume is equal to the loss of 
water corrected for the density of water corresponding to the temperature of the 
water at the time of the submersion (Going 2005).  The equation is shown as below: 
 
Body volume = (weight in air – weight in water) / water density 
Water density depends on water temperature.  It is 0.9937 when the water 
temperature is at 36oC (Brozek, Grande et al. 1963).   
 
Once volume is known, body density can be calculated as following equation (Going 
2005):  
Body density = body mass / body volume 
 
Air in the lungs and flatus in the gastrointestinal tract need to be corrected in the final 
calculation.  The residual volume is the volume of air remaining in the lungs after 
maximal expiration (Rhoades 2008).  It is commonly measured by the closed circuit 
nitrogen/oxygen dilution method of Wilmore (Wilmore 1969).   
 
When the constant densities of fat (0.09 g/mL) and non-fat (1.10 g/mL) at 36oC are 
assumed (Brozek, Grande et al. 1963), percentage of body fat can be calculated as 
following commonly used equations proposed by Siri (Siri 1993) or Brozek et al 
(Brozek, Grande et al. 1963): 
 
Siri:    % Fat = (4.95/D – 4.50) x 100 
Brozek et al: % Fat = (4.570/D – 4.142) x 100 
Where D = body density   
 
Going reviewed previous studies and found that in adults, within-subject coefficients 
of variation for percent body fat have ranged from 1.7-4.5% within a day, and from 
2.0-2.3% between days (Going 2005).   
 
The limitations of UWW include biological error and technical error.  The major 
source of biological error is likely to be due to the assumption of constant density of 
the fat-free mass (Adams, Mottola et al. 1982).  In a study in 29 Canadian 
professional football players, negative values for percent body fat were obtained by 
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using the Siri’s formula (Adams, Mottola et al. 1982).  This was because of the very 
high density of fat-free mass of these athletes.  The major source of technical error is 
due to the variation of the entrapped air in the lungs (measured as residual volume) 
and gastrointestinal tract (Goldberg, Black et al. 1991).   
 
2.10.4 Air displacement plethysmography 
More recently, whole body air-displacement plethysmography body composition 
system, known commercially as BODPOD has been developed and commercially 
available since 1994 (Dempster and Aitkens 1995).  The BOD POD is based on the 
air displacement plethysmography (ADP) measurement of body volume (Dempster 
and Aitkens 1995).  It is based on similar principles to hydrostatic weighing or 
underwater weighing (McCrory, Mole et al. 1998; Fields, Higgins et al. 2005).  The 
difference is that  the method uses air displacement which is more convenient and 
comfortable than water displacement (Dempster and Aitkens 1995),and  therefore, 
this method can  be used to measure infant body composition (Urlando, Dempster et 
al. 2003).  This method has been validated in overweight and obese middle age 
populations (Ginde, Geliebter et al. 2005; Minderico, Silva et al. 2006), healthy 
middle age adults (Iwaoka, Yokoyama et al. 1998), and in children (Sainz and 
Urlando 2003).  A study of  a 16-month weight loss intervention in 93 healthy female 
aged 39±6 years found that the change in total body fat mass measured by DXA and 
ADP were similar (Minderico, Silva et al. 2006).  A validation study compared BOD 
POD and under-water weighing in assessing total body density, and compared the 
BOD POD with the four-compartment model in assessing percentage body fat 
(Fields, Wilson et al. 2001).  In their study, total body water was determined by 
isotope dilution and bone mineral was determined by dual-energy x-ray 
absorptiometry, body density and percentage of body fat were determined by BOD 
POD and under-water weighing.  The four-compartment model was used as the 
criterion measure of body fat.  The study showed there was no significant difference 
in total body density assessed by BOD POD compared with under-water weighing.  
However, the percentage of body fat measured by BOD POD was significantly lower 
than was assessed by the four-compartment model (2.2% lower, p<0.01), which 
indicates that BOD POD under predicted body fat when compared with the four-
compartment model.  A review of validation studies of the ADP method suggested 
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that this method appeared to be a suitable and reliable instrument for the assessment 
of body composition in a wide range of populations and more studies are needed to 
understand sources of measurement error (Fields, Higgins et al. 2005).   
 
2.10.5 Total body water 
Total body water (TBW) measures total body water by measuring the dilution of 
isotopic tracers.  It can estimate body composition at three levels: molecular, cellular 
and tissue.  There are four assumptions, in the measurement of total body water by 
dilution (Schoeller 2005): 
1. The tracer is distributed only in body water 
2. the tracer is equally distributed in all anatomical water compartments 
3. The rate of equilibration of the tracer is rapid 
4. Neither the tracer nor body water is metabolized during the time of tracer 
equilibration. 
 
The widely used two-compartment TBW and other hydrodensitometry methods to 
predict fat-free body mass (FFM) are based on the following equation which assumes 
that everybody has a constant hydration level which is 0.73 of body fat-free mass 
(Mazariegos, Wang et al. 1994): 
TBW/FFM = 0.73 kg/kg 
The density of FFM = 1.100 g/cubic centimetre 
 
This assumption is not applicable for people who are dehydrated or who have 
oedema (Schoeller 2005).  Since there is a general loss of total body water from 
tissues with aging (Schoeller 1989; Aloia, Vaswani et al. 1998), the error would 
occur due to using the same defined parameter to predict body composition for 
elderly people.  The precision of the total body water method is between 1% and 2% 
(Schoeller 2005).  It can be achieved by paying careful attention to details of each 
aspect of the measurement procedures, such as subject preparation, dosing, sample 
collection, and isotope analysis (Schoeller 2005).   
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2.10.6 Whole body counting 
Whole body counting uses nuclear based techniques to measure whole body content 
of chemical components, such as potassium calcium, phosphorus, sodium, chlorine, 
nitrogen, hydrogen and carbon (Ellis 2005).   
 
Total body potassium (TBK) is the commonest used whole body counting method 
for assessing body composition, because more than 90% of the body’s potassium is 
found in fat-free tissues (Hammond 2004).  Natural potassium is distributed in three 
isotopic states: 93.1% 39K, 6.9% 40K and 0.0118% 40K.  Only 40K is radioactive.  
Whole-body counter detects 40K signal from the body and then the signal converts to 
a quantitative assay for the total body potassium.  To convert TBK to the body’s fat-
free mass (FFM), the TBK-FFM ratio of 68.1 mmol/Kg FFM (Forbes and Lewis 
1956) is commonly used.  Recent studies showed that the ratio could be lower and 
differ by gender and age (Wang, Pi-Sunyer et al. 2001; He, Heo et al. 2003).  Thus, 
caution is needed when TBK is used solely to assess FFM.  The TBK precision range 
is between 2% and 5% (Cohn and Parr 1985).  However, the accuracy of the TBK 
estimate for each whole-body counter is less firmly established (Ellis 2005).   
 
Recently, the whole body potassium method also has been used to assess skeletal 
muscle mass.  Wang and colleagues proposed ratios of total body potassium to whole 
body skeletal muscle (SM) for men and women, which are 119.9 ± 6.7 mmol/kg and 
118.7 ± 8.4 mmol/kg respectively (Wang, Zhu et al. 2003).  The ratio tended to be 
lower in subjects aged 70 years or over.  They studied 300 men and women of 
various ethnicities and found a strong correlation between TBK and skeletal muscle 
mass (r = 0.97, P < 0.001).   
 
2.10.7 Bioelectrical impedance analysis 
Bioelectrical impedance analysis (BIA) assesses the relationship of body 
composition to the water content of the body (Chumlea and Sun 2005).  It requires a 
regression equation validated against a criterion body composition method, such as 
TBW or DXA.  This is the only way to interpret the BIA value.  However, cross-
validation studies assessing BIA and other body composition measurement methods 
are few.  BIA was found to have systematically higher value for fat-free mass 
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(Boneva-Asiova and Boyanov 2008), and lower values for fat mass and percentage 
of fat mass than DXA.  Variation of the difference also depends on gender and body 
weight status (Boneva-Asiova and Boyanov 2008; Volgyi, Tylavsky et al. 2008).   
 
The ability of BIA to estimate changes in body composition over time is debatable.  
Phillips and colleagues found BIA provided accurate estimates of the change in both 
fat-free mass and percentage of body fat over time in 196 non-obese girls (Phillips, 
Bandini et al. 2003).  Lohman and colleagues found BIA is less reliable than 
skinfolds in assessing body composition changes over 3 years (Lohman, Thompson 
et al. 2003).   
 
2.10.8 Computed tomography and magnetic resonance imaging 
Computed tomography (CT) and magnetic resonance imaging (MRI) are considered 
the most accurate methods for assessing body composition at the tissue-organ level 
(Ross and Janssen 2005).  They are used as criterion methods to calibrate other 
methods of assessing adipose tissue and skeletal muscle in vivo (Ross and Janssen 
2005).   
 
The principle of CT is to measure x-ray attenuation relative to air and water.  They 
are defined as -1000 to 0 Hounsfield units (HU) for air and water respectively.  The 
density of adipose tissue is lower than water, therefore adipose tissue pixels normally 
range from -190 to -30 HU (Kvist, Chowdhury et al. 1988; Chowdhury, Sjostrom et 
al. 1994; Yoshizumi, Nakamura et al. 1999).  The density of skeletal muscle is 
greater than water, thus its pixels ranges are from 30 to 100 HU (Chowdhury, 
Sjostrom et al. 1994).  MRI uses a magnetic field to align the nuclear magnetization 
of hydrogen atoms in water in the body (Ross and Janssen 2005).  Radio frequency 
fields are used to systematically alter the alignment of this magnetization and 
produce a rotating magnetic field detectable by the scanner to construct an image of 
the body (Tidwell and Jones 1999).   
 
Both CT and MRI can measure the quality of skeletal muscle.  The average 
Hounsfield units of skeletal muscle from CT can be used as an index of skeletal 
muscle lipid content and it was reported to be well correlated with skeletal muscle 
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lipid level determined by muscle biopsy samples (Goodpaster, Kelley et al. 2000).  
The total muscle fat assessed by imaging was strongly correlated with total muscle 
fat determined by magnetic resonance spectroscopy (Schick, Machann et al. 2002).   
Despite the high accuracy of CT and MRI in body composition assessment, the high 
cost and technical skill required in both methods limit their use in large population 
studies. 
 
2.10.9 Peripheral quantitative computed tomography (pQCT)  
Peripheral quantitative computed tomography (pQCT) can be used to assess cross 
sectional muscle structure although it was originally designed to assess cross-
sectional bone structures.  The advantage of using pQCT is the low dose of radiation 
exposure.   
 
The conventional site for studying leg cross-sectional muscle area by using pQCT is 
at 66% of the tibia length, proximal to the terminal end of the tibia (Miljkovic-Gacic, 
Gordon et al. 2008).  The reason to use this site is because it is the region of the 
largest circumference of the calf with very little variability across individuals 
(Simonsick, Maffeo et al. 1997).   
 
There are different models of scanner that can be used depending on the research 
purpose, such as the radius scan model, the tibia scan model or the muscle scan 
model.  The scan image can be analysed by using the software the pQCT producer 
provided to generate data of bone area and volumetric bone density.  If the muscle 
scan model is chosen at the scan stage, the scan image can be analysed using the 
software to generate data of muscle area and intermuscular fat content.  However, 
when the bone scan model is used at the scan stage, although the scan image contains 
muscle image, muscle area is not able to be generated automatically by using the 
analysis software.  For the current study, since the primary interest of the 
intervention study was bone structure, the bone scan model was used, therefore, the 
muscle area was analysed by tracing muscle edge manually, and this method is not 
able to analyse the intermuscular fat content.   
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2.10.10 Anthropometry 
Anthropometry can assess body size and composition.  The anthropometry 
instruments are relatively inexpensive, the measurements non-invasive and suitable 
for the field.  Anthropometry can provide valuable information when done by a 
trained or experienced anthropometrist.  However, the accuracy and sensitivity of 
using anthropometry to monitor small changes in muscle mass associated with 
weight loss or gain in an individual are not clear (Lukaski 2005).   
 
The commonly used anthropometric measurements related to body composition 
assessment include height, weight, skinfolds and, girth measurements.  In general, 
anthropometry is less accurate and sensitive in predicting body composition. 
Anhtropometry also has many limitations in measuring and predicting regional body 
composition when used alone (Bellisari and Roche 2005).  
 
2.10.10.1 Height, weight and BMI  
Anthropometric variables of height and body weight are most commonly reported as 
various indices with the most common being the Body Mass Index (BMI). Height is 
positively correlated with fat-free mass (Kerr, Papalia et al. 2007), but has low 
correlation with percentage body fat (Bellisari and Roche 2005).  Neither height nor 
weight is an effective predictor of fat mass and lean body mass when used alone but 
best reported as an indice.   
 
The BMI can be calculated from height and weight as the following equation: BMI = 
weight (kg) / height2 (m2).  BMI has been widely used as an indicator of relative 
fatness and body frame size in many epidemiological studies.  According to World 
Health Organization, the classification of BMI is as shown below regardless of sex 
(2000): 
Underweight:   <18.5 
Normal:   18.5 – 24.9 
Overweight (or pre-obese):  25 – 29.9 
Obese level 1:   30 – 34.9 
Obese level 2:   35 – 39.9 
Obese level 3:   ≥ 40 
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Although BMI is an acceptable approximation of total body fat at the population 
level, caution is needed when interpreting the correlations between BMI and chronic 
disease.  This is because some subjects can be misclassified by this method, such as 
obese individuals (Rothman 2008), muscular individuals (Witt and Bush 2005), the 
elderly (Baumgartner, Heymsfield et al. 1995; Miller and Wolfe 2008) and Asian 
populations (Dudeja, Misra et al. 2001).  Older adults have more fat than younger 
adults at any BMI due to the loss of muscle mass with age (Baumgartner, Heymsfield 
et al. 1995).   
 
2.10.10.2 Skinfold thickness for assessing body fatness 
Skinfold thickness measures subcutaneous adipose tissue (Khatoon, Tapadar et al. 
2008).  A skinfold caliper reading is the measurement of the thickness of a double 
fold of skin and compressed subcutaneous adipose tissue.  Skinfold readings can be 
measured at different sites of the body.  The triceps and biceps skinfolds are 
commonly used in clinical research for predicting total body fatness.  Skinfold 
thicknesses have high correlations with body fat mass and percent of body fat mass 
(Khatoon, Tapadar et al. 2008).  There are more than 100 equations to predict 
percentage body fat from skinfolds, but these equations are age, sex, population and 
site specific (Lohman 1981; Johnston 1982).  As well as the error inherent in using 
prediction equations, error also occurs in measuring skinfold itself.   
 
The precision of the skinfold measurement is highly dependent on technician skill, 
type of skinfold caliper used and subject factors (e.g. a person’s unique body fat 
distribution) (Heyward, Cook et al. 1992).  By far the most variable factor appears to 
be skinfold compressibility. Significant inter-subject and inter-site differences in 
skinfold compressibility were observed in cadavers (Martin, Ross et al. 1985).  
Skinfold measurements may also be less reliable in older subjects with less 
connective tissue or in obese individual with large folds (Irwin 2006).  Minimising 
measurement error is therefore an important issue in skinfold assessment. Training of 
the anthropometrist, use of a standard protocol and calibrated skinfold callipers are 
all important ways to minimise measurement error (Marfell-Jones, Olds et al. 2006).  
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2.10.10.3 Waist circumferences and waist-to-hip ratio for assessing body fatness 
Age and population specific waist circumference and waist-to-hip ratio (WHR) have 
been used to assess the distribution of body fat in  overweight and obesity (Molarius, 
Seidell et al. 1999).  They have also been used as predictors of cardiovascular risk 
factor in different populations as these measures have been found to provide an 
indirect measure of internal visceral body fat (Huang, Lin et al. 2002; Shahraki, 
Shahraki et al. 2008).  The cut-off points related to health are related to  different 
gender and ethnic groups (Mohan, Deepa et al. 2007).   
 
For women, a waist circumference greater than 80 cm indicates excess internal fat 
deposition and an increasing risk of non-communicable diseases (Han, van Leer et al. 
1995; Expert Panel on the Identification Evaluation and Treatment of Overweight in 
Adults 1998).  Waist circumference had higher sensitivity and specificity for 
identifying cardiovascular risk factors when compared to WHR  or with other 
anthropometry measurements (Esmaillzadeh, Mirmiran et al. 2006).  Studies showed 
that waist circumference was highly correlated with intra-abdominal fat volume 
(Han, McNeill et al. 1997), and its reduction in obese subjects was significantly 
correlated with the fall of total cholesterol, low-density lipoprotein, and diastolic 
blood pressure (Han, Richmond et al. 1997).  Height has little influence on using 
waist circumference to predict intra-abdominal fat volume in women (Han, McNeill 
et al. 1997).   
 
WHR was reported to be a poor indicator of abdominal visceral fat in women 
(Rankinen, Kim et al. 1999).  A randomized controlled trial showed that the changes 
in WHR were not associated with changes in any cardiovascular risk factors in 110 
overweight or obese women (Han, Richmond et al. 1997).  A cross-sectional study of 
a random sample from 18 populations in UK aged 25-64 years found that the age 
standardized mean waist and hip circumferences and WHR ranged 78-91 cm, 97-108 
cm, and 0.76-0.84 in women (Molarius, Seidell et al. 1999).  It is still being debated 
as to whether waist circumference or WHR is the better predictor of cardiovascular 
risk.   
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2.10.10.4 Arm, thigh and calf circumferences 
Arm muscle area or corrected arm muscle area have been used to predict whole body 
lean mass, and has been used as indicator of malnutrition in the elderly (Miller, 
Crotty et al. 2002).   
 
Arm muscle area (AMA) is calculated from triceps skinfold thickness and mid upper 
arm circumference as in the following equations (Heymsfield, McManus et al. 1982):  
 
Arm muscle area (mm2) = (Mid upper arm circumference – π (skinfold))2 / 4π 
Mid upper arm circumference and skinfold are in millimetre (mm) 
 
Corrected arm muscle area (CAMA) which corrects for bone is: 
For women: Corrected arm muscle area (mm2) = arm muscle area (mm2) – 6.5 
For men: Corrected arm muscle area (mm2) = arm muscle area (mm2) – 10 
The within-subject errors of corrected arm muscle area were 7-8% compared to 
computed tomography values (Heymsfield, Olafson et al. 1979).  
 
Total body muscle mass can be predicted by the following equation: 
Total body muscle mass (kg) = (height cm2) (0.0264 + 0.0029 x corrected AMA) 
 
Limb composition, especially leg muscle mass, is important in the elderly, because it 
has been found to be related to the prevalence of falls and fractures (Bellisari and 
Roche 2005).  The US Health ABC study in 3075 well-functioning black and white 
men and women aged 70-79 found that lower cross-sectional thigh area measured by 
computed tomography was associated with increased risks of self-reported mobility 
loss (Visser, Goodpaster et al. 2005).   
 
However, thigh or calf girth measurements provide limited information about the leg 
muscle composition, such as cross-sectional muscle size.  It is difficult to predict 
subcutaneous fat or fat infiltration in the muscle based on limb girth measurements 
alone.   
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Mid-arm circumference was not reliable in predicting lean tissue mass in 354 elderly 
Chinese females aged 69-82 years when compared to DXA measurements (Kwok, 
Woo et al. 1997).  A 3-year longitudinal study of 2032 Hong Kong Chinese aged 70 
and older failed to find any significant change in corrected upper arm muscle area 
over the study period (Woo, Ho et al. 2001).  This may be due to the short study 
duration.  Calf circumference was found to be positively correlated to plantar flexor 
maximum voluntary contraction strength in 39 premenopausal women (Bamman, 
Newcomer et al. 2000).  Their study also found that the cross-sectional muscle size 
determined by magnetic resonance imaging (MRI) correlated to strength better than 
the limb anthropometric measurement (leg circumference).   
 
A study used computed tomography to assess the composition of muscle cross-
sectional area of 13 young and 11 elderly men (Overend, Cunningham et al. 1992).  
The results showed that there was no difference in the total thigh cross-sectional area 
between the young and elderly men. Compared with the young men, the elderly men 
had significantly smaller muscle areas.  The elderly men also had significantly 
greater cross-sectional thickness of skin plus subcutaneous fat, and non-muscle tissue 
within muscles.   
 
Hilton and colleagues compared the leg muscle composition of 6 obese, diabetic and 
peripheral neuropathy patients to 6 healthy obese subjects by magnetic resonance 
imaging (Hilton, Tuttle et al. 2008).  They found that although the leg muscle and fat 
volumes were similar in the two groups, the calf intermuscular adipose tissue 
volumes were significantly higher in the subjects with obesity, diabetes and 
peripheral neuropathy.  The excess fat infiltration in leg skeletal muscle was 
associated with low calf muscle strength, low calf muscle power, and impaired 
physical function.   
 
When using circumference measurements to assess the change of muscle mass, the 
proportionality between size and composition is not always constant (Heymsfield, 
Stevens et al. 1982).  This means that the changes in girth do not always represent 
the changes in muscle size, because the girth measurement cannot distinguish the 
changes that are due to the changes in subcutaneous fat or muscle.  To assess 
sarcopenia in elderly, therefore, girth measurements should be combined with other 
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measurements such as DXA or computed tomography to assess the changes in 
muscle size.   
 
2.11 Muscle strength in the elderly 
2.11.1 Aging and muscle strength 
In general, muscle strength progressively declines from 30 years (Vianna, Oliveira et 
al. 2007) and with greater losses in the elderly (Mateo Lazaro, Penacho Lazaro et al. 
2008).  A cross-sectional and longitudinal study in 847 men and women aged 20-100 
years showed that hand grip strength increased into the thirties and then declined at 
an accelerated rate after 40 years (Kallman, Plato et al. 1990).  Knee extension 
strength declined 14% per decade and knee flexion strength declined 16% per decade 
(Hughes, Frontera et al. 2001).  The age-associated differences in muscle strength are 
highly correlated with the age-related differences in muscle mass (Kallman, Plato et 
al. 1990).   
 
Previous studies showed that there is a gender difference in the rate of loss in muscle 
strength between the upper and lower extremities.  A study reviewed medical records 
collected from 1994 to 2005 in 3648 men and women aged between 18 and 90 years 
(Vianna, Oliveira et al. 2007).  The study found that handgrip strength declined with 
age and differed between genders.  A faster decline in handgrip strength occurred at 
age 30 years for men and 50 years for women.   
 
A longitudinal study examined the changes in elbow and knee strength in 120 
community-dwelling men and women initially aged 46 to 78 years (Hughes, Frontera 
et al. 2001).  Men had greater strength than women in both upper and lower 
extremities at baseline and at follow-up.  After 9.7± 1.1 years, the losses in lower 
limb strength were similar in men and women.  However, the percent losses for 
upper limb strength were greater in men than in women.  Men had similar rates of 
decline in upper and lower limb strength at follow-up.  Women had a greater loss in 
knee extensor strength (-11.8±15.5% per decade) than in elbow flexor strength 
(2±33.8% per decade).  The difference in muscle distribution in men and women 
such that women have a smaller percentage of muscle in their arm (Janssen, 
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Heymsfield et al. 2000) may partially explain the gender differences in the rate of 
loss in muscle strength between the upper and lower extremities. 
 
2.11.2 Muscle strength determinants 
Muscle size and volume are the major determinants of muscle strength among 
healthy young adults (Trappe, Trappe et al. 2001; Holzbaur, Delp et al. 2007) and 
elderly people (Frontera, Hughes et al. 1991; Frontera, Hughes et al. 2000).  Muscle 
cross-sectional area was found to have significant positive correlation with muscle 
strength both in males and females (Maughan, Watson et al. 1983; Bamman, 
Newcomer et al. 2000).  In a cross-sectional study of 3075 well-functioning men and 
women aged 70-79 years, mid-thigh muscle cross-sectional area obtained from 
computed tomography was strongly positively correlated with leg performance 
assessed by 6-meter walk and repeated chair stands (Visser, Kritchevsky et al. 2002).   
 
Lower cross-sectional thigh muscle area and greater fat infiltration into the muscle 
were associated with increased risk of mobility loss in older men and women (Visser, 
Goodpaster et al. 2005).  The decrease in muscle strength was significantly related to 
the reduction in muscle cross-sectional area in older men and women (Frontera, Reid 
et al. 2008).   
 
Aging related decreases in muscle mass (strength) are associated with a reduction in 
both the number and size of muscle fibres, mainly a reduced size of type II fibres 
(Lexell 1995; Porter, Vandervoort et al. 1995; Deschenes 2004).  Type II fibres have 
fast-switch nature and are efficient for short bursts of speed and power and Type I 
fibre are slow to fatigue and suited for endurance. power (The Muscle Physiology 
Laboratory 2009).  The results from many studies on muscle fibre type composition 
using muscle biopsies are rather consistent, that is type II fibre size is reduced with 
aging while type I fibre is reduced much less or no change (Aniansson, Hedberg et 
al. 1986; Poggi, Marchetti et al. 1987; Lexell, Taylor et al. 1988; Lexell and Taylor 
1991).  The loss of lean tissue, in addition to other factors in the elderly contributes 
to the decrease of muscle strength and function (Landers, Hunter et al. 2001).  
Muscle fibre composition studied by muscle biopsy indicated a poor correlation 
between fibre type and maximal isometric force production (Trappe, Trappe et al. 
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2001).  A 10-year longitudinal study of 120 men and women aged 46-78 showed that 
although age-related changes in muscle mass influenced the magnitude of the 
strength changes over time, muscle strength declines in spite of muscle mass 
maintenance or even gain in some subjects (Hughes, Frontera et al. 2001).  This 
means other factors such as cellular, neural or metabolic mediators are also involved 
in changes in muscle strength with aging (Hughes, Frontera et al. 2001).   
 
2.11.3 Muscle strength assessment methods 
There are several ways to assess muscle strength, including manual muscle testing or 
using an isokinetic dynamometer. However the most common method is the one-
repetition maximum (1RM ) test with an isotonic contraction using free or machine 
weights.  Previous studies showed that the 1RM test is reliable for testing muscle 
strength in elderly men, and the coefficients of variation were 4.2-9.0% (Schroeder, 
Wang et al. 2007).  However, another study showed that elderly women required 
significantly more testing sessions (8-9 sessions) to achieve the same consistency of 
measurement compared with young women (3-4 sessions) (Ploutz-Snyder and 
Giamis 2001).  In their study, both young and elderly women had a similar absolute 
increase in strength between the first and final testing sessions, which was 11-13 kg.  
The older women had a significantly greater relative increase (22±4%) in strength 
than the younger women (12±5%).  Therefore, it is import to consider the learning 
effect when using 1RM to assess the magnitude of strength increases in elderly 
women.   
 
In general, it is hard to compare measurements between studies due to the variation 
of test conditions and test subjects (Keating and Matyas 1996).  A review which 
included more than 200 articles suggested that subject factors which lead to 
measurement variation, include age, gender, weight, athletic background, disability 
and limb dominance (Keating and Matyas 1996).  Test conditions that led to 
measurement variation include the range of movement, and the type of contraction or 
movement, such as concentric, axes alignment and preload.  Other factors include 
pretest procedures such as starting position, stabilization and preload, test conditions 
such as speed, test sequence and rest intervals; and type of data analysis (the data 
selected and how they are manipulated).  The authors concluded that most of the 
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publications failed to give these details and therefore lacked replicability (Keating 
and Matyas 1996).   
 
2.11.3.1 Manual muscle test 
The manual muscle test has been widely used clinically to identify abnormal muscle 
strength, such as muscle weakness or asymmetry of the muscle groups.  In a 
traditional manual muscle testing, the examiner assesses how much resistance a 
subject can tolerate and then grades it.  The commonly used scoring system has six 
category levels scores from grade 0 (not contractile activity can be felt in the gravity 
eliminated position) to grade 5 (patient can hold position against maximum 
resistance and through complete range of motion) (Hislop and Montgomery 2007).  
In the new manual muscle testing, the examiner uses a hand-held dynamometer to 
test a patient’s muscle strength.  The new method has reasonable agreement with the 
traditional method (Bohannon 1986; Mulroy, Lassen et al. 1997).  For the traditional 
muscle test which uses word scores, the grading system combines subjective and 
objective factors.  For the hand-held dynamometer method, the examiner’s strength 
or push force would affect the results (Mulroy, Lassen et al. 1997). A recent review 
of studies showed that the correlation coefficient of manual muscle testing ranged 
from 0.63 to 0.98 for individual muscle groups, and from 0.57 to 1.0 for a total 
manual muscle testing score (Cuthbert and Goodheart 2007).   
 
2.11.3.2 Isokinetic and other muscle test methods 
The isokinetic dynamometer and isometric torque methods are commonly used 
methods in research.  Hand grip dynamometry is an easy, cheap and efficient method 
to assess the functional limitations (Arroyo, Lera et al. 2007).  A cross-sectional 
survey of 377 men and women aged 65 years or over found that the self-reported 
functional limitation, such as in the basic activities of daily living, mobility or 
advanced activities were associated with lower handgrip strength in both sexes 
(Arroyo, Lera et al. 2007).  The coefficient of variation of handgrip strength assessed 
by Jamar handgrip dynamometer was 6.3% (Trutschnigg, Kilgour et al. 2008).  A 
reliability study in 31 men and women aged 76 to 87 years showed that the ankle 
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dorsiflexion strength measured by isometric spring gauge had acceptable reliability 
which was 9.7% (Menz, Tiedemann et al. 2003).   
 
Montgomery and colleagues assessed the reliability of an isokinetic test of knee 
extension and flexion muscle strength in 20 adults (11 males) on three separate 
occasions and 2-4 days apart (Montgomery, Douglass et al. 1989).  The subjects 
were assessed by the velocity spectrum test (5 repetitions at velocities ranging from 
90-330 degrees/sec).  They found the reliability was generally higher at lower 
velocities and higher for knee extension than flexion.  The mean intraclass 
correlation coefficients for peak torque were 0.88 for knee extension and 0.79 for 
knee flexion. 
 
A study assessed the test-retest reliability of using an isokinetic dynamometer to test 
hip adductor and flexor strength (Emery, Maitland et al. 1999).  In this study it was 
found that eccentric peak hip adductor torque can be reliably measured at a speed of 
60 degrees/second, but hip flexor torque measurement was less reliable.  Hip 
extensor was shown to have better test-retest reliability than hip abductors; having 
higher interclass correlation coefficient (ICC) and lower coefficient of variation (CV) 
(Pua, Wrigley et al. 2008).   
 
Wyse et al.  also showed that there was a significant variation of muscle strength due 
to time-of-day effects (Wyse, Mercer et al. 1994).  That is, leg muscle strength had 
significantly higher mean scores which were achieved during 18.00-19.30 pm 
compared to the mean scores achieved during morning and noon time.  Many factors 
contribute to the large variation of muscle strength measurements, including the 
differences in study subjects, test conditions, test muscle group, data analysis 
methods, and time-of-day effects.  A validation study is essential for any proposed 
muscle strength test method.   
 
2.12 Assessment of mobility and balance function in elderly people 
Studies have shown that muscle strength is positively correlated with body functional 
performance in elderly women and men (LeBrasseur, Sayers et al. 2006; Misic, 
Rosengren et al. 2007).  Lower extremity performance, such as walking speed and 
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time to complete five chair-stands decreased dramatically with aging in older women 
(Forrest, Zmuda et al. 2006).  The study subjects aged 65-69 years decreased 11% in 
walking speed and increased 38% in chair-stand time ten years after entering the 
study.  Women aged 80 years or older decreased 37% in walking speed and increased 
38% in chair-stand time 10 years later.  A one year randomized controlled clinical 
trial included 80 elderly women aged 75 ± 5 years and showed that leg power was a 
strong predictor of self-reported functional status in elderly women (Foldvari, Clark 
et al. 2000).  The tests used to assess the physical functions varied between previous 
studies, and the tests chosen depend on the study population and purpose of the 
study.  The “Timed Up and Go” test and the Romberg test are widely used in testing 
mobility and standing balance in the elderly.   
 
2.12.1 Timed Up and Go Test 
The ‘Timed Up and Go’ test (TUAG) is the simplest performance-based 
measurement of mobility and balance (Zimmer, Rothenberg et al. 1997) and was 
developed by Mathias and colleagues in 1986 (Mathias, Nayak et al. 1986).  It is also 
called the ‘Get Up and Go’ Test.  The original scoring system was a 5-point 
categorical scale (1=normal, 2=very slightly abnormal, 3=mildly abnormal, 
4=moderately abnormal, and 5=severely abnormal) (Mathias, Nayak et al. 1986).  
Normal healthy elderly usually complete the task in ten seconds or less and a sore 
more than or equal to fourteen seconds has been shown to indicate high risk of falls 
(Jankovic and Tolosa 2007).  Podsiadlo and Richardson further developed and tested 
the reliability of a modified scoring system which was a continuous time scale 
(Podsiadlo and Richardson 1991).  The test times a subjects from getting up from an 
armrest chair, walking 3 meters, turning around and walking back and sitting down.  
The test has been shown to be highly correlated with gait speed, balance, functional 
level, and the ability to go outside alone safely (Podsiadlo and Richardson 1991).  It 
is a sensitive measure for identifying community-dwelling adults who are at risk for 
falls (Shumway-Cook, Brauer et al. 2000).   
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2.12.2 Romberg Test 
Age-related decline in balance also contributes to the increased risk of falls and 
fractures in the elderly along with other risk factors, such as gait and lower-extremity 
muscle strength (El Haber, Erbas et al. 2008).   
 
The original Romberg test requires the patient to stand with their feet together and 
close their eyes.  The test is recorded as positive if  the patient is stable when their 
eyes are open but falls when they shut their eyes, and it indicates a dorsal column 
lesion (Rogers 1980).  Many versions have been developed from the original 
Romberg test, such as semi-tandem eye-open, tandem eye-open, semi-tandem eye-
close, tandem eye-close (also called Sharpen Romberg test).  In these tests, the 
subject is asked to maintain a given position for a specific time.  The researcher’s 
judgement will influence the scoring, such as the variation in judgment of swaying.  
A study showed that it had a larger intra-individual variation in both young and old 
adults (Black, Wall et al. 1982).  Although the Sharpen Romberg test has been 
reported to have reasonable inter-rater reliability and test-retest reliability 
(Franchignoni, Tesio et al. 1998), a study of 132 healthy adults concluded that the 
Romberg performance was too variable, especially for subjects younger than 20 or 
older than 50 years.  Therefore, caution is needed when applying the Romberg test to 
older populations (Yim-Chiplis and Talbot 2000).   
 
2.13 Physical activity 
2.13.1 Aging and physical inactivity 
The prevalence of physical inactivity increases with age and many older Australian 
are predominantly sedentary (Binns 1999).  Physical inactivity increases the risk of 
coronary heart disease, non-insulin dependent diabetes mellitus, and also play an 
important role in the health of muscles, bones and joints (Binns 1999; Department of 
Health and Aging 1999).  American national data indicates that the prevalence of no 
leisure-time physical activity was 18.9% for persons aged 18-24 years and increased 
to 39.1% for those aged ≥ 75 y ears, and inactivity was more common in women than 
in men (Ahluwalia, Mack et al. 2003).  The leisure-time physical activity includes 
golf, gardening or walking.  A study in 1993 showed that 14% of all deaths in the 
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United States were attributed to insufficient activity and inadequate nutrition 
(McGinnis and Foege 1993).  
 
2.13.2 Physical activity guidelines for Australian 
The National Physical Activity Guidelines for Australians recommends that all 
Australian adults engage in at least 30 minutes a day of moderate-intensity exercise 
on most days, or a total of at least 150 minutes of moderate activity per week 
(Department of Health and Aging 1999).  The 30 minutes can be continuous or a 
combination of several short sessions of different activities (at least 10 minutes) 
together.  Moderate-intensity activity includes things such as a brisk walking or 
cycling.  The guidelines emphasise that the recommendation refers to the minimum 
level of physical activity required for the attainment of good health and a healthy 
body weight.  A healthy eating pattern should be combined with physical activity in 
order to achieve the best result.  The American College of Sports Medicine and the 
American Heart Association updated the physical activity guidelines for American in 
2007 (Nelson, Rejeski et al. 2007).  The recommendations for the elderly are to do 
moderately intensive aerobic exercise 30 minutes a day, five days a week, or do 
vigorously intense aerobic exercise 20 minutes a day, 3 days a week, and do eight to 
ten strength-training exercise, 10-15 repetitions of each exercise twice to three times 
per week, and to do balance exercises if you are at risks of falling and have a 
physical activity plan (Nelson, Rejeski et al. 2007).   
 
2.13.3 The role of physical activity in maintenance of muscle mass, strength and 
physical function 
Studies have shown that the physical activity level was significantly positively 
associated with muscle strength (Rolland, Lauwers-Cances et al. 2004) and lean body 
mass (Foo, Zhang et al. 2007).  Physical activity is an important predictor of muscle 
mass both in elderly men and women (Baumgartner, Waters et al. 1999).  However, 
whether the decline in physical activity is directly associated with a decline in muscle 
mass and strength with aging or whether regular exercise can prevent or minimise the 
effect of sarcopenia is still debatable (Marcell 2003).   
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Many studies have shown a positive correlation between physical activity and muscle 
strength and mass (Guo, Zeller et al. 1999; Daly, Ahlborg et al. 2008; Goodpaster, 
Chomentowski et al. 2008; Peterson, Giuliani et al. 2009).  A one year randomized 
controlled trial found that regular physical activity prevented both the age-associated 
loss of muscle strength and the increase in muscle fat infiltration in 42 elderly men 
and women with moderate functional limitations (Goodpaster, Chomentowski et al. 
2008).  A 10-year prospective population-based study of 152 men and 206 women 
aged 50-80 found that those who maintained a habitually active lifestyle had lower 
bone loss and retained better balance than those who were inactive (Daly, Ahlborg et 
al. 2008).  A longitudinal study (average follow up 8.95 years) in 108 women found 
that physical activity was positively associated with increases in fat-free mass and 
decrease in total body fat and percentage body fat in elderly women (Guo, Zeller et 
al. 1999).  A 5-year follow-up population-based study of 2964 older people showed 
that sedentary individuals had a significantly increased risk in developing frailty 
compared with the physically active group (Peterson, Giuliani et al. 2009).  The 
study assessed frailty by a gait speed of less than 0.60 m/s and or inability to rise 
from a chair without using one’s arms.   
 
Long term disuse of muscle groups can lead to a marked loss of muscle strength and 
muscle mass in the elderly (Suetta, Aagaard et al. 2007).  However, not all studies 
have found this relationship.  A study in 120 men and women aged 46-78 years 
followed up for 10 years found that although the change in leg strength was directly 
related to the change in muscle mass with aging, the decline in physical activity was 
not directly associated with strength changes (Hughes, Frontera et al. 2001).  A study 
in 136 women and 180 men over 20 years showed that increasing age was associated 
with decreasing activity and lower fat-free mass, but physical activity levels were not 
related to fat-free mass (Westerterp and Meijer 2001).  Starling’s study in 44 healthy 
white men age 49-85 years suggested that maintaining regular physical activity and 
adequate protein intake may not offset the age-related loss of appendicular skeletal 
muscle mass (Starling, Ades et al. 1999).   
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2.13.4 Physical activity assessment methods 
To assess the habitual physical activity level is important in research because it is a 
potential confounder for many lifestyle-health related issues.  There are many self-
report methods, such as physical activity records, physical activity logs, recalls and 
questionnaires (Denkinger, Coll-Planas et al. 2007).  A physical activity record is a 
diary which records the different types of activities and the time spent on each 
activities during a given time period (Levin, Jacobs et al. 1999).  Physical activity 
logs report the time spent doing different types of activity during a given time period 
(Lamonte and Ainsworth 2001).  Both the self-report record and log methods may 
influence subjects’ behavior due to the act of recording (Lagerros and Lagiou 2007).  
Questionnaires are the most widely used method in research especially when large 
numbers of study subjects are involved.  In addition, they are easy to administer, take 
less time, and do not influence participants’ physical activity behavior as subjects are 
required to recall their activity.   
 
The International Physical Activity Questionnaire (IPAQ) was developed by a 
multinational working group and tested for reliability and validity in many countries 
(Craig, Marshall et al. 2003).  There are two versions, a short form and a long form.  
The short form provides information of time spent on vigorous activity, moderate 
activity, walking and sedentary.  The long form covers time spent in leisure, work, 
household, yard, and sedentary activity and self-powered transport.  The reliability 
has been shown to be high. However, over-reporting has been found to be related to 
lower education level (Fogelholm, Malmberg et al. 2006).  The current study used 
the IPAQ short form to assess the habitual physical activity level of the participants.   
 
2.13.5 Effect of resistance training on muscle mass, strength and physical 
functions in the elderly 
Previous studies have shown that progressive resistance training appears to be an 
effective and feasible way for preventing muscle wasting in elderly people 
(Fiatarone, O'Neill et al. 1994; Bonnefoy, Cornu et al. 2003; Bunout, Barrera et al. 
2004; Daly, Dunstan et al. 2005).  When lifting the weight, the muscle is shortened 
(concentric contraction) in order to produce force, and when lowering the weight, the 
muscle is forced to lengthen (eccentric contraction) to produce force (Evans 2002).  
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Muscle damage (microscopic tears in contractile proteins muscle cells) has been 
shown to occur during these lengthening muscle contractions (Evans 2002).  This 
muscle damage may cause an acute phase response including increased circulation of 
skeletal muscle interleckin-1, mobilization of neutrophis and an increase in muscle 
protein synthesis and degradation (Evans 2002).  These repeated muscle contractions 
stimulate muscle protein turnover and muscle hypertrophy (Evans 2002).  Muscle 
quality and quantity are not the only determinants for the muscle strength but the 
nervous system is also involved in activating the muscle (Sale 1988).  Some 
individuals experience little or no change in muscle cross-sectional area but have 
large gains in muscle strength following a period of resistance training (Evans 2002).  
The proposed explanation is that the neural adaptation occurs after a period of 
resistance training (Bandy, Lovelace-Chandler et al. 1990) and the 
electromyographic (EMG) studies have provided the most direct evidence that the 
increases in muscle strength are associated with the increased muscle activation 
(motor unit activation) (Sale 1988).  Many intervention trials have demonstrated that 
2-3 sets of 8-15 repetitions of moderate to high intensity resistance training can 
enhance muscle strength and mass in the elderly (Kongsgaard, Backer et al. 2004; 
Reeves, Narici et al. 2004; Levinger, Goodman et al. 2007; Henwood, Riek et al. 
2008; Kukuljan, Nowson et al. 2009; Kukuljan, Nowson et al. 2009).  Few studies 
have shown the beneficial effects on improving body functions, such as stair 
climbing time, the number of chair stand in 30 seconds, lung function (Kongsgaard, 
Backer et al. 2004), and balance by resistance training solely in the elderly (Orr, 
Raymond et al. 2008).   
 
Epidemiological studies 
Epidemiological studies have shown that resistance training can effectively increase 
muscle strength, muscle mass and muscle function in postoperative patients (Suetta, 
Magnusson et al. 2004), in elderly men and women after long-term unilateral disuse 
(Suetta, Aagaard et al. 2004) and in healthy elderly men and women (McCartney, 
Hicks et al. 1995; Kongsgaard, Backer et al. 2004).  A study in older adults age 68-
78 years found that muscle strength was significantly greater in those who had 
undertaken endurance or strength training for more than 50 years than those 
untrained elderly subjects (Aagaard, Magnusson et al. 2007).  The muscle fibre size 
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and mechanical muscle performance, particularly the rate of force development were 
consistently elevated in those lifelong trained elderly.   
 
Clinical trials 
Clinical trials have shown that strength training can increase muscle strength or 
muscle size or both, but the effect of traditional resistance training on physical 
function is limited in the elderly (Skelton, Young et al. 1995; Harridge, Kryger et al. 
1999; Campbell, Joseph et al. 2002).  A 12-week strength training study in eleven 
very elderly men and women aged 85-97 years showed that the cross-sectional 
muscle area significantly increased after training and the cross-sectional muscle area 
was positively correlated with muscle strength (Skelton, Young et al. 1995).  
Progressive resistance exercise can produce significant increases in muscle strength 
after adjusted for body weight in healthy, independent and very elderly women (age 
≥ 75 years).  However, the increase in strength may have limited benefit on 
functional abilities in this group of women.   
 
Clinical studies have not reached a consensus on the mechanism of exercise in 
preserving age related decline in muscle mass and strength in the elderly.  A study in 
people aged 68-78 years found muscle fibre size and mechanical muscle performance 
were consistently elevated by strength training (Reeves, Narici et al. 2004; Aagaard, 
Magnusson et al. 2007).  A gene expression study in healthy older (62-75 years old) 
and younger (20-34 years old) men demonstrated an impaired response to exercise 
(resistance training) in the older subjects (Jozsi, Dupont-Versteegden et al. 2000).  A 
study showed that 6-months endurance training did not alter serum IGF-1 in healthy 
older man and women (Vitiello, Wilkinson et al. 1997).  A three month resistance 
training study showed that although the muscle strength improved by training both in 
young and old subjects, there was no significant change in myofibrillar synthesis rate 
in either the young or elderly subjects (Welle, Thornton et al. 1995).  The researchers 
concluded that the disuse cannot explain the slower myofibrillar synthesis rate in the 
elderly subjects.   
 
Randomized controlled trials 
Randomized controlled trials have shown that resistance training significantly 
increased muscle mass and strength (Pyka, Lindenberger et al. 1994; Binder, 
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Yarasheski et al. 2005), increased muscle cross-sectional area (Sipila and Suominen 
1995; McCartney, Hicks et al. 1996), improved physical function (Sipila and 
Suominen 1995) and daily living capacity (Levinger, Goodman et al. 2007) in elderly 
women.  The increased muscle strength obtained by resistance training was 
correlated with significantly increased body lean mass (Binder, Yarasheski et al. 
2005).  Muscle biopsies in 25 elderly men and women found that the increased 
muscle strength by resistance training were accompanied by hypertrophy of both 
type one and type two muscle fibers (Pyka, Lindenberger et al. 1994).   
 
In summary, studies have shown that resistance training is an effective way to 
prevent aging related muscle wasting through increasing muscle mass and strength, 
however, the mechanism is not fully understood.  The results were inconsistent for 
the effect of resistance training on improving physical functions, such as balance.   
 
2.14 Dietary assessment 
2.14.1 Dietary assessment methods 
Assessing dietary intake is important but problematic (Black and Cole 2001) as there 
is no one method that can record the ‘true intake’.  The most important direction of 
bias is the underestimation of dietary intake which occurs with all methods of dietary 
assessment  (Black 2000).   
 
The most commonly used methods to assess the food intake in individuals are  food 
records, 24-hour recall, food frequency questionnaires , and diet histories (Thompson 
and Subar 2001; Bingham 2007).  The food record is a prospective method, where a 
person records everything that they eat and drink at the time of consuming by either 
weighed or household measures, such as cup or teaspoon, for 3 to 14 days.  The other 
methods, 24-hour recall, food frequency, and diet history, are retrospective methods 
and therefore rely on memory, which can be an issue in the elderly.  Each method 
has its strengths and weaknesses, but all the methods depend on the ability of the 
subject to provide accurate information (Nelson and Bingham 1997).  The features of 
all these dietary assessment methods have been well summarized (Black, Bingham et 
al. 1997; Nelson and Bingham 1997; Willett 1998; Thompson and Subar 2001).   
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2.14.1.1 Food records (food diary) 
Food records require the subject to record all food and drinks consumed for a 
specified number of days. The subject weighs all the food and drinks or estimates the 
amount eaten using household measures, such as cups and spoons.  The weighed 
food record has been regarded as the ‘gold standard’ (Livingstone and Black 2003) 
and are used to calibrate other dietary assessment methods.  The advantage of food 
records are that they provide accurate quantitative information; have lower degree of  
error of portion size (especially if a weighed food record); and do not rely on 
memory (Bingham, Cassidy et al. 1995; Willett 1998; Trabulsi, Troiano et al. 2003).  
The main limitation of food records is the underreporting or misreporting of energy 
intake and representativeness of the overall diet (Livingstone, Prentice et al. 1990).   
 
Validation of food records is undertaken by comparison to external biomarkers, such 
as doubly-labeled water (Schoeller and van Santen 1982) or urine nitrogen (Isaksson 
1980; Bingham, Williams et al. 1988).  A study validated dietary assessment 
methods in 156 free-living women over one year at 3-monthly intervals using 
weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C 
and carotenoids as biomarkers (Bingham, Gill et al. 1997).  The study showed a poor 
correlation between urine nitrogen and the food frequency questionnaire (FFQ) and 
24-hour recall (r = 0.10-0.27), but high correlation between 24-hour urine excretion 
and dietary nitrogen intake from the weighed food record (r = 0.78-0.87) and 7-day 
food diary(r = 0.60-0.70) (Bingham, Gill et al. 1997).   
 
To keep an accurate food record, the respondent needs to be trained and the record 
needs to be reviewed by a trained interviewer to clarify what’s recorded and to probe 
for forgotten foods and drinks.  There are a few weaknesses of this method.  First is 
the bias due to sample selection since the participants need to be motivated and 
literate (Willett 1998; Gibson 2005).  It also increases the burden on the participants 
especially if the numbers of days are greater than three to four and if the subject is 
required to weigh all food and drink consumed.  Research has shown that the 
incomplete record increases with the number of recording days, especially for 
recording more than 7 days which could generate respondent fatigue (Gibson 2005).  
 113
Moreover, the act of recording can alter participant’s dietary behaviours (Trabulsi 
and Schoeller 2001).  The high data processing burden and cost make it not suitable 
for studies with more than 500 people (Thompson and Subar 2001).  In the current 
study, study subjects were provided with electronic food scales and were asked to 
record their intake for three days only to minimise subject burden.  
 
2.14.1.2 24-hour recall 
A 24-hour recall requires subjects to recall all food and beverage consumed in the 
previous 24 hours (Gibson 2005).  The recall is usually conducted as an interview by 
trained interviewers.  It is often used in large cross-sectional or longitudinal studies.  
Compared to the food record method, a 24-hour recall doesn’t require literacy.  It 
takes between 30 minutes to 60 minutes to complete.  It has a lower burden both on 
subjects and researchers as the form has pre-coded foods lists which aid the speed of 
recording and processing. Moreover, participants are less likely to change their 
dietary behaviour while being monitored.  More recently, the US Department of 
Agriculture (USDA) has developed computer systems, including the Automated 
Multiple Pass Method (AMPM) for collecting food intakes, the Post-Interview 
Processing System (PIPS) for reformatting data and assigning food codes, and 
Survey Net for final coding, quality review, and nutrient analysis (Raper, Perloff et al. 
2004).   
 
The main limitation of the 24-recall is it requires trained interviewers, preferably 
dietitians.  People may not report food accurately, such as type and amounts of foods 
eaten.  However, the main limitation of this method is a single 24-hour recall cannot 
account for day to day variation in food intake and the previous day may be an 
atypical day.  Therefore, caution is needed when using the data from 24-hour recall 
to represent the habitual intake.  Conducting several 24-hour recalls on non-
consecutive day for the same individuals can improve the reproducibility of the usual 
intake of an individual (Gibson 2005).   
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2.14.1.3 Food frequency questionnaires (FFQ) 
A  Food Frequency Questionnaires obtains information on the frequency of 
consumption and serving size of each specified food and drink for a specific period, 
such as one week or three months (Horwath and Worsley 1990).  They were 
developed for use in large epidemiological studies linking diet and disease (Nelson 
and Bingham 1997).  It can be specific to nutrients of interest, such as calcium or 
protein intake.  There are three formats: qualitative, semi-quantitative and 
quantitative.  The qualitative method only requires information on the frequency of 
specified foods.  The semi-quantitative method requests serving size information for 
some foods but not all foods.  When the quantitative method is used information on 
the amounts of food eaten for all foods is included in the questionnaire.   
 
The strengths of the FFQ are the lower burden on the subjects and researchers.  They 
are easier to code and enter data since most are computer-scannable questionnaires 
that can be completed in 20-30 minutes.  The FFQ can be self-administered or by a 
non-nutritionist and is therefore cheaper to use in large epidemiological studies 
(Zulkifli and Yu 1992; Thompson, Moler et al. 1997).  The semi-quantitative 
questionnaire is especially useful to examine changes in diet due to disease (Willett 
1998), and also provides good estimation of energy intake in free-living and 
nonobese adults (Koebnick, Wagner et al. 2005).  An advantage of the FFQ is that it 
does not influence food intake during the study period.   
 
The weaknesses of the FFQ are the inaccuracies in the quantification of intake.  It is 
especially unreliable for energy intake.  It was reported that there was significant 
underreporting of energy intake from FFQ in higher BMI women (Olafsdottir, 
Thorsdottir et al. 2006).  It was also reported that FFQ lacked reliability for 
estimating the absolute amounts of dietary fats and cholesterol intakes (Schaefer, 
Augustin et al. 2000).  The inaccuracies are due to the incomplete listing of all 
possible foods in the questionnaire, the error in frequency estimation and the errors 
in estimation of usual serving size.  Some researchers think that FFQ is more like a 
measure of attitude than a measure of real consumption (Drewnowski 2001).  
Nevertheless the advantages of the FFQ have led to its widespread use in 
epidemiological studies. 
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2.14.1.4 Diet history 
The diet history method is usually conducted by trained interviewers.  It records 
detailed information of an individual’s usual dietary intake over an extended period 
of time from several weeks or months to one year (Nelson and Bingham 1997).  The 
major strength of this method is that it can better estimate the habitual diet pattern 
and details of food intake than other methods (Nelson and Bingham 1997).  The 
major disadvantage of this method is the necessity for a lengthy face-to-face 
interview and the consequent costs including coding the data (Nelson and Bingham 
1997).  This limits its use in epidemiological studies, and it is more suited to clinical 
situations used by dietitians (Nelson and Bingham 1997).   
 
2.14.2 Dietary assessment in the elderly 
The advantage of dietary assessment in elderly populations is that their diets are 
likely to be more structured when compared to young adults.  Previous studies 
suggest that the validity of dietary information collected from the elderly is 
comparable to that collected from young adults (Nes, Frost Andersen et al. 1992; 
Goldbohm, van den Brandt et al. 1994).  The dietary-history method also showed 
good agreement with a  weighed record in the elderly (van Staveren, de Groot et al. 
1994).  Diet Recall and FFQ may be inappropriate if memory is impaired (Thompson 
and Subar 2001; Pope, Kritchevsky et al. 2007).  Cognitive ability can be assessed 
prior to the dietary assessment if necessary.   
 
2.14.3 Why validate dietary assessment methods? 
There is no one dietary assessment method that can provide ‘true’ information of 
dietary intake.  Underestimation of food intake occurs in most of the current dietary 
assessment methods.  Previous studies reported that 16-81% of women underreported 
their energy intake when their reported energy intake was compared energy 
requirements assessed by basal metabolic rate or by the doubly-labeled water method 
(Briefel, Sempos et al. 1997; Lafay, Basdevant et al. 1997; Pryer, Vrijheid et al. 1997; 
Johansson, Solvoll et al. 1998; Zhang, Temme et al. 2000). Fewer than 9% of 
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subjects over-reported their energy intake compared to their actual energy 
expenditure as measured by the doubly-labeled water method, and the over-reporters 
were characterised with having a lower BMI (Mertz, Tsui et al. 1991; Johansson, 
Solvoll et al. 1998; Zhang, Temme et al. 2000).  The reason for assessing 
underreporting is to evaluate the validity of reported total energy intake which 
provides a check of the quality of the dietary data.  The validation of dietary 
assessment can help to exclude subjects whose measures are believed to be flawed.   
 
2.14.4 Underreporting in dietary assessment 
Underreporting refers to a failure in reporting all food eaten or misreport food 
portions or incorrectly describe the food (Livingstone and Black 2003).  Long term 
metabolic studies have identified underreporting between self-reported energy intake 
and the energy intake required to maintain body weight (Mertz, Tsui et al. 1991; 
Lichtman, Pisarska et al. 1992).   
 
The extent of underreporting can be assessed by comparison with external 
biomarkers.  24-hour urinary nitrogen excretion is used to validate protein intake 
(Isaksson 1980; Bingham and Cummings 1985; Bingham, Cassidy et al. 1995), and 
doubly-labelled water (DLW) validate free-living energy expenditure (Schoeller and 
van Santen 1982; Schoeller, Ravussin et al. 1986; Schoeller 1988; Livingstone, 
Prentice et al. 1992).  A study validated protein intake assessed by 18-day dietary 
records by eight 24-hour urine nitrogen in eight health subjects (Bingham and 
Cummings 1985).  The study found that the within person variation in dietary intake 
ranged from 14 to 26% (CV), and within individual CV of urine nitrogen varied from 
11 to 18%.   
 
Another approach made by Goldberg, Black and his colleagues can be used when 
biomarkers have not been collected.  They developed Goldberg ‘cut-off’ technique 
(Goldberg, Black et al. 1991).  By using this method they found strong bias of 
underreporting habitual energy intake by the dietary assessments (Black, Goldberg et 
al. 1991).   
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2.14.5 Factors associated with underreporting  
Underreporting may be characteristic of some subjects regardless of what dietary 
assessment method is used (Black and Cole 2001).  Females are more likely to 
underreport their food intake compared to males (Livingstone, Prentice et al. 1990; 
de Vries, Zock et al. 1994; Johnson, Goran et al. 1994).  Subjects may record a 
socially desirable dietary intake rather than real intake (Westerterp and Goris 2002).   
 
Weight status is the most significant variable associated with underreporting 
(Livingstone and Black 2003).  Obese subjects are more likely to underreport their 
protein intake (from diet history) (Steen, Isaksson et al. 1977; Prentice, Black et al. 
1996).  Body weight, percentage of body fat and BMI were positively associated 
with underreporting (Johnson, Goran et al. 1994; Johansson, Solvoll et al. 1998; 
Johnson, Soultanakis et al. 1998; Zhang, Temme et al. 2000).  Underreporting may 
also occur due to under eating or a change in food intake during the food recording 
period (Livingstone and Black 2003).  Study participants may simplify their food 
choices to ease the reporting burden when keeping a food record (Livingstone and 
Black 2003).  Recording dietary intake itself could alter eating behaviour even in 
lean women due to the burden of recording (Goris and Westerterp 1999).   
 
2.14.6 Validation of dietary assessments methods  
2.14.6.1 Doubly-Labeled Water method for assessing energy intake 
There is no biomarker available for energy intake (Livingstone and Black 2003).  
The method of using doubly-labeled water to validate reported energy intake  was 
developed by Schoeller in 1982 (Schoeller and van Santen 1982).  The assumption of 
this method is that the habitual energy intake is equal to the habitual energy 
expenditure when weight is stable.  The principle of the method is that carbon 
dioxide production can be estimated from the difference in the elimination rates of 
body hydrogen and oxygen (Frary and Johnson 2004).  The subject is given a dose of 
isotopes deuterium and oxygen-18.  Deuterium is lost in water only, and oxygen-18 
is lost in both water and CO2.  The elimination rates of the two isotopes are measured 
and the difference between the two elimination rates is the carbon dioxide production.  
The total energy expenditure is calculated from carbon dioxide production by using 
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the classical indirect calorimetric equations (Schoeller, Ravussin et al. 1986).  It is 
the current gold standard for measuring energy expenditure and  has a precision of 2% 
to 8% (Schoeller 1988). However, the high cost of laboratory equipment and the 
expertise required to operate a spectrometer and analyse the isotopes make it is 
impractical and expensive for routine use (Frary and Johnson 2004).   
 
2.14.6.2 24-hour urine nitrogen for assessing reported protein intake 
24 hour urinary nitrogen excretion is the most commonly used biomarker to validate 
protein intake.  It also provides a more economical alternative to assess the 
underreporting of dietary assessment methods (Nelson and Bingham 1997; Bingham 
2003).  The assumptions of this method are that subjects are in nitrogen balance and 
the 24-hour urine sample are completely collected (Bates, Thurnham et al. 1997).  If 
the above assumptions are met, the following relationship is applied (Gibson 2005):  
24-hour protein intake (g) = 24-hour nitrogen (g) + 2 (g) 
The used of 2 g is to account for extra-renal nitrogen losses, such as from faeces and 
skin.  This simplified fixed correction may not be appropriate because of the large 
variation both in faecal and dermal losses between individuals (Gibson 2005).  The 
alternative approach is to account for the extra-renal losses as a fixed proportion (e.g. 
~80-81%) of total urinary nitrogen excretion (Bingham 2003).   
 
Early studies showed a good correlation between 24 hour urine nitrogen excretion 
and protein intake estimated from the dietary history method (van Staveren, de Boer 
et al. 1985) and the 24-hour recall (Isaksson 1980; Slimani, Bingham et al. 2003).  In 
1985, Shirley Bingham’s group studied four women and four men in a metabolic 
suite over a 28-day period.  The study subjects were provided duplicate diets each 
day which matched their usual varied diets (Bingham and Cummings 1985).  The 
study found that despite the daily variation in dietary intake, the average 28-day 
urine nitrogen was highly correlated with dietary intake (r = 1.00).  The study also 
found that urine nitrogen underestimated dietary intake in all subjects and was 
progressively greater at higher intakes.  The average 24-hour urine nitrogen 
constantly accounted for 81 ± 2% of nitrogen intake (Bingham 2003).   
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The within-subject variation of 24-hour urinary nitrogen is related to the number of 
the samples collected.  The correlation of nitrogen intake and 24-hour urinary 
nitrogen based on a single day collection is about 0.5 with a CV of 24%.  The 
correlation was  increased to 0.95 with a decreased CV of 5%  when 18 days 24-hour 
urine samples were collected (Bingham 2003), however, this greatly increases the 
subject burden.   
 
Para-amino benzoic acid (PABA) can be used to verify the completeness of the 24-
hour urine collection (Bingham and Cummings 1983).  Three tablets of 80 mg PABA 
are taken with meals and its excretion within 24 hours measured.  Those that contain 
less than 85% of the PABA are classified as unsatisfactory and a cause of 
underestimation of 24-hour urine nitrogen (Bingham, Cassidy et al. 1995).   
In the current study, 24-hour urine nitrogen and 3-day food records were collected.  
2.14.6.3 Goldberg EI:BMR ‘cut-off’ method 
When biomarkers are not measured, the Goldberg method allows a checking of the 
dietary intake data quality.  When comparing reported energy intake (EI) to energy 
expenditure (EE) measured by doubly-labelled water, Black and colleagues used the 
ratio of EI:EE to evaluate the validity of dietary assessment.  They defined 
underreporting, acceptable-reporting and over-reporting as EI:EE ratio of < 0.76, 
0.76-1.24 and >1.24 respectively (Black 2000).  They considered the Goldberg cut-
off point as useful to identify the underreporting at a group level.  This method also 
can provide valuable information on the characteristics of under reporters 
(Macdiarmid and Blundell 1997).   
 
The principle of the Goldberg EI:BMR ‘cut-off’ method is to define the minimum 
cut-off limits for energy intake below which a person of a given sex, age, and body 
weight could not live a normal life-style (Goldberg, Black et al. 1991).  From the 
mean of all of the very inactive calorimeter protocols, they defined that 1.27 * BMR 
(basal metabolic rate) as the ‘survival’ limit.  They adapted the value of 1.35 at CUT-
OFF 1 as the lowest value for habitual energy intake of an individual that is 
compatible with a normal (not bedbound) life style.  They suggested that reported 
energy intakes below 1.35 * BMR either in individuals or populations was most 
unlikely to represent the habitual physical activity level.  However, BMR has been 
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measured (by DLW) rather than predicted.  By using predicted BMR by weight or 
height, they tabulated the CUT-OFF 2 which is the lowest value for the ratio of 
reported energy intake to the estimated BMR (EI:BMRest) according to the sample 
size and study period.  For calculating CUT-OFF 2, 1.55 * BMR was used as energy 
requirement for a sedentary life style.  
 
The following equations summarized the Goldberg EI:EMR ‘cut-off’ method: 
 Assumption: EI = EE 
 EE = BMR * PAL (PAL is the physical activity level) 
 Energy balance equation: EI = BMR * PAL  
 For a person who has a sedentary life style, the equation is: EI = BMR * 1.55 
 The reported EI is not plausible when EI < BMR * 1.55 
 
Basal metabolic rate (BMR) can be estimated by the Schofield Equation (Schofield 
1985) which was included in the 1985 FAO/WHO/UNU report.  BMR is predicted 
from weight with age and gender is taken into account.  For woman aged over 60 
years the equation is:  
BMR = 0.038 weight + 2.755 
BMR is in MJ/day (megajoule/day) and weight is in kg. 
 
A similar approach to the Goldberg cut-off method was investigated by comparing 
reported dietary energy intake with energy requirements estimated by using total 
energy expenditure predicted from age, weight, height and sex using a previously 
published equation (McCrory, McCrory et al. 2002).  Two 24-hour recalls, height 
and weight were assessed in 3755 men and women aged 21-45 years.  The results 
showed that the reported energy intake was 77% and 64% of predicted total energy 
expenditure in men and women respectively.  The authors suggested excluding 
subjects whose reported energy intakes fell outside the ± 1 SD of predicted energy 
expenditures (<70% or >130%) when studying the relationships between diet and 
health.   
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Chapter 3 Methods 
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3.1 Study design 
This study was a double blind, placebo controlled, one year protein supplementation 
intervention study using a whey protein drink.  Major assessments were made of the 
participants at baseline and one year, with continuous delivery of the intervention 
and control products and monitoring of consumption.   
 
3.2 Subjects  
3.2.1 Recruitment 
Two hundred and nineteen women were recruited during April and September 2007.  
Letters were sent to 2356 individuals aged between 70 and 80 years selected 
randomly from the Western Australian Electoral Roll, which has the names and 
addresses of all women of this age range who have registered to vote.  Since voting is 
compulsory in Australia this is the most complete population information available 
which ensured a population based study.  Telephone screening ensured the inclusion 
criteria for each subject was met.  Eligible volunteers were sent a study outline and 
informed consent document and booked for a baseline clinic visit.  The study was 
approved by the Human Ethics Committee of Sir Charles Gardiner Hospital and 
Curtin University (Appendix 1).   
 
3.2.2 Randomisation 
Two hundred and nineteen eligible study participants were assigned to either the 
study or control groups using a computer-generated randomisation program with a 
block size of four to assign participants to protein drink or control drink in a ratio of 
1:1.  They were allocated a number and assigned to one of the treatment groups.  
One hundred and nine women were randomised to the protein supplement group, 
and 110 to the control supplement group (Figure 4.1).  The randomisation code 
were generated by an independent research fellow and placed in sealed envelopes.  
The study participants and the study staff remained blinded to the treatment code 
until all the data had been entered and evaluated for accuracy and the a priori 
hypothesis reviewed.   
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3.2.3 Interventions 
Participants in the protein supplement group were asked to consume the test drink 
daily for the duration of the study.  Every day the trial group drank 250 mls of the 
whey protein based high protein supplement product reconstituted with cold water.  
The reconstituted protein drink provided 30 g of protein, 600 mg of calcium (given 
as calcium lactate) and contained 810 KJ.  The protein source was whey protein 
isolate (Alacen 894).  Participants in the control group received an isocaloric 
placebo drink similarly reconstituted with cold water from the placebo drink 
powder which has the same energy (KJ) and calcium content but only contains 2 g 
protein per 250 ml.  The high protein drink and the placebo drink were similar in 
taste, consistency and ‘mouth feel’.   
 
Participants were instructed to have the assigned drink in the morning before 
breakfast.  The reason for advising participant to have the drink first in the morning 
is that it was expected that the participants would be more compliant with this 
routine and less likely to forget to take the drink. The participants were provided 
supplements with batches on a regular basis.  Each batch contained three month 
supplies (90 small individual containers).  Each small container contains one day’s 
dose of supplement.  They were advised to place all the powder from the container 
provided into the provided milkshake maker (Figure 3.1), and add cold water (from 
the refrigerator) to the 1 cup level (250ml) to the level marked on the container, 
then immediately shake the container with two hands until the powder was well 
mixed.   
 
Figure 3.1 The shaker maker. 
 
  
 124
3.2.4 Inclusion criteria  
Ambulant women aged between 70 and 80 years who were able to comply with the 
requirements of the protocol were included in the study.  This age range was chosen 
because women in this range are declining in muscle mass but are still capable of 
fulfilling the study requirements.  A signed and dated written informed consent was 
obtained prior to participation.   
 
3.2.5 Exclusion criteria 
Subjects were excluded if they had the following conditions: 
 Participation in another clinical trial in the 12 weeks prior  
 Previous osteoporotic fracture 
 Currently or within last year taking medication for osteoporosis 
(Bisphosphonates, such as Fosamax, Actonel, and Zoledronate, Evista, 
Teriparatide, Protos, HRT (hormone replacement treatment)) apart from 
calcium or vitamin D 
 Taking steroid tablets (e.g. Cortisone) in the past 3 months or have taken 
more than 7 g in total in their lifetime 
 Metabolic bone disease (e.g. Paget’s disease) apart from osteoporosis 
 Total hip bone density more than 2SD below the mean for their age. 
 Lactose intolerance or do not like milk products 
 High protein intake as assessed by food frequency questionnaire (equivalent 
to protein intake more than 1.5 g/kg body weight per day) 
 Cognitive impairment (Mini mental state exam<24) (Appendix 10) 
 BMI > 35 kg/m2 
 Bowel surgery resulting in difficulty absorbing food or other reasons caused 
difficulty absorbing food 
 Coeliac disease 
 Clinical hepatic insufficiency 
 Clinical diagnosis of diabetes 
 Renal insufficiency – creatinine more than twofold the upper limit of normal 
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3.3 Study assessments 
All the assessments listed below were made at baseline and repeated at 12 months.   
3.3.1 Body composition and muscle mass by dual energy X-ray absorptiometry 
(DXA) 
3.3.1.1 Instrument and quality control 
Lean body mass (total and regional) were derived from the whole body dual energy 
x-ray absorptiometry (DXA) scan on a Hologic Discovery 4500A Bone mineral 
densitometer (Hologic Corp., Boston, MA, USA).  The spine phantom was scanned 
daily.  The whole body step phantom was scanned weekly.  Follow-up scans were 
done on the same machine as used for the baseline scans.  The CVs for total lean 
mass and total fat mass were 1.1% and 1.6% respectively.   
 
3.3.1.2 Whole Body DXA Scanning 
Participants removed their shoes, socks and bra, and changed into a light hospital 
gown.  They were asked to take off all metal objects including jewellery, glasses, 
wrist watches, and rings.  If a ring could not be taken off, a note was made in the 
checklist, and consistency was kept at the one year visit.   
 
Participants were asked to lie down on the scanning table with their body centered on 
the table.  The feet were placed together but without the ankles and knees touching 
using an elastic band to keep the two big toes together.  The subject’s head was 3cm 
below from the horizontal line marked at the top of the mattress so that the first few 
scan lines above the patient’s head are entirely in air.   
 
Participants were scanned without a pillow, as the pillow may affect the body 
composition results.  The subject’s entire body was within the edges of the scanning 
field marked on the mattress.  The hands were placed palms down with the fingers 
extended and together alongside the body.  There should be a gap between the hands 
and the hips.  If the subject was too large the hands were positioned vertically with 
the thumbs in line.  The participants was instructed to keep very still until the scan 
was finished.   
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3.3.1.3 Scan analysis  
The scan image analysis was done by trained researchers.  The scans were analyzed 
using Hologic Discovery version 12.6.1.  Ten lines were used to separate the body 
into six parts: head, left and right arms, trunk (spine is separated from trunk and 
divided into thoracic and lumbar spine) and left and right legs (Figure 3.2).  Firstly, a 
line is positioned just below the chin to separate the head from the rest of the body.  
Secondly, two lines are drawn to separate the left and right arms from the trunk.  The 
cuts are passed through the centre of the left and right humeral socket.  Another two 
parallel lines are placed close to the spine to separate the spine from the trunk.  
Thirdly, a line is placed above the tip of the pelvis to separate the trunk from the 
lower limbs.  Fourthly, two angled lines are positioned to pass through the femoral 
necks to separate the left and right legs from the trunk.  Finally, one line is placed in 
the middle of the two legs.  The analysis technique followed the instructions in the 
“Clinical bone densitometry training course” provided by the Australia and New 
Zealand Bone and Mineral Society (ANZMBS) (Australia and New Zealand Bone 
and Mineral Society 2005).   
 
The head was excluded from the scanned area and the following data analysis as 
recommended by the manufacturer as bone density of skull and brain fat content are 
not associated with the body composition analysis.  The soft tissue was partitioned 
into fat and lean by the machine derived algorithms.  The lean mass of arms and legs 
was then summed to provide the appendicular lean mass.   
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Figure 3.2 Sample of DXA scan image showing the placement of lines for the 
image analysis. 
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3.3.1.4 Data analysis for DXA  
In the SPSS database, data for the head was excluded from all the analysis in this 
study.  Lean mass refers to bone-free lean mass.  Whole body lean mass refers to 
whole body head-free bone-free lean mass.  Whole body fat mass refers to head-free 
whole body fat mass.   
 
Percentage of whole body fat mass = Whole body fat mass / Total body mass 
Percentage of whole body lean mass = Whole body lean mass / Total body mass 
Total body mass refers to head-free body mass. 
 
The lean mass of arms and legs were summed as appendicular lean mass (ALM).  
The Baumgartner’s adjusted appendicular lean mass was calculated as following 
equation (Baumgartner, Koehler et al. 1998): 
Adjusted appendicular lean mass = appendicular lean mass (kg) / height2 (m2) 
 
3.3.2 Calf muscle cross-sectional area measured by Peripheral Quantitative 
Computed Tomography (pQCT) 
3.3.2.1 Instrument quality control 
The calf muscle cross-sectional areas was measured by the peripheral quantitative 
computed tomography (pQCT) using a Stratec XCT 2000 (Stratec Medizintechnik 
GmbH, Pforzheim Germany).  The position was chosen at 38% of the tibia length 
proximal to the ankle joint.  A standard phantom scan was scanned every week and a 
core phantom scan was scanned every two weeks.   
 
3.3.2.2 Patient positioning 
The scans were taken on the participant’s left leg.  If the participant had a fracture on 
her left ankle, the scans were taken on the right leg.  The participant’s leg was 
measured from inside ankle (medial malleolus) to the anterior tibial tuberosity of the 
knee using a steel segmometer (Rosscraft, Canada) and the data were entered in the 
computer connected with the pQCT scanner.   
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The participants sat in a wheelchair and were instructed to sit back in the chair 
comfortably and lift their leg and point their toe.  The foot was placed in a support 
and a Velcro strap used to keep the foot in position.  A cushion was placed under 
their knee and the leg clamp was tightened (Figure 3.4).  The permission for 
displaying this picture in this thesis has been obtained from this participant.   
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Figure 3.3 Segmometer (Rosscraft, Canada). 
 
 
 
Figure 3.4 Peripheral quantitative computed tomography scan at 38% length of 
tibia. 
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3.3.2.3 Scan sites 
The scan site was at 38% of tibia length.  The reference line was placed at the top of 
the distal of the tibia.  The reference line was placed at the same site for baseline and 
one year by performing the pre CV scan which shows the ankle joint.   
 
The primary outcomes of this study were bone and muscle.  For studying bone 
structure, the 4% and 15% of tibia length are the conventional sites measured, and 
66% is often used to study muscle structure.  For XCT2000 machine, the 66% site 
scan only can be performed under a setting called “Muscle Mask” which is not 
suitable for measuring bone structure.  The scans were taken at 38% of tibia length in 
this study instead of scanning at the conventional 66% site to study both bone and 
muscle estimates at the same time, which minimized the radiation exposure to the 
patient.  The disadvantage of this method is that because of not using the Muscle 
Mask and the scans were taken by using bone parameters, only the muscle area can 
be obtained from the scan.  It is unable to generate the muscle density from the scans 
using the company provided analysis software.  As the automatic muscle analysis 
setting is not applicable for these scans, we used the manual tracing method to obtain 
the area of the cross-sectional muscle.  Fat infiltration is therefore not available.   
 
3.3.2.4 The analysis of pQCT scan of muscle area at 38% site of tibia  
The pQCT scans were analyzed using the Stratec 2000 software version 6.0.  The 
first step was to manually trace the 38% site of tibia muscle total area which included 
calf muscle, tibia bone and fibula bone (Figure 3.5A).  The second step was to 
manually trace the area of tibia bone and fibula bone (Figure 3.5B&C).  Then the 
cross-sectional muscle area of 38% site of tibia was calculated by the following 
equation:  
Muscle area (cm2) = Total muscle cross-sectional area of the leg (cm2) – area of tibia 
bone (cm2) – area of fibula bone (cm2). 
All scans were done by trained operators.  All analysis was done by one researcher 
(the candidate).  The inter- and intra- operator and subject variation were assessed by 
repositioning and reanalysis of the scans on thirty participants.  The CV of muscle 
area at 38% site of tibia length was 1.51%.    
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Figure 3.5 (A-C) Sample of pQCT scan imagine analysis  
A. Cross-sectional area of calf muscle plus bones as traced by the green line 
 
 
B. Cross-sectional area of tibia bone as traced by the green line 
 
 
 133
C. Cross-sectional area of fibula bone as traced by the green line 
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3.3.3 Muscle strength 
3.3.3.1 Hand grip strength 
Hand grip strength was assessed by a hand dynamometer (TTM, Original, Tokyo) on 
the dominant hand (Figure 3.6A).  The dominant hand was found by asking the 
participants the question of ‘Are you right-handed or left-handed?’.  The 
dynamometer was calibrated at baseline and at one year.  The trigger of the 
dynamometer was adjusted to fit each participant’s hand size before the 
measurement.  The participants were in a standing position, held the dynamometer 
with their dominant arm extended, as straight as possible above the head.  They then 
squeezed the trigger as hard as possible while dropping their arm to the front (Figure 
3.6B).  The arm was always kept straight.  The research assistant demonstrated the 
test to the participants first.  The participant repeated the test three times (including 
the first time as a practice) and the maximum reading in kg was recorded.   
 
The coefficient of variation (CV) of hand grip strength was 6.7%.  It was assessed by 
repeating the measurement on 30 participants by an interval of 30 minutes between 
two tests for each person.   
  
Figure 3.6 Hand dynamometer and hand grip strength test. 
A. Hand dynamometer (TTM, Original, Tokyo) 
 
 
B. Procedure of hand grip strength test. 
1. Start position: dominant hand held the dynamometer upright above the head.  
     
2. Arm dropped from the start position. 
 
3. Finish position: arm was placed aside to the body. 
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3.3.3.2 Ankle dorsiflexion strength  
Ankle dorsiflexion strength was measured on the dominant leg.  The participants 
were asked to remove their right shoe and sit on the chair with their foot positioned 
on the footrest device (Figure 3.7A).  The foot was strapped to a plate with a spring 
gauge attached.  The ankle was positioned directly over the hinge (i.e. the back of the 
heel was positioned on the line below the hinge.  The knee joint angle was angled at 
120-degrees determined using the 120-degree metal angle (Figure 3.7B).  This 
ensured the ankle position was at the same level for every participant because a 
previous study showed that the ankle position could significantly influence the ankle 
dorsiflexion torque (Geboers, van Tuijl et al. 2000).  The strap was then tightly 
applied to the foot where the foot can exert the greatest force just proximal to the 
base of the fifth toe.  When the patient’s foot was in place they were asked to cross 
their arms in front of their chest.  The participants kept their heel on the footrest and 
raised the front of their foot as forcefully as they could (Figure 3.7C).  The research 
assistant held the device in position by placing their foot on the front of the base 
plate.  The participants repeated the task three times (including the first time as a 
practice) and the highest results in kg were recorded.  
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Figure 3.7 (A-C) Footrest device, metal angle and ankle dorsiflexion strength 
test. 
A. Footrest device used for testing ankle dorsiflexion strength.  A Velcro strap was 
attached to the foot plate, and the spring gauge was attached to the foot plate.   
 
 
B. Metal angle.  The 90-degrees metal angle was used to ensure the knee angle was 
90-degrees before testing knee strength.  The 120-degrees metal angle was used to 
ensure the knee angle was 120-degrees before testing ankle dorsiflexion strength (see 
picture C3) 
 
  
C. Procedure of ankle dorsiflexion test 
1. Participants’ dominant foot were strapped on the foot plate by the Velcro strap.  
     
 
2. Participants raised the front of their foot from the footrest. 
 
 
3. The 120 degrees metal angle was used to ensure the knee angle was at 120-degrees 
before starting the test. 
     
 
4. Participants were asked to cross their arms in front of their chest while testing 
ankle dorsiflexion strength 
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3.3.3.3 Knee extension and flexion strength tests 
The knee extension and flexion strength test measured the strength of the muscles 
that flex and extend the knee on the dominant leg.  The measurements were taken 
using a dynamometer (TTM, Original, Tokyo) attached to a metal bar on the wall 
(Figure 3.8A-C).   
 
To measure the knee flexion, the participants were asked to stand facing the wall. An 
adjustable strap was attached on the participant’s calf (at the end of the calf muscle) 
and the dynamometer.  The dynamometer was moved up or down to ensure that the 
long strap was horizontal.  Keeping the horizontal strap tight, the participant was 
asked to sit down on a chair facing towards the wall on which the dynamometer is 
attached.  The participants sat upright with their hip and knee at 90-degree measured 
using the metal 90-degree angle.  The participants were instructed to hold on to the 
chair for support and slowly and forcefully pull the lower leg toward the back of the 
thigh as strongly as possible sliding the ball of the foot along the floor holding it for 
as long as possible.  The participants were given two attempts (including the first 
time as a practice) with an interval of 30 seconds and the maximum result in kg was 
recorded.   
 
To measure the knee extension, the participants were asked to stand up and turn to 
face away from the wall while keeping the horizontal strap tight.  The chair was 
moved so it was behind the participants, facing away from the wall with the back 
against the metal bar.  The participants were instructed to hold on to the chair for 
support, and slowly and forcefully push against the strap as strongly as they could.  
The tested foot was kept on the floor.  The participants were given two attempts 
(including the first time as a practice) with an interval of 30 seconds and the 
maximum results in kg were recorded.   
 
Knee flexion strength and knee extension strength were summed and reported as the 
total knee strength.   
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Figure 3.8 (A-C) Wall-attached dynamometer and the procedure of knee 
strength tests. 
A. Wall-attached dynamometer which can move up and down along the metal bar. 
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B. Procedure of knee flexion strength test 
1. Participants’ dominant leg was attached with the wall-attached dynamometer by 
the Velcro strap. Knee was at 90-degrees before starting the test. 
   
 
2. Participants held hands on the chair and pull the lower leg toward the back of the 
thigh.  
 
 
C. Knee extension strength test: participants pushed against the strap attached to the 
wall-attached dynamometer.   
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3.3.3.4 Hip strength (extension, abduction, flexion and adduction) 
The hip strength was tested on the participant’s dominant leg.  The participants were 
given two attempts (including the first time as a practice) with an interval of 30 
seconds.  The maximum results in kg were recorded.  The following procedures 
described the measurements taken on the right leg for example (Figure 3.9A-D).   
 
Hip extension strength 
To measure the strength of hip extensors, participants were asked to stand straight, 
facing the wall.  The strap was attached to the lower edge of the right thigh which 
was just above the participant’s right patella.  The strap also was attached to the 
dynamometer and was adjusted to the height of the dynamometer to a position that is 
horizontal to the strap attached to the participant.  The participants stood so that the 
strap was taut but not causing a reading on the dynamometer.  The participant had 
their back and left leg vertical and they steadied themselves by holding their right 
hand on the chair (the chair was stabilised by the research assistant).  The 
participants were instructed to forcefully pull their leg back from the wall at a 
moderate pace but as strongly as they could.   
 
Hip abduction strength 
To measure the strength of hip abductors, the participants were asked to turn 90-
degree to their right with the strap still in place on their thigh so that the strap was 
running across their left leg to the dynamometer.  They were asked to stand upright 
holding their hands on the chair (the chair was stabilised by the research assistant).  
When ready, the participants were asked to slowly and forcefully pull their right leg 
away from their left leg as strongly as they could.     
 
Hip adduction strength 
To measure the strength of hip adductors, the participants were asked to turn 180 
degree to their left with the strap still in place on their thigh.  The participants were 
asked to stand with their feet together then abduct the left leg to shoulder width to 
allow their right leg room to adduct.  They were asked to stabilise themselves by 
holding their left hand on the chair (the chair was stabilised by the research 
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assistant).  They were instructed to slowly and forcefully pull their right leg away 
from the wall towards their left leg as strongly as possible.   
 
Hip flexion strength 
To measure the strength of hip flexors, the participants were asked to turn 90 degree 
to their left again facing away from the wall.  A chair was placed in front of them to 
hold on to while doing the test.  The chair was stabilised by the researcher during the 
test.  Participants were asked to stand with their left and right legs and body upright 
holding onto the chair with their hands.  The participants were asked to transfer their 
weight to their left leg and then to slowly and forcefully push their right leg against 
the strap (moving foot away from the wall) as strongly as they can.   
 
Hip strength for extension, abduction, flexion and adduction were summed and 
reported as the total hip strengths.   
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Figure 3.9 (A-D) Procedure for the hip strength tests. 
A. Hip extension strength: participants’ leg was attached with the wall-attached 
dynamometer by the strap, and they pulled their leg back from the wall. 
 
 
B. Hip abduction strength: participants pulled their leg away from their left leg. 
 
 
C. Hip flexion strength: participants were facing away from the wall and pushed their 
right leg against the strap.  
 
 
D. Hip adduction strength: participants pulled their right leg towards their left leg.   
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3.3.3.5 The test-retest reliability of leg strength tests 
As pointed out by Keating and Matyas, there is considerable variation between 
studies using dynamometry to test muscle strength (Keating and Matyas 1996).  The 
potential factors causing variations are the subjects factors and test procedures.  The 
subject factors include age, gender, weight, athletic background, disability and limb 
dominance.  The test conditions includes the range of movement; the type of 
contraction or movement, such as concentric, eccentric, isokinetic or isometric etc, 
pre-test procedures such as warm-up, starting position and stabilization etc; the test 
speed, sequence and test intervals.   
 
The coefficients of variation (CV) for the lower limb strength tests were assessed by 
repeating the measurements on 30 participants with a 30 minutes interval between 
two tests for each person.  The test-retest was assessed twice.  First test-retest was 
taken at the beginning of the study and the results were shown in Table 3.1.  Since 
the CVs were too large, the methodology of the tests were reviewed promptly and 
finalized as described above.  The method was improved to reduce the compensation 
of other muscle groups and the consistency of the methods.  The test-retest reliability 
was reassessed and the CVs were improved as shown in Table 3.1.   
 
Previous studies have found that the reliability of knee extension indices generally 
exceeds that of flexion indices (Montgomery, Douglass et al. 1989; Gleeson and 
Mercer 1992).  The current study also found the larger CV for knee flexion strength 
(13.0%) than for knee extension strength (9.5%).  
 
In the data analysis, to reduce the variation of single group of muscle strength, the 
knee flexion and extension were summed up as the total knee strength; and the hip 
extension, abduction, flexion and adduction were summed up as the total hip 
strength.  The CV for total knee strength and total hip strength were 9.0% and 6.9% 
respectively, which improved compared to the single muscle group strength.   
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Table 3.1 CVs of the test-retest of lower limb muscle strength on 30 patients at 
the beginning of the study and the improved tests method. 
Muscle strength (kg) CV of  
first time test-retest on 
the original test method 
CV of  
second time test-retest on 
the improved test method 
Ankle dorsiflexion  15.0% 7.0% 
Knee flexion 21.8% 13.0% 
Knee extension 13.7% 9.5% 
Hip extension 14.0% 8.6% 
Hip abduction 20.5% 9.3% 
Hip flexion 15.2% 9.8% 
Hip adduction 15.6% 12.1% 
Total knee strength - 9.0% 
Total hip strength - 6.9% 
 
  
 147
3.3.4 Mobility and balance 
3.3.4.1 Timed Up and Go Test (TUAG)  
Mobility function was measured by the Timed Up and Go Test.  It is a test of basic 
functional mobility for elderly persons (Podsiadlo and Richardson 1991).  The 
TUAG test requires the participant to be timed while getting up from a chair, walking 
3m, turning, returning to chair and sitting down again.  
 
The test score was recorded in seconds to the nearest 0.1 second using a sport stop 
watch (Sportline digital watch as shown in Figure 3.10 A).  The chair with arms of 
approximately 46 cm in height was placed 3 metres from a marked green line (Figure 
3.10 B).  The participants wore their regular footwear and used their usual walking 
aids if required.  The participants started seated with their back against the back of 
the chair, arms on the chair arms, walking aids were within ready if needed.  The 
participants were instructed on the word “GO” to get up, walk at a comfortable safe 
pace to the 3 metre mark, turn, return to the chair and sit down again.  The 
participants walked through the test once as practice then being timed.   
 
The coefficient of variation (CV) of TUAG is 5.7%.  It was assessed by repeating the 
measurement on 30 participants with a 30 minutes interval between two tests for 
each person.   
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Figure 3.10 Stop watch and TUAG test. 
A. Stop watch for testing TUAG (Sportline sport digital watch) 
 
 
B. Timed Up and Go test settings: a chair was placed three meters away from the 
green line marked on the ground.   
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3.3.4.2 Romberg test 
Standing balance was assessed by a modified test (Guralnik, Ferrucci et al. 1995) 
based on the Romberg test.  The participants were asked to attempt to maintain their 
feet in the side-by-side, semi-tandem (heel of one foot beside the big toe of the other 
foot), and tandem (heel of one foot directly in front of the other foot) positions for 10 
seconds each.  If the participants were not able to hold side-by-side for 10 seconds, 
they were given a score of zero.  They were given a score of 1 if they could hold this 
position for 10 second, a score of 2 if they could hold semi-tandem position for 10 
seconds, a score of 3 if they could perform tandem position but only hold the 
position for less than 10 seconds, and a score of 4 if they could hold tandem position 
for 10 seconds.  The participants were asked to attempt these tests first with their 
eyes open, then with their eyes closed.  The final scores of tests with the eyes-open 
and the eyes-closed were recorded on the checklist sheet (Appendix 12).  The 
participants completed the tests with their shoes on.  For each stand, the 
demonstration of the task was given first.  The participants were allowed to hold on 
to the support (the metal bars beside them) whilst they got into position.  When the 
participants were ready, they released the support and the researcher started timing.  
The research assistant stopped timing when the participant moved their feet or 
grabbed for support.   
 
3.3.5 Anthropometry 
The anthropometry measurements were height, weight, mid upper arm girth, triceps 
skin-fold, calf girth, hip girth and waist girth.  The measurements were taken prior to 
the DXA scan on the morning clinic visit in a hospital gown.  All the measurements 
followed the standard procedures as detailed in the International Standards for 
Anthropometric Assessment (Marfell-Jones, Olds et al. 2006) and described below.  
All anthropometrists underwent training conducted by a level four accredited 
anthropometrist.  A flexible steel tape (Lufkin, Executive Thinline, W606PM) was 
used to measure all girths.  The Technical Error of Measurement was <7.5% for 
skinfolds and <1.5% for girths; as required for Level 1 anthropometry accreditation 
for the International Society for the Advancement of Kinanthropometry (Marfell-
Jones, Olds et al. 2006).  
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Figure 3.11 (A-C) Anthropometry measurement devices. 
A. Lufkin steel tape (Lufkin, Executive Thinline, W606PM) and Harpenden skin fold 
caliper (John Bull British Indicators LTD, England): used to measure skin-fold and 
girth.   
 
 
B. Stadiometer (Veeder-Root, Elizabethown, N.C., USA): used to measure height 
 
 
C. Electronic scale (August Sauter GmbH D-7470 Albstadt 1 Ebingen, West 
Germany): used to measure weight. 
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3.3.5.1 Height 
Standing height was measured using a wall-mounted stadiometer (Veeder-Root, 
Elizabethown, N.C., USA) (Figure 3.11B) to the nearest 0.1 cm.  The participant 
removed their shoes and socks and stood against the wall with the heels together and 
the heels, buttocks and upper part of back touching the scale.  The head was 
positioned in the Frankfort plane (orbitale is in the same horizontal plane as the 
tragion), and the participant was instructed to take a deep breath and hold.  The head 
board was placed firmly down on the vertex, compressing the hair as much as 
possible, and the reading was recorded to the nearest 0.1 cm.   
 
3.3.5.2 Weight 
Body weight was measured in a light hospital gown by an electronic scale (August 
Sauter GmbH D-7470 Albstadt 1 Ebingen, West Germany) (Figure 3.11C) to the 
nearest 0.1 kg.  The electronic scale was calibrated yearly.  Body mass index was 
calculated as body weight kg/height m2.   
 
3.3.5.3 Triceps skinfold 
Triceps skinfold was measured by a Harpenden skinfold caliper (John Bull British 
Indicators LTD, England) to the nearest 0.1 mm (Figure 3.11A). The measurement 
was taken parallel to the long axis of the right arm at the triceps skinfold site, which 
is the point on the posterior surface of the arm, in the mid-line, at the level of the 
marked mid-acromiale-radiale landmark.  The participants assumed a relaxed 
standing position with the arm hanging by the side in the mid-prone position.   
 
3.3.5.4 Mid upper arm girth 
Mid upper arm girth was measured at the level of the mid-acromiale-radiale site on 
the right arm by a tape to the nearest 0.1cm. The participants assumed a relaxed 
standing position with the arms hanging by the sides.   
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3.3.5.5 Upper arm muscle area and corrected upper arm muscle area 
Upper arm muscle area was derived from the measurements of mid upper arm girth 
and triceps skin fold using the following formula (Hammond 2004):  
 
Upper arm muscle area (cm2) = (mid upper arm girth in cm– π (triceps skinfold in 
cm))2/4π 
Corrected upper arm muscle area (cm2) = arm muscle area – 6.5 
 
3.3.5.6 Waist girth 
Waist circumference was the narrowest point of the abdomen girth.  The participants 
assumed a relaxed standing position with the arms folded across the thorax.  The 
participants were instructed to breathe normally and the measurement was taken at 
the end of a normal expiration by a tape to the nearest 0.1 cm.   
 
3.3.5.7 Hip girth 
Hip girth was measured at the level of the greatest posterior protuberance, 
perpendicular to the long axis of the trunk by a tape to the nearest 0.1 cm.  The 
participants assumed a relaxed standing position with the arms folded across the 
thorax and feet together.    
 
3.3.5.8 Waist-to-hip ratio 
Waist-to-hip ratio (WHR) was calculated by dividing the waist girth by hip girth.   
 
3.3.5.9 Calf girth 
Calf girth was measured on the right leg at the level of the medial calf skinfold site 
which is the calf at the level of the maximal calf girth.  The participants assumed a 
relaxed standing position with the arms hanging by the sides and feet separated.   
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3.3.6 Biochemical markers 
Fasting blood and urine samples and a 24-hour urine collection were taken at 
baseline and 12 months.  The venous blood sample was collected in the morning 
after an overnight fast from 10pm.  The participants were instructed to empty the 
bladder and drink at least two glasses of water before they came to the clinic.  The 
serum was separated from the blood within 30 minutes after collection and stored in 
a -79 Celsius freezer until analyzed.   
 
3.3.6.1 Serum insulin-like growth factor one (IGF-1)  
Serum IGF-1 was measured by IMMULITE 2000 IGF-1 Analyzer (Catalog Number: 
L2KGF2) in Royal Perth Hospital.  IMMULITE 2000 IGF-1 is a solid-phase, 
enzyme-labeled chemiluminescent immunometric assay.  It determined if the effects 
of increased dietary protein on muscle mass and strength was related to changes in 
IGF-1.   
 
3.3.6.2 24-hour urine nitrogen 
24-hour urine nitrogen was used as a biomarker of the validation of dietary protein 
intake.  The participants were given written (Appendix 14) and verbal instructions on 
the collection of the 24-hour urine specimens.  The participants were asked to collect 
a 24 hour urine sample on days two and three of the food recording period.  They 
were asked to discard the first urine specimen at the first morning of collection and 
collect all specimens for the following 24 hours including the first urine specimen of 
the next day.  They were provided with a urinary hat and a 5 L plastic collection 
bottle which contained 20 ml of 1M HCL as a preservative.  They were asked to 
record the day and time of the start and end on a provided checklist (Appendix 14) 
and to keep the bottle in a cool place.  The returned urine samples were weighed 
(minus the bottle weight) and recorded on the checklist (Appendix 12).  Five ml 
sample was dispensed into a 5 ml screw cap tubes and stored in -20 Celsius freezer 
until analyzed.    
 
The urine nitrogen concentration was measured by the Kjeldahl method which 
involves three steps: digestion, neutralization and titration (McClements 2003).  The 
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analysis was completed by the laboratory staff at Curtin University.  In the Kjeldahl 
method, protein is digested (oxidized) and the nitrogen is converted to (NH4)2SO4.  
The alkaline was added to the mixture to convert the NH4 to free NH3.  Then the 
solution is titrated to determine the amount of NH3 captured.  The 24 hour total 
urinary nitrogen in grams was calculated as multiplying the weight of 24 hour urine 
with the urinary nitrogen concentration.  The urinary nitrogen refers to all sources of 
urinary nitrogen, which included urea urinary nitrogen and nonurea nitrogen, such as 
ammonia and creatinine.   
 
The estimated dietary protein intake in gram equals 6.25 x (N + 2), where N is the 
number of grams of total urinary nitrogen in the 24 hour urine, and 2 (g) is the 
estimated nitrogen excretion by routes other than urine (i.e. faeces and sweat) 
(Carlson 2004; Gibson 2005).   
 
3.3.7 Dietary assessment 
At the baseline screening visit, participants completed a simplified, self-
administered, quantitative food frequency questionnaire (FFQ) requesting 
information on the normal eating pattern over the last year (Appendix 13).  The daily 
dietary intake of protein was calculated.  Participants with protein intakes greater 
than 1.5 g/kg/d were considered as high protein intake, and were excluded from the 
study.   
 
The participants’ diets were also assessed by 3-day food record (Appendix 13) at 
baseline and 12 months.  The participants were asked to record everything they ate 
and drank for three consecutive days which included two week days and one 
weekend day (Thursday, Friday and Saturday, or Sunday, Monday and Tuesday).  
They watched a training video on how to complete their food record, and they were 
also provided with electronic food scales (Philips, HR 2385/A, Hungary).  They were 
instructed not to alter what they ate or drank during this time and record as accurately 
as they could using either the food scales provided or household measures (for 
example cups and spoon measures).  On the day they returned the food record, the 
participants were interviewed by a trained research assistant to clarify types and 
amount of food recorded.  A dietitian and university students majoring in nutrition, 
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who had undergone advanced competency training in dietary assessment completed 
all analysis of the food and drink records.  The food record was analyzed for protein, 
energy and other nutrients intakes using the AusNut database (Foodworks 
Professional edition version 3.02).  Vitamin and mineral supplements were included 
in the analysis.   
 
3.3.8 Physical activity assessment 
Physical activity level was assessed by the International Physical Activity 
Questionnaire (IPAQ) (www.ipaq.ki.se) short form (Appendix 7).  The participants 
completed the questionnaire during the morning clinic.   
 
One metabolic energy turnover (MET) equals to one kcal per kg body mass per hour 
(Denkinger, Coll-Planas et al. 2007).  The MET-minutes/week (Mets) was calculated 
as below and used as the continuous scores of total physical activity level 
(http://www.ipaq.ki.se/scoring.pdf).  The calculation method is described as below: 
 
Walking Mets/week = 3.3 * walking minutes * walking days 
Moderate Mets/week = 4.0 * moderate-intensity activity minutes * moderate days 
Vigorous Mets/week = 8.0 * vigorous-intensity activity minutes * vigorous-intensity 
days 
Total physical activity Mets/week = sum of Walking + Moderate + Vigorous MET-
minutes/week scores. 
 
Physical activity was also evaluated as category variables as low, moderate, and high 
following the IPQA user instructions (http://www.ipaq.ki.se/scoring.pdf).  The low 
was defined as the total physical activity less than 600 Mets/week, moderate was 
defined as the physical activity between 600-3000 Mets/week, and high was defined 
as at least 3000 Mets/week.   
 
3.3.9 General health status assessment 
General health status was assessed by the SF-36 questionnaire, IQOLA (International 
Quality of Life Assessment), English (Australia), version 1.0 (Appendix 8) designed 
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by Medical Outcomes Trust (http://www.outcomes-trust.org/instruments.htm).  This 
is self-administered or by trained interviewers either in person or by telephone.  The 
questionnaire contains 36 questions in 8 domains.  The eight health concepts are 
physical functioning, role limitation due to physical health problems; bodily pain, 
general health, vitality (energy/fatigue), social functioning, role limitations due to 
emotional problems and mental health (psychological distress and psychological well 
being) (http://www.outcomes-trust.org/instruments.htm#SF-36).  There are two 
versions: standard (4-weeks recall) and acute (1-weeks recall).   
 
The current study used Standard Australian version 1.0 which is a 4-week recall 
version.  Study participants completed the questionnaire at the clinic visit and were 
assisted by research staff where needed.  The completion was checked by research 
staff at interview section.   
 
The data was analyzed by Stata software (Intercooled 9.0) using a designed program 
for calculation of summary statistics for SF-36 (Ryan 1999).  The results gave the 
raw scores and transformed scores for each of the eight domains and country-
weighted (such as Australia, UK or USA) two summary scores (physical health 
scores and mental health scores).  Since the raw data could be negative and eight 
domains also have different scales, the transformed scores are preferable by 
researchers.  The transformed scores for each of eight domains and two summary 
scores are from 0-100 (Ware).  The two summary scores are national specific.  For 
Australia, the Stata program uses zero to represent the worst health status and 100 to 
represent the best health status.  The standard population normal health score is mean 
of 50 and standard deviation of 10.  The current study used transformed scores to 
describe the participants’ general health status.   
 
3.3.10 Compliance with test drink consumption 
To assess compliance with the test drink consumption, study participants were asked 
to return their emptied containers at the one year visit.  They were also provided with 
a drink record calendar to cross the date they consumed the drink.   
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3.4 Sample size calculation 
Sample size was calculated by ‘Power and Sample Size Calculation’ Version 2.1.31 
(http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize).  A sample 
size of 85 in each group would be sufficient to detect a difference of 3% on change in 
total body lean mass, the primary outcome variable, assuming a standard deviation of 
6% based on the previous study (Bonnefoy, Cornu et al. 2003), at 90% power and 
5% level of significance.  This sample size would also allow the detection of a 16.5 
μg/L (16.5 ng/ml) difference in serum IGF-I concentration (SD 33 μg/L) (Schurch, 
Rizzoli et al. 1998), a main biochemistry outcome, at 90% power and 5% level of 
significance.  This number has been increased to 110 per group (total of 220) to 
allow for a predicted drop-out from treatment of around 30% which we have reported 
in previous studies of a similar age group (Prince, Devine et al. 2006).   
 
3.5 Data management and Statistical analysis 
3.5.1 Data management 
Data was entered from the hard copy source data into a Microsoft Access database 
designed for the study and then into SPSS (version 15.0).  Stata Intercooled 9.0 
software (StataCorp, College Station, Texas) was used to analyze SF-36 data by a 
designed program for calculation of summary statistics for SF-36 (Ryan 1999).   
 
The initial screening of data revealed the extreme and missing values.  These values 
were checked with the original hard records and the Access database.  The entry 
errors were corrected and data re-exported to SPSS.  The doctoral candidate was 
responsible for this process.   
 
The normality of all the numerical variables have been examined by normality test, 
histograms and normal q-q plots, showing no severe skewness of these variables 
except physical activities.  Physical activity (Mets/week) was transformed to 
log(Mets/week) due to the severe right skewness.   
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3.5.2 Data analysis 
All data were analyzed by SPSS (version 15.0; SPSS Inc, Chicago, IL) and graphs 
were made using Graph Pad PRISM (Version 4, Graph pad software, San Diego, 
CA) and Microsoft Office Excel 2003.  Primary outcome measures in this study were 
DXA measured lean body mass, pQCT measured cross-sectional muscle mass, 
muscle strength, mobility and biochemistry variables.  Explanatory covariates were 
the drink test consumption and 24-hour urine nitrogen.  The homogeneity of variance 
and normality assumptions were checked by Levene and Kolmogorov-Smirnov test.  
Spearman’s rank correlation test was used to examine the correlation between 
baseline participants’ characteristics and muscle mass and size measurements (whole 
body lean mass, appendicular lean mass, calf muscle cross-sectional area and 
adjusted upper arm muscle area).   
 
The ‘intention to-treat’ principle (U.S. Food and Drug Administration 1998) was 
used in analysis to measure the effectiveness of the protein supplementation while 
ignoring the lack of full compliance.   
 
Intention-to-treat analysis (ITT) analysis is to  
 
“Includes all randomized patients in the groups to which they 
were randomly assigned, regardless of their adherence with the 
entry criteria, regardless of the treatment they actually received, 
and regardless of subsequent withdrawal from treatment or 
deviation from the protocol”(Fisher, Dixon et al. 1990).  
 
It has been widely used in analysis of randomized clinical trial data.  Because, 
theoretically, in randomized clinical trials, patients randomly assigned in different 
treatment groups should have equal chance to be incompliant.  Therefore, ITT is the 
first analysis expected to be performed in a randomized clinical trial (Fisher 1999).   
 
The primary outcome variables was analyzed using general linear model (GLM) 
repeated measures analysis consisting of time effect (within-subjects variables of 
baseline and one year) and treatment effect (between-subjects factors: drink group) 
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and the interactions of treatment and visits time.  The advantage of GLM is that it 
allows the missing values and the variable intervals between visits.  If the GLM 
analysis indicated a significant treatment effect or a significant effect of treatment 
and visits interaction, the treatment effects (changes since baseline) at year one was 
analyzed by univariate analysis of covariance (ANCOVA), with drink groups as the 
fixed factor and baseline values as covariates.  The time effect was then evaluated by 
ANOVA paired-sample t-test in the treatment and control groups separately.  
Differences in categorical variables between groups were analyzed by chi-square test 
or logistic regression where appropriate.  The significance level for test statistics was 
set at P < 0.05.   
 
3.6 Ethic issues 
The Medical and Allied Health and the Human Research Ethics Committee have 
approved this study.  The major ethical issues of this study related to consent, 
confidentiality and the potential risks and discomforts to the participants.   
 
Consent: All participants have received an explanation sheet to inform them in lay 
terms the purpose, demands, risks, methods, inconveniences and possible outcomes 
of the study by mail before they come to the screening visit.  At the screening visit, 
an investigator explained the benefits and risks of participation in the study to each 
participant.  Participants who agreed to participate signed the consent form with 
investigator’s witness before undertaking any study related procedures.  The consent 
form also states that they may withdraw from the study at any time without reason or 
justification.   
 
Confidentiality: All information has been stored in a locked filing cabinet and all the 
blood and urine samples have been stored in a locked freezer.  All identifiable 
information has been coded.  All personal information such as name, address and 
phone number have been used for contact purpose only.  The proposed publication 
will have no means of being able to identify.   
 
Potential risk and discomfort: There are no substantial risks involved in this study.  
The radiation dose involved in this study is about 5.7 mSv.  This is below the 
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NHMRC established guidelines for individuals participating in a medical research 
programme which states that the annual effective dose received by volunteers should 
be limited less than 5 mSv per year.  The intervention in this study is the natural food 
supplement (whey protein based drink).  Previous studies have showed that it is 
benefit to bone and muscle health in the elderly.  The control group may also benefit 
from the study since the placebo drink contains the same amount of calcium as in the 
test drink but without additional protein.  Blood sampling via venipuncture may 
involve mild physical and psychological discomfort to the participants.  The physical 
discomfort is comparable to a pinprick.   
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Chapter 4 Results 
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4.1 Baseline data analysis 
4.1.1 Baseline data overview 
A total of 219 elderly women were recruited from the Western Australian general 
population of women aged between 70 and 80 years.  Letters were sent to 2356 
individuals selected randomly from the electoral roll.  A total of 837 (36% of letters 
sent) women responded, and 254 (30% of the respondents) women were eligible to 
attend the clinic screening.  After the screening visits one and visit two, 35 subjects 
were found to be ineligible for the study and were excluded.  Initially, as planned 
there were a total 220 women enrolled in the study, but one woman was excluded 
from the study after she had been randomized because she was found to be taking 
hormone replacement treatment.  The final sample size was 219 women, who 
commenced the study, and 109 were in the protein supplement group and 110 
allocated to the control group.  These two groups are referred to as the protein group 
and the control group.  The detail is shown in Figure 4.1. 
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Figure 4.1 Flowchart of the study population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* The primary study is a 2-year trial.  This subject stayed in the study and will attend 
the 2-year study, but was excluded from one year data analysis.   
 
Letter sent: 2356 
Respondents: 837 
Eligible to attend screening clinic first visit: 257 
Eligible to attend screening clinic second visit: 225 Not eligible: 6 
Not eligible: 580
Not eligible: 32 
Randomized at baseline 
219
Withdrawn 
15 
Withdrawn 
8 
Protein group 
109 
Control group 
110 
Completed 1 
year visit 
100 
Active 
82 
Intention
-to-treat 
18
Active 
80 
Intention
-to-treat 
15
Completed 1 
year visit 
95
*Active but failed to 
come to 1-year visit: 1 
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4.1.2 Management of baseline data analysis 
Baseline data were examined the following way: 
 Descriptive statistics of baseline characteristics, including demographic, 
general health status, anthropometry, body composition, physical activity, 
muscle strength, mobility, balance, and dietary intake. 
 Correlations between baseline characteristics, including correlation between 
body composition, muscle strength, mobility and balance. 
 Assessment of baseline sarcopenia by three defined methods. 
 Relationship between baseline protein intake and baseline characteristics. 
 Underreporting of baseline dietary intake and comparison to urinary nitrogen 
excretion.  
 
The data was first explored to check the outliers and extreme values.  All the outliers 
and extreme values were then checked.  The original records and the entered errors 
were corrected.  The distribution of each variable has been examined.  Except for the 
physical activity results that are highly skewed, all other variables were normally 
distributed.  Physical activity (Mets/week) was transformed into log (Mets/week) to 
achieve a normal distribution.  There were six participants who had Mets/week equal 
to zero.  These participants were treated as missing value when the results were 
transformed to log (Mets/week).   
 
4.1.3 Baseline characteristics 
4.1.3.1 Demographic characteristics at baseline 
At baseline, the average age of the participants was 74.2 ± 2.7 years (mean ± SD).  
There were no significant differences in age between the two groups (p = 0.96 in t-
test).  Among the 219 participants, 67% were born in Australia or New Zealand, 16% 
originally came from United Kingdom of Great Britain and Northern Ireland, and the 
remainder were from twenty different countries.  Almost one half were married and 
one third were widowed.  For the majority (73%) the highest education level attained 
was high school or equivalent.  Thirty-five percent of them were smokers, but only 
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three of them (1% in the total number of participants) were current smokers.  Most of 
them (93%) stated that they went outside on most days.  Only four participants (2%) 
were using a walking aid. The mean age of the last menstrual period was 48 ± 7 (SD) 
years.  The average number of children were 3 ± 2 (SD), ranging from zero to nine.  
Details are shown in Table 4.1.  There were no significant differences between the 
two drink groups in any of their demographic variables  (all p values >0.05 in chi-
square test). 
 
The majority (90%) of the participants had not experienced a fall in the past three 
months and only four (2%) had had multiple falls in the last three months.  However, 
there was a significant difference in the fall rate between the two groups (χ2 =10.4, p 
= 0.02 in Pearson chi-square test).  It can be seen from Table 2.1, the protein group 
had greater frequencies of falls in the categories of fallen once (10 cases versus 2 
cases) and multiple falls (4 cases versus 0) than the control group at baseline.   
 
4.1.3.2 General health status at baseline 
The self-reported general health status was assessed using the SF-36 questionnaire.  
The participants’ mean score for each health domain was above or similar to the 
normal health level (Ware, Kosinski et al. 1994) as shown in Table 4.2. The 
participants had a high level of social functioning with a mean score of 90 out of 100.  
After adjustment for Australian population data, the summary standardised physical 
health score was 46 ± 10, slightly lower than the normal Australia national level for 
adults which is 50 ± 10 (mean ± SD) (Ware, Kosinski et al. 1994; Ryan 1999).  
Mental health status was 54 ± 8, just above the normal Australia national mental 
health level which is 50 ± 10 (mean ± SD) (Ware, Kosinski et al. 1994; Ryan 1999).  
There were no significant differences in these scores between the two drink groups 
(all p values >0.05 in the t-test).   
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Table 4.1 Baseline demographic data. 
 Number (% of total) 
 Protein group Control group Total 
Country of birth (n=219)  
Australia 72 (33%) 74 (34%) 146 (67%)
United Kingdom  17 (8%) 17 (8%) 34 (16%)
Others 20 (9%) 19 (8%) 39 (17%)
Marital status (n=219)  
Married 54 (25%) 50 (23%) 104 (48%)
Divorced 16 (7%) 13 (6%) 29 (13%)
Never married 1 (1%) 7 (3%) 8 (4%)
Separated 3 (1%) 2 (1%) 5 (2%)
Widowed 35 (16%) 38 (17%) 73 (33%)
Education level (n=219)  
Primary school 9 (4%) 8 (4%) 17 (8%)
High school or equal 75 (34%) 84 (39%) 159 (73%)
≥ Tertiary degree  25 (11%) 18 (8%) 43 (19%)
Frequency of going out (n=219)  
2-3 days 2 (1%) 7 (3%) 9 (4%)
4-5 days 2 (1%) 4 (2%) 6 (3%)
Most days 105 (48%) 99 (45%) 204 (93%)
Use a walking aid (n=219)  
No 107 (49%) 108 (49%) 142 (98%)
Yes 2 (1%) 2 (1%) 77 (2%)
Frequency of fall in the past 3 
month (n=216) 
 
0 91 (42%) 104 (48%) 195 (90%)
1 10 (5%) 2 (1%) 12 (6%)
2 2 (1%) 3 (1%) 5 (2%)
≥3 4 (2%) 0 (%) 4 (2%)
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Table 4.2 Baseline general health status assessed by SF-36 questionnaire. 
* The scores were adjusted for the Australia population data. 
 
  
   Mean ± SD  
Protein group Control group Total 
Physical Function (n=219) 76 ± 19 73 ± 21 74 ± 20 
General Health (n=217) 76 ± 17 76 ± 14 76 ± 15 
Vitality (energy/fatigue) (n=219) 67 ± 19 65 ± 19 66 ± 19 
Mental Health (n=219) 82 ± 14 82 ± 15 82 ± 14 
Role limitation due to physical  
health problems (n=219) 
75 ± 36 73 ± 38 74 ± 37 
Role limitation due to emotional 
problem (n=218) 
86 ± 26 84 ± 30 85 ± 28 
Social Function (n=219) 90 ± 19 90 ± 17 90 ± 18 
Bodily Pain (n=219) 69 ± 23 70 ± 21 70 ± 22 
Standardised Physical Health 
Summary (n=216) 
46 ± 9 46 ± 10 46 ± 10 
Standardised Mental Health 
Summary (n=216) 
54 ± 8 54 ± 9 54 ± 8 
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4.1.3.3 Anthropometry, body composition and physical activity level at baseline 
Among the 219 study participants, 32% were in the normal range for the BMI (18.5 – 
24.9 kg/m2), 44% of participants were classified as overweight (25 – 29.9 kg/m2), 
and 23% moderately obese (30 – 34.9 kg/m2).  Only 1% were underweight (<18.5 
kg/m2).  As shown in Table 4.3, there were no significant differences in body 
composition measured by DXA and pQCT or any anthropometry measurements 
between the two drink groups, except that the control group had a slightly larger (0.8 
cm) calf girth than the protein group at baseline (p = 0.049).   
 
The physical activity level of participants was calculated as Mets (Met-minutes) per 
week.  A few of the participants were extremely active, but the majority had 
Mets/week ranges from 855 to 4095 (interquartile range).  There were 6 participants 
who had Mets/week equal to zero.  Since the physical activity data was significantly 
positively skewed (skewness = 3.116), log transformation was used.  The 
transformed data then had a normal distribution (skewness = -0.129).  When the 
participants were grouped into three IPAQ physical activity levels, 15% of them had 
low levels of physical activity (<600 Mets/week), 48% of them had moderate levels 
of physical activity (600 – 3000 Mets/week) and 37% of them had high levels of 
physical activity (>3000 Mets/week).   
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Table 4.3 Baseline anthropometry, body composition and physical activity 
comparing the protein group with the control group. 
 Mean ± SD 
 Overall 
n=219 
Protein group 
n=109 
Control group 
n=110 
Anthropometry 
Height (cm) 159.9 ± 6.0 160.0 ± 6.3 159.8 ± 5.8 
Weight (kg) 68.5 ± 11.3 67.4 ± 11.1 69.7 ± 11.5 
BMI (kg/m2) 26.8 ± 3.9 26.3 ± 3.8 27.3 ± 3.9 
Waist circumference (cm) 88.7 ± 9.6 87.5 ± 9.5 90.0 ± 9.6 
Hip circumference (cm) 104.6 ± 9.0 103.8 ± 8.5 105.5 ± 9.5 
Waist-to-hip ratio 0.85 ± 0.06 0.84 ± 0.06 0.85 ± 0.06 
Arm girth (cm) 31.5 ± 3.4 31.2 ± 3.3 31.8 ± 3.5 
Triceps skinfold (mm) 28.7 ± 8.3 28.2 ± 8.1 29.1 ± 8.5 
CUAMA (cm2)a 34.3 ± 10.3 33.9 ± 10.2 34.6 ± 10.4 
Calf girth (cm) 35.7 ± 2.9 35.3 ± 2.8 36.1 ± 3.1* 
      
Body composition measured by DXA and pQCT 
Whole body lean mass (kg) 37.5 ± 4.7 37.2 ± 4.7 37.8 ± 4.7 
Appendicular lean mass (kg) 16.5 ± 2.4 16.3 ± 2.4 16.6 ± 2.4 
Whole body fat mass (kg) 26.1 ± 7.5 25.2 ± 7.2 27.1 ± 7.7 
% of whole body fat mass (%) 39.4 ± 5.7 38.8 ± 5.4 40.1 ± 6.0 
Calf muscle cross-sectional 
area measure by pQCT (cm2) 
31.2 ± 5.6 30.7 ± 5.1 31.7 ± 5.9 
      
Physical activity assessed by International Physical Activity Questionnaire 
Mets/weekb  2101 (855-4095) 2160 (1120-5201) 1826 (740-3779) 
log(Mets/week)  3.31 ± 0.46 3.38 ± 0.44 3.26 ± 3.3 
a CUAMA: corrected upper arm muscle area (cm2) = ((Arm girth in cm) – π (triceps 
skinfold in cm))2/4π – 6.5; b Values are median (interquartile range); * p < 0.05 in the 
independent sample t-test of the differences between two drink groups. 
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4.1.3.4 Muscle strength, mobility, balance and self-reported falls at baseline 
There were no significant differences in hand grip strength or in any of the lower 
limb muscle strength measures between the two drink groups at baseline (see Table 
4.4).  Overall, the total mean knee and total hip muscle strength were 24.9 ± 8.4 and 
51.2 ± 17.9 kg respectively.  In the following analysis, the summed lower limb 
muscle strength (total knee strength and total hip strength) were also examined.   
 
As shown in Figure 4.2, the majority of the participants (87%) were able to hold the 
tandem position (heel of one foot directly in front of the other foot) more than 9 
seconds with their eyes open (scored 4).  With their eyes closed, only about 28% 
could hold the tandem position for more than 9 seconds.  There were no differences 
in the distributions of Romberg scores with the eyes-open test between the two drink 
groups (p = 0.61 in chi-square test).  There was a significant difference in the 
distributions of Romberg scores with the eye-closed test between the two drink 
groups (p = 0.03 in chi-square test).  The details of these distributions are shown in 
Appendix 20.   
 
The overall prevalence of self-reported falling during the preceding three months was 
10% (detail data is shown in Appendix 20).  The prevalence of falls during the 
preceding three months was 15% in the protein group and 5% in the control group, 
and the difference was significant between the two groups (χ2 =5.0, p = 0.02).   
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Table 4.4 Baseline muscle strength, mobility and balance tests comparing the 
protein group with the control group. 
 Mean ± SD 
 Overall 
n=219 
Protein group 
n=109 
Control group 
n=110 
Muscle strength (kg) 
Hand grip strength  21.6 ± 5.4 21.9 ± 5.1 21.4 ± 5.7 
Ankle dorsiflexion  10.5 ± 4.6 10.9 ± 5.1 10.1 ± 4.1 
Knee flexion  9.3 ± 3.8 9.2 ± 4.0 9.4 ± 3.7 
Knee extension  15.6 ± 6.2 15.4 ± 5.4 15.8 ± 6.9 
Hip extension  16.5 ± 6.5 17.0 ± 6.6 16.0 ± 6.3 
Hip abduction  11.0 ± 4.6 11.2 ± 4.2 10.9 ± 4.9 
Hip flexion  11.9 ± 4.5 12.1 ± 4.5 11.6 ± 4.4 
Hip adduction  11.8 ± 5.6 11.9 ± 5.5 11.8 ± 5.6 
Total knee strengtha  24.9 ± 8.4 24.6 ± 7.9 25.2 ± 8.9 
Total hip strengthb  51.2 ± 17.9 52.2 ± 17.9 50.2 ± 18.0 
      
Mobility and balance tests 
Timed Up and Go (second) 8.0 ± 1.4 7.9 ± 1.3 8.0 ± 1.5 
Romberg (eyes-open) (0-4)c   4 (4 – 4)       4 (4 – 4)      4 (4 – 4) 
Romberg (eyes-close) (0-4)c   3 (3 – 4)       3 (3 – 4)      3 (3 – 3) 
a Total knee strength = knee flexion + knee extension 
b Total hip strength = hip extension + hip abduction + hip flexion + hip adduction 
c Values are median (interquartile range) 
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 Figure 4.2 The distribution of subjects of Romberg tests at baseline (n = 219). 
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4.1.3.5 Dietary intake at baseline 
Baseline dietary protein intake was assessed by a 3-day food record.  A 24-hour 
urinary nitrogen was assessed as an external biomarker of the protein intake.  One of 
the participants in the protein group did not complete the24-hour urine and the 3-day 
food diary.   
 
Protein intake assessed by the 3-day food record was higher (76 ± 19 g/day or 1.14 ± 
0.33 g/kg/day) than the estimation from the 24-hour urine nitrogen (66 ± 19 g/day or  
0.98 ± 0.30 g/kg/day).  Total energy intake was 7140 ± 1518 KJ/day and protein 
provided 19±4 % of energy intake.  Carbohydrate and fat intake provided 46 ± 7 % 
and 33 ± 6% energy intake respectively.  The details of other nutrient intakes are 
shown in Table 4.5.  There were no significant differences in any of the nutrient 
intakes or 24-hour urinary nitrogen between the two drink groups at baseline (all p 
value > 0.05 in the independent sample t-test).   
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Table 4.5 Baseline dietary intake comparing the protein group with the control group.  
 Overall 
n=218 
Protein group 
n=108 
Control group 
n=110 
24-hour urine nitrogen (n = 218)     
24 hour urine nitrogen (g) 8.6 ± 3.0 8.8 ± 3.0 8.4 ± 3.0 
Protein intake assessed by urine nitrogen (g/day) † 66 ± 19 67 ± 19 65 ± 19 
Protein intake assessed by urine nitrogen (g/kg/day)* 0.98 ± 0.30 1.02 ± 0.32 0.95 ± 0.28 
     
Dietary intake assessed by 3-day food record (n = 218)     
Energy (KJ/day) 7140 ± 1518 7166 ± 1590 7114 ± 1451 
Protein (g/day) 76 ± 19 77 ± 22 76 ± 17 
Protein (g/kg/day) 1.14 ± 0.33 1.17 ± 0.34 1.12 ± 0.31 
Carbohydrate (g/day) 189 ± 47 187 ± 49 191 ± 45 
Fat (g/day) 62 ± 19 63 ± 18 61 ± 20 
 Saturated-fat (g/day) (% of fat intake) 24 ± 9 (43%) 25 ± 9 24 ± 8 
 Polyunsaturated-fat (g/day) (% of fat intake) 9 ± 4 (17%) 9 ± 4 9 ± 4 
 Monounsaturated-fat (g/day) (% of fat intake) 22 ± 8 (40%) 23 ± 7 22 ± ± 9 
Cholesterol (mg/day) 244 ± 103 245 ± 103 243 ± 103 
Calcium (mg/day) 904 ± 382 927 ± 420 881 ± 342 
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 Overall 
n=218 
Protein group 
n=108 
Control group 
n=110 
% of energy intake from protein (%) 19 ± 4 19 ± 4 19 ± 3 
% of energy intake from fat (%) 33 ± 6 33 ± 5 32 ± 6 
% of energy intake from saturated fat (%) 13 ± 3 13 ± 4 13 ± 3 
% of energy intake from carbohydrate (%) 46 ± 7 45 ± 6 47 ± 7 
% of energy intake from alcohol (%) 3 ± 4 3 ± 4 3 ± 4 
Values are mean ± SD.  † Protein intake (g) = 6.24 x (urinary nitrogen (g) + 2), * g/kg/day refers to gram per kilogram body weight per day. 
 
 176
4.1.3.6 Prevalence of sarcopenia at baseline 
The prevalence of sarcopenia was calculated using the widely used cut-off point of 
appendicular lean mass (ALM)/height2 < 5.454 kg/m2 to define sarcopenia.  The 
average of ALM/height2 was 6.4 ± 0.8 (kg/m2) in the current study.  Only 20 
participants (9% of total study sample) were categorized as having sarcopenia 
according to this criterion.  As can be seen in Table 4.6, both groups had a similar 
number of subjects who were classified as sarcopenic (Fisher’s Exact test, F=0.36, p 
= 0.24), which means there was no significant difference in the prevalence of 
sarcopenia between two groups at baseline.   
 
Table 4.6 Baseline prevalence of sarcopenia in two drink groups.  
Number of cases (%) 
Protein group Control group Total 
Sarcopenic 12 (11%) 8 (7%) 20 (9%) 
Non-sarcopenic 97 (89%) 102 (93%) 199 (81%) 
Total 109 (50%) 110 (50%) 219 (100%) 
 
 
4.1.4 Baseline cross-sectional study one - the relationship of body composition 
with mobility, balance and upper and lower limb muscle strength 
4.1.4.1 Correlation of body lean mass and muscle strength 
Age, weight, BMI, physical activity, and protein and energy intake 
Age was only negatively correlated with knee extension strength (r = -0.21, p < 
0.01).  Weight and BMI were positively correlated with hand grip strength and all 
lower limb strength measurements except hip abduction and adduction strengths 
(Table 4.7).  No correlation was found between measures of muscle strength and 
physical activity, or protein or energy intake.   
 
Body composition 
Hand grip strength was positively correlated with all of the muscle mass and size 
measurements, including whole body lean mass, appendicular lean mass, adjusted 
appendicular lean mass, calf muscle cross-sectional area and corrected upper arm 
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muscle area, as shown in Table 4.7.  Hand grip strength had the strongest correlation 
with appendicular lean mass (r = 0.38, p < 0.01) and the weakest correlation with 
whole body fat mass (r = 0.14, p < 0.05).  After adjustment for age and BMI in linear 
regression, hand grip strength remained significantly associated with whole body 
lean mass (Beta = 0.44, p < 0.001) and appendicular lean mass (Beta = 0.44, p < 
0.001), but its correlation with calf muscle cross-sectional area and upper arm muscle 
area disappeared.   
 
Similar patterns were found in the relationships between lower extremity muscle 
strength values (ankle dorsiflexion, knee and hip strengths) and body composition as 
shown in Table 4.7.  The lower limb muscle strength values had higher correlations 
with lean mass measurements (ranged from r=0.16 to 0.38) than with fat mass 
measurements (ranged from r=0.07 to 0.21) as expected.  After adjusted age and 
BMI in the linear regression model, total knee strength remained significantly 
correlated with whole body lean mass (Beta = 0.23, p = 0.007), appendicular lean 
mass (Beta =0.20, p = 0.02) and calf muscle cross-sectional area (Beta = 0.21, p = 
0.002).  The total hip strength was also significantly association with whole body 
lean mass (Beta = 0.22, p = 0.12), appendicular lean mass (Beta = 0.22, p =0.01), and 
calf muscle cross-sectional area (Beta = 0.15, p = 0.04) after adjustment for age and 
BMI.  After the adjustment, ankle dorsiflexion was not associated with calf muscle 
cross-sectional area , but remained significantly associated with whole body lean 
(Beta = 0.24, p = 0.005) and appendicular lean mass (Beta = 0.20, p = 0.03).   
 
In summary, hand grip strength was significantly correlated with whole body lean 
mass, appendicular lean mass and the association remained significant after 
adjustment for age and BMI.  Lower limb strength including ankle dorsiflexion, total 
knee strength and total hip strength were significantly associated with whole body 
lean mass, appendicular lean mass and calf muscle cross-sectional area and the 
association remained significant after adjustment for age and BMI. The one 
exception was that no association was found between ankle dorsiflexion and calf 
muscle cross-sectional area.   
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Table 4.7 Correlation of muscle strength with baseline characteristics and body composition (n=219). 
 Hand grip 
strength 
(kg) 
Lower limb muscle strength (kg) 
 Ankle 
dorsiflexion 
Knee  
flexion 
Knee  
extension 
Hip  
extension 
Hip  
abduction 
Hip  
flexion 
Hip  
adduction
Total  
knee  
Total  
hip  
Age (years)      -0.10     -0.11   -0.01   -0.21**   -0.07 0.01   -0.11    -0.06   -0.15*    -0.06 
Height (cm) 0.26** 0.15* 0.18* 0.05 0.14* 0.10 0.11 0.11 0.11 0.13 
Weight (kg) 0.25** 0.20** 0.24** 0.15* 0.19* 0.13 0.24** 0.11 0.22** 0.20**
BMI (kg/m2) 0.14* 0.14* 0.20** 0.17* 0.17* 0.10 0.22** 0.09 0.22** 0.17* 
Physical activity 
(log(Mets/week)) 
     -0.01     -0.04   -0.07 0.03   -0.02 0.03 0.05    -0.03 0.00 0.02 
Protein intake (g/d) † 0.07     -0.01 0.06   -0.01   -0.04   -0.05   -0.07    -0.02 0.04    -0.04 
Energy intake (kcal/d) † 0.06    -0.02 0.01 0.08 0.01   -0.01   -0.05    -0.07 0.08   -0.03 
           
Body composition a           
Whole body lean mass (kg) 0.36** 0.24** 0.32** 0.19** 0.25** 0.19** 0.24** 0.16* 0.28** 0.25**
ALM (kg) 0.38** 0.20** 0.33** 0.19** 0.26** 0.18** 0.24** 0.18** 0.28** 0.26**
Whole body fat mass (kg) 0.14* 0.15* 0.16* 0.10 0.13 0.07 0.21** 0.06 0.14* 0.14* 
% of fat mass (%)      -0.03 0.07 0.05 0.03 0.03   -0.02 0.13    -0.03 0.04 0.04 
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 Hand grip 
strength 
(kg) 
Lower limb muscle strength (kg) 
 Ankle 
dorsiflexion 
Knee  
flexion 
Knee  
extension 
Hip  
extension 
Hip  
abduction 
Hip  
flexion 
Hip  
adduction
Total  
knee  
Total  
hip  
Calf muscle cross-sectional 
area (cm2) 
0.17* 0.14* 0.23** 0.22** 0.20** 0.15* 0.12 0.20** 0.26** 0.20**
CUAMA (cm2) 0.18** 0.06 0.17* 0.05 0.07 0.09 0.12 0.08 0.12 0.11 
Values are Spearman rank correlation coefficients.  * p < 0.05; ** p < 0.01. † assessed by 3-day food record. 
a Whole body lean mass and fat mass, appendicular lean mass (ALM) and percentage of fat mass were derived from DXA; Calf muscle cross-
sectional area was derived from pQCT measurements at 38% length of tibia; CUAMA: Corrected upper arm muscle area (cm2) = (Arm girth in 
cm) – π(triceps skin fold in cm))2 / 4π – 6.5. 
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4.1.4.2 Correlation of ‘Timed Up and Go’ (TUAG) and Romberg tests with 
body lean mass and muscle strength 
Age, weight, BMI, physical activity, dietary protein and energy intakes 
As shown in Table 4.8, age was significantly positively correlated with TUAG 
(r=0.24, p < 0.01) and negatively correlated with the Romberg eyes-open and the 
eyes-closed tests (r = -0.15, p < 0.05 and r = -0.18, p < 0.01 respectively).  
Participants who were older were slower and took longer to complete the TUAG 
task, and had worse balance.  The TUAG and Romberg tests were not correlated with 
height, weight, BMI, physical activity level, or dietary protein or energy intakes.   
 
Body composition 
The TUAG and Romberg tests were not correlated with any of the absolute and 
adjusted muscle mass derived from DXA measurements, or muscle size measured by 
calf girth and pQCT (calf cross-sectional muscle area).  However, percentage body 
fat was significantly positively correlated with the TUAG test (r = 0.14, p<0.05).  
This means that participants with a higher percentage of body fat took a longer time 
to accomplish the TUAG task.  After adjustment for age and height in the linear 
regression model, the percentage body fat remained significant.  Romberg balance 
performance was not related to percentage body fat.   
 
Muscle strength 
The TUAG was inversely correlated with almost all lower extremity muscle strength 
tests which included ankle dorsiflexion (r = -0.16, p < 0.05), total knee strength (r = -
0.32, p < 0.001) and total hip strength (r = -0.20, p < 0.01).  The participants with 
stronger lower extremity strength were faster in performing the TUAG test.  Knee 
extension strength had the highest correlation with TUAG (r=0.34, p < 0.001). No 
correlation was found between hip adduction and TUAG.  Compared to hip strength, 
knee strength had a stronger correlation with TUAG performance (Table 4.8).   
After adjustment for age in the linear regression model, the significant correlation 
between TUAG with ankle dorsiflexion strength (Coefficients Beta = -0.14, p = 
0.03), total knee (Coefficients Beta = -0.32, p < 0.001) and total hip strength 
(Coefficients Beta =-0.20, p = 0.002) remained.   
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The ‘Romberg eyes-open’ test was positively correlated with ankle dorsiflexion and 
hip extension strength (r = 0.22, p < 0.001 and r = 0.14, p< 0.05 respectively).  After 
adjusting for age in the linear regression model, the significant correlation between 
‘Romberg eyes-open’ and ankle dorsiflexion remained (Coefficients Beta = 0.20, p = 
0.002) but the correlation with hip extension strength disappeared.  The Romberg 
eyes-closed scores were not correlated with any of the muscle strength 
measurements.  Hand grip strength was not correlated with mobility or balance 
performance in this study population.   
 
In summary, both mobility (TUAG) and balance (Romberg) were inversely 
correlated with age, but not correlated with any lean body mass measurement 
including whole body lean mass, appendicular lean mass or calf muscle cross-
sectional area.  Mobility was significantly inversely correlated with percentage body 
fat, but significantly positively correlated with almost all lower extremity strength 
measurements after adjustment for age.  The Romberg eyes-open test was only 
significantly positively correlated with ankle dorsiflexion after adjusted for age, but 
not with other lower extremity strengths.   
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Table 4.8 Correlation of Timed Up and Go (TUAG) and Romberg tests with 
baseline characteristics (n=219).  
 TUAG 
(second) 
Romberg 
(eyes open) 
Romberg 
(eyes close) 
Age (years) 0.24**      -0.15*      -0.18** 
Height (cm)      -0.10 0.07 0.03 
Weight (kg) 0.01 0.07      -0.03 
BMI (kg/m2) 0.06 0.06      -0.03 
Physical activity (log(Mets/week))      -0.09 0.11 0.08 
Protein intake (g/d) †      -0.03 0.04      -0.02 
Energy intake (kcal/d) †      -0.09     -0.00      -0.02 
Body composition a 
Whole body lean mass (kg)      -0.08 0.03      -0.01 
% of whole body lean mass      -0.13      -0.07 0.07 
Appendicular lean mass (kg)      -0.05 0.06      -0.02 
Whole body fat mass (kg) 0.07 0.09      -0.05 
% of whole body fat mass (%) 0.14* 0.06      -0.08 
Calf cross-sectional muscle area (cm2) 0.02 0.10 0.13 
Muscle strength 
Hand grip strength (kg) -0.11 0.11     -0.04 
Ankle dorsiflexion (kg) -0.16* 0.22** 0.10 
Knee flexion (kg) -0.21** 0.02 0.03 
Knee extension (kg) -0.34** 0.10 0.10 
Hip extension (kg) -0.24** 0.14* 0.11 
Hip abduction (kg) -0.14* 0.07 0.12 
Hip flexion (kg) -0.21** 0.08 0.06 
Hip adduction (kg) -0.07 0.07 0.13 
Total knee strength (kg) -0.32** 0.07 0.08 
Total hip strength (kg) -0.20** 0.11 0.11 
Values are Spearman rank correlation coefficients.  * p<0.05; ** p<0.01.  † assessed 
by 3-day food record.  a Whole body lean mass and fat mass, appendicular lean mass 
(ALM) and percentage of fat mass were derived from DXA; calf muscle cross-
sectional area was derived from pQCT measurements at 38% length of tibia. 
 183
 
4.1.5 Baseline cross-sectional study two: assessing underreporting of dietary 
intake at baseline 
Assessing dietary intake is always a difficult task that requires a systematic approach 
to minimizing measurement error.  The most common error in dietary assessment is 
the underreporting or misreporting of food intake.  Doubly-labeled water (DLW) 
which measures energy expenditure, is an excellent biomarker of energy intake.  In 
this study, DLW was not measured.  The EI:EE (ratio of energy intake and energy 
expenditure) provides an estimation of the degree of underreporting of energy both at 
the group and individual level (Black, Bingham et al. 1997).  The ratio of urinary 
nitrogen and dietary nitrogen intake provides an estimation of underreporting of 
protein intake and identifies the most obvious under-reporters of energy (Black, 
Bingham et al. 1997).   
 
Underreporting assessment method 
For the analysis of underreporting, the energy intake and protein intakes were 
assessed by a 3-day food record. These results were examined using the Goldberg 
EI:BMR ‘cut-off’ method (Goldberg, Black et al. 1991) and 24-hour urinary 
nitrogen.   
 
The reported energy intake (EI) by the 3-day food record was compared to the 
energy expenditure (EE) which was calculated using the adjusted basal metabolic 
rate (BMR).  Firstly, the BMR for women aged over 60 years was calculated using 
the Schofield Equation (Schofield 1985) which was used in the 1985 
FAO/WHO/UNU report:   
BMR = 0.038 x weight + 2.755 
BMR is in MJ/day (megajoule/day) and weight is in kg. 
 
In order to calculate the minimal energy intake for survival, BMR was adjusted by 
1.27 (Goldberg, Black et al. 1991).  The current study used 1.27 x BMR as the cut-
off point for energy expenditure (EE).  Although Goldberg and colleagues suggested 
that reported energy intakes of below 1.35 x BMR (known as CUT-OFF point 1 in 
their study) either in individuals or populations was most unlikely to represent 
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habitual intake, they used 1.55 x BMR (known as CUT-OFF point 2 in their study) as 
the energy requirement for a sedentary life style (Goldberg, Black et al. 1991).   
 
The ratio of EI:EE in this study can be calculated from the following equation (BMR 
x 1000 was used in order to convert BMR to kJ from MJ from): 
The ratio of EI:EE = Energy intake (kJ) / (BMR x 1000 x 1.27) (kJ) 
 
The final equation for the ratio of EI:EE is as below: 
The ratio of EI:EE = Energy intake (kJ) / ((0.038 x weight + 2.755) x 1000 x 1.27) 
(kJ) 
 
Participants were then grouped into three groups using the Black method, which is to 
defines underreporting, acceptable-reporting and over-reporting as EI:EE <0.76, 
0.76-1.24 and >1.24 respectively (Black 2000) (EE in their study was measured by 
doubly-labelled water).   
 
Characteristics of under-reporters 
Using the method described above, 24 participants (11%) were categorized as under-
reporters in the current study (Table 4.9).  Compared to the over-reporters, the under-
reporters had significantly higher body weight, BMI, waist and hip girth, triceps 
skinfold, arm girth, and calf girth.  The under-reporters also had a significantly 
higher total body fat mass than acceptable-reporters and over-reporters.  However, 
there were no significant differences in weight, BMI, waist and hip girths or 
percentage of whole body fat mass between under-reporters and acceptable-reporters.  
There were no differences in age and height between the groups.  Compared to the 
acceptable-reporters and over-reporters, the under-reporters had significantly lower 
total energy intake, and protein, fat and carbohydrate intakes.  However, the 24-hour 
urinary nitrogen showed no statistical differences across the three groups.    
 
In summary, the under-reporters had larger body size, higher proportion of whole 
body fat mass compared to the over-reporters.  They reported significantly lower 
total energy, protein, fat and carbohydrate intakes than both acceptable-reporters and 
over-reporters.  However, 24-hour urinary nitrogen showed that protein intakes were 
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not significantly different across the groups, indicating that underreporting of protein 
intake was likely to have occurred in this sample.   
 
The agreement between protein intake assessed by 3-day food record and 24-hour 
urinary nitrogen by BMI groups 
There was no difference in the 24-hour urine nitrogen between the three groups 
Table 4.10.  As this method is used as external validation of dietary protein intake, 
the assumption is it more accurately reflects dietary protein intake and will show the 
degree of underreporting or misreporting.  Comparing the protein intake assessed by 
the 3-day food record with the protein intake assessed by 24-hour urinary nitrogen by 
BMI groups, no significant differences were found between groups (Table 4.10).  
There were no significant differences in the ratio of protein intake assessed by the 
two assessment methods across the BMI groups either (p = 0.45).  Therefore, by 
using 24-hour urinary nitrogen as external recovery biomarker representing a more 
accurate assessment of protein intake, participants with a larger body size should 
have been consuming more protein than they reported eating.  As shown in Table 
4.9, the reported protein intake (57.0 ± 12.6 g) was lower than protein intake 
assessed by 24-hour urinary nitrogen (61.1 ± 19.1) in the under-reporters.  In 
contrast, the reported protein intake was higher than protein intake assessed by 24-
hour urinary nitrogen in those acceptable-reporters (74.4 ± 15.9 g vs. 65.7 ± 16.4 g) 
and over-reporters (92.2 ± 20.2 g vs. 70.0 ± 24.6).  The reason for underreporting 
may be due to the recording process which could affect eating habits during the 
recording period, known as the ‘Hawthorne’ effect.   Subjects improve an aspect of 
their behaviour simply in response to the fact that they are being studied (McCarney, 
Warner et al. 2007).   
  
 186
Table 4.9 Baseline characteristics of under-reporters, acceptable reporters, and 
over-reporters defined by the EI:EE ratios (n=218) *. 
 Under-
reporters 
EI:EE 
<0.76 
n = 24 
Acceptable-
reporters 
EI:EE 
0.76–1.24 
n = 145 
Over-reporters 
EI:EE 
>1.24 
n = 49 
P value 
of 
ANOVA 
test 
Age (year) 73.3 ± 2.3 74.5 ± 2.7 74.0 ± 2.8 0.10 
Height (cm) 160.3 ± 8.1 159.9 ± 5.8 159.4 ± 5.2 0.83 
Weight (kg)  74.1 ± 13.4c 69.5 ± 10.6c 62.8 ± 10.2ab <0.001
BMI (kg/m2)  28.7 ± 3.6c 27.2 ± 3.6c 24.8 ± 4.1ab <0.001
Waist girth (cm)  93.1 ± 10.1c 89.5 ± 8.9c 84.4 ± 10.1ab <0.001
Hip girth (cm)  109.9 ± 10.3c 105.5 ± 8.5c 99.6 ± 7.8ab <0.001
Waist-to-hip ratio 0.85 ± 0.06 0.85 ± 0.06 0.85 ± 0.06 0.96 
Triceps skinfold (mm)  29.3 ± 8.0 29.7 ± 8.2c 25.4 ± 8.1b   0.006 
Arm girth (cm)  32.8 ± 3.4c 31.9 ± 3.2c 29.7 ± 3.4ab <0.001
Calf girth (cm)  36.5 ± 3.6 35.8 ± 2.8 34.8 ± 2.7 0.04 
Physical activity 
(log(Mets/week)) 
3.31 ± 0.45 3.31 ± 0.48 3.34 ± 0.41 0.95 
      
Dietary intake assessed by 3-day food record 
Energy intake (kJ/day)  4696 ± 607bc 6929 ± 986ac 8959 ± 908ab <0.001
Protein intake (g/day)  57.0 ± 12.6bc 74.4 ± 15.9ac 92.2 ± 20.2ab <0.001
Protein intake (g/kg/day) 0.78 ± 0.17bc 1.08 ± 0.24ac 1.49 ± 0.30ab <0.001
Fat intake (g/day)  36.5 ± 7.8ab 60.0 ± 14.6ac 80.9 ± 16.0ab <0.001
Carbohydrate intake (g/day) 130.7 ± 26.5ab 183.4 ± 33.3ac 234.6 ± 49.9ab <0.001
% energy from protein  21.3 ± 4.7bc 18.7 ± 3.2ac 17.8 ± 3.2ab <0.001
% energy from fat  29.5 ± 4.9bc 32.5 ± 5.6a 34.1 ± 5.9a   0.005 
% energy from carbohydrate 48.2 ± 6.6 45.8 ± 6.4 45.0 ± 7.3 0.16 
      
24-hour urinary nitrogen      
24-hour urinary nitrogen 
(g/day) 
7.77 ± 3.06 8.51 ± 2.63 9.20 ± 3.94 0.15 
Protein intake assessed by 61.1 ± 19.1 65.7 ± 16.4 70.0 ± 24.6 0.15 
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 Under-
reporters 
EI:EE 
<0.76 
n = 24 
Acceptable-
reporters 
EI:EE 
0.76–1.24 
n = 145 
Over-reporters 
EI:EE 
>1.24 
n = 49 
P value 
of 
ANOVA 
test 
urinary nitrogen (g/day) 
      
Body composition †      
Whole body lean mass (kg) 38.4 ± 5.5 37.6 ± 4.7 36.5 ± 4.1 0.21 
Appendicular lean mass (kg) 16.8 ± 3.1 16.5 ± 2.3 16.0 ± 2.2 0.35 
Whole body fat mass (kg)  30.7 ± 8.2bc 26.9 ± 6.8ac 21.4 ± 7.0ab <0.001
% of whole body fat mass  42.9 ± 4.5c 40.3 ± 5.0c 35.2 ± 6.3ab <0.001
Calf muscle cross-sectional 
area (cm2) 
30.1 ± 5.6 31.1 ± 5.0 32.1 ± 7.0 0.35 
Corrected upper arm muscle 
area (cm2)  
38.4 ± 11.0c 34.4 ± 10.3 31.6 ± 9.5a 0.03 
Results are mean ± SD. * EI (energy intake in kJ) was assessed by 3-day food record. 
EE (energy expenditure in kJ) = ((0.038 x weight + 2.755) x 1000 x 1.27) (kJ). 
† Whole body lean and fat mass, appendicular lean mass and percentage of whole 
body fat mass were derived from DXA; Calf muscle cross-sectional area was 
obtained from pQCT measurements at 38% length of tibia; Corrected upper arm 
muscle area (cm2) = ((Arm girth in cm) – π(triceps skin fold in cm))2 / 4π – 6.5.  
a significantly different from the 1st tertile, b significantly different from the 2nd tertile, 
c significantly different from 3rd  tertile (ANOVA with Tukey’s test, p<0.05). 
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Table 4.10 Baseline protein intake assessed by 24-hour urinary nitrogen and by 
3-day food record by BMI groups. 
 Protein intake 
measured by 24-hour 
urinary nitrogen (g)
Protein intake 
assessed by 3-day 
food record (g) 
Ratio of protein 
intake assessed 
by two methods
BMI <25 (n=73) 64.7 ± 20.1 77.4 ± 18.9 0.86 ± 0.27 
BMI 25-29.9 (n=95) 65.4 ± 15.5 74.9 ± 20.5 0.92 ± 0.32 
BMI ≥30 (n=50) 69.7 ± 22.4 78.1 ± 17.9 0.91 ± 0.30 
P value of ANOVA test 0.58 0.30 0.45 
Values are in mean ± SD.   
 
The distribution of the under-reporters at baseline 
As underreporting may affect the results relating to the dietary intake, the distribution 
of the under-reporters at baseline was assessed by chi-square test.  As can be seen in 
Table 4.11, the proportion of under-reporters, acceptable reporters and over-reporters 
were equally distributed in the two drink groups (χ2 =1.217, p = 0.544).   
 
Table 4.11 The distribution of the under-reporters in the protein supplement 
group and the control group at baseline. 
             Number (%)  
 Protein group Control group Total 
Under-reporters 13 (12%) 11 (10%)     24 (11%) 
Acceptable reporters 68 (63%) 77 (70%) 145 (66.5%) 
Over-reporters 27 (25%) 22 (20%)   49 (22.5%) 
Total 108 110 218 
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4.1.6 Baseline cross-sectional study three – the relationship between the habitual 
dietary protein intake and body composition at baseline 
Participants were grouped into three groups according to their protein intake as 
assessed by the 3-day food record.  Protein intakes were <69 g/day, 69-83 g/day, and 
>83 g/day in the 1st, 2nd, and 3rd tertiles respectively.  Total energy intake, other 
macronutrient intakes and calcium intake had similar patterns to the protein intake. 
That is, the nutrient intakes were significantly different across the protein groups 
with the lowest energy and nutrient intakes in the 1st tertile and highest energy and 
nutrient intakes in the 3rd tertile as shown in Appendix 17.  
 
Whole body lean mass and appendicular lean mass were significantly lower in the 1st 
tertile compared to the 2nd and 3rd tertiles of baseline protein intake (Figure 4.3 
A&B).  There were no differences in whole body fat mass or percentage whole body 
fat across the tertile of protein intake groups.  The adjusted appendicular lean mass 
(ALM/height2) and calf muscle cross-sectional area showed similar patterns as the 
whole body lean mass.  That is, the participants in the 1st tertile of protein intake had 
a significantly lower adjusted appendicular lean mass and calf muscle cross-sectional 
area than those in the 1st tertile than in the 3rd tertile (Figure 4.3 C&D).   There was 
no difference in the corrected upper arm muscle area across the tertile of protein 
intake groups.   
 
There were no significant differences in age, weight, BMI, self-reported health 
status, physical activity level, mobility or balance functions, or any of the muscle 
strength measurements across the tertile of protein intake groups (details are shown 
in Appendix 17).  However, participants in the 2nd tertile were significantly taller 
than those in 1st tertile (161.2 ± 5.3 cm and 158.3 ± 6.4 cm respectively, p<0.05).   
 
ANCOVA analysis with Bonferroni test was therefore used to further examine 
muscle mass and size by tertile of protein intake adjusted for height.  The differences 
in these muscle mass and size measurements between the tertile of protein intake 
groups disappeared (Appendix 18).   
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As underreporting dietary intake may affect the analysis results associated with the 
dietary intake, all the analyses in this section have been repeated after the exclusion 
of the under-reporters.  There was no difference in the results when the 
underreporters were included or excluded.  The  exception is that, in the ANCOVA 
analysis with Bonferroni test, after adjusted for height, the lowest protein intake 
group remained significantly lower in whole body lean mass than the highest protein 
intake group (Figure 4.4 A), and also remained significantly lower in appendicular 
lean mass than the acceptable protein group (Figure 4.4 B).  However, when total 
energy intake was entered into the ANCOVA model as a covariate, the positive 
correlation between protein intake and whole body and appendicular lean mass 
disappeared.   
 
In summary, participants in the lowest protein intake group (1st tertile) had 
significantly lower whole body lean mass and appendicular lean mass than those in 
the acceptable protein intake group (2nd tertile) or highest protein intake groups (3rd 
tertile). This relationship was independent of total body fat mass.  These differences 
disappeared after adjustment for height and total energy intake.  The results were 
similar in these analyses after excluding the under-reporters.  There were no 
significant differences in body functional tests or muscle strength measurements 
between participants who were having a lower or higher protein intake in their 
habitual diet at baseline.   
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Figure 4.3 (A-D) Baseline body composition by tertiles of protein intake.  
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C. ALM/height2 by tertiles of protein intake  
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D. Calf muscle cross-sectional area by tertiles of protein intake 
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Body composition (whole body lean mass, appendicular lean mass, ALM/height2) 
was assessed by DXA, calf muscle cross-sectional area was assessed by pQCT, and 
protein intake was assessed by 3-day food record.  Values are reported as mean ± 
SD.  Groups with different lower case letters are significantly different, p < 0.05 
(ANOVA with Tukey test) 
 
  
 193
 
Figure 4.4 (A-B) Baseline body composition by tertile of protein intake after 
excluded the under-reporters in the analysis and adjusted for height. 
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Estimated marginal mean (SE) of whole body lean mass and appendicular lean mass 
by baseline protein intake in tertiles (after excluding the under-reporters in the 
analysis).  The values were adjusted for baseline height.  Groups with different lower 
case letters are significantly different, p < 0.05 (ANCOVA with Bonferroni test). 
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4.1.7 Differences in baseline characteristics and compliance between the two 
drink groups and between those who withdrew and those who completed the 
one year intervention 
4.1.7.1 Differences between the two study groups in baseline characteristics of 
subjects who completed the one year study 
There were no significant differences in the baseline characteristics (e.g. age, 
physical activity, anthropometry measurements, muscle mass and size, muscle 
strength and body functional tests) between the two drink groups (details are shown 
in Appendix 21).  The exception was when participants in the protein 
supplementation group were compared to the control group at baseline, they had 
significantly lower waist girths (protein group: 87.1 ± 9.4; control group: 90.3 ± 9.6; 
p=0.02) and whole body fat mass (protein group: 24.8 ± 7.2; control group: 27.0 ± 
7.6; p=0.04).  These differences would not affect the following comparison analysis 
of drink effects because for the primary outcomes, body lean mass and muscle 
strength, baseline values are adjusted for in the analysis models as covariates.   
 
4.1.7.2 Differences in compliance at one year between two drink groups 
Assessed by returned drink bottles 
Compliance was calculated based on the number of the drink bottles that participants 
returned at one year.  There were a total of 179 participants (91 in the protein group 
and 88 in the control group) who returned the consumed drink bottles including those 
who reported consuming zero bottles of drink.  There were 16 participants who failed 
to return any drink bottles and they were treated as missing values in the analysis.   
 
The mean consumption of drinks at one year in the protein group and the control 
group were 190 ± 94 and 152 ± 92 bottles respectively.  The protein group consumed 
38 (11, 66) (mean and 95% CI) more bottles than the control group.  To be 
considered 100% compliant, participants were required to consume a total of 365 
bottles over the period of a year.  The overall compliance was 47% and the 
distribution was shown in Figure 4.5.  The compliance of the protein group and the 
control group were 52% and 42% respectively.  The compliance was significantly 
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different between the two groups (p=0.007 in two-sample t-test).  Among 179 
participants who were in the compliance analysis, 141 (79%) participants’ recorded a 
compliance of less than 70%, and 38 (21%) participants’ had a compliance greater 
than 70% or higher.  Among these 38 high compliance participants, only eight (4% 
out of 179 participants) consumed more than 90% of their allocated drinks. Of these 
participants, 25 were from the protein drink group, and 13 were from the control 
drink group.   
 
Further ANCOVA analysis, which included adding the BMI as a covariate, showed 
that there was a similar decline in the trend of drink consumption with increasing 
baseline BMI in both groups (Figure 4.6).  However there was no significant 
differences in compliance by BMI groups within the same drink group.   
 
Compliance to the Test Drink as Assessed by 24-hour urinary nitrogen  
Compliance was also tested by 24-hour urinary nitrogen measurements at one year.  
The 24-hour urinary nitrogen of the protein group had increased significantly over 
the placebo group (protein group: +1.3 g/day, placebo group: -0.5 g/day, p<0.05) at 
one year as anticipated (detail is shown in Table 4.12).  There was no difference in 
baseline urinary nitrogen between the two drink groups (protein group: 8.8 ± 3.1 
g/day, n=100; placebo group: 8.7 ± 3.0 g/day, n=93; p=0.96).  As there was no 
difference at baseline between the two drink groups, the significant difference in 24-
hour urinary nitrogen at one year between the two groups indicates a moderate 
compliance of the participants to the protein drink.   
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Figure 4.5 The distribution of compliance with drink consumption (n=179).  
 
 
Figure 4.6 Drink consumption at one year by drink groups and baseline BMI.    
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Drink consumption was estimated by the number of empty drink bottles that 
participants returned after one year (protein group n = 91, placebo group n = 88). 
Values are estimated marginal mean and 95% confidence interval (ANCOVA with 
Bonferroni test) after adjusted BMI as covariate.  
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Table 4.12 Changes in 24-hour urinary nitrogen at one year in two drink groups. 
 Protein group (n = 99)  Placebo group (n = 94) 
 Value at 1 year Absolute change 
from baseline 
% change from 
baseline (%) 
 Value at 1 
year 
Absolute change 
from baseline 
% change 
from baseline 
(%) 
24-hour urinary nitrogen (g) 10.1 ± 3.01,* 1.3 (0.5, 2.0)2,* 26 (15, 38)*  8.2 ± 3.1 -0.5 (-1.2, 0.2) 0.1 (-8.2, 8.0) 
Protein intake assessed by 24-
hour urinary nitrogen (g/day) † 
75.8 ± 18.5*  8.0 (0.5, 12.7)* 19 (11, 27)*  63.9 ± 19.6 -3.1 (-7.3, 1.1) -1 (-7, 5) 
1 Mean ± SD (all such values).  2 Mean (95% confidence interval).  Absolute change =value at 1year – value at baseline.  Percentage 
change=(value at 1 year – value at baseline)/value at baseline x 100.  † Protein intake (g) =6.24 x (urinary nitrogen (g) + 2).  * p<0.05 compared 
to the control group tested by the independent-sample t-test. 
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4.1.7.3 Differences in baseline characteristics between those who withdrew and 
those who completed the one year intervention 
A total of 23 participants (protein group n=8, control group n=15) withdrew and 195 
completed the study at one year.  Twenty-one percent of those who withdrew (a total 
of 5 participants: 3 in the protein group and 2 in the control group) stated they did so 
because they felt ill after taking the drink, (this included nausea, constipation and 
gastro-intestinal discomfort).  Thirteen percent withdrew due to not liking the drink 
(a total of 3 participants: 2 in the protein group and 1 in the control group).  Eight 
percent (one participant in each of the drink groups) withdrew due to medical 
reasons.  The majority (54%: 3 in the protein group and 10 in the control group) 
withdrew without giving any specific reasons.  Compared to those who completed 
the one year study, the withdrawals had significantly lower scores in self-reported 
physical health status (withdrawals: 40.9 ± 11.0, completed: 46.4 ± 9.2, p=0.007 in t-
test), and significantly lower 24-hour urinary nitrogen (withdrawals: 7.07 ± 2.09, 
completed: 8.77 ± 3.06, p=0.009 in t-test).  The withdrawals also had lower physical 
activity level and lower ankle dorsiflexion strength than those who completed the 
study but the differences were not statistically significant (both p values =0.08).  
There were no significant differences in other baseline characteristics between the 
participants who withdrew and those who completed the one year intervention 
(details are shown in Appendix 22).   
 
4.2 Data analysis after one year of intervention 
At one year, of the 219 participants randomized at baseline, 23 women (11%) had 
withdrawn from the study (8 from the protein group and 15 from the control group).  
One participant could not participate in the one year examination because of a hip 
replacement operation and was excluded from the one year data analysis.  The final 
number of participants who completed the one year study was 195.  Amongst the 195 
participants, 100 were in the protein supplement group and 95 were in the control 
group.  The details are shown in Figure 4.1, the flow chart of the study participants. 
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4.2.1 The effect of one year protein supplement intervention on anthropometry, 
physical activity level, and self-reported health status 
Weight (p < 0.001), BMI (p < 0.001), triceps skinfold (p=0.007) and calf girth 
(p<0.001) showed a significant time effect in the GLM (general linear model) 
repeated measures tests.  Therefore the study participants overall had increased 
significantly in these variables at one year.  When the drink groups were analysed 
separately using a paired sample t-test, both groups showed a significant increase in 
weight (Figure 4.7), BMI and calf girth at one year (all p values <0.05).   
 
There were a significant drink treatment effect for BMI (p = 0.04), waist (p = 0.02) 
and waist-to-hip ratio (p = 0.04) at one year as shown in Table 4.13.  ANCOVA 
analysis was performed for these three variables.  The drink treatment effect on BMI 
disappeared (p = 0.36) after adjustment for age and baseline BMI.  After adjustment 
for baseline waist, age and height, the treatment effect on waist (p = 0.83) and waist-
to-hip ratio also disappeared (p = 0.52).  There was no difference for any other 
anthropometry measurements (including weight), physical activity, or self-reported 
health status at one year between the two drink groups using the GLM (general linear 
model) repeated measures test (all p values >0.05 in the models).  
 
These results indicate that there was no protein treatment effect for the following: 
weight, height, BMI, waist or hip girth, waist-to-hip ratio, physical activity and self-
reported health status.  Furthermore there were no significant interactions of the 
drink treatment and the time effect for anthropometry, physical activity and self-
reported health status.   
 
The details of the absolute and percentage changes of these variables at one year are 
shown in Table 4.13.  A subgroup (participants whose compliance >70%) analysis 
was performed using GLM repeated measures test. There was a significant time 
effect on weight gain but there was no protein treatment effect (F = 1.411, p = 
0.237).  Other results were similar to the results as using the whole study population 
data in the analysis.   
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Figure 4.7 Weight at baseline and one year in participants who completed one 
year study (comparing the protein group with the control group). 
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(The protein group n = 100, and the placebo group n = 95.  Values are mean and 95% 
confidence interval.  The within drink group changes between baseline and one year 
were tested by the paired sample t-test.) 
 
 
 
 
 201
 
Table 4.13 The absolute and percentage changes in anthropometry, physical activity and health status after one year intervention for the 
protein group and the control group.  
 Absolute change  Percentage change (%) P values P values P values
 Protein group Control group     Protein group Control group (1) (2) (3) 
Height (cm)  -0.2  (-0.2, 0.1) -0.1  (-0.2, 0.0)  -0.1  (-0.2, 0.0) -0.1  (-0.1, 0.0) 0.99 0.22 0.03 
Weight (kg) 0.6  ( 0.2, 1.0) 1.0  ( 0.6, 1.5)  0.8  ( 0.2, 1.5) 1.5  ( 0.9, 2.2) 0.06 0.15 0.13 
BMI (kg/m2) 0.3  ( 0.1, 0.5) 0.4  ( 0.3,0.6)  1.0  ( 0.4, 1.7) 1.6  ( 1.0, 2.3) 0.04 0.23 0.55 
Waist girth (cm)  0.3  (-0.6, 1.2) 0.3  (-0.5, 1.3)  0.4  (-0.6, 1.5) 0.4  (-0.6, 1.5) 0.02 0.91 0.80 
Hip girth (cm)  -0.1  (-0.7, 0.5) -0.2  (-0.8, 0.4)  -0.1  (-0.7, 0.5) -0.2  (-0.7, 0.3) 0.16 0.81 0.32 
Waist-to-hip ratio  0.0  ( 0.0, 0.0) 0.0  ( 0.0, 0.0)  0.6  (-0.4, 1.6) 0.7  (-0.3, 1.7) 0.04 0.79 0.51 
Physical activity (log(Mets/week)) 0.0  (-0.1, 0.1) -0.0  (-0.1, 0.1)  -0.3  (-3.5, 2.8) 2.1  (-1.1, 5.3) 0.26 0.30 0.62 
SF-36 standard physical health (0-100) 0.5  (-1.0, 2.0) -0.2  (-1.6, 1.2)  2.2  (-1.5, 5.8) 1.3  (-2.3, 4.8) 0.54 0.50 0.19 
SF-36 standard mental health (0-100) -1.4  (-3.2, 0.3) -0.5  (-2.4, 1.3)  -1.4  (-5.3, 2.4) 0.9  (-3.2, 5.0) 0.69 0.49 0.58 
Values are mean and 95% confidence interval.  The protein group n =100, and the control group n =95.  Absolute change = value at 1year – 
value at baseline.  Percentage change = (value at 1 year – value at baseline)/value at baseline x 100.  P values (1) were for the treatment effect 
derived from General Linear Model (GLM) repeated measures tests using the whole study population data (n = 195), p values (2) were for the 
interaction of treatment and visit time in the model.  P values (3) were for the treatment effect derived from GLM model using data of 
participants (n = 38, 25 in the protein group and 13 in the control group) whose compliance > 70%.   
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4.2.2 The effect of one year protein supplement intervention on muscle mass and 
size and body composition 
Whole body lean mass (p<0.001), appendicular lean mass (p<0.001), and total fat 
mass (p<0.001) showed a significant time effect in the GLM (general linear model) 
repeated measures tests.  This means that the participants overall (both in the protein 
supplemented group and the control group) increased in these measurements as a 
result of the one year intervention.  The percentage of whole body lean mass and fat 
mass measured by DXA or calf muscle cross-sectional area did not change at one 
year.   
 
There was no difference for whole body lean mass, appendicular lean mass, or calf 
muscle cross-sectional area at one year tested between two drink groups using the 
GLM (general linear model) repeated measures test (all p values >0.05 in the 
models) as shown in Table 4.14, which means there was no protein treatment effect 
for any of these variables.   
 
There were no significant interactions of treatment and time for whole body lean 
mass, appendicular lean mass and calf muscle cross-sectional area.  When the trial 
and control drink groups were analysed separately using a paired sample t-test, both 
groups showed a significant increase in whole body lean mass (protein group: 
+1.6%, p<0.05; control group: +2.3%, p<0.05) (Figure 4.8) and appendicular lean 
mass (protein group: +1.3%, p<0.05; control group: +1.8%, p<0.05) (Figure 4.9).  
However, only the control group had a significant increase in total fat mass, (+1.5%, 
p=0.04) as shown in Figure 4.10, and the changes between two drink groups were 
not significant.  ANCOVA analysis was performed by adjusting for baseline age and 
height and controlled for baseline total body fat mass, and this showed there was no 
difference in changes between the two drink groups at one year (drink effect: F = 
1.23, p = 0.27).  The percentage of body fat mass slightly decreased in both group by 
0.5% at one year (Table 4.14), but the changes were not statistically significant for 
either drink group.   
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The details of the absolute and percentage changes at one year are shown in Table 
4.14.  The subgroup analysis which only included the high compliers (compliance 
>70%) was performed to assess the effect on these outcomes using the GLM 
repeated measures test, but there were no significant findings (p values of protein 
treatment effect were reported in Table 4.14). 
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Figure 4.8 The whole body lean mass at baseline and one year in participants 
who completed the one year intervention. 
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(The protein group n = 100, and the placebo group n = 95.  Values are mean and 95% 
confidence interval.  The within drink group change between baseline and one year 
were tested by the paired sample t-test.) 
 
Figure 4.9 The appendicular lean mass at baseline and one year in participants 
who completed the one year intervention.  
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(The protein group n = 100, and the placebo group n = 95.  Values are mean and 95% 
confidence interval.  The within drink group change between baseline and one year 
were tested by the paired sample t-test.) 
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Figure 4.10 The total body fat mass at baseline and one year in participants who 
completed the one year intervention. 
protein group control group
0
10
baseline
1 year
22.5
25.0
27.5
30.0
p=0.19
p=0.04
To
ta
l b
od
y 
fa
t m
as
s 
(k
g)
 
(The protein group n = 100, and the placebo group n = 95.  Values are mean and 95% 
confidence interval.  The within drink group change between baseline and one year 
were tested by the paired sample t-test.) 
 
 206
 
Table 4.14 The absolute and percentage change in body composition and muscle size after one year intervention comparing the protein 
group with the control group. 
 Absolute change Percentage change (%) P values P values P values
    Protein group    Control group    Protein group Control group (1) (2) (3) 
Whole body lean mass (kg) 0.6 ( 0.4, 0.8) 0.9 ( 0.6, 1.1) 1.6 ( 1.0, 2.1) 2.3 ( 1.7, 2.9) 0.22 0.08 0.14 
% of whole body lean mass 0.2 (-0.1, 0.6) 0.2 (-0.1, 0.5) 0.4 (-0.1, 1.0) 0.4 (-0.1, 1.0) 0.08 0.93 0.45 
Appendicular lean mass (kg) 0.2 ( 0.1, 0.3) 0.3 ( 0.1, 0.4) 1.3 ( 0.5, 2.0) 1.8 ( 1.0, 2.6) 0.23 0.42 0.48 
Whole body fat mass (kg) 0.2 (-0.1, 0.6) 0.4 ( 0.0, 0.8) 0.7 (-0.7, 2.1) 1.5 ( 0.1, 2.9) 0.054 0.16 0.11 
% of whole body fat mass -0.2 (-0.5, 0.1) -0.2 (-0.5, 0.1) -0.5 (-1.4, 0.3) -0.5 (-1.3, 0.4) 0.08 0.96 0.53 
Calf muscle cross-sectional area (cm2) 0.0 (-0.3, 0.2) 0.0 (-0.2, 0.4) 0.0 (-0.9, 0.9) 0.4 (-0.5, 1.4) 0.13 0.45 0.52 
Values are mean and 95% confidence interval.  The protein group n=100, and the control group n=95.   
Absolute change = value at 1year – value at baseline.  Percentage change = (value at 1 year – value at baseline)/value at baseline x 100.  Whole 
body and percentage of whole body lean and fat mass and appendicular lean mass were derived from DXA.  Calf muscle cross-sectional area 
was obtained from pQCT measurements at 38% length of tibia.   
P values (1) were for the treatment effect derived from General Linear Model (GLM) repeated measures tests using the whole study population 
data (n = 195), and p values (2) were for the interaction of treatment and visit time (DO YOU MEAN LENGTH OF INTERVENTION?) in the 
model.  P values (3) were for the treatment effect derived from GLM model using data of participants (n = 38, 25 in the protein group and 13 in 
the control group) whose compliance > 70%. 
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4.2.3 The effect of one year protein supplement on muscle strength 
Participants overall (both in the protein and the control group) had a significant 
decrease in hand grip strength (p=0.001), and a significant increase in ankle 
dorsiflexion (p=0.005) and total knee strength (p<0.001) at one year using the GLM 
(general linear model).  When the two drink groups were analysed separately using a 
paired sample t-test, both drink groups showed a significant decline in hand grip 
strength (Figure 4.11), but a significant increase in ankle dorsiflexion strength 
(Figure 4.12) and total knee strength (Figure 4.13).  There was no difference for total 
hip strength at baseline and one year between the two drink groups (p=0.29 for time 
effect in the model).  There was no significant interaction between drink treatment 
and time for any of these variables except for the hip extension strength (p = 0.02 in 
GLM model for interaction of treatment and visit time).  When the two drink groups 
were analysed separately using a paired sample t-test, only the control group showed 
a significant increase (p = 0.04), and there was no significant difference between 
group differences for changes in hip extension strength (treatment effect p = 0.76 in 
GLM model).   
 
The changes in hand grip, ankle dorsiflexion, knee and hip strength at one year were 
not significantly different between the two drink groups, using the GLM (general 
linear model) repeated measures test (all p values for drink treatment were >0.05 in 
the models as shown in Table 4.15).   
 
The absolute and percentage changes at one year for the two drink groups are shown 
in Table 4.15.  The subgroup analysis including only the high compliers (>70% drink 
compliance) was performed, but there were no significant differences found between 
the control and trial  drink groups in any of these muscle strength tests at one year 
(Table 4.15).   
 
 208
 
Figure 4.11 The hand grip strength at baseline and one year in participants who 
completed the one year study.  
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(The protein group n = 98, and the placebo group n = 93.  Values are mean and 95% 
confidence interval.  The within drink group change between baseline and one year 
were tested by the paired sample t-test.) 
 
Figure 4.12 The ankle dorsiflexion strength at baseline and one year in 
participants who completed the one year study. 
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(The protein group n=98, and the placebo group n=94.  Values are mean and 95% 
confidence interval.  The within drink group change between baseline and one year 
were tested by the paired sample t-test.) 
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Figure 4.13 The total knee strength at baseline and one year in participants who 
completed the one year study. 
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(The protein group n = 98, and the placebo group n = 94.  Values are mean and 95% 
confidence interval.  The within drink group change between baseline and one year 
were tested by the paired sample t-test.) 
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Table 4.15 The changes in muscle strength and TUAG after one year intervention comparing the protein and the control group. 
 Absolute change  Percentage change (%) P values P values P values 
    Protein group   Control group  Protein group Control group (2) (2) (3) 
Hand grip strength (kg) -0.8 (-1.7,-0.1) -1.1 (-1.9,-0.3)  -1 ( -6, 4) -3 ( -7,  2) 0.83 0.67 0.85 
Ankle dorsiflexion (kg) 1.1 ( 0.3, 1.9) 1.4 ( 0.6, 2.2)  27 (14, 40) 32 (17, 46) 0.80 0.55 0.54 
Knee flexion (kg) 1.8 ( 1.1, 2.6) 1.6 ( 0.8, 2.5)  37 (23, 52) 28 (18, 38) 0.18 0.78 0.58 
Knee extension (kg) 2.1 ( 1.0, 3.2) 2.8 ( 1.5, 4.2)  17 ( 9, 25) 30 (18, 42) 0.21 0.39 0.35 
Hip extension (kg) -0.6 (-1.7, 0.5) 1.4 ( 0.1, 2.7)  4 (-4, 11) 21 (  9, 34) 0.76 0.02 0.29 
Hip abduction (kg) 0.7 (-0.1, 1.5) 0.9 (-0.1, 1.8)  15 ( 6, 24) 23 (11, 35) 0.91 0.77 0.42 
Hip flexion (kg) 1.5 ( 0.6, 2.4) 2.2 ( 1.2, 3.2)  21 (11, 31) 30 (19, 41) 0.89 0.29 0.28 
Hip adduction (kg) -2.1 (-3.1, -1.0) -1.6 (-2.8, -0.4)  -15 (-25, -5) -11 (-24, 2) 0.50 0.56 0.73 
Total knee strength (kg) 3.9 ( 2.4, 5.3) 4.5 ( 2.8, 6.2)  20 (12, 27) 23 (15, 32) 0.15 0.60 0.37 
Total hip strength (kg) -0.5 (-3.2, 2.2) 2.8 (-0.6, 6.3)  4 ( -2, 9) 14 (  5, 23) 0.77 0.13 0.34 
TUAG (second) -0.1 (-0.4, 0.1) -0.2 (-0.5, 0.1)  -1 ( -4, 2) -2 ( -5, 2) 0.64 0.91 0,34 
Values are mean and 95% confidence interval.  The protein group n=99, and the control group n=94.   
Absolute change = value at 1year – value at baseline. Percentage change = (value at 1 year – value at baseline)/value at baseline x 100. 
P values (1) were for the treatment effect derived from General Linear Model (GLM) repeated measures tests using the whole study population 
data (n = 193), and p values (2) were for the interaction of treatment and visit time in the model.  P values (3) were for the treatment effect 
derived from GLM model using data of participants (n = 37, 25 in the protein group and 12 in the control group) whose compliance > 70%. 
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4.2.4 The effect of one year protein supplement on mobility and balance 
Mobility (Timed Up and Go) 
There were no differences in mobility between the trial and control drink groups at 
baseline and after one year using the GLM (general linear model) repeated measures 
test.  The model showed that there was no significant drink effect (p=0.64), time 
effect (p=0.12), or interaction of treatment and time (p=0.91) for the ‘Timed Up and 
Go’ test.  The absolute and percentage change for the ‘Timed Up and Go’ test at one 
year are shown in Table 4.15.   
 
Balance (‘Romberg eyes-open’ and ‘eyes-closed’ tests) 
There were no significant differences in the Romberg eyes-open (χ2=8.9, p=0.54) or 
eyes-closed (χ2=29.9, p=0.27) tests at one year between the two drink groups using 
the ordinal regression. The drink groups were used as factors and baseline values 
were used as covariates in the model (details are shown in Appendix 23).   
 
Further analysis was conducted by defining poor standing balance as being unable to 
maintain a tandem stance for 10 seconds with the eyes-open (Guralnik, Ferrucci et al. 
1995; Austin, Devine et al. 2007).  The overall prevalence of poor balance was 
significantly increased at one year (odd ratio=4.33, p=0.001, 95% confidence interval 
1.76 to 10.70) using logistic regression (drink group and baseline poor balance were 
entered in the model as covariates).  When the two drink groups were analyzed 
separately using chi-square test, both drink groups showed an increase in the 
prevalence of poor balance from baseline to one year, but only the control group 
increased significantly as shown in Figure 4.14.  There was no significant difference 
in the prevalence of poor balance between the protein group (18%) and the control 
group (22%) at one year (odds ratio: 0.74, 95% confidence interval: 0.36 to 1.53) 
using the logistic regression.   
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Figure 4.14 The percentage of subjects with poor standing balance at baseline 
and one year in the two drink groups.   
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(Poor standing balance was defined as being unable to maintain a tandem stance for 
10 seconds with eyes-open.  The within group changes were tested by chi-square 
test.) 
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4.2.5 Changes in the prevalence of falls at one year 
The prevalence of falls was assessed using the question of ‘How many times had you 
fallen in the last three months?’ which was added to the demographic questionnaire.  
The participants were grouped as ‘fallers’ and ‘non-fallers’.  The fallers were those 
who had at least one fall in the three months prior to the clinic visit.   
 
The prevalence of falls in the trial (protein drink) group was 13% at baseline and 
16% at one year, and the control group were 5% at baseline and 14% at one year 
(details shown in Appendix 24).   
 
There was no significant difference in the prevalence of falls between the protein 
group (16%) and the control group (14%) at one year (odds ratio: 1.07, 95% 
confidence interval: 0.47-2.41) using the logistic regression (drink group and 
baseline fall risk were as covariates in the model).  However, there was a significant 
time effect on falls prevalence at one year (odds ratio: 3.21, p = 0.036, 95% 
confidence interval: 1.08-9.55), which means that overall there were more 
participants who had fallen at least once at one year compared with the baseline.  
When the two drink groups were analyzed separately using chi-square test, the 
control group showed a significant increase in falls rate at one year (χ2 = 3.93, p = 
0.047), but the protein group remained at the similar level as at baseline compared 
with one year (χ2 = 0.30, p = 0.59) (Figure 4.15).   
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Figure 4.15 The percentage of subjects who had fallen at least once in the past 
three months before the clinic visit comparing baseline and one year in the two 
drink groups.   
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The within group changes between baseline and one year were tested by chi-square 
test.  The protein group n = 98 at baseline and n = 99 at one year.  The control group 
n = 94 at baseline and one year.   
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4.2.6 Serum IGF-1 analysis  
4.2.6.1 Serum IGF-1 and baseline characteristics 
There was no significant difference in Serum IGF-1 at baseline between the trial and 
control groups as shown in Table 4.16.  The mean (±SD) IGF-1 concentration in all 
participants was 108.6 ± 39.0 ng/ml at baseline (n = 184).  Baseline serum IGF-1 
concentration was significantly correlated with whole body lean mass (r = 0.17, 
p=0.02 in spearman correlation test).  There were no significant correlations of IGF-1 
with other baseline characteristics, such as age, weight, muscle strength or protein 
intake.    
 
4.2.6.2 Changes in Serum IGF-1 at one year 
There were 184 participants (protein group n = 93 and control group n = 91) who had 
blood samples taken at baseline and at one year.  The mean (±SD) IGF-1 in all 
participants was 110.9±10.1 ng/ml at one year.  Eight participants did not have a 
serum sample at baseline or at one year.  Another two participants had either baseline 
or one year blood sample, but not both.  Where blood samples were not available it 
was due to difficulty in obtaining a blood sample and these were treated as missing 
values and excluded from IGF-1 analysis.   
 
There was a significant increase in the serum IGF-1 at one year in the protein group 
compared with the control group (F = 7.024, p = 0.009) using ANCOVA analysis 
(baseline IGF-1 as covariate and drink code as fixed factor in the GLM model).  The 
tests of between-subjects effects showed that both time and drink effects were 
significant (all p<0.01).  These indicate that the serum IGF-1 level was not only 
significantly different between two drink groups, but also significantly different at 
one year within the same drink group.  The two drink groups were separately tested 
for a time effect using the paired sample t-test.  The protein group showed a 
significant increase in serum IGF-1 at one year (+6.5 ng/ml, p = 0.009) while the 
control group decreased in serum IGF-1 at one year (-2.1 ng/ml, p=0.28) as shown in 
Figure 4.16.   
 
The absolute and percentage changes of serum IGF-1 at one year between two drink 
groups were also tested by the independent sample t-test.  There were significant 
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differences in the absolute and percentage changes in serum IGF-1 at one year 
between two drink groups as shown in Table 4.17 and Figure 4.17.   
 
As there was a significant protein treatment effect on serum IGF-1 level, ANCOVA 
analysis was performed (drink group was entered as the fixed factor, baseline age 
and IGF-1 level were entered as covariates).  After adjustment for baseline serum 
IGF-1 level and age, the protein group remained with a significantly higher IGF-1 at 
one year than the control group (F = 7.068, p = 0.009).   
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Figure 4.16 Serum IGF-1 concentrations comparing baseline and one year in 
the two drink groups.  
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Values are mean and SD.  The within group changes between baseline and one year 
(protein group n = 93, control group n = 91) were tested by paired sample t-test.  
 
Figure 4.17 The absolute changes of serum IGF-1 concentration comparing the 
protein group with the control group after one year intervention.  
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Values are mean and standard error.  The difference in changes at one year between 
two drink groups was tested by the independent sample t-test (protein group n = 93, 
control group n = 91). 
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Table 4.16 Baseline and one year serum IGF-1 concentration in the two drink 
groups. 
 Baseline IGF-1 (ng/ml) 1 year IGF-1 (ng/ml) 
Protein group 106.1 ± 39.2 (n = 94) 112.7 ± 42.5 (n = 93) 
Control group 111.1 ± 38.6 (n = 91) 108.9 ± 37.6 (n = 92) 
p value of t-test of 
difference between drink 
groups 
0.38 0.52 
Values are mean ± SD.  
 
 
Table 4.17 The absolute and percentage changes of serum IGF-1 concentration 
comparing the protein group with the control group after one year intervention. 
 Absolute change (ng/ml) % change 
Protein group (n = 93)  6.5 (1.7, 11.3)  7.6 (2.6, 12.7) 
Control group (n = 91) -2.1 (-5.8, 1.7) -1.0 (-4.2, 2.2) 
p value of t-test of 
difference between drink 
groups 
0.006 0.005 
Values are mean and 95% confidence interval.  
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4.2.7 Changes in dietary intake at one year 
A random sample of 40 participants had 3-day food records at one year (protein 
group n = 20, control group n = 20).   
 
There were significant differences in the daily carbohydrate intakes at one year 
between the two drink groups (p = 0.03 for the drink effect in ANCOVA analysis, 
baseline value entered in the model as covariate and drink groups as the fixed factor).  
When the two drink groups were analysed separately using a paired sample t-test 
(Table 4.18), the control group showed a significant increase in daily carbohydrate 
intake at one year compared to at baseline (p = 0.03).  The one year carbohydrate 
intake in the protein group was similar to the baseline values.   
 
At one year, the protein group increased their total energy intake by 5% (120 kJ), 
protein intake 23% (7.6 g), and fat intake 10% (3.6 g).  There was no change in 
carbohydrate intake at one year.  The control group increased total energy intakes by 
13% (648 kJ), protein intake 5% (2.2 g), fat intake 21% (4.8 g), and 17% (26.8g) at 
one year.   
 
There was no significant difference in daily total energy intake (p = 0.40), protein 
intake (p = 0.11) or fat intake (p = 0.81) between two drink groups at one year using 
ANCOVA analysis to adjust for their baseline values as the covariate.   
 
Table 4.18 Dietary intake of baseline and one year. 
 Protein (n = 20) Control (n = 20) 
 Baseline 1 year p value Baseline 1 year p value
Energy (kJ/d) 7166 ± 1730 7287 ± 1344 0.76 6970 ± 1664 7618 ± 1602 0.16 
Protein (g/d) 81 ± 31 89 ± 18 0.35 75 ± 20 77 ± 24 0.66 
Fat (g/d) 62 ± 17 65 ± 20 0.39 62 ± 24 67 ± 19 0.46 
Carbohydrate 
(g/d) 
  193 ± 64   187 ± 38 0.59   186 ± 48 212 ± 53 0.03 
Values are mean ± SD.  The dietary intake was assessed by 3-day food record.  The 
within group differences between baseline and one year were tested by the paired 
sample t-test. 
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4.3 Summary of the key findings of the study 
In summary, at one year, both the protein group and the control group significantly 
increased whole body lean mass, appendicular lean mass and body weight.  Only the 
control group had a significant increase in total body fat mass.  However, there were 
no significant differences in these variables between the two groups at baseline or at 
one year.  Both drink groups significantly decreased hand grip strength, but increased 
ankle dorsiflexion strength, and total knee strength at one year.  However, no 
significant differences were observed between the two groups in these variables at 
baseline or at one year.  The prevalence of ‘poor standing balance’ and falls, at one 
year, were significantly increased in the control group, but remained at the same 
levels as at baseline in the protein group.  Serum IGF-1 was significantly increased in 
the protein group and significantly decreased in the control group at one year, and the 
changes were significantly different between the two groups.  The 24-hour urinary 
nitrogen was significantly increased in the protein group at one year, but remained at 
the same level as at baseline in the control group.  These results will be discussed in 
the next chapter.   
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Chapter 5 Discussion  
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5.1 Baseline cross-sectional study  
Dietary protein and energy intake at baseline 
The mean protein intake at baseline was 76 g/day (or 1.14 g/kg/day) which was 
higher than the current recommendation of 0.94 g/kg/day level for Australian women 
age over 70 year (National Health and Medical Research Council 2006).  The 
proportion of energy derived from protein intake in the current study was 19 ± 4 %, 
and carbohydrate and fat intake provided 46 ± 7 % and 33 ± 6 % energy intake 
respectively, which was consistent with the Acceptable Macronutrient Distribution 
Range recommended for chronic disease prevention (National Health and Medical 
Research Council 2006).  The total energy intake in this study was 7140 kJ/day 
slightly higher than the Australia National Nutrition Survey of 1995-1996 for age 
group of 70-79, which was 6200 kJ/day (Australian Bureau of Statistics 1998).   
 
Underreporting of dietary intake 
The prevalence of underreporting in the current study was 11% as measured by the 
Goldberg EI:BMR ‘cut-off’ method (details are in section 2.14.6.3 and 4.1.5).  The 
prevalence of underreporting ranged from 18-54% in large nutritional surveys and it 
can be as high as 70% in some subgroups (Macdiarmid and Blundell 1998).  Similar 
to the previous study, the under-reporters identified in the current study also had 
higher BMI and body fat mass than the acceptable reporters and over-reporters.  In 
general, women are more likely to under-report than men, and people with a high 
BMI are more likely to under-report than people with a low BMI (Macdiarmid and 
Blundell 1998).  A study of 484 men and women aged 40-69 years found that 7% of 
women underreported both energy and protein intake using a 24 hours recall and 23% 
by food-frequency questionnaire (Subar, Kipnis et al. 2003). The use of doubly-
labelled water would be the best way to obtain energy expenditure that was not 
related to subject compliance. 
 
24 hour urinary nitrogen has been widely used as an external biomarker of dietary 
protein intake.  The 24-hour urine nitrogen accounted for 90 ± 2 % (mean ± SE) of 
protein intake in the current study.  Bingham’s review of previous studies found that 
the average 24-hour urinary nitrogen constantly accounted for 81 ± 2% of nitrogen 
intake (Bingham 2003).  The consistency of the 24-hour urinary nitrogen and protein 
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intake assessed by 3-day food record in the under-reporters in the current study 
indicated that the process of recording dietary intake influenced the eating habits in 
this subgroup during the recording period.   
 
Correlation of baseline protein intake and body composition 
Baseline whole body lean mass was significantly positively correlated with baseline 
protein intake, and baseline percentage of fat mass was significantly negatively 
correlated with protein intake assessed by the 3-day food record (Spearman rank 
correlation test).  However, the beneficial effect of protein on lean body mass 
disappeared when adjusted for height and total energy intake in the model.  This 
result is true even if the under-reporters were excluded from the analysis.  This result 
is different from our previous cross-sectional cohort study in 862 elderly women, 
which found a strong correlation between the habitual high protein intake, as 
assessed by a food frequency questionnaire, and higher body lean mass (Meng, Zhu 
et al. 2009).  However it is impossible to determine the direction of the relationships 
and the exact nature of risk factor in a cross sectional study.  The relatively small 
sample size of the current study and the exclusion of the high protein intake 
volunteers at baseline may also help explain the difference between the two studies.   
 
Prevalence of sarcopenia  
At baseline, the prevalence of sarcopenia in this study population was 9% (20 
subjects out of 219) when using the conventional definition of ALM/height2 ≤ 5.454 
kg/m2.  As discussed in the literature review, the reported prevalence of sarcopenia 
varies depending on the definition used.  Based on the same definition used in this 
study, the prevalence of sarcopenia for elderly women in most of studies was around 
25% (Iannuzzi-Sucich, Prestwood et al. 2002; Estrada, Kleppinger et al. 2007), but 
also can be as high as 50% in 216 women aged 74 ± 5 years outpatient women in 
Italy (Coin, Perissinotto et al. 2008).   
 
The prevalence of sarcopenia in our study population is low compared to the 
previous studies.  The sources of study populations between studies may contribute 
to these differences.  The participants in this current study were relatively healthy, 
community-dwelling ambulant elderly women.  For example, women who had been 
diagnosed as osteoporosis and were taking bone active agents were excluded from 
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the study at the beginning.  These women would be more likely to have sarcopenia.  
The physical activity level assessed at baseline showed that the study participants 
were overall fairly active and functional.  The majority of the study participants had 
good performance in the TUAG and Romberg tests at baseline.   
 
The current study used cut-points of 5.454 kg/m2 for ALM/height2 to define 
sarcopenia.  This cut-point was derived from a random sample of Hispanic and white 
women and men from New Mexico (Baumgartner, Koehler et al. 1998).  Therefore it 
may not be appropriate to apply this cut-point to a population of Australian elderly 
women, particularly since the previous study used a Lunar DXA and the current 
study used Hologic DXA.  The mean (SD) of appendicular lean mss and 
ALM/height2 in their study were 14.5 (2.2) and 5.9 (0.7) respectively in persons 
older 70 years.  Participants in the current study had much higher values (mean±SD) 
of ALM and ALM/height2 (16.5±2.4 and 6.4±0.8 respectively) compared to the 
Baumgartner study (Baumgartner, Koehler et al. 1998).   
 
The prevalence of sarcopenia in the current study is close to the level found in a 
cross-sectional study conducted in Denmark which investigated the body 
composition in 754 healthy women aged 18 to 85 years (Tanko, Movsesyan et al. 
2002).  The body composition was measured by DXA QDR 4500A which is the 
same as the current study.  The mean (SD) of ALM and ALM/height2 for women 
aged >70 years were 15.7 (2.4) and 6.2 (0.8) respectively.  These values are slightly 
lower than our current study, which were 16.5 (2.4) and 6.4 (0.8) respectively.  The 
reason for small difference may be because this subgroups in their study (n=67) were 
slightly older than the current study population (70-80).  In their study, the young-
normal means were determined from 216 women aged 18 to 39 years in their study.  
Sarcopenia was defined as ALM/height2 < young-normal mean 2 SD, which was 5.4 
kg/m2.  In our lab, we have DXA body composition data measured on 71 young 
healthy females aged 24-36 years.  The surprising finding is that the mean (SD) of 
ALM/height2 of this young normal population was only 5.597 (0.681) kg/m2.  
Therefore, if the value of <2SD is used from the young normals to define sarcopenia, 
the cut-point would be 4.235, which is even lower than 5.454.  A larger normal 
young healthy female population sample may be needed in order to obtain a mean of 
ALM/height2 which can represent this population.   
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The main difference in the study population between the current study and previous 
protein supplemented studies (Lauque, Arnaud-Battandier et al. 2000; Payette, 
Boutier et al. 2002; Bonnefoy, Cornu et al. 2003) was that the participants in the 
current study were generally healthy.  They were recruited and selected at random 
from the electoral roll which includes all women aged between 70 and 80 years in 
Western Australian.  Women such as those who were diagnosed as osteoporotic and 
on bone active agents, diabetic, obesity degree II or over (BMI≥30kg/m2) were 
excluded from study.  The majority of previous studies of protein and energy 
supplementation were conducted in apparently unwell populations; especially those 
who had some degree of muscle wasting, such as occurs in bedridden hip fracture 
patients.  In a meta-analysis, protein supplementation was found to have fewer 
unfavourable outcomes’ compared to non-supplement hip fracture patients, but no 
significant effect of protein on mortality rate (Avenell and Handoll 2006).   
 
Sarcopenia is defined as the progressive loss of muscle mass and strength with aging.  
However, there has been no agreed method to assess sarcopenia (Rolland and Vellas 
2009), especially in the muscle strength or physical functions aspects, which varied 
widely between studies.  Appendicular lean mass assessed by DXA, adjusted for 
body size or body fat mass, are the widely used methods to quantified muscle mass 
(Baumgartner, Koehler et al. 1998; Delmonico, Harris et al. 2007).  For muscle 
strength or physical function, at an individual level, the muscle mass is not 
necessarily linearly correlated with muscle strength; and the muscle strength is not 
necessarily linearly correlated with physical function.  All must be evaluated 
separately. 
 
In a recent cross-sectional study of 1308 community-dwelling elderly women aged ≥ 
75 year in France, researchers found that sarcopenia was not associated with 
difficulty in physical function in the nonobese but had a negative effect in the obese 
(Rolland, Lauwers-Cances et al. 2009).  The physical functions were assessed by the 
self-reported difficulty in walking, climbing stairs, going down the stairs, rising from 
a chair or a bed, picking up and object from the floor, lifting heavy objects or 
reaching an object, and moving difficulties.   
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Correlation of body lean mass with muscle strength, mobility and balance  
Most cross-sectional studies demonstrate that lean body mass is related to muscle 
strength in the elderly (Pedersen, Ovesen et al. 2002; Bunout, Barrera et al. 2004).   
The baseline data in the current study also indicated that whole body lean mass and 
appendicular lean mass were positively correlated with upper and lower limb muscle 
strength (hand grip, ankle dorsiflexion, knee and hip strengths).   
 
Appendicular lean mass measured by DXA showed stronger correlation with hand 
grip strength (r=0.38, p<0.01) than the correlation between the corrected upper arm 
muscle area (CUAMA) and hand grip strength (r=0.18, p<0.01).  CUAMA was 
derived from mid upper arm girth and skin fold measurements.  A study of 874 free-
living, apparently healthy Irish-born elderly people aged over 65 years, found that 
the arm muscle area was associated with handgrip strength (Corish and Kennedy 
2003).   
 
CUMAM tends to overestimate the arm muscle area in overweight or obese people 
because of the failure to account for the muscle fat infiltration by anthropometric 
skinfold techniques which measure only subcutaneous adipose tissue (Forbes, Brown 
et al. 1988).  A study of 244 non-obese American men and women aged 40 ± 14 
(SD) years found that of all the limb circumferences, including corrected thigh girth 
and corrected calf girth, the skinfold corrected upper arm girth had the highest 
correlation with total-body skeletal muscle mass assessed by magnetic resonance 
imaging (MRI) (Lee, Wang et al. 2000).  The inconsistency between the previous 
studies may be due to the differences in age, gender, race, and health status in their 
study populations (Lee, Wang et al. 2000).  Women have larger skinfolds than men 
and elderly have thinner skinfolds than young adults when assume they have similar 
percentage of body fat mass (Bellisari and Roche 2005).  This indicates that fat tissue 
within and between muscles may be larger in women and in the elderly (Bellisari and 
Roche 2005).  Therefore, using skinfold corrected upper arm muscle area to estimate 
the muscle size may not be reliable or accurate for this elderly female population.   
 
Muscle quality may play a more important role in mobility and balance functions 
than muscle mass or size in elderly women.  Muscle quality is generally defined as 
the relationship between muscle strength and muscle mass (Newman, Haggerty et al. 
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2003), such as maximal force production per unit of muscle mass (Ivey, Tracy et al. 
2000).  In a relatively healthy population, elderly woman may be able to function 
well despite having the smaller muscle mass.  A study of 55 elderly men and women 
aged 70 ± 6 years in Switzerland found that muscle quality is the most important 
predictor of lower limb physical function (Misic, Rosengren et al. 2007).  Their study 
assessed leg muscle quality by leg strength normalized for leg mineral free lean 
mass, and assessed lower limb functions using computed dynamic posturography and 
stair ascent/decent, a time up-and-go task and a 7-meter walk with and without 
obstacle.  Another study of 2623 elderly men and women aged 70-79 in America 
found that body fat had a significant inverse association with muscle quality (defined 
by taking the ratio of strength to muscle mass for both upper and lower extremities) 
(Newman, Haggerty et al. 2003).  Other factors, such as deterioration in neurological 
functions may also play a role in the decline in mobility and balance functions in the 
elderly.   
 
The baseline data showed that ‘Romberg eyes-closed test’ had no correlation with 
any lower limb muscle strength.  The ‘Romberg eyes-open test’ was only positively 
correlated with ankle dorsiflexion strength.  The lack of correlation between 
Romberg test and muscle mass or strength could be due to two reasons.  One is the 
larger inter and intra variation in study participants and observers as discussed 
before.  Another is that the use of four categories for the test would attenuate the 
statistical power especially in the intervention studies which generally have much 
smaller sample sizes than epidemiological studies.   
 
A cross-sectional validation study of the FICSIF (Frailty and Injuries: Cooperative 
Studies of Intervention Techniques) common database found that the parallel stance 
is an easy task and is only useful in populations with moderate to severe mobility 
problems such as nursing home residents (Rossiter-Fornoff, Wolf et al. 1995).  
Tandem stance has acceptable reliability and validity (Heitmann, Gossman et al. 
1989).  The current study found that to define participants who were unable to 
maintain a tandem stance for 10 seconds with eyes open as ‘poor balance’ is a better 
method for studying the correlation between standing balance performance and fall 
risk.  This method was previously described by Guralnik (Guralnik, Ferrucci et al. 
1995).   
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Physical activity level was not correlated with age or muscle mass or strength in the 
current study.  An eight year longitudinal study also found no changes in physical 
activity level in twelve elderly men and women (Frontera, Reid et al. 2008). Previous 
studies also suggested that the loss of muscle with age could not be explained by 
declining physical activity levels (Rutherford and Jones 1992).   
 
5.2 The effect of one year of protein supplementation  
Introduction 
This study examined the effect of adding a protein supplement drink or a placebo 
drink to the subject’s usual diet for one year. The effect on muscle mass and strength 
and physical function was studied in 219 women aged 70-80 years.  The 
randomization of the participants into the two groups was successful and there were 
no significant differences in the baseline main characteristics between the trial and 
the control groups.  Inevitably some participants drop out of any study and in this 
case there were no significant differences between those who withdrew and those 
who completed the one year study.   
 
The overall compliance of all participants both in the protein supplemented group 
and the control group with their allocated supplements was 47% in the current study.  
This is similar to a 18-month nutritional supplementation and resistance training 
study conducted in US in 149 healthy people aged ≥ 70 years, which the compliance 
was 48% (Bunout, Barrera et al. 2001), but slightly lower than a 9 month study of 57 
men and women aged over 72 years living in a retirement home, which had a 54% 
compliance (Bonnefoy, Cornu et al. 2003).  The compliance in the Bonnefoy study 
was assessed by monthly telephone interviews to ask the participants the number of 
days in the week and the number of times a day that they were consuming the 
product.  In our study compliance was assessed by counting the empty bottles that 
the participants returned. This method is more likely to underestimate compliance 
when compared to other methods.  Despite the modest compliance, consumption of 
the protein drink did result in an increase in the 24-hour urinary nitrogen in the 
protein supplemented group which confirmed that the participants were compliant 
with their allocated drinks.  
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Key findings 
The key findings of the study were that both the protein supplemented and the 
control group experienced similar, and significant (p<0.05) increases in the whole 
body lean mass, appendicular lean mass, weight, ankle dorsiflexion strength and 
knee strengths (knee flexion and extension) at one year.  Whole body lean mass 
increased by 1.6% in the protein supplemented and 2.3% in the control group.  
Appendicular lean mass, which is mainly muscle, increased by 1.3% in the protein 
supplemented group and 1.8% in the control group.  Ankle dorsiflexion strength 
increased 27% in the protein supplemented and 31% in the control group.  Total knee 
strength increased 20% in the trial (protein) group and 23% in the control group.  
The trial (protein) group did not differ from the control group in any of these 
variables as a result of the one year intervention.   
 
There was, however, a significant increase in the serum IGF-1 level by 7.5% (+6.5 
ng/ml) in the protein supplemented compared to a decrease by 1.0% (-2.1 ng/ml) in 
the control group at one year, and the changes were significantly different between 
the two drink groups (p=0.006).  Self-reported falls were significantly increased in 
the control group (+9%) but not in the protein supplemented (+3%) at one year.  
Moreover, the total fat mass increased from baseline only in the control group 
(protein supplemented: +0.7%, p=0.19; control group: +1.5%, p<0.05).   
 
Body composition 
After one year of the intervention, whole body lean mass increased by 1.6% 
(p<0.001) in the protein supplemented and 2.3% (p<0.001) in the control group.  
Appendicular lean mass, which is mainly muscle, increased by 1.3% (p=0.001) in the 
protein supplemented and 1.8% (p<0.001) in the control group.  Both groups 
significantly increased their body weight (trial group: +0.8% or 600g, p<0.05; 
control group: +1.5% or 1000g, p<0.05) and BMI (protein supplemented: +1.0%, 
p<0.05; control group: 1.6%, p<0.05).  There were no significant differences in 
changes in these variables between the trial (protein) and the control group.   
 
The initial explanation for no differences in changes in these variables was that the 
extra energy intake from the supplements may play a role in increasing whole body 
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and appendicular lean mass, body weight and BMI, regardless of the differences in 
the macronutrient composition of the supplements.  Previous studies have suggested 
that without any intervention, elderly women would in general, experience a decrease 
in total body mass and body lean mass, and an increase in body fat mass with 
advancing age (Baumgartner, Waters et al. 1999; Guo, Zeller et al. 1999; Bunout, de 
la Maza et al. 2007; Fantin, Di Francesco et al. 2007; Chen, Lin et al. 2008).  This 
phenomenon is more significant in white women aged over 75 years (Obisesan, 
Aliyu et al. 2005).  In a population based study conducted in America, body 
composition was assessed in 2040 well-functioning black and white men and women 
aged 70-79 years using DXA (Visser, Pahor et al. 2003).  In the women, total body 
mass, fat-free mass, and fat mass decreased by 0.3%, 0.1%, and 0.5% respectively 
after one year.  A cross-sectional study in 1307 older (age≥70 years) and 576 young 
adults showed that women lost a mean of 221 ± 399 (SD) g of lean body mass per 
year (Bunout, de la Maza et al. 2007).  Given no changes in the physical activity at 
one year in either the trial or the control group, the increased body mass in the 
current study subjects after one year intervention may due to the effect of the 
supplements.  As there was no difference in changes between the trial and control 
groups in these variables (whole body and appendicular lean mass, body weight and 
BMI), the extra energy from the supplemented drink, regardless of macronutrient 
content, may contribute to these changes. 
 
However, the analysis of the one year dietary intake showed that the energy intake 
(assessed by 3-day food record) did not increase, within the range of error inherent in 
this methodology, in either the trial or control group at one year (Table 4.18).  The 
drinks consumed by the trial and control groups provided an energy supplement for 
the participants in both groups.  After examining their 24-hour urinary nitrogen 
excretion, however, it appeared that underreporting of food intake may have 
contributed to the failure in detecting any changes in energy intake.  The evidence of 
underreporting dietary intake was that the protein supplemented significantly 
increased their 24-hour urinary nitrogen excretion at one year (Table 4.12), but the 
reported protein intake derived from the 3-day food record did not show this increase 
in the trial (protein supplemented) group (Table 4.18).  These data indicate that at 
least the trial (protein supplemented) group under reported their protein intake at one 
year.  It was only possible for reasons of time to process and analyse 40 subjects’ one 
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year 3-day food records.  The results from the 40 records showed an increased trend 
in energy intake at one year in both the trial and control groups, although the changes 
were not statistically significant.  The small sample size of this analysis may lack the 
power to detect the magnitude of the change expected.  Therefore, it cannot be 
excluded that participants did increase their energy intake at one year, and the extra 
energy intake obtained from the supplements may have contributed to the increase in 
whole body and appendicular lean mass, weight and BMI.  In order to exam whether 
there was a change in dietary energy or macronutrient intake at one year it will be 
necessary to analyse all of the participants’ one year 3-day food records in the future.   
 
If it is assumed that the energy intake did not change over one year, the other 
explanation for the increase in body weight and BMI would be a decrease in energy 
expenditure.  Daily energy expenditure can be divided into three main components: 
basal metabolic rate, diet induced thermogenesis and physical activity, and the 
portion of each component varies between individuals (Butte 2006).   
 
The current study did not detect any significant change in physical activity at one 
year in either the trial or control groups.  There are two possible explanations: a) the 
study participants did not change their physical activity over one year; b) the change 
was smaller than can be detected by the International Physical Activity Questionnaire 
(IPAQ).  The IPAQ was developed in the late 1990s to obtain internationally 
comparable data on health-related physical activity (Craig, Marshall et al. 2003).  
The short version, which is the one the current study used, is suitable for national and 
regional surveillance systems at a population level (International Physical Activity 
Questionnaire).  Its reliability in detecting the potential changes over a short period 
in a small population is unknown, particularly in this age group.  Validation studies 
have compared the IPAQ with the use of  motion detectors such as accelerometer 
measurements, and these showed low correlations in the range of 0.26-0.33 
(Johnson-Kozlow, Sallis et al. 2006; Wolin, Heil et al. 2008).  As the sensitivity of 
detecting the changes in physical activity in the current study population using IPQA 
is unknown, it is not possible to exclude decreased physical activity as the reason for 
the increase in weight and BMI.   
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If it is assumed that the physical activity and energy intake did not change over one 
year, a decline in basal metabolic rate may account for the weight gain in the current 
study population.  Basal metabolic rate represents about 70% of total daily energy 
expenditure in most people, and is the primary component of total caloric 
expenditure (Butte 2006).  The main determinant of basal metabolic rate is body 
weight and body composition, and skeletal muscle consumes about 20% of resting 
energy expenditure.  (Hill, Catenacci et al. 2006).  In a sedentary person, the main 
determinants of energy expenditure is lean body mass which starts declining from the 
third decade of life (Evans and Cyr-Campbell 1997).  Therefore, the reduction in 
body lean mass with aging is responsible for the decrease in basal metabolic rate 
found in the elderly (Tzankoff and Norris 1977; Ritz 2001).  A four year study of 
2163 (47% women) healthy elderly aged 70-79 showed that both weight loss and 
weight gain occurred (Newman, Lee et al. 2005).  Their study showed that there were 
significantly more subjects with a loss of lean mass with weight loss than with 
weight gain, and more fat mass gain with weight gain than with weight loss.  Small 
amounts of lean mass loss and fat mass gain were observed in weight stable subjects 
in their study.  In contrast, participants in the trial (protein supplemented) group in 
the current study, significantly increased their body lean mass and their body fat 
mass did not change significantly, which implies that the protein supplement may 
play a positive role in preserving lean body mass and restricting body fat mass gain 
with weight gain.  Therefore is seems less likely that a decrease in basal metabolic 
rate would account for the weight gain observed between the two groups.  
 
Dietary intake appears to decline gradually with aging (Clarkston, Pantano et al. 
1997; Morley 1997).  It has been proposed that the low energy intake is the major 
reason for potential malnutrition in the elderly (Nes, Sem et al. 1992), which 
contributes to the occurrence of sarcopenia.  The current study design provided an 
extra 30 g protein per day in the trial (protein supplemented) group when an energy 
controlled placebo was used in the control group.  In contrast, there are few 
intervention studies which have tested the effectiveness of a supplement in this age 
group (Bunout, Barrera et al. 2001; Bonnefoy, Cornu et al. 2003; Bunout, Barrera et 
al. 2004) or in even older populations (Fiatarone, O'Neill et al. 1994; Payette, Boutier 
et al. 2002; Wouters-Wesseling, Van Hooijdonk et al. 2003).  None of those studies 
used an isocaloric supplement without protein as a control drink.  Therefore, any 
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effect have been detected from those studies could be due to the extra energy intake, 
and not specifically the high protein effect.   
 
Bunout and colleagues conducted a nutritional supplementation study in 149 healthy 
free-living men and women aged 70 years or older recruited from three public 
outpatient clinics (Bunout, Barrera et al. 2001).  The subjects were randomly 
allocated into four groups: supplement group (Total energy 873 kJ, protein 13 g), 
training group, supplement + training group, no intervention group.  After the 18 
months intervention, whole body lean mass and weight did not change in either 
group, and all subjects in the study gained ~1.9kg fat.  The authors proposed that the 
reason for the lack of change in weight and whole body lean mass in their study may 
be because their study participants were healthier and had better baseline conditions 
than other studies which targeted frail elders and reported increases in body weight.  
Although their study reported a compliance of 49%, the lack of information on the 
changes in the total energy intake over the study period made it hard to confirm the 
reasons for their results.  It is impossible to know if these dietary supplements 
resulted in increasing participants’ total energy intake or just substituted for part of 
their habitual food intake.  Consequently, the lack of significant changes in body 
composition, muscle strength or physical function found in the protein-energy 
supplemented group in their studies, may be because the supplements were 
substituted for their food intake resulting in no change in overall energy or 
macronutrient intake.  Although the current study did not find a significant change in 
the participants’ food intake over one year either, the evidence from the significant 
changes in 24-hour urinary nitrogen excretion at one year in the protein 
supplemented suggests the existence of underreporting food intake in the current 
study population or the dietary measurement method was not sensitive enough to 
detect the changes.    
 
The results from the current study suggest that the difference in the source of energy 
made no difference to the weight change.  Buchholze and Schoeller reviewed weight 
loss studies and found that neither macronutrient composition differences of the diet 
nor changes in energy expenditure explained the difference in weight loss but total 
energy intake did (Buchholz and Schoeller 2004).  Evidence from previous short 
term (Noakes, Keogh et al. 2005) and long term (Brinkworth, Noakes et al. 2009) 
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weight loss studies in obese persons showed that energy restricted diets had similar 
effect on the weight loss and body composition changes independent of the 
composition of the diets.  However, whether the high satiety of protein supplements 
contribute to the decreased total energy intake in an ad libitum diet needs to be 
investigated further.  Whey protein is high in branched chain amino acids, especially 
leucine, and was found to be able to stimulate ‘satiety’ hormones, such as 
cholecystokinin (Veldhorst, Smeets et al. 2008).  Findings from previous studies are 
inconsistent on whether the high satiation property of whey protein would impact 
subsequent energy intake (Lam, Moughan et al. 2009; Veldhorst, Nieuwenhuizen et 
al. 2009).  Although the changes in weight were not statistically significant between 
the trial and control groups, there was a trend towards a smaller increase in weight in 
the trial (protein) group (+0.8% or 600g) when compared to the control group 
(+1.5% or 1000g) at one year.   
 
Previous studies have found that high quality proteins, such as whey protein which is 
rich in essential amino acids, shows larger increases in energy expenditure than do 
lower-quality protein (Westerterp-Plantenga, Nieuwenhuizen et al. 2009).  This is 
important for elderly people to manage weight gain when taking protein supplements.  
However in the current study no effect of the whey protein could be demonstrated 
between the trial and control groups.  
 
The control group had a greater increase in the total energy intake (+13%) than the 
trial protein supplemented group (+5%), though the differences were not significant.  
The control group had a significant increase in carbohydrate intake, but there was no 
change in carbohydrate intake in the trial group.  The differences in the level of 
changes in the total energy intake and carbohydrate intake between the two drink 
groups may explain the significant increase in body fat mass in the control group but 
not in the protein supplemented at one year.  One of the study limitations is that the 
one year dietary intake was calculated based on 40 participants’ food records.   
 
Muscle mass and muscle strength 
In previous studies, protein-energy supplements alone showed the effects on weight 
gain (Gray-Donald, Payette et al. 1995; Payette, Boutier et al. 2002) or an increase in 
fat mass (Bunout, Barrera et al. 2001; Bunout, Barrera et al. 2004) . These studies did 
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not show a significant effect on increasing muscle mass, muscle strength or physical 
functional improvement in the elderly.  The differences in protein content and protein 
type in the supplements between these studies and the current study may partially 
explain the differences in the results regarding the changes in muscle mass and 
muscle strength.   
 
In these previous studies (Bunout, Barrera et al. 2001; Bunout, Barrera et al. 2004), 
the supplement used provided 13-15 g protein (~15% of energy of supplement), 
although the total energy of the supplements were similar or even higher than the 
current study.  These protein levels were much lower than the current study in which 
the protein supplements contained 30 g protein (60% of the energy content of the 
supplement), and the protein sources were not reported.  There were two other 
studies which had a similar protein content (protein 30g/day) in their supplements 
and much high total energy content compared to the current study (Payette, Boutier 
et al. 2002; Bonnefoy, Cornu et al. 2003).  Both studies used a commercial drink 
(Ensure or Ensure Plus) in which the proteins are mainly casein and soy protein 
isolate.  The protein used in the current study was whey protein which contains the 
highest concentration in essential branched-chain amino acids among all protein 
sources and thought to have the highest bioavailability (Walzem, Dillard et al. 2002).  
They are easily digested and utilized (Dangin, Boirie et al. 2002; Hall, Millward et 
al. 2003; Layman 2004; Bowen, Noakes et al. 2006) as whey protein is emptied 
rapidly from the stomach into the duodenum and thus amino acids appear in the 
blood stream faster (Boirie, Dangin et al. 1997).  The branched chain amino acid are 
unique because they are metabolized by muscle not by liver (Walzem, Dillard et al. 
2002).  By contrast with whey protein, casein is a slow acting protein as it forms a 
gel or clot in the stomach, and the clot is able to slow the release of amino acid into 
the blood stream (Boirie, Dangin et al. 1997).  Casein has been shown to induce a 
lower but more prolonged hyperaminoacidaemia and higher postprandial leucine 
deposition than whey protein in young men (Dangin, Boirie et al. 2001). Whey 
protein was digested faster than casein protein in both young (24±1 years) and older 
men (71±1 years), and protein synthesis was higher with whey protein than casein 
protein, especially in the elderly group (Dangin, Guillet et al. 2003).  The use of 
whey protein in the trial group in the current study did not show any benefit 
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compared to the carbohydrate control supplements in improving muscle mass and 
strength aspects.   
 
The adequate energy and protein intake in the current study population at baseline 
may also have contributed to the failure in detecting a protein supplement effect on 
improving muscle mass and strength.  The average protein intake of this study 
population at baseline was already 76 ± 19 g/day or 1.14 ±0.33 g/kg/day.  This level 
is higher than the current recommended protein intake for Australian or New Zealand 
female aged over 70 years, which is 0.94 g/kg/day.  At baseline, total energy intake 
was 7140 ± 1518 kJ/day, which is slightly higher than the Australian National 
Nutrition Survey of 1995-1996 for the age group of 70-79, which was 6200 kJ/day 
(Australian Bureau of Statistics 1998).  This indicates that the participants in the 
current study already had adequate protein intake and sufficient energy intake.  As 
the protein intake from their habitual diet already met their recommended 
requirements for protein, the extra protein from the supplement may not be of benefit 
on increasing muscle mass or strength compared to the extra carbohydrate intake.   
 
Two population-based long-term studies, have demonstrated a positive relationship 
between high protein intake (habitual diet) and higher muscle mass or a slow rate of 
loss of muscle mass with aging (Houston, Nicklas et al. 2008; Meng, Zhu et al. 
2009).  The relationship between baseline protein intake and lean and bone mineral 
content five years later was examined in a cohort of 862 community-dwelling 
women aged 75 ± 3 years (Meng, Zhu et al. 2009).  The study found women with a 
higher protein intake (>87 g/d) had 5.4-6.0% higher whole body and appendicular 
lean mass.  The effects remained after adjustment for potential confounders (height, 
physical activity and energy intake).   
 
The current study found no differences in change in muscle mass and strength 
between the control and trial groups at one year, suggesting that the effect of a high 
protein diet on muscle mass and strength may need a longer time to achieve results.  
This may explain why most of the long term cross-sectional or longitudinal studies 
have found a positive correlation between habitual high protein intake and high 
muscle mass and/or strength in the elderly (Hughes, Frontera et al. 2002; Meng, Zhu 
et al. 2009). However, most of the protein-energy intervention studies failed to show 
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this correlation (McMahon and Bistrian 1990; Fiatarone, O'Neill et al. 1994; Bunout, 
Barrera et al. 2001; Payette, Boutier et al. 2002).  Elderly people with a habitual high 
protein diet may also benefit from a lower risk in developing non-communicable 
diseases, such as diabetes and heart disease (Hu, Stampfer et al. 1999; Farnsworth, 
Luscombe et al. 2003).  The presence of chronic disease causes deterioration in the 
overall health status in the long term, including muscle mass and strength and 
physical functions.   
 
There was no significant fat mass gain in the trial (protein) group in the current study 
suggesting that the protein supplement may slow the expected gain in fat mass in 
these elderly women, despite the extra energy intake.  One possible underlying 
mechanism is that protein can produce a larger diet-induced thermogenesis than 
carbohydrate and fat, resulting in an increase in energy expenditure (Raben, 
Agerholm-Larsen et al. 2003).  Moreover, it has also been observed that with the 
same energy density (2500 kilojoules for women), postprandial fat oxidation was 
unchanged after protein meals (31.8% of energy), but was suppressed after 
carbohydrate meals (65.4% of energy) (Raben, Agerholm-Larsen et al. 2003).  None 
of the previous protein-energy supplement intervention studies in this age group 
(Fiatarone, O'Neill et al. 1994; Bunout, Barrera et al. 2001; Bonnefoy, Cornu et al. 
2003; Bunout, Barrera et al. 2004) compared the differences in fat mass gain between 
isocaloric protein and carbohydrate supplements. The total body fat mass increased 
in the control group (+1.5%, p=0.04) but not in the trial (protein) group (+0.7%, 
p=0.19) at one year in the current study.  However the changes were not significantly 
different between control and trial groups.  Caution is needed when interpreting this 
change in the percentage body fat as there was no significant difference between 
groups.  The mean percentage of the total body fat mass of all participants in the 
control group in this study was 39.4 ± 5.7% at baseline and was similar to the level 
found in other studies.   
 
The percentage body fat mass for 267 Italian women aged 70-80 years living in the 
Mediterranean area was 36.6 ± 5.5%, (Coin, Sergi et al. 2008).  They used the same 
brand of DXA machine as was used in the current study to measure the body 
composition.  A high protein diet has been found to be associated with more 
favorable results for weight loss compared with high carbohydrate or low fat diets in 
 238
overweight or obese individuals (Farnsworth, Luscombe et al. 2003; Labayen, Diez 
et al. 2003; Due, Toubro et al. 2005).  The effects on regulating body composition 
seem to be due to protein high satiety (Paddon-Jones, Westman et al. 2008) and diet-
induced thermogenesis compared with fat or carbohydrate (Due, Toubro et al. 2005; 
Bowen, Noakes et al. 2006).   
 
The current study showed that both protein and control groups significantly increased 
ankle dorsiflexion (protein supplemented +27%, control group +31%) and knee 
strengths (protein supplemented +20%, control group +23%) as a result of the 
intervention with no difference in changes between the trial and control groups.  A 
12-year follow-up study of eleven women aged over 73 years showed that ankle 
dorsiflexion strength declined 0.3% per year (Winegard, Hicks et al. 1996).  The 
increase in the lower limb strength in the current study implies that the dietary 
supplements may play a role in preserving muscle strength.  However, this result 
differs from previous randomized control trials of energy-protein supplementation 
with or without exercise (Fiatarone, O'Neill et al. 1994; Payette, Boutier et al. 2002; 
Bonnefoy, Cornu et al. 2003; Wouters-Wesseling, Van Hooijdonk et al. 2003).  Most 
of the previous trials did not find that a dietary supplementation alone had any 
beneficial effect on increasing muscle strength in older people.  Many studies 
however, found that exercise or resistance training alone or combined with dietary 
supplements had positive effect in the preserving of muscle strength (Fiatarone, 
O'Neill et al. 1994; Bunout, Barrera et al. 2001; Bunout, Barrera et al. 2004; Binder, 
Yarasheski et al. 2005; Aagaard, Magnusson et al. 2007; Levinger, Goodman et al. 
2007) and balance (Orr, Raymond et al. 2008) in the elderly.  LaStayo and co-authors 
have suggested that for studies which have combined resistance training with 
supplementation the ‘learning effect’ need to be considered in the analysis (LaStayo, 
Ewy et al. 2003).  In the current study, hip strength increased at one year in the trial 
and control groups but the increases were not statistically significant in either group 
and there were no differences in changes between the drink groups.  
 
The results of the increase in muscle strength in the trial and control groups, with no 
change between the groups are different from previous dietary intervention studies.  
Some previous studies (Fiatarone, O'Neill et al. 1994; Payette, Boutier et al. 2002; 
Wouters-Wesseling, Van Hooijdonk et al. 2003) which provided even higher energy 
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content supplement to their participants compared to the current study, failed to 
detect any changes in muscle strength following the intervention.  Therefore, the 
extra energy intake from the supplements may not have an additional benefit for 
increasing muscle strength.   
 
In a 16-week study of 83 elderly men and women aged 80±7 years, participants were 
provided a nutrient-dense protein-energy liquid supplements (total energy 710 
kcal/day, 30g protein) (Payette, Boutier et al. 2002).  Their study found that although 
the total energy intake and weight gain were significantly higher in the supplemented 
group compared to the control group after 16 weeks, no differences in upper and 
lower limb muscle strength were detected.  However, their elderly study participants 
were frail and under-nourished. The definition of frail and undernourished either an 
involuntary weight loss>5% body weight in the past month, 7.5% in the past 3 
months, or >10% in the past 6 months and BMI<27 or a BMI<24.  The current study 
participants, by comparison, were well-nourished (average BMI was 26.8 at 
baseline).  Moreover, the current study duration is longer than their 16-week study.   
 
Another study investigated the effect of dietary supplement and resistance training in 
100 healthy, free-living men and women aged 70 years or older (Bunout, Barrera et 
al. 2004).  Compared to the current study, their study had the same study duration 
(one year), a similar level of compliance in taking supplements (48% versus current 
study 47%) higher energy content (1600 kJ versus current study 810 kJ) but lower 
protein content (15 g versus current study 30 g) in the supplements.  After the one 
year intervention, the protein-energy supplemented group did not change their lean 
body mass or muscle strength.  However, no assessment of dietary intake was made 
to observe if total energy intake increased or not following the intervention.  
Therefore, it is hard to evaluate whether the lack of changes in muscle strength 
following the protein-energy intervention was due to no effect of the supplements or 
due to compensation of normal food intake by the supplements.   
 
Hand grip strength showed a different pattern from lower limb strength at one year in 
the current study.  The protein supplements did not have a protective effect on 
preserving hand grip strength in the current study.  Both the trial and control groups 
decreased hand grip strength at one year with a significant level in the trial (protein) 
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group but not in the control group.  In general, hand grip strength peaks at 35 years 
of age and is positively correlated with forearm girth and length, hand size and body 
mass (Gunther, Burger et al. 2008).  The CVs of hand grip strength varied largely 
between studies, and effort level was suggested to contribute to the high CV values 
over test occasions (Fairfax, Balnave et al. 1995).  A CV above 7.5% indicates 
submaximal effort (Fairfax, Balnave et al. 1995).  Submaximal effort was found to 
produce larger CVs, and females were also found to have greater strength variability 
(Fairfax, Balnave et al. 1995).  The CV of hand grip strength in this study was 6.7%, 
which was within the acceptable range.  The reasons for differences in response to 
the supplements between hand grip strength and lower limb strength are not 
understood and need further study.   
 
Muscle size 
Muscle size was evaluated by calf muscle cross-sectional area at 38% length of tibia 
and did not change over one year study period in the trial or control groups.  Calf 
muscle cross-sectional area demonstrated a strong correlation with lower limb 
muscle mass and strengths at baseline.  No correlation was found between the 
changes in calf muscle cross-sectional area and the increased in lower limb muscle 
strength after one year intervention.  The calf muscle cross-sectional area as 
measured in this study had an acceptable inter and intra subjects and observers 
variation (detailed in 3.3.2.4).  However, whether the muscle mass increased or 
decreased due to the intervention, the change of muscle size at this site was be too 
small to detect at the one year intervention.  The site chosen to assess the muscle 
cross-sectional area in this current study also could affect the ability to detect any 
change, as calf muscle cross-sectional at 38% length of tibia is small, and is not the 
site of maximum calf muscle area.  The reliability of using this site to detect change 
over one year period has not been tested previously.  Conventionally, muscle cross-
sectional area at 66% tibia site were obtained using peripheral quantitative computed 
tomography (pQCT) (Stevenson, Moyer-Mileur et al. 2005; Popp, Hughes et al. 
2009).  As discussed in the methodology section, the manual tracing method was the 
only method available to our study to detect muscle density and intermuscular fat.  If 
intermuscular fat increased, this method may not be sensitive enough to detect small 
changes in muscle area.  
 
 241
Following an extensive literature search, there have been few dietary protein 
intervention studies that have assessed muscle cross-sectional area in this age group 
of females. The one study that did, did not find any change in muscle cross-sectional 
area following the nutritional intervention (Fiatarone, O'Neill et al. 1994).  Fiatarone 
and colleagues conducted a nutrition and exercise intervention trial in 100 men and 
women aged 72-98 years living in nursing homes (Fiatarone, O'Neill et al. 1994).  
The subjects were randomly allocated into four groups: supplement group (total 
energy 360 kcal, 17% protein which is about 15 g), resistance training group, 
supplement + training, no intervention group.  After a 10 week study period, the 
midthigh muscle cross-sectional area was assessed by the computed tomography, and 
did not change in the supplemented group.   
 
Data from previous longitudinal observation studies, however, showed an annual 
decline of thigh muscle cross-sectional area when measured by computed 
tomography in the range of 0.6-1.5% (Frontera, Reid et al. 2008; Delmonico, Harris 
et al. 2009).  Previous studies demonstrated a strong correlation between muscle 
strength and cross-sectional area measured by quadriceps cross-sectional area from 
mid-thigh using X-ray computed tomography (CT) (Maughan, Watson et al. 1983; 
Visser, Kritchevsky et al. 2002; Visser, Goodpaster et al. 2005).  A longitudinal 
study followed up twelve older volunteers (5 men) aged 71 ± 5 years for 8.9 years 
and found the knee extensor strength declined after eight years accompanied by a 
significant reduction in cross-sectional area of thigh muscle (-5.7% over 8.9 years 
which is about 0.6% per year) measured by computed tomography (Frontera, Reid et 
al. 2008).  The variation of muscle fibre composition between individuals may 
contribute to the large variation in the ratio of strength to muscle cross-sectional area 
assessed by CT mid-thigh method (Maughan, Watson et al. 1983).   
 
Fat infiltration into muscle may partially account for differences in muscle strength 
not attributed to muscle quantity (Goodpaster, Carlson et al. 2001).  Evidence from 
magnetic resonance imaging also suggests that excess fat infiltration in leg skeletal 
muscle is associated with low calf muscle strength and impaired physical function 
(Hilton, Tuttle et al. 2008).  It is worth remembering that although muscle mass 
changes influence the magnitude of the strength changes over time, strength declines 
in spite of muscle mass maintenance or even muscle mass gain in some subjects 
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(Hughes, Frontera et al. 2001).  A combination of other factors such as cellular, 
neural or metabolic mediators may be involved in changes in muscle strength with 
aging (Hughes, Frontera et al. 2001).  
 
A five year longitudinal study of 1678 ambulant men and women aged 70-79 showed 
that adjusted annualized (mean±SE) decrease in muscle torque (knee extensor) was 
2-5 times greater than the loss of thigh muscle cross-sectional area measured by 
computed tomography (CT) in those who lost weight (thigh muscle area: -1.5±0.1% 
cm2, knee extensor toque: -3.6±0.3%) and in those who remained weight-stable 
(thigh muscle area: -0.3±0.1%, knee extensor toque: -1.9±0.3%) (Delmonico, Harris 
et al. 2009).  In those whose weight increased, there was a small increase in thigh 
cross-sectional muscle area, but this increase did not prevent the loss of muscle 
torque (thigh muscle area: 0.4±0.1%, knee extensor toque: -1.9±0.3%).   
 
Mobility, balance function and falls risk 
After the one year intervention, mobility tested by the ‘Time Up and Go’ test 
(TUAG) did not show any difference in either in the trial or control group in the 
current study.  A study of 68 men and women aged 82±7 years living in the nursing 
home also showed that there was no difference in changes in TUAG over a 6 months 
study period between the protein-energy supplemented group (1050 kJ/day, 
contained 14% protein) and the control group (Wouters-Wesseling, Van Hooijdonk 
et al. 2003).  The baseline mean of the test in their study was 18.9 seconds.  This is 
much higher than the baseline value of the current study, which was only 8.0 
seconds.  The much older study participants in their study may partially explain the 
difference of average of TUAG performance between the two studies.   
 
In the protein supplemented, there was no change in the prevalence of poor balance 
and falls at one year.  In comparison, the prevalence of poor balance was 
significantly increased in the control group (+9%), and the fall rate also significantly 
increased in the control group (+9%).  These results are similar to a study of fifty 
community-living under-nourished men and women aged 78±7 years, which showed 
that the supplemented group had significantly fewer falls after a twelve week study 
period (Gray-Donald, Payette et al. 1995).  The study subjects were randomly 
assigned to the supplement and placebo groups.  The supplemented group received 
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235mls of a commercial liquid (Ensure, Enrich with fibre, and Ensure Plus) twice 
daily which contained 1045-1480 kJ in total, and 14-14.7% of protein (about 8-13g).  
The proteins in these commercial liquid products are milk and soy protein 
concentrate.  After 12 weeks intervention, the number of falls was significantly lower 
in the supplemented group (baseline: 25, 12-weeks: 0) than the control group 
(baseline: 4, 12-weeks: 21).  It was suggested that malnutrition may be play a role in 
the deterioration of muscle capacity and the loss of central and peripheral 
neurological function involved in gait and balance  (Kinney 2004), however the 
underlying mechanism is not clear.  The difference between the current study and 
Gray-Donald’s study is that, the control group in the current study received an 
isocaloric carbohydrate drink but in Gray-Donald’s study, the control group did not 
receive any treatment.  As both studies observed an increase in fall rate in the control 
group, but no change or a decrease in fall rate in the protein supplemented, it is 
reasonable to consider that the protein supplement may have contributed to the 
preservation of balance function and may protect against falls in elderly women.  
 
A common assumption made in intervention studies in the elderly is that the 
intervention designed to improve muscle mass or strength should lead to a greater 
physical function (Dutta 2000).  However, most dietary or exercise intervention 
studies have failed to show this correlation (Bonnefoy, Cornu et al. 2003; 
Kongsgaard, Backer et al. 2004; Orr, Raymond et al. 2008).  Similarly, in the current 
study, lean mass gain was not correlated to strength gain in all muscle groups.  For 
example, hip strength did not change significantly at one year although lower limb 
lean mass increased in this current study.  A three year longitudinal study of 1880 
older adults in America also showed that maintaining or gaining muscle mass does 
not prevent aging-associated decline in muscle strength which suggested a decline in 
muscle quality with aging (Goodpaster, Park et al. 2006).  The larger inter- and intra-
variation of lower limb muscle strength may also contribute to the lack of 
relationship between changes of lower limb muscle strength and changes of muscle 
mass or size.  The coefficient of variation (CV) of the lower limb muscle strength 
(flexion, extension, abduction and adduction) of the current study ranged from 8.6% 
to 12.1%.  These are similar to a study that examined the test-retest reliability of leg 
muscle strength in twelve mean and women age 50-84 years (Pua, Wrigley et al. 
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2008).  Their study found that the CV of leg muscle strength (flexors, abductors and 
extensors) ranged from 8% to 15.7%.   
 
In the current study, the improvement in lower limb muscle strength was not 
correlated with physical functional performance.  At baseline, ankle dorsiflexion, 
total knee and total hip strength were significantly negatively correlated with the 
‘Time Up and Go’ test results (r=-0.21, p<0.01). However, although ankle 
dorsiflexion and knee strength increased at one year in both the trial and control 
groups, no changes were detected in TUAG performance in either group.   
 
There are three possible explanations for the inconsistent results between the 
physical functional performance and lower limb muscle strength.  One is referred to 
as a ‘ceiling effect’ (Stucki, Stucki et al. 1995; Colman 2006).  That is, the TUAG 
test may not be challenging enough for this study population to detect a decline in 
mobility.  Another possibility is that the study power was not great enough to detect 
the difference in TUAG in this population.  The mean (SD) of TUAG in the current 
study was 8.0 (1.4) seconds at baseline.  This was similar to the mean for 60 to 69 
year olds in a meta-analysis which was 8.1 (7.1–9.0) seconds (Bohannon 2006).  
Even participants classed as sarcopenic might easily achieve the highest scores in 
this test.  Therefore no difference could be detected between the groups or between 
study periods.  Another reason is the large inter and intra variations of test subjects 
and observers, which leads to lack of precision of the tests, especially for the 
Romberg tests as  discussed in the literature review (2.12.2).  The third possibility is 
that muscle mass may not be highly correlated with physical function in this 
population.  The possible non-linear age-related decline in balance and muscle 
strength reported by previous studies suggested the existence of threshold effects 
between these measurements (El Haber, Erbas et al. 2008).  The threshold effects 
may also be a reason for the failure to detect the changes in TUAG and Romberg test 
in the current study.   
 
The prevalence of falls at baseline in all participants was 10% and increased to 15% 
at one year.  The finding of the decline in balance function with age in this study  
was consistent with the previous study which also suggested that postural balance 
deteriorates markedly after age 75 years old (Era, Heikkinen et al. 2002).  Fall 
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prevalence can vary, largely depending on the study population and the definition of 
falls that is used.  The one year fall prevalence of the current study was found to be 
similar to that reported by the Centers for Disease Control and Prevention (CDC), 
which used the same definition (self-reported falling during the preceding three 
months) to identify falls (Stevens, Mack et al. 2008).  It was 15.9% in persons aged 
65 years or over (14% in those aged 70-74; 15.7% in those aged 75-59; 20.8% in 
those aged ≥80).  The CDC used data from Behavioural Risk Factor Surveillance 
system survey in 2006 which interviewed 92,808 elderly persons to assess fall rates.   
 
The fact that there was no difference in changes in muscle mass or strength, but the 
differences in changes in standing balance between the trial and control groups over 
one year in the current study, indicated that the protective effect of protein on the 
deterioration of balance function with aging may be due to other mechanisms rather 
than simply an increase in lower limb strength.  A study compared an inadequate 
protein intake (0.5 g/kg/d) to a control adequate diet (protein intake 1.2 g/kg/d) in 
twenty-one men and women aged 55-80 years by muscle biopsy.  The study found 
that short-term inadequate protein intake changed the skeletal muscle transcript 
levels in these elderly participants and may resulted in muscle wasting, adverse 
metabolic and functional events (Thalacker-Mercer, Fleet et al. 2007) which means 
low protein intake could affect muscle quality.   
 
The results reported in the literature from previous dietary intervention studies (Table 
2.5) on the effect of a higher protein intake on muscle mass and function are 
inconsistent.  Many of the reported dietary intervention studies in relatively healthy 
elderly people used protocols that combined supplements with resistance training..  
The discrepancy in the results between studies may be due to the heterogeneity of the 
study cohort (sample size and target population which varied from chronically ill or 
fragile subjects to those who are relatively healthy), study duration, tests used, 
outcomes measured, the composition and amount of the supplements given, and the 
level of  compliance with the trial regime.  
 
The current study sample was population based.  The participants were recruited 
randomly using the Electoral Roll, which included all women of this age range who 
have registered to vote.  The participants were relatively healthy when they entered 
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in the current study.  Ensuring that the trial (protein) supplement and the control 
supplement provided the same amount of energy and this enabled the current study to 
compare the effect of high protein supplement versus low protein supplement on 
preventing sarcopenia.   
 
Serum IGF-1 
Serum IGF-1 was significantly increased at one year in the protein supplemented 
group (+6.5 ng/ml) but decreased in the control group (-2.1 ng/ml).  The difference 
of the changes between the two drink groups was highly significantly (p = 0.009 in t-
test) at one year.  A 3-month randomized controlled trial of high or moderate protein 
diet combined with resistance and cardiovascular training was conducted in 24 
overweight or obese adults aged 31-59 years (Arciero, Gentile et al. 2008).  The 
study found that all groups lost significant amount of body weight and total body fat 
after 3 months, and the serum IGF-1 was significantly increased in the subjects in the 
high protein diet with or without training groups.  The increase in serum IGF-1 may 
explain the preservation of lean body mass despite having an overall loss of body 
weight.   
 
It was hypothesized that participants in the trial (protein supplemented) group would 
have more lean mass gain than the control group over a one year period, and the 
increase would be associated an increase in the serum IGF-1 level.  Although it was 
found that both the control and trial groups had similar increases in body lean mass 
after one year, there were significant differences in serum IGF-1 levels.  The high 
protein diet of the trial group has a beneficial effect through increasing serum IGF-1 
in the elderly women after one year.  Given the fact that serum IGF-1 decreases with 
age (Corpas, Harman et al. 1993), the current study showed the beneficial effect of a 
high protein diet in increasing serum IGF-1.   
 
As expected the overall serum IGF-1 concentration at baseline was significantly 
correlated with whole body lean mass in the current study.  IGF-1 regulates muscle 
metabolism through complex biochemical pathways (Booth 2006).  A decline in 
IGF-1 is correlated with a decrease in muscle mass and muscle strength 
(Baumgartner, Waters et al. 1999; Payette, Boutier et al. 2002; Roubenoff, Parise et 
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al. 2003), and poor lower limb function (Cappola, Bandeen-Roche et al. 2001) in  
elderly people.   
 
Previous studies have shown that IGF-1 has positive effects on muscle and bone 
systems (Baumgartner, Waters et al. 1999; Roubenoff, Parise et al. 2003).  Previous 
animal and human studies have also provided evidence of an inverse correlation of 
IGF-1 with some diseases, including diabetes (Bergerot, Fabien et al. 1995; 
Capoluongo, Pitocco et al. 2006; Chu, Moreland et al. 2008) and heart disease (Juul, 
Scheike et al. 2002).  In the animal studies, IGF-1 was reported to protect non-obese 
mice from developing diabetes (Bergerot, Fabien et al. 1995) and reversed 
hypoalgesia and improved mobility in the mouse mode of diabetic peripheral 
neuropathy (Chu, Moreland et al. 2008).  A cross-sectional study in 170 subjects 
with metabolic syndrome, with or without diabetes, found that IGF-1 was 
significantly inversely correlated with C-reactive protein (CRP), a well-known 
marker of inflammation (Efstratiadis, Tsiaousis et al. 2006).  A study of 246 type 1 
diabetes patients in France found that serum IGF-1 concentration was significantly 
lower in patients with the diabetic complications, or a family history of diabetes 
(Capoluongo, Pitocco et al. 2006).  A population-based case-control study in the US 
found that low serum IGF-1 was associated with increased risk of ischemic heart 
disease (Juul, Scheike et al. 2002).   
 
The significant increase in serum IGF-1 in the trial (protein supplemented) group 
may play a role in preserving the balance functions in the protein supplemented 
group.  All body tissues contain IGF-1 (Clemmons 2007), and IGF-1 levels decline 
with aging, and this phenomenon exists in community-dwelling elderly with no 
malnutrition and no inflammation (Raynaud-Simon 2003).  The prevalence of poor 
balance and falling in the trial (protein) group did not change significantly at one 
year compared to the baseline, but the prevalence of poor balance and the reported 
falls were significantly increased in the control group at one year.  As both the trial 
and the control groups increased in muscle mass at one year with no difference 
between the groups, the increased in muscle mass alone cannot explain the 
differences in changes in the balance functions between the drink groups.  The 
increased IGF-1 may contribute to an improvement in the quality of muscle (Wang, 
Messi et al. 2002) and/or neurological functions (Gonzalez, Messi et al. 2003).   
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Muscle quality includes fibre-type composition, contractile properties, innervations, 
capillarity and metabolic capacity (Dutta 2000).  Muscle quality in humans can be 
assessed by muscle testing  and muscle biopsy to assess the number of muscle fibre 
or the cross-sectional area of muscle type I and II fibres (Brooks, Layne et al. 2007).  
One-repetition maximum (1 RM) is used by many studies to assess muscle quality 
(Kostek, Delmonico et al. 2005; Tanton, Cappaert et al. 2009), and most of these 
studies assessed the effect of resistance training on muscle quality.  Other methods, 
such as muscle function per unit of muscle mass (Ivey, Tracy et al. 2000) or muscle 
function per unit of muscle cross-sectional area (Delmonico, Harris et al. 2009) have  
also been used.  Muscle function can be defined as 1 RM, muscle peak power, or 
torque (Dutta 2000).  A study was undertaken to compare the influence of age and 
gender on muscle quality response to strength training in 42 young and elderly men 
and women (Ivey, Tracy et al. 2000).  The study calculated muscle quality by 
dividing quadriceps 1RM strength by quadriceps muscle volume determined by 
magnetic resonance imaging.  Evidence supporting the existence of a positive 
correlation between IGF-1 and muscle quality are mainly from animal studies 
(Saatman, Contreras et al. 1997; Messi and Delbono 2003; Payne, Zheng et al. 2006).   
 
A study in mice showed that an increased level of IGF-1 reduced age-related losses 
of skeletal muscle motor neurons and type IIB muscle fibres (Messi and Delbono 
2003).  IGF-1 administration improved neuromotor function in brain injured rats 
(Saatman, Contreras et al. 1997).  A study that used a tetanus toxin fragment-C 
fusion protein to target IGF-1 to motor neurones in mice was used to study age-
related declines in muscle function. It was shown in mice to be associated with motor 
neurone loss, (Payne, Zheng et al. 2006).  After three monthly injections of IGF-1,   
muscle weight or muscle fibre size did not change but the single fibre specific force 
increased significantly.  Their study demonstrates that IGF-1 administration prevents 
muscle fibre specific force decline.  Although both animal and human studies have 
demonstrated the positive correlation between IGF-1 and muscle quality (as 
discussed above), and the beneficial effect of growth hormone treatment on 
improving muscle mass and strength (Barton-Davis, Shoturma et al. 1998; Attanasio, 
Bates et al. 2002), whether these improvements translate into improved physical 
function, such as balance performance, in elderly remains largely unknown.   
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The mean IGF-1 level varies considerably between studies.  The mean ± SD of IGF-
1 concentration was 108.6 ± 39.0 ng/ml at baseline and 110 ± 40.1 ng/ml at one year 
in all participants in the current study.  These levels are similar to previous studies 
(Barber, Braid et al. 2003; Dantas, Pires et al. 2008).  A study of 98 elderly women 
aged 63-78 years found that the mean ± SD of IGF-1 in women engaged in weight 
training for at least six months was 107.5 ± 38.6 ng/ml, and the control group was 
60.1 ± 6.4 ng/ml (Dantas, Pires et al. 2008).  The median (interquartile range) IGF-1 
level at baseline (when admitted to the rehabilitation unit) of 32 patients (12 females) 
with median age of 79 years who had surgical fixation for proximal femoral fracture 
was 120.0 (92.0-129.5) ng/ml (Barber, Braid et al. 2003).  The differences between 
studies could be due to the differences in analytical methods (Brabant and 
Wallaschofski 2007), and the study populations,  including differences in age, gender 
and  health status.  The results from previous dietary intervention studies are 
inconsistent regarding the effect of protein-energy supplement on IGF-1.   
 
A study of 62 postmenopausal women aged 55±5 showed that IGF-1 increased in 
both the soy protein supplemented group (25 g soy protein) (+12.8%) and the control 
diet group (+26.3%) after one year of study (Arjmandi, Lucas et al. 2005).  The 
reason for a significantly lower increase in IGF-1 in the soy protein supplemented 
group compared to the control group is unknown.  The authors did not mention the 
composition of the control diet in their paper, and therefore it is hard to assess 
whether the control diet was an appropriate control.  Moreover, compared to the 
current study, the study subjects are much younger.  A study investigated the effect 
of combined exercise and dietary supplements on IGF-1 in 51 young adult men and 
women aged 18-25 years (Lee, Pivarnik et al. 1996).  After 6 months of intervention, 
the increase in plasma IGF-1 was greater in the protein supplemented group (42 g 
protein, 24 g carbohydrate, 2 g fat) compared to the carbohydrate controlled group 
(70 g carbohydrate).  Their paper did not report the exact values of the changes, but 
from the graph in their paper, IGF-1 was slightly decreased in the carbohydrate 
controlled group (about 2 ng/ml), and IGF-1 was increased about 3 ng/ml in the trial 
group, and the difference between two groups was significant (p = 0.01).  Although 
the effect of protein supplements in their study is similar to the current study which is 
that the protein supplements significantly increased IGF-1 level, caution is needed 
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when making the comparison, as their study population is much younger than the 
current study population.   
 
Previous observation studies have shown that deprivation of nutrients is associated 
with decreased essential amino acids and circulating regulatory hormones and either 
of these factors could affect the formation of IGF-1 in the liver (Phillips and Young 
1976; Phillips and Young 1976; Phillips, Harp et al. 1990).  Both animal (Phillips, 
Orawski et al. 1978) and human (Clemmons, Klibanski et al. 1981) studies revealed 
that protein is particularly important in sustaining levels of circulating IGF-1 as well 
as circulating IGF bioactivity.  An in vitro study in rat hepatocytes found that 
deprivation of  the essential amino acids lysine or tryptophan from culture medium 
for 3-5 days led to 63% and 76% declines in IGF-1 release respectively, but no 
significant change occurred when the non-essential amino acids, cysteine, was 
deleted(Harp, Goldstein et al. 1991).   
 
Muscle and IGF-I levels may respond to extra protein or energy intake differently.  
Muscle mass or strength may be more sensitive to energy intake regardless of the 
nutrient component. IGF-1 may be more related to specific dietary components, such 
as protein.  Muscle mass and strength alone cannot provide a full range of 
information on muscle quality.   
 
The current study has shown that one year of dietary protein supplementation 
significantly increased serum IGF-1 level compared with the control drink.  The 
mechanisms that link an increase in IGF-1 levels and changes in muscle mass and 
strength, body composition and balance function need further investigation.  Because 
of the strong correlation between IGF-1 and health of musculoskeletal system, the 
significant increase in IGF-1 in the trial group (protein supplemented) group provides 
support for increasing the recommended protein intake for the elderly, a non-
pharmaceutical strategy to prevent sarcopenia.   
 
Summary of this section 
The results of the current study suggests that the extra energy intake from the 
supplements (control and trial drinks) may have a role in increasing muscle mass and 
improving lower limb muscle strength in these elderly women regardless of the 
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macronutrient composition of the supplement.  However, data that shows that energy 
intake actually increased in the groups at one year, it is difficult to draw a final 
conclusion.  A longer study period is needed and to complete the analysis together 
with more data on energy intake. Ideally this would be done through the use of 
doubly-labeled water.   
 
The protein supplement showed a tendency to preserve balance function with aging 
and had a beneficial effect on preventing increased fall risk with aging.  The 
isocaloric carbohydrate drink did not show these beneficial effects.  However, the 
trial drink (protein supplement) was similar to the control (carbohydrate) drink in 
building lean body mass and muscle strength in these elderly women during twelve 
months period.  As nutritional intake and muscle mass decrease with age, a small 
increase in energy intake irrespective of its nutritional composition, may reverse the 
reduction in muscle mass and strength.  Moreover, the increase energy intake 
obtained from protein has been shown in this study to have a beneficial effect on the 
preservation standing balance functions.  However, caution is needed before 
recommending increasing energy intake for people who are overweight or obese.  
The observation of a significant increase in serum IGF-1 concentration and improved 
standing balance and decreased prevalence of falls in the trial (protein) group 
indicates that protein supplement may have a role in improving muscle quality.  A 
longer follow-up period is needed to confirm the positive correlation of the improved 
IGF-1 level with balance performance and rate of falls.  More studies are needed to 
investigate the underlying mechanisms involved.   
 
5.3 Limitations of the study 
There are a few limitations that need to be considered when interpreting the result so 
this study and some of these are related to the measurement methods.  The first is 
that the para-amino benzoic acid test (PABA) was not used to verify the 
completeness of 24-hour urine collection. The conclusion drawn in this report was 
based on the assumption that participants collected their 24-hour urine completely.  
The second limitation is that using IPAQ for testing physical activity may not be 
appropriate for this one year study.  IPAQ was validated for large population based 
studies, but its reliability in detecting the potential changes in physical activity over a 
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short period in a small population is unknown.  The third limitation was the issue of 
measurement error for the anthropometric data.  The same anthropometrist was not 
used throughout the study, increasing the possibility of measurement error between 
the baseline values and the one year testing.  Ideally, all anthropometric 
measurements should be done in duplicate or triplicate but time did not always 
permit this to occur.  However the measurements were conducted by experienced 
anthropometrists following a strict protocol. Therefore, while it is unlikely, 
measurement error cannot be ruled out as a cause of the changes in these variables.  
The fourth limitation is that due to the use of bone parameters in performing pQCT 
scan for leg, calf muscle cross-sectional area was analysed by the manual tracing 
method, therefore the information about muscle density is not available.  Moreover, 
measuring of calf muscle cross-sectional area at 38% length of tibia may not be able 
to detect the change of muscle as this muscle at this site is relatively small.    
 
The compliance (overall 47%) rate was comparable to similar studies at overseas 
centres, but is still of some concern. The slight imbalance in compliance between the 
two drink groups (higher compliance in the protein supplemented group) may affect 
the outcomes.  However this could also be due to the subjects in the trial group (the 
protein supplemented group) may have perceived a positive benefit, even though 
every possible effort was made to maintain a strictly double blind study. Although 
we conducted a subgroup analysis which only included those whose compliance 
>70% this showed no significant difference from the analyses using whole study 
population, the limit number of this subgroup (n = 38) would affect the power to 
generalize the conclusion.   
 
Moreover, the baseline data indicates that there may have been a limited expected 
effect.  As shown in Appendix 19, at baseline there was no difference in any 
measures of mobility and balance or in muscle strength between subjects in the 
lowest, middle and highest tertile of protein intake.  The difference between the 
highest and lowest tertile was 11.1 g of protein/day assessed by food-record but as 
high as 39.4 g estimated using 24 hour urinary excretion.  With a supplement of just 
30 g protein and a 52 % compliance in the protein supplemented group, the ‘average’ 
supplement achieved would be only about 15g/day.  The changes of protein intake 
assessed by 24-hour urinary nitrogen excretion showed that the protein supplemented 
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group only increase average of 8 g/day of protein intake at one year.  Given the 
baseline data, 30 g/day protein supplement is not likely to be effective for achieving 
the changes in mobility, balance or muscle strength.   
 
Although it is best practice to use an ‘intention to treat’ analysis, it would also be 
beneficial to know if there was any tendency for an effect on any of the outcomes if 
only the high compliers were assessed.  This analysis approach was also attempted 
but did not find any significant finding.  Higher levels of supplementation could be 
tested in future studies.   
 
The extra energy intake had a beneficial effect on preventing muscle wasting with 
aging.  However, accompanied with the increased muscle mass and strength, the 
weight also increased in both drink groups.  A longer period of follow-up is needed 
to verify that if the weight gain would continue over a longer period.   
 
For the assessment of dietary energy intake it would be preferable to use the doubly-
labeled water method as this is relatively independent of compliance and is now 
regarded as the gold standard for assessing energy expenditure and the extent of 
underreporting.  Unfortunately it remains prohibitively expensive for similar levels 
of funding available to this study.  
 
Due to the small number of falling reports, the correlations between protein 
supplement, serum IGF-1 and improved balance and fall rates in the protein 
supplemented group need to be interperated with caution.  A longer follow-up period 
is needed to confirm this finding.   
 
The use of the cut-point of 5.454 kg/m2 to define sarcopenia may not be appropriate 
for this study population as this cut-point was derived from a random sample of 
Hispanic and white women and men from New Mexico.  A study investigating body 
composition using the same DXA machine in normal young healthy female 
Australian population is needed for obtaining a mean value which can represent this 
population. This may then to be used to calculate more appropriate population cut-
points for the elderly female Australia to identify the prevalence of sarcopenia.  
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Chapter 6 Summary and Conclusions 
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1) Underreporting of food intake at baseline, prevalence of sarcopenia at baseline, 
and the correlation of baseline dietary protein intake and body composition: 
 
The mean protein intake was 76 g/day (1.14 g/kg/day) at baseline.  By using the 
Goldberg ‘cut-off’ method, 24 subjects (11% of study population) were defined as 
under-reporters.  Baseline protein intake was not correlated with baseline whole body 
lean mass or appendicular lean mass after adjusting for height in the analysis.  The 
prevalence of sarcopenia was 9%, which is low compared to previous studies.  Using 
a cut-point of 5.454 kg/m2 of ALM/height2 to define sarcopenia may not be 
appropriate for the current study population.  Upper and lower limb muscle strength 
were significantly positively correlated with DXA measured whole body lean mass 
and appendicular lean mass, and the correlation remained significant after adjusted 
age and BMI.   
 
2) The effect of one year protein supplementation on muscle mass, muscle size, and 
body composition measured by dual energy x-ray absorptiometry and peripheral 
computed tomography (objective 1, 2, &6): 
 
Whole body lean mass (protein supplemented group +1.6%; control group +2.3%) 
and appendicular lean mass (supplemented group +1.3%; control group +1.8%) 
measured by DXA were increased significantly both in the protein supplemented 
group and the control groups after a one year intervention.  There were no significant 
differences in changes of these parameters between the two groups.  Body weight 
also increased significantly in both the protein supplemented group (+0.8%) and the 
control group (+1.5%).  Total body fat mass only significantly increased in the 
control group (+1.5%, p<0.05) but not in the protein supplemented group (+0.7%, 
p=0.19). There was no significant difference in changes in total body fat mass 
between the two groups.  Calf muscle cross-sectional area measured by the 
peripheral computed tomography did not change in either the protein supplemented 
group or the control group after the one year intervention.  No changes in any 
anthropometry measurement were detected in either the protein supplement group or 
the control group after the one year intervention.   
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3) The effect of one year protein supplementation on muscle strength, mobility, 
balance, falling risk, and serum IGF-1level (objective 3, 4, & 5): 
 
Lower limb strength, including ankle dorsiflexion strength (protein supplemented 
group +27%; control group +31%) and knee strength (protein supplemented group 
+20%; control group +23%), increased significantly both in the protein and the 
control groups after the one year intervention.  There were no significant differences 
in changes in lower limb muscle strength after one year intervention between the two 
drink groups.  The prevalence of poor balance (baseline 13%, one year 22%, p<0.05) 
and falls (baseline 5%, one year 14%, p<0.05) were significantly increased only in 
the control group.  In contrast, after the one year intervention, the protein 
supplemented group maintained similar levels of poor balance rate (baseline 13%, 
one year 18%, p=0.44) and self-reported falling rate (baseline 13%, one year 16%, 
p=0.59) as at baseline.  The serum IGF-1 level was significantly increased in the 
protein supplemented group ((+7.6%, p=0.008) but slightly decreased in the control 
group (-1.0%, p=0.28), and the difference was significant between the two groups 
(p=0.006).   
 
The protein supplement has shown to be superior to the isocaloric control drink in 
the current study in three areas.  Firstly, the standing balance at one year remained at 
the similar level as at baseline in the protein supplemented, but became worse in the 
control group.  These differences were consistent with the changes in the prevalence 
of falls at one year, the protein supplemented stayed at the similar level as at baseline 
but there was an increase in the control group.  Longer follow-up is needed to 
confirm these findings.  Secondly, the protein supplements limited body fat gain 
compared to the control supplements.  Fat mass increased only in the control group at 
one year. Thirdly, protein supplements resulted in a significant increase in serum 
IGF-1 level at one year compared with the control group in which the IGF-1 level 
slightly decreased.  The significantly increased serum IGF-1 level in the protein 
supplemented group may relate to the stable balance function and fall rate in this 
group at one year.  Whereas, the slight decrease in serum IGF-1 level in the control 
group at one year may contribute to the decrease in balance function and the increase 
in fall rate in this group.  However, given the small changes in serum IGF-1 although 
significantly different between the groups, caution is needed when interpreting these 
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results.  A longer follow-up is needed to confirm these correlations and further 
studies are needed to investigate the mechanisms involved in the relationship 
between IGF-1 and muscle quality and balance function. 
 
These data are consistent with the concept that in this age group increased energy 
intake regardless of the macronutrient composition of the supplements improves 
muscle mass and function.  It is possible that achieving this through increased protein 
rather than carbohydrate intake may prevent the increase in fat mass noted with the 
carbohydrate supplement.  The metabolic significance of this remains to be explored.    
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Appendix 2 Recruitment letter 
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                        6th March 2007 
      <Given Name> <Surname>                                             
      <Address>  
      <Suburb> <State> <Postcode> 
 
Dear Mrs <Surname>, 
We would like ask you to become a research participant in the Protein Intake and 
Metabolic Effects Study 
Researchers from the University of Western Australia, Sir Charles Gairdner Hospital, 
Curtin University and Edith Cowan University are looking at ways to prevent bone 
and muscle weakness through increased protein intake in the diet. Bones weakness is 
called osteoporosis, a condition in which bones become fragile and brittle, leading to 
a high risk of fractures. Muscle weakness may lead to increased risk of falling. To try 
and stop these problems occurring we have been given money by the National Health 
and Medical Research Council (NHMRC) to study the effects of a daily high protein 
drink or an identical low protein drink on your bones and muscles. The study is for 2 
years during which time you would have take one of the two drinks every day and 
come to Sir Charles Gairdner Hospital seven times. If you are eligible you will 
receive (at no charge):  
* bone density scans * blood tests * diet assessment * ongoing study care 
You are not eligible for this study if you are on:  
* bone active treatment such as Fosamax or Actonel  * lactose intolerant 
I appreciate that you did not ask to receive this letter. However, many of you have 
been prepared to help in similar studies in the past. So I thank you for considering 
this request. Your assistance is very much appreciated as it might be of assistance to 
yourself and others. The study has been approved by the Human Ethics Research 
Committee of Sir Charles Gairdner Hospital as well as the NHMRC. 
 
Yours sincerely,                                       
A/Prof Richard Prince, Chief Investigator       
Bone and Mineral Research Group, Sir Charles Gairdner Hospital 
    
If you are interested in finding out more please fill in the form below and  
a)   return in the reply paid envelope enclosed    OR    
b)   fax it to us on 9346 1317    OR  c)   contact us by telephone 9346 1747  
--------------------------------------------------------------------------------------------------- 
I would like one of your staff to contact me about the “Protein intake and Metabolic 
Effects Study”.  
My name is ____________________________My date of birth is ___________________ 
My address is______________________________________________________________ 
__________________________________________________Postcode_______________ 
My contact phone number is_____________ Other comments_______________________ 
Signed _____________________________ 
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Appendix 3 PIMES study telephone recruitment prompter 
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PIMES Study Telephone Recruitment Prompter 
 
Hello, could I please speak to Mrs/Miss/Ms ____________________. 
Good morning/afternoon Mrs/Miss/Ms ______________, my name is____________. 
I am calling from the Bone and Mineral Research Group at the University of Western 
Australia.  You recently responded to a letter in regards to a protein study. Is it 
possible to talk to you for the next 5 minutes, regarding the selection criteria utilised 
in this particular study? There are a few important questions that I need to clarify 
with you.  
 
Yes   /   No 
If no, Time:___________  Day:___________________________ 
If yes 
 
Would you mind proceeding with the following screening questionnaire, so we can 
determine if you will be eligible for the present study?   
 
Ineligible 
Mrs/Miss (name) thank you very much for your time and assistance. Unfortunately 
the selection criteria make you ineligible to participate in the present study. 
 
Eligible 
With all the questions I asked you so far, you are eligible to come in for clinic 
screening visits. There will be two screening visits, in which we will further 
determine whether this study suit you.  Before I book you in for the clinic visit, I just 
briefly explain to you what the study will involve.  
 
The purpose of this study is to determine whether high protein intake will prevent 
bone loss and osteoporotic fracture in elderly people. Should you choose continue, 
this study will run for 2 years and would require you to consume 250ml of a milk 
like fluid every day.  We would require you to come to Sir Charles Gairdner Hospital 
in Nedlands a total of 7 times over this 2 year period.  The visits can take up to four 
hours and will include a variety of tests and questionnaires.  You may be required to 
attend the hospital on three separate occasions at the baseline or beginning of the 
study, at 1 and 2 years you may need to come back to the hospital on 2 separate 
occasions. A physical general examination, blood and urine tests, anthropometry, 
bone density, muscle function, and food intake will be incorporated into your base-
line visit. 
 
Should you be eligible and choose to be part of the (PIMES) study, on your second 
visit you will be randomized into one of the two groups. Both groups will be asked to 
drink 250ml of the milk like fluid (in chocolate, caramel or coffee flavors) per day. 
The first group is a treatment group with the milk product containing 600mg calcium 
and 30g of extra protein per day for 2 years.  The second is a placebo or dummy milk 
fluid, which looks and tastes the same but doesn’t contain protein, however still 
contains the 600mg of calcium.  You will be randomly assigned to one of the two 
groups and both you and I/staff won’t know which milk product you have been 
assigned until the end of the study, unless there is a medical emergency.  We call this 
a double blinded study. 
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During the study, you will also be asked to complete of a health diary, that will assist 
us in making informed decisions about any health or dietary problems that may 
develop. Your contribution to the study will help to determine whether we can 
prevent or delay disease through the use of extra protein. 
 
What is your local GP or Doctors name? Find/ look up list OR type in details. 
GP Name: ___________________________________________________ 
GP Address: ___________________________________________________ 
GP Telephone ___________________________________________________ 
 
We run our clinics on Tuesday and Thursday, so you can choose the day that suits 
you.  The clinic starts at 8.30 am and goes for 4 hours until 12.30pm.  When is the 
soonest convenient day for you to come into the study clinic. 
 
Make appointment Day/Date:_____________________________________ 
 
We will send you the information in the mail, the soonest I can get it to you is in the 
next day or two.  I will now explain the contents of the letter that I am going to send 
to you.  You do not need to write anything down as it is explained in a covering letter 
to you. 
 
There are green sheets which explain the study and the protein milk drink, have a 
read and there is a consent form that you need to bring with you and sign when you 
get here. As we will be taking blood and urine samples, it is essential that you fast 
prior to your appointment. There is a sheet of paper asking you to fast from the night 
before until you get here and just drink water.  We will give you toast and tea or 
coffee once you have had your blood taken.  ie. no breakfast the morning of your 
appointment.  
 
There is a stapled blue questionnaire asking you lots of questions about your 
lifestyle.  It will be great if you could complete as much of it as you possibly can.  
Anything you’re unsure about or uncomfortable with, just leave blank until you get 
here and you can discuss it with us then. The last page of this questionnaire is asking 
about your medications and illnesses.  If you can complete this and bring in your 
medications with you to the clinic that would be great (only say this section if we 
are going to mail the demographic questionnaire).   
 
We will send you directions and a map on where to come, and a car parking voucher. 
The clinic will take four hours, so if you want to bring some knitting, a crossword or 
a book with you to pass the time that’s okay.  There are about eight other ladies in 
the clinic and they usually say they are really happy they came.  They were a little bit 
anxious about coming but had a lovely morning once they got here.  I will put the 
information to be sent to you in the outside/university mail today and you will get it 
within the next few days. Our phone number is on the sheets of paper we send to 
you.  So if you have any queries, or want to change your appointment or cancel it for 
whatever reason, please phone us.  
 
Thank you for your time on the phone now and I look forward to seeing you on the 
___________. 
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Appendix 4 Telephone screening and visit 1 questionnaire  
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Protein Intake Metabolic Effects Study (PIMES) – Study Entry Criteria 
Grey section – telephone screening White section – screening visit section 
 
8. Have one of the following: 
Liver failure     
Kidney failure on dialysis 
  
Full name:              Date of Birth: 
Contact phone Home Mobile 
Mailing address: 
                                                                                                        Post Code: 
Telephone screening: 
  Eligible        Date booked for first clinic screening visit:      /    /       
ask participants to bring the medications they are using and their GP’s details 
  Exclude     Reason for exclusion: 
Date of telephone screening:                 Name of person completing this form:   
Inclusion Criteria – IF NO EXCLUDE Yes No 
Aged 70-80 years   
Have transport to get to SCGH?   
Exclusion Criteria – IF YES EXCLUDE Yes No 
1. Lactose intolerant or do not like milk products   
2. Currently or within last year taking any of the following medications 
for osteoporosis (Bisphosphonates, Fosamax, Actonel, Zoledronate by 
drip, Evista, Teriparatide injection, Protos (strontium ranelate), HRT, 
Premarin or any other oestrogens )  
Name of medication_________________________ 
  
3. Taking steroid tablets (eg Cortisone prednisone)  in the past 3 
months or have taken more than 7 g in total in life (daily dose 
______mg, start date _________, stop date ________) 
  
4. Metabolic  bone disease eg Paget’s disease   
5. Clinical diagnosis of diabetes   
6. Any fracture at wrist, hip or spine in the last 10 years falling from 
standing height or less than 1 meter   If yes write details of 
when/what________________________________ 
The patient should be informed that they may be eligible for 
osteoporosis treatment covered by the Pharmaceutical benefits scheme 
(PBS).  If patient is interested in receiving treatment, they should 
investigate this further before committing to PIMES. 
  
7. Participation in another clinical trial in the past 3 months. If yes 
write details of when/what__________________________________ 
  
Screening ID: 
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Bowl Surgery or difficulty in absorbing foods 
Coeliac disease 
9. BMI > 35 kg/m2 Height: _________m      Weight: _________kg      
BMI: _________ kg/m2    
  
10. Clinical hepatic insufficiency   
Screening visit inclusion exclusion criteria 
Inclusion Criteria – IF NO EXCLUDE Yes No 
1. A signed and dated written informed consent obtained prior to 
participation and given to patient 
  
2. Able to comply with the requirements of the protocol, including 
consumption of the drink 
  
Exclusion Criteria – IF YES EXCLUDE Yes No 
3. A Mini Mental State Score of less than 24    
4. Total hip bone density more than 2 SD below the mean for their age   
5. High protein intake as assessed by Food Frequency Questionnaire 
(equivalent to protein intake more than 1.5 g/kg body weight per day) 
  
6. Renal insufficiency  - creatinine more than twofold the upper limit 
of normal 
  
7. Participants who, in the opinion of the investigator are not likely to 
complete the study for any reason 
  
8. Participants who, in the opinion of the investigator are not likely to 
complete the study due to serious physical or mental disease 
  
9. Participants who, in the opinion of the investigator, abuse alcohol or 
drugs 
  
10.Participants with any clinically significant abnormality following 
review of screening laboratory data 
  
11. Contraindicated medications for osteoporosis, oestrogen or 
corticosteroids 
  
Clinic screening: 
  Eligible  for randomization   (has fulfilled all inclusion/exclusion criteria) 
  Eligible to act as community control   (has high protein intake but fulfilled all the 
other inclusion / exclusion criteria )                    
  Excluded  
Reason for exclusion: 
 
To be reviewed and completed at screening visit two 
The participant has fulfilled all inclusion/exclusion criteria: Yes            No            
Study Coordinator’s Signature: _________________            Date: ________ 
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Appendix 5 Screening visit appointment letter 
 
 
                   Sir Charles Gardiner Hospital  
                  Department of Diabetes and Endocrinology 
1st Floor, C Block 
NEDLANDS WA 6009 
Telephone: 61 8 9346 1747 
 
Dear Mrs,        05/09/2009 
 
Thank you for agreeing to come in to see us. This visit is to determine if you are 
eligible for the study. The following information is important for your visit on: 
Date: Tuesday 11 September 2007 
Time: Start at 9.30am and finish at approximately 1.30PM 
At: Department of Endocrinology & Diabetes, 1st Floor C Block, Sir Charles 
Gairdner Hospital, Hospital Ave, Nedlands 6009 (please find map enclosed) 
 
Before your appointment: 
Please fast from 10pm the night before your appointment and follow the enclosed 
instructions carefully (Yellow) 
Please read the enclosed Participant Information Sheet and Consent Form (Green and 
white) 
 
Please bring the following to your appointment: 
ALL your medications (prescription AND non-prescription) 
Your local GP or Doctors details (Name, address, telephone) 
Reading Glasses, and Interpreter/Assistant if required 
Please do not wear pantyhose and wear enclosed comfortable shoes 
Parking voucher (enclosed).  Place this on your dashboard so you don’t need to pay 
for parking 
The Participant Information and Consent (Green and white) 
 
At your visit you will: 
Go through the Participant Information Sheet and Consent Form 
Have FASTING blood and urine samples collected 
Have height, weight and body measurements 
Undergo DXA and pQCT bone density scans 
Complete several questionnaires 
 
If you are unable to attend the appointment that has been made to you, please contact 
us on 9346 1747 or 9346 4970. We look forward to seeing you at your appointment.  
 
Yours sincerely, 
 
 
Rosie Meng 
PIMES study coordinator 
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Appendix 6 Demographic questionnaire 
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PARTICIPANT QUESTIONNAIRE 
 
All personal details contained within this questionnaire will be treated in the strictest 
confidence.  All the questions asked are designed to aid our research. 
  
THANK YOU FOR YOUR TIME AND EFFORTS WITH COMPLETING 
THIS QUESTIONNAIRE. 
 
You may find some of the details required are hard to recall – if so, please answer 
these to the best of your ability by making estimates that are as accurate as possible.  
 
INSTRUCTIONS: 
1. Please tick the appropriate answer where required. 
2. Please bring the completed questionnaire and medications you are using 
along with you to your appointment at Sir Charles Gairdner Hospital. 
 
NAME (Miss/Ms)___________________________________________ 
    (First name) (Second name)  (Family name) 
 
Date of Birth           
 
 
1.What is your country of birth?  
 
 (a) What language do you usually speak at home?  
 
 (b) Do you need an interpreter? (please tick one) 
   Yes 
   No 
 
If yes, bring a friend or relative with you to the appointment. 
 
 
2. Which one of the following best describes your marital status? 
(please tick one) 
  Married    
  Divorced    
  Never married   
  Separated    
  Widowed    
   
day month   year 
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3. Which one of the following best describes your normal place of 
residence?  
 (please tick one) 
  House/Flat/Unit/Villa   
  Granny flat/Self-care unit/Retirement village 
  Boarding house/Rooming house  
  Hostel/Hostel type   
  Caravan    
 
 
4. Do you (or your Husband or partner) own your own home? 
  Yes 
  No 
 
 
5. Which one of the following best describes your living arrangements?  
 (please tick one) 
  Live alone    
  Lives with Husband/partner ONLY  
  Lives with relative(s)   
  Has resident housekeeper   
  Other __________________________  
 
6. Which one of the following best describes your main source of 
income? (please tick one) 
 Government pension or benefit   
 Superannuation (including annuities, interest and dividends)  
 Wage or salary from an employer   
 Private business or rental property(ies)  
 Other __________________________   
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7. Have you ever undertaken paid employment for more than one year?  
 (please tick one) 
    Yes 
    No 
    Don’t know 
 
If yes, which one of the following best describes your main paid 
occupation during your working life? (please tick one) 
  Professional  
  Teaching/Nursing  
  Clerical 
  Domestic Duties 
  Factory/Agriculture 
  None of the above 
 
 
8. At what age did you achieve your highest level of education?  
 
    yrs 
 What is the highest level of education that you have completed? 
(please tick one) 
  Primary School 
  Some High School  
  Year 12 High School 
  Trade or technical qualifications 
  Degree from a University, College of Advanced Education 
or other tertiary institution 
 
 
9. How many children have you had?   
 (Do not count miscarriages) 
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10. Did you breastfeed any children? 
 (3 or more times a day for the first month of their life.) 
 For each child tick “Yes” or “No”. If yes, please tell us how long 
you breastfed that child. 
 
 (a) First child  Yes     If yes, how many months _________
    No 
 (b) Second child  Yes     If yes, how many months _________
    No   
 (c) Third child  Yes     If yes, how many months _________
    No   
 (b) Fourth child  Yes     If yes, how many months _________
    No 
 (e) More than four children 
    Yes      If yes, how many months ________ 
    No 
 
11. How old were you when you had your last menstrual period?  
    yrs 
 
12. Have you had a hysterectomy? (please tick one) 
   Yes 
   No 
 (a) If yes, at what age was this?  yrs 
 
 (b) If you had a hysterectomy: 
   
How many ovaries did you have removed? (please tick one) 
   None 
   One 
   Two 
   Don’t Know 
 
Did you have hot flushes? (please tick one) 
    Yes 
    No 
 If yes, how old were you when they started? yrs 
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13. (a) How old was your mother when she died? yrs 
  (if still alive leave blank) 
 (b) How old was your father when he died? yrs 
  (if still alive leave blank) 
 
14. How often do you go outside into the street or garden per week? 
(please circle one) 
 
Never 2-3 days 4-5 days Most days 
 
15. Do you avoid direct sunshine? (please circle one) 
 
Never Usually Always 
 
16. Have you had a suntan in the past 12 months? (please circle one) 
 
No Slight Obvious 
 
17. Do you use a walking aid? (please tick one)  
   Yes 
   No 
  
 If yes, what aid(s) do you use inside the house?
 _____________________ 
 If yes, what aid(s) do you use outside the house?
 _____________________ 
 
18. How many times have you fallen in the last 3 months?  
 (If no falls write “0”) 
 
19. Are you afraid of falling? (please tick one) 
   Yes 
   No 
 
20. Do you limit any household activities because you are frightened you 
may fall? (please tick one) 
   Yes 
   No 
 
21. Do you limit any outdoor activities because you are frightened you 
may fall?  
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 (please tick one) 
   Yes 
   No 
 
22. Please tick the category that best describes the number of times you 
experience pain in each of the following parts of your body: 
 
 
 
 Never Less than 
once a 
month 
Once a week 
to once a 
month 
Once a day 
to once a 
week 
Once a 
day or 
more 
Hip joints      
Knee 
joints 
     
Feet 
joints  
     
Lower 
Back 
     
Upper 
Back 
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23. Have you ever smoked at least one cigarette per day for as long as 
three months?  
 (please tick one) 
  Yes 
  No 
 
 (a) If yes, what year did you start? 
 
 (b) What year did you stop?  
 (Leave blank if currently smoking) 
 
 (c) On average, how many cigarettes do/did you smoke per day?
 
 
24. Have you had any serious illnesses or operations?  YES/NO   
If YES, could you please give details: 
a  
 
e  
b  
 
f  
c  
 
g  
d  
 
h  
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25. Are you taking/using any prescribed or over the counter 
medications? YES/NO   
If YES, could you please  give details: 
Name of drug  
(generic or trade 
name) 
For condition Regimen 
eg: once a 
day 
Dose 
Eg: 5 
mg  
Comments / 
checked MIMS 
(study staff use 
only) 
Example: 
Tritace 
Hypertension Once 
daily 
10 mg  
1     
2     
3   
4     
5     
6   
7     
8     
 
 
 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE 
 
PLEASE REMEMBER TO BRING THE COMPLETED 
QUESTIONNAIRE ALONG WITH YOU TO YOUR 
APPOINTMENT AT SIR CHARLES GAIRDNER HOSPITAL 
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Appendix 7 International physical activity questionnaire – short last 7 days self 
– administered format 
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Appendix 8 SF-36 questionnaire 
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ENGLISH (AUSTRALIA) 
 
SF-36 
 
 
 
 
 
 
 
 
 
 IQOLA SF-36 English (Australia) Version 1.0 
Copyright c 1994 Medical Outcomes Trust              286 
All rights reserved 
(IQOLA SF-36 Standard Australian Version 1.0) 
SF-36  HEALTH SURVERY 
INSTRUCTIONS: This questionnaire asks for your views about your 
health, how you feel and how well you are able to do your usual 
activities. 
Answer every question by marking the answer as indicated. If you are 
unsure about how to answer a question, please give the best answer you 
can. 
 
2. Compared to one year ago, how would your rate your health in 
general now?         (circle one) 
 Much better now than one year ago 1 
 Somewhat better now than one year ago 2 
 About the same 3 
 Somewhat worse now than one year ago 4 
 Much worse now than one year ago 5 
3. The following items are about activities you might do during a typical 
day. Does your health now limit you in these activities? If so, how much?  
(circle one number on each line)  
1. In general, would you say your health is: 
(circle one ) 
 Excellent 1 
 Very good  2 
 Good 3 
 Fair 4 
 Poor 5 
Copyright c 1994 Medical Outcomes Trust              287 
All rights reserved 
(IQOLA SF-36 Standard Australian Version 1.0) 
 
ACTIVITIES 
Yes, 
Limited 
A Lot 
Yes, 
Limited 
A Little 
No, Not 
limited 
At All 
a. Vigorous activities, such as 
running, lifting heavy objects, 
participating in strenuous sports  
1  2  3  
b. Moderate activities, such as 
moving a table, pushing a vacuum 
cleaner, bowling, or playing golf  
1  2  3  
c. Lifting or carrying groceries  1  2  3  
d. Climbing several flights of stairs  1  2  3  
e. Climbing one flight of stairs  1  2  3  
f. Bending, kneeling, or stooping  1  2  3  
g. Walking more than a mile  1  2  3  
h. Walking several blocks  1  2  3  
i. Walking one block  1  2    
j. Bathing or dressing yourself  1  2  3  
 
4. During the past 4 weeks, have you had any of the following problems 
with your  work or other regular daily activities as a result of your 
physical health?      (circle one number on each line)  
 Yes  No  
a. Cut down the amount of time you spent on work or 
other activities  
1  2  
b. Accomplished less than you would like  1  2  
c. Were limited in the kind of work or other activities  1  2  
d. Had difficulty performing the work or other 
activities (for example, it took extra effort)  
1  2  
5. During the past 4 weeks, have you had any of the following problems 
with your  work or other regular daily activities as a result of any 
emotional problems  (such as feeling depressed or anxious)?  
(circle one number on each line)  
Copyright c 1994 Medical Outcomes Trust              288 
All rights reserved 
(IQOLA SF-36 Standard Australian Version 1.0) 
 Yes No 
a. Cut down the amount of time you spent on work 
or other activities  
1  2  
b. Accomplished less than you would like  1  2  
c. Didn't do work or other activities as carefully as 
usual  
1  2  
 
6. During the past 4 weeks, to what extent has your physical health or 
emotional  problems interfered with your normal social activities with 
family, friends,  neighbors, or groups?  
(circle one)  
Not at all ………………………………………………………………………………………1  
Slightly …………………………………………………………………………………………2  
Moderately ……………………………………………………………………………………3  
Quite a bit ……………………………………………………………………………………4  
Extremely …………………………………………………………………………………….5  
 
7. How much bodily pain have you had during the past 4 weeks?  
(circle one)  
None ……………………………………………………………………………………………1  
Very mild …………………………………………………………………………………….2  
Mild ……………………………………………………………………………………………..3  
Moderate …………………………………………………………………………………….4  
Severe …………………………………………………………………………………………5  
Very severe …………………………………………………………………………………6  
8. During the past 4 weeks, how much did pain interfere with your normal 
work  (including both work outside the home and housework)?  
(circle one)  
Copyright c 1994 Medical Outcomes Trust              289 
All rights reserved 
(IQOLA SF-36 Standard Australian Version 1.0) 
Not at all ……………………………………………………………………………………………..1  
A little bit ……………………………………………………………………………………………..2  
Moderately ……………………………………………………………………………………………3  
Quite a bit …………………………………………………………………………………………….4  
Extremely ……………………………………………………………………………………………..5  
 
9. These questions are about how you feel and how things have been with 
you during the past 4 weeks. For each question, please give the one 
answer that comes closest to the way you have been feeling. How much 
of the time during the past 4 weeks -   (circle one number on each 
line)  
 
 
10. During the past 4 weeks, how much of the time has your physical 
health or  emotional problems interfered with your social activities (like 
visiting with friends,  relatives, etc.)?  
 All of 
the 
Time  
Most 
of the 
Time  
A Good 
Bit of 
the 
Time  
Some 
of the 
Time  
A Little 
of the 
Time  
None 
of the 
Time  
a. Did you feel full of 
life?  
1  2  3  4  5  6  
b. Have you been a 
very  nervous person?  
1  2  3  4  5  6  
c. Have you felt so 
down in the dumps 
that nothing could 
cheer you up?  
1  2  3  4  5  6  
d. Have you felt calm 
and  peaceful?  
1  2  3  4  5  6  
e. Did you have a lot 
of energy?  
1  2  3  4  5  6  
f. Have you felt down?  1  2  3  4  5  6  
g. Did you feel worn 
out?  
1  2  3  4  5  6  
h. Have you been a 
happy person?  
1  2  3  4  5  6  
i. Did you feel tired?  1  2  3  4  5  6  
Copyright c 1994 Medical Outcomes Trust              290 
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(Circle One Number)  
All of the time ……………………………………………………………………………….1  
Most of the time ……………………………………………………………………………2  
Some of the time ………………………………………………………………………….3  
A little of the time …………………………………………………………………………4  
None of the time …………………………………………………………………………..5  
 
 
11. How TRUE or FALSE is each of the following statements for you.  
(circle one number on each line)  
 Definitely 
True 
Mostly 
True 
Don't 
Know 
Mostly 
False 
Definitely 
False 
a. I seem to get 
sick a little easier 
than other people  
1  2  3  4  5  
b. I am as healthy 
as anybody I know  
1  2  3  4  5  
c. I expect my 
health to get worse  
1  2  3  4  5  
d. My health is 
excellent  
1  2  3  4  5  
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Appendix 9 Food frequency questionnaire 
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Affix Participant’s Label Here     Study ID ___________ 
         Date_______________  
 
FOOD FREQUENCY QUESTIONNAIRE 
 
This questionnaire has been developed to provide information on your normal eating 
patterns, over the last 12 months. On the following pages please write in number of 
times each week OR each day that you have a serving of each food. Do not use a X 
or a . If you eat a food less than once a week, DO NOT include it. If you eat a food 
every day, write the number of servings in the “every day” column. If you eat a food 
weekly, then write the number of servings in the “every week” column.  
 
For example: 
You drink 1 middle-size glass of milk every day and  
You eat 3 doughnuts every week. 
 
 
Food Type Serving size
 
I Eat This Food 
Every Week 
(Write Number of 
Servings)
I Eat This Food 
Every Day 
(Write Number 
of Servings)
Milk  1 Small Cup (100 ml)   
1 Middle-size glass (200 ml)  1 
1 Big glass, bowl (250 ml)   
Doughnuts 
(cream sweets) 
110 g (1 doughnut) 3  
Food Type Serving size I Eat This Food 
Every Week 
(Write Number of 
servings)
I Eat This Food 
Every Day 
(Write Number  
of servings)
Milk (any type) 1 Small Cup (100 ml)   
1 Middle-size glass (150 ml)   
1 Big glass, bowl (250 ml)   
Yoghurt (any type) 150-180 g carton   
Doughnuts (cream 
sweets) 
110 g (1 doughnut)   
Ice cream  2 large scoops   
White cheese (ricotta, 
cottage) 
150 g   
Swiss/cheddar cheese 1 slice   
Melted cheese 30 g   
Grated cheese 30 g   
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Food Type Serving size I Eat This Food 
Every Week 
(Write Number of 
servings)
I Eat This Food 
Every Day 
(Write Number 
of servings)
Soft cheese (Camembert) Small (1/8 or 30g)   
Middle (1/4 or 60 g)   
Red meat (65-100 g = 
1/2C mince, 2 chops, 2 
slices roast meat) 
Small (50g)   
Middle-size (80-100 g)   
Large (150-200g)   
Poultry  (50 g - 1 thick 
slice, 1/4 chicken -155g, 1 
large drumstick-100g ) 
Small (50g)   
Middle-size (80-100 g)   
Large (150-200g)   
Fish (1 fillet = 100 g) 
Small (50g)   
Middle-size (80-100 g)   
Large (150-200g)   
Processed meat (e.g. ham, 
polony) 
Small (1 slice)   
Middle-size (2 slices)   
Large (1 Cup)   
Eggs 1 Egg (55g)   
Potato Small (100g)   
Middle-size (140g)   
Large (200g)   
Pasta, rice or polenta Small (1/2 Cup)   
Middle-size (3/4 Cup)   
Large (1 Cup)   
Peas, beans, lentils Small (3 Tb)   
Middle-size (5 Tb)   
Large (10 Tb)   
Vegetables, cooked Small (75g or ½ Cup)   
Middle-size (1 Cup)   
Large (1 ½ Cup)   
Bread (any type) 1 slice (Thick toast cut)   
1 slice (Sandwich cut)   
Pizza (any type) 400 g per serve   
Cheese cake  1 moderate slice   
Sandwich, pannino, 
foccacia 
1 Serving   
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Appendix 10 Mini mental state exam 
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Affix Participant Label Here     Screening ID____________ 
Date______________ 
MMSE 
 
1. Ask the patient for the following information. Score 1 for each correct answer. 
 
Today’s date ______Season ______day _____month ______year ________  /5 
 
2. Ask the patient for the following information in regards to where they are. Score 1 for 
each correct answer. 
 
State ______ Country ______Town/City ______Hospital ______Floor___  /5 
 
3. Name three objects (apple, penny, table) taking one second to say each.  Repeat the 
answers until the patient learns all three. Then ask the patient to tell you the three. 
Score1 point for each correct answer.       /3 
 
4. Ask the patient to begin with 100 and count backwards by 7. Stop after 5 subtractions (93, 
86, 79, 72,65). Score the total number of correct answers. If the patient cannot or will not 
perform the task, ask him or her to spell the word ‘world’ backwards. The score is the 
number of letters in correct order, eg, dlrow 5, dlowr 3.  
____________________________________________________________/5 
 
5. Ask for the names of the three objects learned in #3. Score 1 point for each item recalled 
correctly (in any order) 
____________________________________________________________/3 
  
6. Point to a pencil and a watch.  Have the patient name them as you point.. Score 1 point for 
each item correctly identified          /2 
 
7. Have the patient repeat ‘no if’s, ands or but’s’. If patient does not pronounce ‘s’ score 0.
             /1 
 
8. Have the patient follow this three-stage command, “take the paper in your right hand. fold 
the paper in half. put the paper on the floor.” Score one point for each part correctly 
executed.             /3 
 
9. Have the patient read and obey the following “close your eyes”. (Write in large letters). 
Score one point only if patient closes their eyes.      /1 
 
10. Have the patient write a sentence of his or her own choice. Do not dictate a sentence. The 
sentence must contain a subject and a verb. Score 1 point.     /1 
 
11. Have the patient copy the design attached (overlapping pentagons).  /1 
 
 
Education: 
Primary of less                                              Total               /30 
Secondary   
Tertiary   
 
RA Name_______ 
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Appendix 11 Screening visit one checklist 
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Protein Intake Metabolic Effects Study 
Checklist – Screening Visit 1 
 
 
 
Name and address label here 
 
Date of screening visit 1:     /     /     Study ID:         
1. Consent form signed 
(and copy given to patient) 
  YES      NO Initials:  
 
 
2. Inclusion/exclusion form completed   YES      NO Initials:  
 
 
3. Mini Mental State passed 
(tick yes or no on exclusion criteria 11) 
  YES      NO Initials:  
 
 
4. Questionnaires 
 
 Demographic  
 
 
  YES      NO 
Initials: 
 
 
 SF-36    YES      NO  
 International Physical Activity  YES       NO  
 FFQ  YES       NO  
5. Blood and urine samples 
 
Blood sample               YES      NO 
If yes, Sample ID __________             Time of blood ___________Initials 
________ 
 
Urine sample               YES      NO 
If yes, Sample ID __________             Time of urine ___________Initials 
________ 
 
6. Weight:        .   kg                 Height:      .   cm                    
7. Waist circumference       .   cm   
     Hip circumference       .   cm 
8. Triceps skin fold:          .  mm  
    Upper arm girth:        .    cm  
    Calf girth:                    .    cm  
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9. Blood pressure:   1.        mm Hg /       mm Hg 
2.       mm Hg /       mm Hg 
3.       mm Hg /       mm Hg 
Mean       mm Hg /       mm Hg 
 
11. Protein intake ___________g/day  
      Protein intake / Weight  = _________ g/kg body per day (tick yes or no or 
exclusion criteria 13) 
12. DXA  
 
Scan site Scan 
speed 
Scan No. Comment 
Hip L/R   Z score < -2 
  YES   NO (tick yes or no 
on exclusion criteria 12) 
Total 
body 
   
VFA    
 
13. pQCT 
 
Scan site Pixel 
Resolution 
Scan No. Comment 
Forearm    
Tibia    
  
 
14. Final check list 
 
 3-day food record and scale given to 
participant 
 
 
 
  YES     
 Urine bottles given to participant   YES     
 3-day test drink given to participant 
 
  YES    
 Clinic visit booked    YES 
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Appendix 12 Screening visit 2 checklist 
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Protein Intake Metabolic Effects Study 
Checklist – Screening Visit 2 
 
 
 
Name and address label here 
 
 
Date of screening visit 2:     /     /     Study ID:         
1. 24-hour urine bottles collection  Initials: ______ 
 Total weight (bottle and urine)___________gram 
 Bottle weight  Urine Volume ____________ml 
Collection start date      /     /           Time _____hrs 
Collection finish date      /     /          Time _____hrs 
2. 3-day food record returned and checked   YES    Initials: ______ 
 
 
3. Timed Up and Go     .   seconds 
 
  
 
4. Grip strength     .    kg/N 
 
 
5. Lower limb muscle strength 
 
Ankle dorsiflexion  Hip extension   
Knee flexion  Hip abduction  
Knee extension  Hip flexion  
  Hip adduction  
 
 
6. Romberg 
 
Position Open Closed 
Unable to perform 0 0 
Side-by-side 1 1 
Semi Tandem 2 2 
Tandem (0-9 secs) 3 3 
Tandem (>9 secs) 4 4 
 
 
 
 
7.   Drink acceptability  
  YES   
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8.   Check eligibility for randomization from 
telephone screening questionnaire                        
 
 
9.  Completed all screening requirements 
  NO   
 
  YES   
  NO   
 
  YES  – go to 9 
  NO  – go to 10 
 
10.  3-month supply of test drink given to participant           YES      NO 
 
 
11.  Preferred way of getting future test drink supply:
 
 Pick up from the Sir Charles Gairdner Hospital 
 Pick up from the Curtin University of Technology  
 Deliver to home 
 Every   3 months    6 months 
 
12.  Date of appointment for QCT visit:             /     /      
 
 
13.  Eligible to act a community control       
 
 YES  Inform participant that we will contact her after one year to make 
an appointment for clinic visit 
 
  NO  
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Appendix 13 3-day food record log book 
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Affix participant label here  
 
 
PIMES STUDY 
FOOD RECORD 
 
The food record should include two weekdays and one weekend day (i.e. 
Thursday, Friday and Saturday or Sunday, Monday and Tuesday). 
 
Started Diary on ____/____/____dd/mm/yy  
Day of week _______________ 
 
Finished on ____/____/____dd/mm/yy  
Day of week _______________ 
 
Name______________________________________________  
Contact telephone number__________________ 
 
Date of Birth_______________ 
Height_________ 
Weight _________  
Email ________________________________________ 
 
 
Please don’t hesitate to contact the PIMES study team on 9346 1747 for further 
assistance. 
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Guidelines for keeping your 3-day Food Diary 
 
PLEASE RECORD EVERYTHING THAT YOU EAT AND DRINK FOR 
THREE CONSECUTIVE DAYS. 
 Start a new page for each day 
 Record the date, the day and the time 
 Record each item as close to the time of eating/drinking as possible 
 Try to carry the diary with you always and record food as you eat it, so that 
nothing is forgotten 
1. GIVE A FULL DESCRIPTION OF YOUR FOOD 
 Record the type and brand of each item, which cut of meat is used and whether 
the fat has been trimmed, which brand of spread is used and which type of bread 
 How the food is prepared and which cooking method has been used (for 
example; boiling, frying, roasting or baking).  If fat has been added, please state 
the bran and the amount 
 When ‘take-aways’ have been bought please say where they have been bought 
from 
2. DESCRIBE THE AMOUNT OF FOOD YOU EAT & RECORD 
INDIVIDUAL ITEMS 
 Where possible weigh the food with the scales provided (this is the most 
accurate) and provide the quantity consumed in grams 
 Record all fluids even water and where possible measure the volume with the 
measure cup provided and provide the volume consumed in mls. If you provide 
the volume consumed in cups, please indicate the size of the cup (eg a medium 
glass, a paper cup, coffee mug) 
 If you are unable to weigh the food or drink record the amount in household 
measures (for example: cups, spoons, volume or teaspoons) 
 Estimate the ingredients of a mixed dish separately (eg a salad with 1 lettuce leaf, 
½ tomato and 3 slices of cucumber lightly dressed with French dressing) 
 Don’t forget accompaniments such as; butter, gravies, salt, butter added to 
vegetables, milk and sugar in coffee 
 Record all recipes: there is a ‘notes’ section at the end of each page for this.  
Record the recipe and then tell us how much of the total is your portion 
3. EATING AWAY FROM HOME 
When eating away from home, it will not be possible to include recipes but we 
would like you to describe the food and the amount as much as possible. 
4. PLEASE REMEMBER: 
 Record what you eat and drink as close as possible to the time that you consume 
it 
 At the end of the day – think back – you may have forgotten to record a biscuit or 
a piece of cake eaten with a cup of tea: please write it all down 
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EXAMPLE OF HOW TO RECORD WHAT YOU EAT AND DRINK 
Time  Food and Drink Eaten  
 Description 
eg. Weetbix 
Quantity 
eg. 50 grams 
7.30am Cornflakes – Kellogs 
Milk – Brownes Calcium Plus 
Sugar - white 
Toast, white bread – Helgas 
Margarine – Flora Light 
Tea – Lipton 
Milk – Brownes Skim 
Sugar - white 
45g 
250 ml 
2 teaspoons 
2 large thick slices 
3 teaspoons 
1 cup 
30ml 
3 teaspoons 
10.30a
m 
Granita – Arnotts 
Black Coffee 
Green Apple – Granny Smith 
1 biscuit 
1 cup 
1 medium 
1 pm Bought from deli: 
1 x cheese & salad sandwich  
White bread – brand unknown 
Butter – brand unknown 
Cheese grated - brand unknown 
Lettuce 
Tomato 
Beetroot, canned 
Apple – Red Delicious 
 
 
2 standard slices 
Thickly spread 
½ a cup 
2 small leaves  
3 medium slices 
3 slices 
1 large 
3.30pm Water – Mount Franklin 
Chocolate slice from deli 
1 bottle 750ml 
1 medium slice 
7.30pm 
 
 
 
 
 
 
9.00pm 
Emu Export 
Spaghetti, white – Maggi 
Bolognaise Sauce – lean mince 
Parmesan Cheese – Kraft 
Red wine, Shiraz 
Salad   carrots 
    tomatoes 
    lettuce 
French dressing – Kraft Fat Free 
Ice cream (vanilla) – Blue Ribbon 
1 x 375ml can 
320g 
1.5 cups (half the recipe) 
3 teaspoons 
2 glasses 
3 slices 
1 whole 
4 small leaves 
1 tablespoon 
3 scoops 
 Notes: Bolognaise Sauce: 500g lean mince, 1 x 420g can tinned whole tomatoes, 2 
tablespoons Leggo tomato paste, 1 tablespoon canola oil, ½ cup dry white wine, 
oregano, thyme, basil, salt and pepper 
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Day 1 
 
Date:  __________    Day of week: ___________ 
 
Time  Food and Drink Consumed  
Description 
eg. Weetbix 
Quantity 
eg. 50 grams 
 ______________________ 
_______________________________
_____________ 
_______________________________
_______________________________
____ 
 
______________
__________ 
______________
__________ 
 _______________________________
_______________________________
_______________________________
_________________ 
 
______________
______________
____________ 
 _______________________________
_______________________________
_______________________________
_______________________________
________ 
______________________ 
______________
______________
______________
______________ 
 
 
 
Was it a usual day?             Yes              No   
 
If not, please comment:  
 
Notes:  
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Day 2 
 
Date:  __________    Day of week: ___________ 
 
Time  Food and Drink Consumed  
Description 
eg. Weetbix 
Quantity 
eg. 50 grams 
 ______________________ 
_______________________________
_____________ 
_______________________________
_______________________________
____ 
 
_____________
___________ 
_____________
___________ 
 _______________________________
_______________________________
_______________________________
_________________ 
 
_____________
_____________
_____________
_ 
 _______________________________
_______________________________
_______________________________
_______________________________
________ 
______________________ 
_____________
_____________
_____________
_____________
____ 
 
 
 
Was it a usual day?             Yes              No   
 
If not, please comment:  
 
Notes:  
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Day 3 
 
Date:  __________    Day of week: ___________ 
 
Time  Food and Drink Consumed  
Description 
eg. Weetbix 
Quantity 
eg. 50 grams 
 ______________________ 
_______________________________
_____________ 
_______________________________
_______________________________
____ 
 
______________
__________ 
______________
__________ 
 _______________________________
_______________________________
_______________________________
_________________ 
 
______________
______________
____________ 
 _______________________________
_______________________________
_______________________________
_______________________________
________ 
______________________ 
______________
______________
______________
______________ 
 
 
 
Was it a usual day?             Yes              No   
 
If not, please comment:  
 
Notes:  
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Appendix 14 Checklist for recording 3 days food record and 24 hour urine  
 
 310
Checklist for after your 1st appointment 
 
1. 3-day Diet Record    
 
1.  Record everything you eat and drink for 3 days starting on ___________. 
 
2   Try not to alter what you eat or drink during this time and record as 
accurately as you can (but don’t worry we will clarify any minor details). 
 
3   Follow the guidelines for keeping the 3-day food diary. 
 
2. 24-hour Urine Collection 
 
This involves collecting your urine for a period of 24 hours.  Please begin and 
finish as close to the same time of the day as possible e.g. 7:00am one day 
to 7:00am the next.  To collect your 24-hour specimen, please follow these 
instructions.  
 
* Begin your 24 hour collection in the morning of:________________. 
 
* To begin, empty your bladder in the toilet as usual. 
 
Record the time.     Time:____________(am) 
 
* Every time you go to the toilet in the next 24 hours, collect your urine with 
the urinary hat provided and pour it into the plastic collection bottle 
provided. 
 
* Keep your urine collection bottle in a cool place (no need to refrigerate). 
 
* Collect your last specimen in the morning of:___________________ 
 (As close to the same time as you began the morning before.) 
 
Record the time.     Time:_____________(am) 
 
Your collection is now complete.   
----------------------------------------------------------------------------------------------------- 
If you are unsure about anything, please do not hesitate contact us on: 
9346 1747 or 9346 4970. 
 
Please bring your urine collection along with this sheet, your 3-day food 
diary and the food scale to your next appointment on: ______________ at 
Bone Mineral Research Group, Sir Charles Gairdner Hospital (see over for 
map).  
 
At your next appointment, you will have measurements of balance, mobility 
and muscle strength, so please wear enclosed comfortable shoes. You do 
not need to be fasting. 
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Appendix 15 Baseline characteristics by quartile of ALM/height2 (n = 219). 
 1st quartile 
< 5.88 kg/m2 
(n = 53) 
2nd quartile 
5.88–6.34kg/m2 
(n = 55) 
3rd quartile 
6.34–6.86kg/m2 
(n = 55) 
4th quartile 
> 6.86 kg/m2 
(n = 56) 
P value of 
ANOVA test
Age (year)       74.6 ± 2.7       74.1 ± 2.7 74.3 ± 2.8 74.0 ± 2.5 0.60 
Height (cm)     159.2 ± 6.4     159.1 ± 5.1 160.8 ± 6.9 160.3 ± 5.5 0.39 
Weight (kg)    59.3 ± 8.7bcd 65.4 ± 6.6ad      69.3 ± 9.6ad       79.6 ± 9.1abc <0.001 
BMI (kg/m2)    23.3 ± 2.7bcd 25.8 ± 2.5ad      26.8 ± 2.8ad       31.0 ± 2.8abc <0.001 
SF-36 standard physical health (0-100)  47 ± 10          46 ± 9   48 ± 8     43 ± 10 0.06 
SF-36 standard mental health (0-100) 53 ± 9          56 ± 8   53 ± 9   55 ± 8 0.44 
Physical activity (log(Mets/week))    3.27 ± 0.50    3.49 ± 0.48cd       3.25 ± 0.37b      3.27 ± 0.45b 0.015 
      
Body composition † 
Whole body lean mass (kg) 33.3 ± 3.5bcd   35.9 ± 2.5acd        38.2 ± 3.7abd      42.3 ± 3.7abc <0.001 
Whole body fat mass (kg) 21.4 ± 6.3bcd   24.6 ± 5.5ad      26.1 ± 6.9ad      32.2 ± 6.9abc <0.001 
Percentage of whole body fat mass (%)       37.4 ± 6.2d 39.3 ± 5.3     39.0 ± 5.7d     41.9 ± 5.0ac 0.001 
ALM/height2 (kg/height2)    5.49 ± 0.29bcd       6.16 ± 0.13acd          6.58 ± 0.15abd        7.43 ± 0.44abc <0.001 
Calf muscle cross-sectional area (cm2)   26.9 ± 3.4bcd    30.5 ± 4.7ad       31.9 ± 4.5ad      35.3 ± 5.8abc <0.001 
Corrected upper arm muscle area (cm2) 28.7 ± 9.0cd    32.0 ± 8.3cd       36.8 ± 8.6ab       39.2 ± 11.7ab <0.001 
      
Protein intake assessed by 24-hour urinary nitrogen 
Protein intake (g/day) 58.3 ± 18.2cd    66.8 ± 15.3        68.8 ± 20.6a     70.4 ± 19.1a 0.004 
      
Dietary intake assessed by 3-day food record 
Protein intake (g/day) 73.3 ± 17.6   73.2 ± 18.7      77.8 ± 24.5     81.3 ± 14.8 0.08 
Protein intake (g/kg/day)    1.25 ± 0.32d   1.13 ± 0.33     1.14 ± 0.37      1.04 ± 0.24a 0.007 
Total fat intake (g/day) 62.3 ± 18.9   59.8 ± 18.3     59.8 ± 17.5     66.6 ± 20.6 0.20 
Carbohydrate intake (g/day)  184.7 ± 40.1  179.4 ± 43.7d 188.6 ± 43.8  203.5 ± 56.7b 0.045 
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 1st quartile 
< 5.88 kg/m2 
(n = 53) 
2nd quartile 
5.88–6.34kg/m2 
(n = 55) 
3rd quartile 
6.34–6.86kg/m2 
(n = 55) 
4th quartile 
> 6.86 kg/m2 
(n = 56) 
P value of 
ANOVA test
Energy intake (kJ/day)   7004 ± 1367   6877 ± 1514   7055 ± 1578   7608 ± 1535 0.05 
% of energy from protein (%) 18.3 ± 3.1 18.6 ± 3.5 19.0 ± 3.6 19.0 ± 3.8 0.69 
% of energy from fat (%) 33.3 ± 6.2 32.5 ± 5.1 31.7 ± 5.2 32.9 ± 6.4 0.51 
% of energy from carbohydrate (%) 45.9 ± 6.1 45.4 ± 7.8 46.6 ± 5.6 45.8 ± 7.0 0.83 
      
Mobility and balance 
Timed Up and Go (second) 7.9 ± 1.3 7.9 ± 1.3  8.1 ± 1.5   8.0 ± 1.6 0.81 
Romberg eye-open (0-4)  3.8 ± 0.4 4.0 ± 0.2  3.8 ± 0.5   3.9 ± 0.3 0.047 
Romberg eye-close (0-4) 3.1 ± 0.6 3.3 ± 0.7  3.1 ± 0.7   3.1 ± 0.7 0.13 
      
Muscle strength 
Hand grip strength (kg)  19.6 ± 5.4cd 21.0 ± 4.8  22.5 ± 6.0a   23.4 ± 4.8a 0.001 
Ankle dorsiflexion (kg)       10.0 ± 4.5 10.3 ± 4.2 10.7 ± 5.8   11.2 ± 3.9 0.57 
Knee flexion (kg)   7.7 ± 3.4cd   9.1 ± 3.5    9.9 ± 4.2a   10.5 ± 3.8a 0.001 
Knee extension (kg) 13.6 ± 4.7d  15.7 ± 5.7 15.7 ± 6.1   17.4 ± 7.4a 0.02 
Hip extension (kg) 14.7 ± 5.1d  16.3 ± 6.0 16.5 ± 6.4   18.3 ± 7.6a 0.03 
Hip abduction (kg) 10.2 ± 3.4d  10.6 ± 3.9 10.9 ± 4.2   12.4 ± 6.0a 0.05 
Hip flexion (kg)      11.0 ± 4.8  11.6 ± 4.0 12.0 ± 4.6  12.8 ± 4.4 0.18 
Hip adduction (kg)      10.3 ± 5.0  12.4 ± 5.9 12.1 ± 5.4  12.4 ± 5.8 0.16 
Total knee strength (kg)   21.3 ± 6.6cd  24.7 ± 7.6   25.5 ± 9.0a    27.9 ± 9.0a 0.001 
Total hip strength (kg)    46.2 ± 16.4d    50.8 ± 16.9    51.4 ± 17.4      55.9 ± 20.0a 0.042 
Results are mean ± SD.  
† Whole body fat mass and percentage of fat mass were derived from DXA; Calf muscle cross-sectional area was obtained from pQCT 
measurements at 38% length of tibia; Corrected upper arm muscle area (cm2) = ((Arm girth in cm) – π(triceps skin fold in cm))2 / 4π – 6.5. 
a significantly different from the 1st quartile, p< 0 .05, b significantly different from the 2nd quartile, p< 0.05, c significantly different from 3rd  
quartile, d significantly different from the 4th quartile (ANOVA with Tukey test). 
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Appendix 16 Baseline characteristics by quartile of regression residuals* (n = 219). 
 1st quartile 
Residual  
<-1136  
(n = 55) 
2nd quartile 
Residual 
(-1136) – (-162) 
(n = 54) 
3rd quartile 
Residual 
(-162) – (1047) 
(n = 54) 
4 quartile 
Residual 
>1047 
(n = 56) 
P value of 
ANOVA test 
Age (year) 74.4 ± 2.6         74.4 ± 3.0       74.1 ± 2.6     74.1 ± 2.5 0.83 
Height (cm)     160.4 ± 6.2       158.7 ± 4.8     160.4 ± 6.4   160.0 ± 6.5 0.40 
Weight (kg)     66.1 ± 10.5d    66.9 ± 10.1d       67.9 ± 11.4    73.2 ± 12.0ab 0.003 
BMI (kg/m2)   25.6 ± 3.3d  26.5 ± 3.4d       26.4 ± 4.0d   28.6 ± 4.1abc <0.001 
SF-36 standard physical health (0-100)  46 ± 10 45 ± 9         45 ± 10       47 ± 9 0.40 
SF-36 standard mental health (0-100)  53 ± 10 55 ± 7         56 ± 7 52 ± 10 0.05 
Physical activity (log(Mets/week))   2.09 ± 0.75  2.26 ± 0.62      2.35 ± 0.65 2.16 ± 0.71 0.15 
      
Body composition † 
Whole body lean mass (kg) 34.8 ± 4.1cd 36.0 ± 3.6d   37.8 ± 4.0ad 41.2 ± 4.5abc <0.001 
Whole body fat mass (kg)      26.4 ± 7.0         25.9 ± 7.0 25.1 ± 7.8    27.0 ± 8.3 0.59 
Percentage of whole body fat mass (%)  41.5 ± 5.0cd         40.2 ± 5.3 38.1 ± 5.9a    37.9 ± 6.0a 0.001 
ALM/height2 (kg/height2)     5.67 ± 0.44bcd     6.20 ± 0.42acd     6.54 ± 0.45abd 7.28 ± 0.58abc <0.001 
Calf muscle cross-sectional area (cm2)  27.5 ± 3.8cd 29.9 ± 4.6d  32.1 ± 4.7ad 35.4 ± 5.7abc <0.001 
Corrected upper arm muscle area (cm2)   30.8 ± 10.0d       34.5 ± 9.8       33.7 ± 9.9 38.0 ± 10.4a 0.003 
      
Protein intake assessed by 24-hour urinary nitrogen 
Protein intake (g/day)  60.4 ± 17.1d 66.2 ± 18.6 67.9 ± 16.7 70.1 ± 21.6a 0.04 
      
Dietary intake assessed by 3-day food record 
Protein intake (g/day) 70.7 ± 17.6 76.5 ± 23.0 79.6 ± 20.0 79.1 ± 15.3 0.06 
Protein intake (g/kg/day)  1.09 ± 0.31 1.16 ± 0.36 1.21 ± 0.37 1.11 ± 0.25 0.23 
Total fat intake (g/day) 59.2 ± 19.8 60.2 ± 15.7 63.5 ± 18.4 65.7 ± 21.3 0.26 
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 1st quartile 
Residual  
<-1136  
(n = 55) 
2nd quartile 
Residual 
(-1136) – (-162) 
(n = 54) 
3rd quartile 
Residual 
(-162) – (1047) 
(n = 54) 
4 quartile 
Residual 
>1047 
(n = 56) 
P value of 
ANOVA test 
Carbohydrate intake (g/day)  176.1 ± 38.6 193.0 ± 47.8 187.9 ± 40.2 199.7 ± 57.6 0.06 
Energy intake (kJ/day)   6729 ± 1393   7114 ± 1484   7246 ± 1421   7473 ± 1697 0.07 
% of energy intake from protein (%) 18.4 ± 3.4 18.7 ± 3.4 19.2 ± 3.8 18.8 ± 3.5 0.73 
% of energy intake from fat (%) 32.8 ± 6.7 31.8 ± 4.5 32.7 ± 5.4 32.9 ± 6.1 0.76 
% of energy intake from carbohydrate (%) 45.8 ± 7.1 46.8 ± 6.0 45.1 ± 7.1 45.9 ± 6.4 0.61 
      
Mobility and balance 
Timed Up and Go (second) 7.8 ± 1.2 8.1 ± 1.4 8.3 ± 1.5 7.8 ± 1.4 0.14 
Romberg eye-open (0-4)  3.9 ± 0.3 3.9 ± 0.4 3.8 ± 0.5 3.9 ± 0.3 0.29 
Romberg eye-close (0-4) 3.1 ± 0.7 3.2 ± 0.6 3.0 ± 0.8 3.2 ± 0.7 0.58 
      
Muscle strength 
Hand grip strength (kg)  20.7 ± 5.4d 20.5 ± 5.4d 21.8 ± 4.9    23.6 ± 5.6ab 0.008 
Ankle dorsiflexion (kg) 10.1 ± 4.4 10.7 ± 5.6 10.2 ± 3.8    11.1 ± 4.6 0.65 
Knee flexion (kg)    8.4 ± 3.3d  9.5 ± 4.4  8.7 ± 3.5   10.6 ± 3.8a 0.01 
Knee extension (kg) 15.2 ± 5.6  15.0 ± 5.6d  14.0 ± 5.1d   18.1 ± 7.6bc 0.004 
Hip extension (kg)  15.5 ± 5.4d  15.5 ± 5.6d  15.6 ± 5.6d 19.2 ± 8.2abc 0.003 
Hip abduction (kg) 10.5 ± 4.0 10.7 ± 3.6  10.3 ± 3.9d   12.5 ± 6.0c 0.03 
Hip flexion (kg) 11.6 ± 4.7 12.2 ± 4.3 11.1 ± 4.4   12.4 ± 4.4 0.40 
Hip adduction (kg) 10.8 ± 5.0 12.6 ± 6.1 11.0 ± 5.5    12.9 ± 5.4 0.10 
Total knee strength (kg)    23.6 ± 7.3d   24.5 ± 8.6d   22.8 ± 7.1d   28.7 ± 9.4abc 0.001 
Total hip strength (kg)    48.3 ± 16.8   51.1 ± 17.1    48.0 ± 15.9d  57.0 ± 20.5c 0.03 
* The residuals were obtained from linear regression of appendicular lean mass (kg) adjusted for height (m) and total body fat mass (kg).  Values 
are mean ± SD.   
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† Whole body fat mass and percentage of fat mass were derived from DXA; Calf muscle cross-sectional area was obtained from pQCT 
measurements at 38% length of tibia; Corrected upper arm muscle area (cm2) = ((Arm girth in cm) – π(triceps skin fold in cm))2 / 4π – 6.5.   
a significantly different from the 1st quartile, p< 0 .05, b significantly different from the 2nd quartile, p< 0.05, c significantly different from 3rd  
quartile, d significantly different from the 4th quartile (ANOVA with Tukey test). 
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Appendix 17 Baseline characteristics by protein intake tertile assessed by 3-day 
food record (n = 218). 
 1st tertile 
Protein intake
< 69 g/day 
(n = 74) 
2nd tertile 
Protein intake
69 - 83 g/day
(n = 72) 
3rd tertile 
Protein intake 
> 83 g/day 
(n = 72) 
P value of 
ANOVA 
test 
Age (year) 74.5 ± 2.7  74.6 ± 2.7  73.6 ± 2.6 0.05 
Height (cm) 158.3 ± 6.4b 161.2 ± 5.3a 160.0 ± 5.7 0.01 
Weight (kg)    67.1 ± 11.7    69.7 ± 11.8     68.7 ± 10.4 0.37 
BMI (kg/m2)  26.7 ± 3.6  26.8 ± 4.1   26.9 ± 3.9 0.94 
SF-36 standard physical 
health (0-100) 
 46 ± 9  46 ± 9    45 ± 10 0.62 
SF-36 standard mental health
(0-100) 
 55 ± 9  54 ± 8   54 ± 9 0.86 
Physical activity 
(log(Mets/week)) 
  3.33 ± 0.49   3.35 ± 0.46     3.27 ± 0.44 0.50 
     
Protein intake assessed by 24-hour urinary nitrogen 
Protein intake (g/day) 58.3 ± 14.8bc 68.1 ± 20.3a 72.2 ± 18.7a <0.001 
     
Dietary intake assessed by 3-day food record 
Protein intake (g/day)   57.7 ± 9.2bc  75.1 ± 4.0ac  97.1 ± 15.6ab <0.001 
Protein intake (g/kg/day)  0.88 ± 0.20bc  1.11 ± 0.22ac   1.44 ± 0.28ab <0.001 
Fat intake (g/day)  51.6 ± 18.0bc  61.6 ± 14.9ac   73.6 ± 17.1ab <0.001 
Carbohydrate intake (g/day) 160.9 ± 32.3bc 192.0 ± 42.6ac 215.4 ± 48.7ab <0.001 
Energy intake (kJ/day)  5910 ± 1123bc 7140 ± 1144ac 8403 ± 1114ab <0.001 
% of energy from protein 17.3 ± 3.2bc 18.8 ± 3.5ac  20.2 ± 3.2ab <0.001 
% of energy from fat    32.3 ± 6.5    32.4 ± 4.6 33.0 ± 6.0 0.73 
% of energy from 
carbohydrate 
  47.5 ± 7.3c 46.2 ± 5.6  44.1 ± 6.5a 0.007 
Calcium intake (mg/day) 768 ± 411c 891 ± 305c 1056 ± 371ab <0.001 
     
Body composition 
Whole body lean mass (kg) 36.0 ± 4.6bc 38.3 ± 4.6a 38.1 ± 4.6a 0.004 
Appendicular lean mass 
(kg) 
15.7 ± 2.4bc 16.9 ± 2.3a 16.7 ± 2.3a 0.002 
Whole body fat mass (kg)    26.2 ± 7.7     26.5 ± 8.1 25.6 ± 6.8 0.78 
% of whole body fat mass        40 ± 5 39 ± 6 39 ± 5 0.16 
ALM/height2 (kg/m2) 6.23 ± 0.69c   6.50 ± 0.76    6.54 ± 0.79a 0.03 
Residuals  -532 ± 1469bc 158 ± 1700a 356 ± 1624a 0.003 
Calf cross-sectional muscle 
area (cm2)  
  29.9 ± 4.6c 31.6 ± 5.9   32.1 ± 5.9a 0.04 
Correct upper arm muscle 
area (cm2) 
34.4 ± 10.6 34.2 ± 11.0 34.0 ± 9.4 0.97 
     
Mobility and balance 
Timed Up and Go (second) 8.0 ± 1.4 8.1 ± 1.3 7.9 ± 1.5 0.80 
Romberg eye-open (0-4)  3.8 ± 0.5 3.8 ± 0.3 3.9 ± 0.3 0.60 
Romberg eye-close (0-4) 3.1 ± 0.8 3.1 ± 0.8 3.2 ± 0.6 0.50 
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 1st tertile 
Protein intake
< 69 g/day 
(n = 74) 
2nd tertile 
Protein intake
69 - 83 g/day
(n = 72) 
3rd tertile 
Protein intake 
> 83 g/day 
(n = 72) 
P value of 
ANOVA 
test 
     
Muscle strength 
Hand grip strength (kg)  21.4 ± 5.0 21.4 ± 5.9 22.1 ± 5.3 0.63 
Ankle dorsiflexion (kg) 10.0 ± 4.3 11.3 ± 5.4 10.2 ± 4.0 0.21 
Knee flexion (kg)  8.8 ± 2.6  9.7 ± 4.0 9.3 ± 4.0 0.36 
Knee extension (kg) 15.3 ± 5.6 15.7 ± 6.6  15.8 ± 6.5 0.85 
Hip extension (kg) 16.7 ± 6.1 16.0 ± 6.3 16.6 ± 7.0 0.77 
Hip abduction (kg) 11.3 ± 4.8 10.6 ± 3.8 11.1 ± 5.0 0.64 
Hip flexion (kg) 12.2 ± 4.4 11.4 ± 4.2 12.0 ± 4.8 0.50 
Hip adduction (kg) 11.9 ± 5.3 11.6 ± 5.7 12.0 ± 5.8 0.88 
Total knee strength (kg)  24.1 ± 7.4 25.4 ± 9.1 25.1 ± 8.8 0.60 
Total hip strength (kg)    52.1 ± 17.7   49.5 ± 16.9   51.8 ± 19.5 0.65 
Total leg strength (kg)    86.4 ± 24.7   86.0 ± 25.3   87.1 ± 27.1 0.97 
Results are mean ± SD.  
† Whole body and percentage of whole body lean and fat mass and appendicular lean 
mass (ALM) were derived from DXA; Residuals was the regression residual of ALM 
adjusted for height2 and fat mass; Calf muscle cross-sectional area was obtained from 
pQCT measurements at 38% length of tibia; Corrected upper arm muscle area (cm2) 
= ((Arm girth in cm) – π(triceps skin fold in cm))2 / 4π – 6.5.  
a significantly different from the 1st tertile, b significantly different from the 2nd tertile, 
c significantly different from 3rd  tertile (ANOVA with Tukey’s test, p < 0.05). 
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Appendix 18 Estimated marginal means (SE) of baseline muscle mass 
measurements by protein intake tertile assessed by 3-day food record adjusted 
for height (n = 218). 
 1st tertile 
Protein intake
< 69 g/day 
(n = 74) 
2nd tertile 
Protein intake
69 - 83 g/day
(n = 72) 
3rd tertile 
Protein intake 
> 83 g/day 
(n = 72) 
P value of 
ANCOVA 
test  
Whole body lean mass (kg) 36.7 ± 0.4 37.6 ± 0.4 38.0 ± 0.4 0.11 
Appendicular lean mass (kg) 16.0 ± 0.2 16.6 ± 0.2 16.7 ± 0.2 0.07 
Whole body fat mass (kg) 26.2 ± 0.7 26.5 ± 0.8 25.6 ± 0.7 0.56 
% of whole body fat mass     40 ± 0.5    39 ± 0.6    39 ± 0.5 0.14 
Calf cross-sectional muscle 
area (cm2)  
30.2 ± 0.6 31.4 ± 0.6 32.1 ± 0.6 0.10 
Correct upper arm muscle 
area (cm2) 
34.6 ± 0.1 34.1 ± 0.1 34.0 ± 0.1 0.93 
Results are mean ± SD.  † Whole body and percentage of whole body lean and fat 
mass and appendicular lean mass (ALM) were derived from DXA; Calf muscle 
cross-sectional area was obtained from pQCT measurements at 38% length of tibia; 
Corrected upper arm muscle area (cm2) = ((Arm girth in cm) – π(triceps skin fold in 
cm))2 / 4π – 6.5.  
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Appendix 19 Baseline characteristics by protein intake tertile assessed by 24-
hour urinary nitrogen (n = 218). 
 1st tertile 
Protein intake
< 56.7 g/day 
(n = 72) 
2nd tertile 
Protein intake
56.7 - 73 g/day
(n = 73) 
3rd tertile 
Protein intake 
> 73 g/day 
(n = 73) 
P value of 
ANOVA 
test 
Age (year) 74.3 ± 2.7 74.6 ± 2.6   73.8 ± 2.6 0.22 
Height (cm)   159.3 ± 6.4    159.7 ± 6.3 160.6 ± 5.3 0.40 
Weight (kg)   66.7 ± 11.9   69.3 ± 11.3 69.6 ± 10.8 0.24 
BMI (kg/m2) 26.2 ± 4.0 27.1 ± 3.8    27.0 ± 3.8 0.31 
SF-36 standard physical 
health (0-100) 
47 ± 9 45 ± 9  46 ± 10 0.48 
SF-36 standard mental health
(0-100) 
54 ± 9 54 ± 8 54 ± 9 0.97 
Physical activity 
(log(Mets/week)) 
  3.34 ± 0.45   3.25 ± 0.43   3.37 ± 0.49 0.28 
     
Protein intake assessed by 24-hour urinary nitrogen 
Protein intake (g/day) 47.4 ± 6.7bc 64.0 ± 4.3ac 86.8 ± 14.8ab <0.001 
     
Dietary intake assessed by 3-day food record 
Protein intake (g/day)  70.9 ± 18.3c 76.5 ± 20.7 82.0 ± 17.7a 0.002 
Protein intake (g/kg/day)  1.09 ± 0.34 1.13 ± 0.33 1.20 ± 0.31 0.13 
Fat intake (g/day)  59.6 ± 20.7 60.4 ± 17.5 66.3 ± 18.2 0.07 
Carbohydrate intake (g/day)  182.9 ± 50.4   190.7 ± 48.3  192.5 ± 41.6 0.43 
Energy intake (kJ/day)  5910 ± 1123  7140 ± 1144  8403 ± 1114 0.10 
% of energy from protein    18.0 ± 3.2 18.9 ± 3.8 19.4 ± 3.4 0.06 
% of energy from fat    32.4 ± 6.8 31.8 ± 5.5 33.5 ± 4.8 0.23 
% of energy from 
carbohydrate 
  46.3 ± 8.0 46.2 ± 6.1 45.1 ± 5.5 0.45 
Calcium intake (mg/day) 818 ± 348 919 ± 388 969 ± 400 0.05 
     
Body composition 
Whole body lean mass (kg)  36.4 ± 4.9c 37.9 ± 4.7 38.2 ± 4.4a 0.04 
Appendicular lean mass (kg)  15.9 ± 2.5 16.7 ± 2.4 16.8 ± 2.1 0.03 
Whole body fat mass (kg)  25.5 ± 7.8      26.5 ± 7.5 26.4 ± 7.3 0.68 
% of whole body fat mass      39 ± 6         40 ± 5 39 ± 6 0.91 
ALM/height2 (kg/m2)  6.23 ± 0.81b    6.54 ± 0.72a   6.49 ± 0.71 0.03 
Residuals  -424 ± 1782b      246 ± 1560a     129 ± 1502 0.03 
Calf cross-sectional muscle 
area (cm2) 
3002 ± 649     3186 ± 466  3171 ± 525 0.08 
Correct upper arm muscle 
area (cm2) 
34.4 ± 10.8 35.3 ± 10.8 33.1 ± 9.4 0.41 
     
Mobility and balance 
Timed Up and Go (second) 7.8 ± 1.4 8.2 ± 1.5 7.9 ± 1.3 0.12 
Romberg eye-open (0-4)  3.9 ± 0.3 3.9 ± 0.3 3.8 ± 0.5 0.63 
Romberg eye-close (0-4) 3.1 ± 0.7 3.2 ± 0.6 3.1 ± 0.8 0.94 
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 1st tertile 
Protein intake
< 56.7 g/day 
(n = 72) 
2nd tertile 
Protein intake
56.7 - 73 g/day
(n = 73) 
3rd tertile 
Protein intake 
> 73 g/day 
(n = 73) 
P value of 
ANOVA 
test 
Muscle strength 
Hand grip strength (kg)  21.0 ± 5.4 21.8 ± 5.4 22.1 ± 5.5 0.45 
Ankle dorsiflexion (kg) 10.2 ± 4.5 10.4 ± 5.1 11.0 ± 4.3 0.60 
Knee flexion (kg)   9.6 ± 3.9  9.1 ± 4.0   9.3 ± 3.7 0.76 
Knee extension (kg) 15.8 ± 7.1 15.0 ± 6.0  16.0 ± 5.5 0.52 
Hip extension (kg) 16.9 ± 6.6 15.6 ± 5.7 16.9 ± 7.0 0.35 
Hip abduction (kg) 11.2 ± 4.6 11.0 ± 4.0 10.9 ± 5.1 0.93 
Hip flexion (kg) 11.9 ± 5.0 11.8 ± 3.9 11.9 ± 4.5 0.99 
Hip adduction (kg) 12.4 ± 5.6 11.6 ± 5.2 11.4 ± 6.0 0.57 
Total knee strength (kg)  25.4 ± 8.9 24.0 ± 8.7 25.3 ± 7.7 0.55 
Total hip strength (kg)    52.4 ± 19.0   49.9 ± 15.2   51.1 ± 19.6 0.72 
Total leg strength (kg)    88.0 ± 27.2   84.6 ± 23.3   87.2 ± 26.5 0.71 
Results are mean ± SD. Whole body and percentage of whole body lean and fat mass 
and appendicular lean mass were derived from DXA; Calf muscle cross-sectional 
area was obtained from pQCT measurements at 38% length of tibia; Corrected upper 
arm muscle area (cm2) = ((Arm girth in cm) – π(triceps skin fold in cm))2 / 4π – 6.5.  
* p < 0.05 of ANOVA F-ratio. 
a significantly different from the 1st tertile, p< 0 .05, b significantly different from the 
2nd tertile, p< 0.05, c significantly different from 3rd  tertile (ANOVA with Tukey’s 
test). 
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Appendix 20 Romberg tests and percentage of subjects who reported falling at 
least once during the preceding three month at baseline. 
 Number of subjects (%)  
Balance test Overall 
n = 219 
Protein group 
n = 109 
Control group 
n = 110 
Romberg eyes-open    
1 1 (1%)      0  1 (1%) 
2      0      0      0 
3 28 (13%) 14 (13%) 14 (13%) 
4 190 (86%) 95 (87%) 95 (86%) 
Romberg eyes-closed    
1 10 (5%) 1 (1%) 9 (8%) 
2 12 (5%) 8 (7%) 4 (4%) 
3 136 (62%)  65 (60%) 71 (64%) 
4   62 (28%)  35 (32%) 26 (24%) 
    
Self-reported falling Overall 
n = 216 
Protein group 
n = 107 
Control group 
n = 109 
 Ever had a fall  21 (10%) 16 (15%)  5 (5%) 
 Never had a fall 195 (90%) 91 (85%) 104 (95%) 
0 = not be able to perform side by side stance; 1 = side by side stance; 2 = semi 
tandem stance; 3 = tandem stance (1-9 seconds); 4 = tandem stance (>9 seconds). 
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Appendix 21 Differences in baseline characteristics between two drink groups in 
the participants who completed the one year study. 
 Protein group 
mean ± SD 
(n = 100) 
Control group 
mean ± SD 
(n = 95) 
p value of 
t-test 
Age (year) 74 ± 3 74 ± 3 0.75 
Height (m2)    159.8 ± 6.3   159.8 ± 5.7 0.96 
Weight (kg)   66.8 ± 11.1   69.6 ± 11.3 0.08 
BMI (kg/m2)       26.1 ± 3.8 27.2 ± 4.0 0.05 
Waist circumference (cm)       87.1 ± 9.4     90.3 ± 9.6 0.02 
Hip circumference (cm)     103.6 ± 8.6   105.4 ± 9.5 0.15 
Triceps skinfold (mm)  28.0 ± 7.8 29.2 ± 8.5 0.30 
Arm girth (cm)  31.0 ± 3.2 31.8 ± 3.5 0.09 
Calf girth (cm)  35.3 ± 2.8 36.0 ± 3.0 0.08 
Physical activity (log(Mets/week))   3.35 ± 0.52   3.32 ± 0.51 0.66 
    
Dietary intakes assessed by 3-day food record 
Energy intake (kJ/day)   7140 ± 1633   7147 ± 1422 0.97 
Protein intake (g/day)   77.6 ± 22.2   76.9 ± 16.9 0.81 
Fat intake (g/day)   63.0 ± 18.6   61.7 ± 19.7 0.64 
Carbohydrate intake (g/day) 187.5 ± 49.9 190.7 ± 44.1 0.63 
% energy intake from protein (%) 19.0 ± 3.8 18.8 ± 3.4 0.72 
    
Body composition † 
Whole body lean mass (kg)  37.0 ± 4.7 37.7 ± 4.7 0.29 
Appendicular lean mass (kg) 16.2 ± 2.4 16.6 ± 2.4 0.27 
Whole body fat mass (kg)  24.8 ± 7.2 27.0 ± 7.6 0.04 
% of whole body fat mass (%)  38.6 ± 5.5 40.0 ± 6.1 0.08 
Calf cross-sectional muscle area 
(cm2) 
30.6 ± 5.3 31.8 ± 6.2 0.16 
CUAMA (cm2)    33.3 ± 10.0   34.9 ± 10.2 0.30 
    
Mobility and balance tests 
Timed Up and Go test (second)   7.9 ± 1.3   8.0 ± 1.5 0.61 
Romberg eye-open (0-4) * 4 (4 - 4) 4 (4 - 4) 0.47 
Romberg eye-close (0-4) * 3 (3 - 4) 3 (3 - 4) 0.05 
    
Muscle strength measurements 
Hand grip strength (kg)  21.7 ± 5.2 21.6 ± 5.6 0.92 
Ankle dorsiflexion (kg) 10.4 ± 4.5 10.2 ± 4.2 0.72 
Total knee strength (kg) a 24.6 ± 7.5 25.8 ± 9.1 0.31 
Total hip strength (kg) b   52.1 ± 18.1   51.0 ± 18.6 0.67 
* Results are median (interquartile range) with p value of Chi-square test.  
† Whole body and percentage of whole body lean and fat mass and appendicular lean 
mass were derived from DXA; Calf muscle cross-sectional area was obtained from 
pQCT measurements at 38% length of tibia; CUAMA: Corrected upper arm muscle 
area (cm2) = ((Arm girth in cm) – π(triceps skin fold in cm))2 / 4π – 6.5.  
a Total knee strength = knee flexion + knee extension 
b Total hip strength = hip extension + hip abduction + hip flexion + hip adduction 
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Appendix 22 Differences in baseline characteristics between those who 
withdrew and those who completed the one year study. 
 Completed 
n = 195 
Withdrawals 
n = 23 
p value 
t-test 
Age (year)  74.2 ± 2.7 75.0 ± 2.5 0.17 
Height (m2) 159.8 ± 6.0  160.5 ± 6.1 0.61 
Weight (kg) 68.1 ± 11.2   71.8 ± 11.6 0.14 
BMI (kg/m2)    26.7 ± 3.9  27.8 ± 3.3 0.19 
SF-36 standard physical health (0-100)   46.4 ± 9.2    40.9 ± 11.0   0.007 
SF-36 standard mental health (0-100)   54.4 ± 8.3    52.9 ± 10.2 0.41 
Physical activity (log(Mets/week))  3.34 ± 0.46    3.16 ± 0.44 0.08 
24 hour urinary nitrogen (g/d)  8.77 ± 3.06    7.07 ± 2.09   0.009 
    
Dietary intake assessed by 3-day food record 
Energy intake (kJ/day) 7143 ± 1530 7111 ± 1452 0.92 
Protein intake (g/day) 77.2 ± 19.7 70.3 ± 15.4 0.10 
Fat intake (g/day) 62.4 ± 19.0 60.4 ± 18.1 0.64 
Carbohydrate intake (g/day) 189.1 ± 47.0 189.7 ± 49.4 0.95 
    
Mobility and balance 
Timed Up and Go test (second) 7.9 ± 1.4 8.4 ± 1.3 0.14 
Romberg (eye-open) (0-4) 3.9 ± 0.4 3.8 ± 0.4 0.33 
Romberg (eye-close) (0-4) 3.2 ± 0.7 3.0 ± 0.6 0.37 
    
Muscle strength 
Hand grip strength (kg)  21.6 ± 5.4 21.8 ± 5.8 0.92 
Ankle dorsiflexion (kg) 10.3 ± 4.3 12.1 ± 6.5 0.08 
Total knee strength (kg) 25.2 ± 8.3 22.9 ± 9.2 0.21 
Total hip strength (kg)   51.5 ± 18.3   48.0 ± 14.8 0.36 
Total leg strength (kg)   87.1 ± 25.7   82.9 ± 25.1 0.46 
Values are mean ± SD.  
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Appendix 23 Romberg tests by drink groups at baseline and at one year in the 
participants who completed one year visit. 
 Protein group Control group 
 Baseline 
n = 100 
1 year 
n = 99 
Baseline 
n = 95 
1 year 
n = 94 
Romberg eyes-open     
1      0 1 (1%) 1 (1%) 1 (1%) 
2      0 1 (1%)       0       0 
3 13 (13%) 16 (16%) 11 (12%) 20 (21%) 
4 87 (87%) 81 (82%) 83 (87%) 73 (78%) 
Romberg eyes-close     
0       0       0       0 2 (2%) 
1 1 (1%) 1 (1%) 8 (9%) 1 (1%) 
2 7 (7%) 6 (6%) 4 (4%) 11 (12%) 
3 58 (58%) 73 (74%) 59 (62%) 58 (62%) 
4 34 (34%) 19 (19%) 24 (25%) 22 (23%) 
0 = not be able to perform side by side stance; 1 = side by side stance; 2 = semi 
tandem stance; 3 = tandem stance (1-9 seconds); 4 = tandem stance (>9 seconds). 
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Appendix 24 Percentage of subjects who ever had a fall in the past three months 
before the clinic visit at baseline and one year by drink groups in participants 
who completed one year visit.  
 Protein group  Control group 
 Baseline 
n = 98 
1 year 
n = 99 
Baseline 
n = 94 
1 year 
n = 94 
Ever had a fall 13 (13%) 16 (16%) 5 (5%) 13 (14%) 
Never had a fall 85 (87%) 84 (84%) 89 (95%) 81 (86%) 
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Appendix 25 Statement of the role of the candidate in this clinical trial. 
 
The current study is part of a two year randomized controlled trial funded by the 
NHMRC.  The large study title is: ‘Dietary protein effects in elderly women: 
musculoskeletal, renal, cardiovascular and body composition endpoints’.  The 
investigators include: A Prof Richard Prince, Dr Kathy Zhu, Dr Deborah Kerr, Dr 
Amanda Devine, A Prof Vicky Solah and Prof Colin Binns.   
The NHMRC study has two arms, outcomes related to bone health and muscle 
health.  I was responsible for baseline and one year muscle outcome measurements.  
A detailed list has been made as below to state what my work involved, and an 
acknowledgement to others who contributed to this project. 
My role in this one year study reported in the thesis: 
1. Preparation for the equipment for the trial: ordering laboratorial materials, 
such as blood and urine sample tubes, urine bottles, and electronic food 
scales; participants’ document files preparation; drafted the standardized 
operating procedure, such as 24-hour urinary nitrogen collection instruction 
for participants and the instruction of manipulation of the samples for the 
research team; prepare the instruction for operating DXA and peripheral 
quantitative computerized tomography (pQCT); and the instruction for 
muscle strength, mobility and balance test. 
2. Involvement in the recruitment (e.g., letter printing, sending and telephone 
screening). 
3. Conducted all pQCT scans and some DXA scans and anthropometry 
measures when needed. 
4. Conducted the majority of the baseline and one year muscle strength, 
mobility, and balance tests. 
5. Conducted the majority of the baseline clinical preparation, clinical data 
entry, and Realbeach data entry (medications and medical conditions). 
6. Analyzed all pQPCT scan for calf muscle cross-sectional area for baseline 
and one year.  
7. Involved in some DXA scan imagine analyses and re-analyses when cleaning 
the baseline and one year data.  
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8. Conducted all the CVs tests and the CVs analyses for pQCT calf muscle 
cross-sectional area, muscle strength and mobility test.   
9. Cleaned all the baseline data and part of the one year data (DXA, pQCT 
muscle area, dietary intake and 24-hour urinary nitrogen).   
10. Performed all the baseline and one year data analyses presented in this thesis.  
11. Responsible for all the data analyses interpretation presented in this thesis.   
Acknowledgement to those who involved in this one year study: 
1. PIMES research team:  
1) Prof Richard Prince, the main investigator of this study has used any 
possible resource to ensure this trial followed the protocol and finished on 
time.   
2) Other investigators for this NHMRC funded projects are Dr Kathy Zhu, 
Associate Professor Deborah Kerr, Dr Amanda Devine, Associate 
Professor Vicky Solah, and Professor Colin Binns.  I was part of the 
management team for the project and attended regular management 
meetings.  
3) The clinical research team, especially Monika Trapanovski, Cynthia 
Adikara, Emily Greenwood and Maria Pollock recruited most of the 
participants and telephone screened them.   
4) Kathy Zhu, Deborah Kerr and Amanda Devine conducted most of the 
DXA scan and analyzed the baseline scan imagines and Emily 
Greenwood interviewed most of the baseline participants and checked 
most of their questionnaires and medications. 
5) Maria Pollard, study coordinator collected most of the baseline and one 
year blood samples, ensuring a smooth communication between the 
research team and study participants and their GPs, and also prepared all 
the one year visit invitation letters. 
6) Felicia Novana assisted with the one year clinic visit preparation, checked 
the participants’ one year questionnaires and medications, recorded the 
number of the returned consumed drink containers, and also involved the 
one year data entry and cleaning.  
7) Emily Greenwood checked the baseline 3-day food records and Felicia 
Novana checked the one year 3-day food records.   
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8) Senior students studying nutrition in Curtin University entered most of 
the baseline 3-day food records in the Foodworks database. 
9) Deborah Kerr and Felicia Novana entered forty of the one year 3-day 
food records in the Foodworks database. 
2. The Laboratory staff of the School of Public Health, Curtin University 
analyzed the baseline and one year 24-hour urinary nitrogen. 
3. Royal Perth Hospital analyzed the baseline and one year serum IGF-1 
concentration. 
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